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GOLD is for the mistress—silver for the maid— 
Copper for the craftsman cunning at his trade.” 
―Good!‖ said the Baron, sitting in his hall, 
―But Iron—Cold Iron—is master of them all.‖ 
 
Rudyard Kipling 
1865-1936 
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Abstract 
This study set out to analyse C. pseudotuberculosis within an environment relevant to that 
which would be encountered within its natural host.  The impact of the availability of iron 
within the growth environment of numerous bacteria has been widely reported, and an 
equivalent investigation was conducted to determine whether the same was true of C. 
pseudotuberculosis.  To this end, a novel chemically-defined medium was designed, which 
supported the growth of C. pseudotuberculosis, but in which the concentration of specific 
growth factors could be manipulated.  Subsequently, iron was shown to be essential for C. 
pseudotuberculosis growth, and analysis of secreted protein profiles revealed differential 
expression between low- and high-iron growth conditions.  Furthermore, growth experiments 
conducted in the defined medium revealed that C. pseudotuberculosis is capable of obtaining 
iron from the host iron-binding proteins, transferrin and lactoferrin.  Subsequently, C. 
pseudotuberculosis was discovered to produce a siderophore, which is likely to contribute to 
the organism‘s ability to acquire iron in vivo.   
 
Continuing with the investigation of iron, it was observed that C. pseudotuberculosis, C. 
ulcerans and C. diphtheriae, when infected with a corynebacteriophage carrying the diphtheria 
toxin-encoding gene (tox), have all been shown to produce the toxin in an iron-dependent 
manner (Maximescu, et al. 1974).  Significant work has been conducted in C. diphtheriae, 
which has shown the involvement of an iron-dependent regulatory protein, the diphtheria toxin 
repressor or DtxR, is essential for the iron-dependent regulation of tox expression.  Therefore, 
it was considered likely that an equivalent regulator also existed within C. pseudotuberculosis 
(and C. ulcerans).  A previous study conducted in this laboratory had allowed the PCR-
amplification of a small fragment of a gene sharing similarity to C. diphtheriae DtxR (Malloy, 
2004).  In the current study, a 6.5 kb chromosomal locus, which contained the sequence 
previously amplified by PCR, was cloned and sequenced.  Subsequently, this chromosomal 
locus was found to be equivalent to that present in other sequenced corynebacteria, in that the 
genes encoding (from 5‘- to 3‘-) an RNA-polymerase sigma factor (sigB), the DtxR protein 
(dtxR), a UDP-galactose 4-epimerase (galE), and 2 further proteins were all present.  The 
transcription of sigB, dtxR or galE was analysed and found to be linked.  Furthermore, 
although the expression of these genes themselves was not found to be controlled in an iron-
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dependent manner, C. pseudotuberculosis was shown to control the expression of known C. 
diphtheriae DtxR-regulated genes in direct response to environmental iron concentration. 
 
In order to confirm the involvement of C. pseudotuberculosis DtxR in the regulation of 
expression of target genes, a highly-efficient allele-replacement mutagenesis procedure was 
adapted and enhanced for use in this organism, which included the employment of a novel 
enrichment procedure to aid in the isolation of the desired mutants.  Subsequently, a DtxR-
deficient mutant derivative was created, allowing comparisons of expression of target genes to 
be conducted in the isogenic mutant and wild-type parent strains, under low- and high-iron 
growth conditions. The results of these studies confirmed C. pseudotuberculosis DtxR in the 
regulation of the C. pseudotuberculosis ferrous acquisition gene (fagA); however, the results 
proved that the serine protease (cp40) was not regulated by DtxR.  
 
Towards the end of the study, the partial C. pseudotuberculosis genome sequence became 
available, which allowed the identification of a gene, designated ORF02949, which 
potentially-encoded the siderophore.  Although preliminary attempts to confirm the gene as 
that of the siderophore were unsuccessful, a putative DtxR-binding motif was found 
immediately upstream of the gene, and the involvement of DtxR in its regulation, in an iron-
dependent manner was subsequently demonstrated.  Taken together, the results presented in 
this thesis confirm the importance of iron to C. pseudotuberculosis, and reveal the existence of 
an iron-dependent regulator which is involved in regulating the expression of multiple target 
genes.     
 v 
 
Declaration 
 
The work reported in this thesis was carried out under the supervision of Dr Michael C. 
Fontaine and Professor Willie Donachie at the Moredun Research Institute and Professor 
David G. E. Smith at the Moredun Research Institute and the Faculty of Veterinary Medicine, 
University of Glasgow.  All results presented, unless otherwise stated, are the sole work of this 
author, as is the composition of this thesis.  
 
 
Signed:        Date: 
 vi 
 
Acknowledgments 
First and foremost I would like to thank my supervisor Dr Mike Fontaine for his guidance, 
support and encouragement throughout this project. I would also like to thank my other 
supervisors Professor David G.E Smith and Professor Willie Donachie for their helpful 
discussions during our meetings. Thanks must also go to The Moredun Foundation for the 
Peter Docherty studentship which funded this work. 
 
 I would like to thank Professor Randall K. Holmes and his lab at the University of Colorado 
for making me very welcome during my research visit. I would particularly like to thank Dr 
Sheryl Zajdowicz for being a fantastic mentor and very good friend. I would also like to thank 
the Society for General Microbiology for the Presidents fund for Research Visits which 
allowed me to take up this fantastic opportunity to work in an American lab for a few months.   
 
Thanks must also go to both past and present members of lab 3.060, in particular Malcolm 
Quirie and Karen Rudge for their technical help, but not forgetting Tammy, Sandy, David, 
Gordon and Colin for making those long days in the lab much more fun. I would also like to 
thank my fellow PhD students for their comradery especially; Tammy Gillian, Sarah, Ewan, 
Sandy, Carol and Darryl. Also huge thanks to Eleanor for helping me survive the ‗write up‘ 
and Tom for being a great friend and helping me out on several occasions.   
 
A big thanks must also go to all the members of St Andrew Boat Club, in particular Elle‘s 
Belle‘s, Jen, Myrah, Debs and Marianne for being amazing friends over the last few years.    
 
I especially want to thank Mum, Dad, James, Andrew, Jess, Vicki and Andrea for their 
constant love and encouragement.  Last but not least, Thanks to my boys, Brian and Elvis, you 
have been amazing!    
 
 
 
 
 
 vii 
 
Table of Contents 
Abstract ..................................................................................................................... III 
Declaration ................................................................................................................ V 
Acknowledgments ................................................................................................... VI 
Table of contents .................................................................................................... VII 
List of figures ........................................................................................................... XI 
List of tables ........................................................................................................... XIV 
Abbreviations .......................................................................................................... XV 
Chapter One:  General Introduction ......................................................................... 1 
1.0 The corynebacteria .................................................................................................................................. 1 
1.1 Other notable corynebacteria ................................................................................................................. 2 
1.1.1 Non-pathogenic corynebacteria ............................................................................................................. 2 
1.1.2 The pathogens ....................................................................................................................................... 3 
1.1.2.1 Corynebacterium diphtheriae ............................................................................................................. 3 
1.1.2.2 Corynebacterium ulcerans .................................................................................................................. 4 
1.1.2.3 Corynebacterium jeikeium .................................................................................................................. 4 
1.2 Corynebacterium pseudotuberculosis ...................................................................................................... 4 
1.2.1 Phenotypic characterisation................................................................................................................... 5 
1.2.2 Virulence factors ................................................................................................................................... 7 
1.2.2.1 Mycolic acid ....................................................................................................................................... 8 
1.2.2.2 Phospholipase D ............................................................................................................................... 10 
1.2.2.3 Serine protease .................................................................................................................................. 12 
1.3 Caseous lymphadenitis .......................................................................................................................... 13 
1.3.1 Prevalence of CLA .............................................................................................................................. 14 
1.3.2 Economic consequences of CLA ........................................................................................................ 14 
1.3.3 Pathogenicity and disease in sheep ..................................................................................................... 15 
1.3.3.1 Primary infection .............................................................................................................................. 15 
1.3.3.2 Dissemination ................................................................................................................................... 17 
1.4 C. pseudotuberculosis infection in other species................................................................................... 18 
1.4.1 C. pseudotuberculosis infection in horses ........................................................................................... 18 
1.4.2 C. pseudotuberculosis infection in cattle ............................................................................................ 19 
1.4.3 Zoonotic Infections ............................................................................................................................. 19 
1.5 Antimicrobial therapy ........................................................................................................................... 20 
1.6 Vaccines against C. pseudotuberculosis ................................................................................................ 21 
1.7 Iron-regulated proteins as vaccines ...................................................................................................... 26 
 viii 
 
1.8 Iron-homoeostasis .................................................................................................................................. 27 
1.9 Genes Involved In Iron Sequestration.................................................................................................. 29 
1.10 Microbial “sensing” of the environment .............................................................................................. 30 
1.11 Iron-regulation in corynebacteria ........................................................................................................ 31 
1.12 DtxR-like proteins in other bacteria ..................................................................................................... 33 
1.13 Overall objectives and aims of the study.............................................................................................. 34 
Chapter Two: Materials and Methods .................................................................... 36 
2.1 Chemicals ................................................................................................................................................ 37 
2.2 Bacterial strains, plasmids and media .................................................................................................. 37 
2.2.1 Escherichia coli ................................................................................................................................... 37 
2.2.2 Corynebacterium pseudotuberculosis ................................................................................................. 37 
2.3 Measurement of Bacterial Growth ....................................................................................................... 41 
2.4 Nucleic Acid Extraction and Purification ............................................................................................ 41 
2.4.1  Small scale extraction and purification of plasmid DNA .................................................................... 41 
2.4.2 Large scale extraction and purification of plasmid DNA .................................................................... 42 
2.4.3  Extraction and purification of C. pseudotuberculosis genomic DNA ................................................. 43 
2.4.4 Isolation of genomic DNA for Colony PCR ....................................................................................... 44 
2.4.5 Extraction and purification C. pseudotuberculosis RNA .................................................................... 44 
2.5 General DNA manipulations ................................................................................................................. 45 
2.5.1 Restriction endonuclease digests ......................................................................................................... 45 
2.5.2 Dephosphorylation of DNA ................................................................................................................ 46 
2.5.3 End-filling of DNA fragments ............................................................................................................ 46 
2.5.4 Ligation of DNA fragments ................................................................................................................ 46 
2.5.5 Polymerase Chain Reaction ................................................................................................................ 47 
2.5.5.1 KOD DNA Polymerase .................................................................................................................... 47 
2.5.5.2 Platinum Taq Polymerase ................................................................................................................. 48 
2.5.5.3 Inverse PCR ...................................................................................................................................... 48 
2.5.5.4 Reverse Transcription-PCR (RT-PCR) ............................................................................................. 49 
2.4.5.5 Quantitative real time reverse transcription PCR (qRT-PCR) .......................................................... 49 
2.6 Agarose gel electrophoresis ................................................................................................................... 50 
2.6.1 Analysis of DNA samples ................................................................................................................... 50 
2.6.2 Analysis of RNA samples ................................................................................................................... 56 
2.7 DNA Clean up ........................................................................................................................................ 56 
2.7.1 DNA extraction from agarose gels ...................................................................................................... 56 
2.7.2 Isolation of DNA from PCR reactions and other enzymatic solutions  using GENECLEAN® Turbo 
 Kit (Q. Biogene) .................................................................................................................................. 57 
2.7.3 De-salting of ligations prior to transformation .................................................................................... 58 
2.8 Bacterial transformation ....................................................................................................................... 58 
2.8.1 Preparation of E. coli chemically-competent cells .............................................................................. 58 
2.8.2 Transformation of E. coli .................................................................................................................... 58 
2.8.2.1 Chemical transformation................................................................................................................... 58 
2.8.2.2 Electroporation ................................................................................................................................. 59 
2.8.3 Preparation of electrocompetent C. pseudotuberculosis ..................................................................... 59 
2.8.4 Transformation of C. pseudotuberculosis ........................................................................................... 60 
 ix 
 
2.9 Southern hybridisation .......................................................................................................................... 60 
2.9.1 Digoxygenin-dUTP (DIG) Labelling of DNA .................................................................................... 61 
2.9.2 Hybridisation ....................................................................................................................................... 61 
2.9.3 Immunological detection of DIG labelled probes ............................................................................... 62 
2.10 General Proteomic Techniques ............................................................................................................. 63 
2.10.1 Isolation of exported proteins from C. pseudotuberculosis ............................................................ 63 
2.10.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS- PAGE) ............................... 63 
2.10.3 Visualisation of proteins in SDS-PA gels ....................................................................................... 64 
2.10.3.1 Colloidal Coomassie blue staining .................................................................................................. 64 
2.10.3.2 Silver staining ................................................................................................................................. 64 
2.10.4       Drying of SDS-PAGE Mini-Gel‘s .................................................................................................. 65 
2.10.5         Western blotting ............................................................................................................................. 65 
2.11 Allele replacement mutagenesis ............................................................................................................ 66 
2.11.1 Targeted plasmid integration into the C. pseudotuberculosis    chromosome ................................ 66 
2.11.2 Secondary cross-over mutagenesis ................................................................................................. 67 
2.11.3 Ampicillin enrichment of secondary crossover mutations ............................................................. 67 
2.12 β-galactosidase promoter-fusion assays ............................................................................................... 68 
2.13 Siderophore Assay ................................................................................................................................. 69 
2.14 DNA Sequencing .................................................................................................................................... 69 
2.15 Computational analyses ......................................................................................................................... 70 
2.16 Statistical analyses ................................................................................................................................. 70 
2.17 Proteomic data interrogation ................................................................................................................ 70 
Chapter Three:  Investigation of the Effects of Environmental Iron on 
Corynebacterium pseudotuberculosis .................................................................. 71 
3.0 Introduction ............................................................................................................................................ 72 
3.1 Results ..................................................................................................................................................... 75 
3.1.1 Development of a chemically defined medium to investigate iron-  regulation of gene expression C. 
 pseudotuberculosis .............................................................................................................................. 75 
3.1.2 Growth Characteristics of C. pseudotuberculosis in rich media ......................................................... 75 
3.1.3 C. pseudotuberculosis chemically defined medium ............................................................................ 77 
3.1.4 Modulating the iron content of CCDM ............................................................................................... 81 
3.1.5 Concentration of metal ions in C. pseudotuberculosis growth media ................................................. 85 
3.1.6 C. pseudotuberculosis acquisition of iron from host iron-binding proteins ........................................ 86 
3.1.6.1 Transferrin ........................................................................................................................................ 86 
3.1.6.2 Lactoferrin ........................................................................................................................................ 86 
3.1.6.3 Haemoglobin .................................................................................................................................... 87 
3.1.7 Environmental iron-dependent production of exported proteins ......................................................... 91 
3.1.8 Western blot analysis of C. pseudotuberculosis exported proteins ..................................................... 93 
3.1.9 Preliminary proteomic analyses .......................................................................................................... 95 
3.2 Discussion ............................................................................................................................................... 97 
Chapter Four: Site-directed Mutagenesis of Corynebacterium 
pseudotuberculosis ............................................................................................... 105 
4.0 Introduction .................................................................................................................................................. 106 
 x 
 
4.1 Results ................................................................................................................................................... 116 
4.1.1 Construction and utilisation of pCARV in C. pseudotuberculosis .................................................... 116 
4.1.2 Chromosomal integration of pCARV-based constructs .................................................................... 119 
4.1.3 Secondary crossover recombination .................................................................................................. 120 
4.1.4 Application of a novel enrichment method to isolate secondary crossover  mutants ........................ 122 
4.1.5 Site-directed mutagenesis of the C. pseudotuberculosis cp40 gene .................................................. 124 
4.2 Discussion ............................................................................................................................................. 127 
Chapter Five: The Iron Dependent Regulatory Protein DtxR of Corynebacterium 
pseudotuberculosis ............................................................................................... 134 
5.0 Introduction .................................................................................................................................................. 135 
5.1 Results ................................................................................................................................................... 141 
5.1.1 Characterization of a C. pseudotuberculosis chromosomal locus  containing dtxR .......................... 141 
5.1.2 Analysis of expression of genes within the C. pseudotuberculosis locus containing the dtxR-
 homologue ......................................................................................................................................... 151 
5.1.3 Assessment of the involvement of C. pseudotuberculosis DtxR in the iron-dependent regulation of 
 tox ...................................................................................................................................................... 154 
5.1.4 Analysis of expression of the genes within the C. pseudotuberculosis dtxR chromosomal locus ..... 156 
5.1.6 Construction of a dtxR-deficient mutant strain of C. pseudotuberculosis ......................................... 167 
5.1.7 Analysis of C. pseudotuberculosis DtxR regulation of target genes ................................................. 173 
5.1.8 Complementation of the C. pseudotuberculosis dtxR mutant ........................................................... 174 
5.1.9 Transition metal activation of C. pseudotuberculosis DtxR .............................................................. 178 
5.2 Discussion ............................................................................................................................................. 180 
Chapter Six:  Identification of a Corynebacterium pseudotuberculosis 
siderophore ............................................................................................................ 196 
6.0 Introduction .......................................................................................................................................... 197 
6.1 Results ................................................................................................................................................... 203 
6.1.1 Production of siderophore by C. pseudotuberculosis ........................................................................ 203 
6.1.2 Optimal growth conditions for the study of iron-dependent regulation of gene expression.............. 205 
6.1.3 C. pseudotuberculosis chromosomal siderophore-encoding locus .................................................... 207 
6.1.4 Complementation of a C. diphtheriae siderophore-deficient mutant with C. pseudotuberculosis 
 siderophore ........................................................................................................................................ 210 
6.1.5 Analysis of expression of the C. pseudotuberculosis putative  siderophore-encoding gene ............. 212 
6.1.6 Involvement of DtxR in the regulation of the C. pseudotuberculosis  putative siderophore-encoding 
 gene ................................................................................................................................................... 214 
6.1.7 Construction of a putative siderophore-deficient mutant of C.  pseudotuberculosis ......................... 217 
6.2 Discussion ............................................................................................................................................. 218 
Chapter Seven: General discussion ..................................................................... 227 
References.............................................................................................................. 235 
Appendices............................................................................................................. 262 
Appendix One: Common Buffers and reagents ............................................................................................... 263 
Appendix Two: Siderophore assay solutions ................................................................................................... 266 
 xi 
 
List of Figures 
 
Chapter 3                                                                                                         Page no.  
 
Figure 3.1 Typical growth curve of C. pseudotuberculosis 3/99-5 in BHIT broth at 37°C with constant 
shaking. ................................................................................................................................................... 76 
 
Figure 3.2 Typical growth curve of C. pseudotuberculosis 3/99-5 in CCDM ....................................... 80 
 
Figure 3.3 Growth of C. pseudotuberculosis in CCDM supplemented with varying concentrations of 
FeCl3. ...................................................................................................................................................... 82 
 
Figure 3.4 Growth of C. pseudotuberculosis in CCDM supplemented with varying concentrations of 
the iron chelator dipyridyl. ...................................................................................................................... 84 
 
Figure 3.5 Growth of C. pseudotuberculosis 3/99-5 in CCDM supplemented with dipyridyl and 
transferrin. ............................................................................................................................................... 88 
 
Figure 3.6 Growth of C. pseudotuberculosis 3/99-5 in CCDM supplemented with varying 
concentrations of apo-transferrin. ........................................................................................................... 89 
 
Figure 3.7 Growth of C. pseudotuberculosis 3/99-5 in CCDM supplemented with lactoferrin. ........... 90 
 
Figure 3.8 Supernatant proteins derived from C. pseudotuberculosis 3/99-5 cultures. ......................... 92 
 
Figure 3.9 Western blot analysis of C. pseudotuberculosis exported proteins. ..................................... 94 
 
Figure 3.10 Colloidal Coomassie stained (10 %) SDS-PA gel, showing C. pseudotuberculosis 3/99-5 
exported proteins purified from cultures cultivated under high- (lane 1) and low-iron (lane 2) growth 
conditions. ............................................................................................................................................... 96 
 
Chapter 4                                                                                                         Page no.  
 
Figure 4.1 Schematic representation of single crossover integration (SCO) ....................................... 110 
 
Figure 4.2 Schematic representation of secondary or double crossover (DCO) .................................. 111 
 
Figure 4.3 Corynebacterium pseudotuberculosis colony morphology. ............................................... 117 
 
Figure 4.4 Cloning strategy for the construction of pCARV ............................................................... 118 
 
Figure 4.5 Integration rates of pCARV-based constructs containing cp40 fragments into the C. 
pseudotuberculosis chromosome by homologous recombination ........................................................ 121 
 
Figure 4.6 PCR analysis of C. pseudotuberculosis secondary-crossover mutants ............................... 126 
 
Chapter 5                                                                                                         Page no.  
 
Figure 5.1 Analysis of the affect of iron on C. pseudotuberculosis growth. ........................................ 143 
 
Figure 5.2  Schematic representation of inverse PCR .......................................................................... 144 
 xii 
 
 
Figure 5.3 Southern blot analysis of C. pseudotuberculosis ................................................................ 145 
 
Figure 5.4 Inverse PCR products ......................................................................................................... 147 
 
Figure 5.5 Schematic representation of the C. pseudotuberculosis locus containing the dtxR-
homologue............................................................................................................................................. 148 
 
Figure 5.6 Clustal Wallace multiple alignment of C. pseudotuberculosis (cp), C. glutamicum (cg) and 
C. diphtheriae (cd) DtxR protein .......................................................................................................... 151 
 
Figure 5.7 The 312bp transcript of the C. pseudotuberculosis dtxR gene amplified by RT-PCR ....... 151 
 
Figure 5.8 Assessment of the affect of environmental iron concentration on the expression of tox- and 
irp3-promoter/lacZ fusions in C. pseudotuberculosis. .......................................................................... 153 
 
Figure 5.9 Assessment of C. pseudotuberculosis DtxR regulation of tox. ........................................... 155 
 
Figure 5.10 Schematic representation of the C. pseudotuberculosis dtxR locus. ................................. 157 
 
Figure 5.11 Determination of functional promoters within the dtxR chromosomal locus, using pSPZ/ 
lacZ fusions. .......................................................................................................................................... 158 
 
Figure 5.12 Schematic representation of the C. pseudotuberculosis dtxR chromosomal locus 
highlighting the locations of qRT-PCR primer and probe binding sites. .............................................. 160 
 
Figure 5.13 Relative transcript abundance of genes within the C. pseudotuberculosis dtxR 
chromosomal locus. .............................................................................................................................. 161 
 
Figure 5.14 Detection of sigB-dtxR-galE transcripts using RT-PCR ................................................... 163 
 
Figure 5.15 Iron-dependent regulation of gene expression of genes encoding published C. 
pseudotuberculosis virulence factors .................................................................................................... 166 
 
Figure 5.16 Analysis of single-crossover intermediate mutants of C. pseudotuberculosis.................. 168 
 
Figure 5.17 PCR analysis of the region across dtxR in C. pseudotuberculosis wild-type and Cp-ΔdtxR 
strains .................................................................................................................................................... 170 
 
Figure 5.18 Southern Blot analysis of C. pseudotuberculosis wild-type and Cp-ΔdtxR genomic DNA
 .............................................................................................................................................................. 171 
 
Figure 5.19 Determination of the presence of sigB-dtxR-galE polycistronic mRNA in C. 
pseudotuberculosis wild-type and Cp-ΔdtxR strains ............................................................................ 175 
 
Figure 5.20 Assessment of DtxR-regulation of C. pseudotuberculosis genes ..................................... 176 
 
Figure 5.21 Growth of C. pseudotuberculosis wild-type, Cp-ΔdtxR and Cp-ΔdtxR + DtxR strains 
under high- and-low iron conditions ..................................................................................................... 177 
 
Figure 5.22 Promoter fusion assay to determine the efficiency of zinc and manganese in the activation 
of DtxR and subsequent repression of the fagA promoter .................................................................... 179 
 xiii 
 
Chapter 6                                                                                                         Page no.  
 
Figure 6.1 CAS assay for the detection of C. pseudotuberculosis siderophore production ................. 204 
 
Figure 6.2 Siderophore production by C. pseudotuberculosis under low- and high-iron growth 
conditions .............................................................................................................................................. 206 
 
Figure 6.3 Schematic representation of the C. pseudotuberculosis and C. diphtheriae 
siderophore loci .................................................................................................................................. 209 
 
Figure 6.4 Complementation of a C. diphtheriae C7 (-) ΔciuE with C. pseudotuberculosis siderophore 
containing supernatant .......................................................................................................................... 211 
 
Figure 6.5 Iron-dependent regulation of C. pseudotuberculosis putative siderophore biosynthetic gene 
expression ............................................................................................................................................. 213 
 
Figure 6.6 Assessment of DtxR-regulation of C. pseudotuberculosis putative siderophore biosynthetic 
gene expression. .................................................................................................................................... 216 
 
 
 
 xiv 
 
List of Tables 
 
Chapter 2                                                                                                         Page no.  
 
Table 2.1 Bacterial strains ...................................................................................................................... 39 
 
Table 2.2 Plasmid vectors ...................................................................................................................... 40 
 
Table 2.3 Miscellaneous oligonucleotide primers .................................................................................. 51 
 
Table 2.4 Sequencing primers for the C. pseudotuberculosis dtxR locus .............................................. 53 
 
Table 2.5 Primers for PCR amplification of promoter regions .............................................................. 54 
 
Table 2.6 qRT-PCR primers ................................................................................................................... 55 
 
Table 2.7 qRT-PCR probes .................................................................................................................... 56 
 
Chapter 3                                                                                                         Page no.  
 
Table 3.1 Comparison of growth media ingredients .............................................................................. 79 
 
Table 3.2 ICP-MS analysis of C. pseudotuberculosis growth media ..................................................... 85 
 
Chapter 4                                                                                                         Page no.  
 
Table 4.1 pCARV001-004 plasmid excision rates ............................................................................... 122 
 
Table 4.2 pCARV001-004 plasmid excision rates following ampicillin enrichment .......................... 124 
 
 xv 
 
Abbreviations  
 
°C     Degrees centigrade 
Acc #     Accession number 
ANOVA    Analysis of Variance  
ATCC     American Type Culture Collection 
bfrA     Bacterioferritin 
bfrB     Ferritin 
BHI     Brain heart Infusion  
BHIA     Brain Heart Infusion agar 
BLAST    Basic Local Alignment Search Tool 
bp     Base pair 
BSA     Bovine serum albumin 
C. pstb     Corynebacterium pseudotuberculosis  
CCDM    Corynebacterium Chemically Defined Medium 
CDM     Chemically Defined Medium 
cDNA     Complementary Deoxyribonucleic acid 
CLA      Caseous Lymphadenitis 
cm     Centimetre  
Cp40     Corynebacterial Protease 40 
DAB     3,3‘-Diaminobenzidine 
DCO     Double crossover 
ddH2O     Double distilled water  
DIG     Digoxigenin  
DMSO     Dimethyl sulfoxide 
DNA     Deoxyribonucleic acid  
dNTP‘s     Deoxynucleotide triphosphates 
Dps     DNA-binding proteins of starved cells 
DSO     Double stranded origin  
DT     Diphtheria Toxin 
DtxR     Diphtheria toxin repressor 
EDDA     ethylenediaminediacetic acid 
EDTA     ethylenediaminetetraacetic acid 
EF 2     Elongation factor 2 
ETOH     Ethanol 
FA     Formaldehyde 
Fe
2+
     Ferrous Iron (reduced) 
FeCl3     Ferric Chloride 
Fe
3+
     Ferric Iron (oxidised) 
g     Grams  
G+C     Guanine and Cytosine 
h     Hours 
H2O2     Hydrogen Peroxide 
HIB     Heart Infusion Broth 
ICP-MS    Inductively coupled plasma mass spectrometry  
IdeR     Iron-dependent regulator  
iPCR     Inverse Polymerase Chain reaction 
IROMP    Iron regulated outer membrane protein 
 xvi 
 
IRP     Iron regulated protein  
kb     Kilobase 
kDa     Kilodalton  
kV     Kilovolts  
L     Litres 
LC-ESI MS/MS   Liquid Chromatography electrospray ionisation  
     tandem mass spectrometry  
M     Moles 
mF     Millifarad 
mg     Milligrams 
min     Minutes 
Ml     Millilitres 
MOPS     3-[N-morpholino] propanesulfonic 
Mr      Relative molecular weight 
mRNA     Messenger Ribonucleic acid 
MSG     Monosodium Glutamate 
NADPH    Nicotinamide adenine dinucleotide phosphate 
NCTC     National Collection of Type cultures 
ng     Nanograms 
NIS     Nonribosomal Peptidase Synthetase-Independent  
     Siderophore 
NRPS     Nonribosomal Peptidase Synthetase  
ONPG      o-nitrophenyl-ß-D-galactoside 
ORF     Open Reading frame 
PAI     Pathogenicity Island  
PBS     Phosphate buffered Saline 
pCARV    Corynebacterium allele replacement vector  
PCR     Polymerase Chain reaction 
PFGE     Pulsed Field Gel Electrophoresis 
PLD     Phospholipase D 
qRT-PCR    Quantitative Reverse Transcription Polymerase  
     Chain reaction  
RC     Rolling circle 
RNA     Ribonucleic acid  
ROS     Reactive Oxygen Species 
rPLD     Recombinant Phospholipase D 
RT-PCR    Reverse Transcription Polymerase chain reaction  
SAP     Shrimp alkaline phosphatase   
SCO     Single crossover  
SDS     Sodium dodecyl sulphate  
SDS-PAGE    Sodium dodecyl sulphate polyacrylamide gel  
     electrophoresis  
Sec      Seconds 
SOB     Super optimal Broth 
SSC     Saline-sodium citrate 
SSE     Sodium salicylate extract 
SSO     Single stranded origin 
TAE     Tris-acetate EDTA 
Tbps      Transferrin binding proteins 
 xvii 
 
TBS     Tris Buffered saline 
Tm     Melting temperature 
Ts plasmid    Temperature sensitive plasmid 
TW     Tween
80
 
Tween
80
    Polyoxyethylenesorbitan monooleate 
U     Units 
v/v     volume for volume 
w/v     weight for volume  
Zur     Zinc uptake Regulator  
Δ     Delta 
μg     Micrograms 
μl      Microlitres 
Ω     Ohms 
 
  1 
 
 
 
 
 
 
 
 
Chapter One  
General Introduction 
Chapter 1                                                                                                                   General Introduction 
 1 
 
1.0 The corynebacteria 
 
The Corynebacteria form a diverse group of organisms occupying a variety of ecological 
niches including skin, soil and sewage. Corynebacteria are Gram-positive bacteria with a high 
content of guanine and cytosine (G+C) nucleotides in their DNA (Connell, 2001). The genus 
forms part of the order of bacteria known as ―Actinomycetales‖, within which the 
corynebacteria belong to a suprageneric taxon (or sub-order) referred to as the Mycolata or 
Corynebacterianeae (Stackebrandt, 1997) (Zhi, et al. 2009). This taxon includes mycobacteria, 
nocardiae and rhodococci, where grouping is based on similarities between the complex cell 
wall structures of the three genera (Barksdale, et al. 1981; Dover, et al. 2004). The chemical 
structure of the cell wall of Corynebacterium, Mycobacterium and other related genera has 
been extensively studied. It has been shown that lipids make up a large portion of the cell wall; 
the most significant of these lipids being mycolic acid. When compared to mycobacteria and 
nocardia, corynebacteria have the shortest chain mycolic acids which are known as 
corynemycolic acids. 
 
 The genus Corynebacterium was originally created in 1896 by Lehmann and Neumann, to 
accommodate the diphtheria bacillus (Corynebacterium diphtheriae) and a few other species 
pathogenic to animals (Jones, 1986). Over the years, however, many other non-spore-forming, 
irregularly-stained, Gram-positive species, both aerobic and anaerobic, were assigned to the 
genus. Essentially, this resulted in a collection of heterogeneous, unrelated organisms (Jones, 
1986).  The heterogeneity of the genus became evident upon analyses of cell wall composition 
(Jones, 1986). Subsequently, as more biochemical information (such as cell wall chemistry 
and lipid composition) became available the genus became more precisely-defined based on 
the cell wall characteristics. The genus Corynebacterium is now confined to species that are 
characterised by the presence of arabinogalactan and meso-diaminopimelic acid (meso-DAP) 
in their cell wall, contain corynemycolic acid, and a have a G + C content of 51-63% 
(Barksdale, 1970; Jones, 1986; Schleifer & Kandler, 1972).  
 
Often referred to as ―diphtheroids‖, corynebacteria are non-motile, non-spore forming, straight 
to slightly-curved Gram-positive rods. On occasion, corynebacteria appear as cocci or 
coccobacilli with club-shaped ends, hence the term coryne (the Greek word for club). 
Interestingly, staining can sometimes be irregular, and when viewed under a microscope the 
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bacteria show a palisade arrangement which has been described as reminiscent of the 
appearance of Chinese letters (Brown & Olander, 1987). These characteristics are probably 
due to the cell surface composition and the resulting hydrophobic interactions of the external 
lipid layer, together with the irregular nature of the dividing septa, since corynebacteria divide 
by snapping division (Hard, 1969b).  
 
1.1 Other notable corynebacteria 
1.1.1 Non-pathogenic corynebacteria 
 
Corynebacterium glutamicum is the work-horse of the genus Corynebacterium, and is one of 
the most biotechnologically-significant bacterial species in use today. The importance of this 
bacterium lies in its ability to overproduce L-glutamate commonly known as Mono-sodium-
glutamate (MSG), and annual production of this amino acid lies in excess of two million tons 
(Burkovski, 2008; Kimura, 2003). The mechanism of L-glutamate overproduction by C. 
glutamicum exploits the organism‘s auxotrophy for biotin. This phenomenon was first 
observed by Shiio et al. (1962) who demonstrated that excess biotin in the culture medium 
lowers the cellular permeability of amino acids hence, there is less L-glutamate released in 
excess biotin and, in contrast, low biotin levels  in the growth medium results in an 
overproduction of  L-glutamate (Shiio et al. 1962). Interestingly, even in the presence of 
excess biotin, C. glutamicum can be induced to overproduce L-glutamate.  This phenomenon 
is achieved by the addition of a detergent, such as polyoxyethylene sorbitane monopalmitate 
(Tween 40), or polyoxyethylene sorbitane monostearate (Tween 60) (Duperray et al. 1992). 
Significantly, polyoxyethylene sorbitane monolaurate (Tween 20) and polyoxyethylene 
sorbitane monooleate (Tween 80) are not able to induce the overproduction of L-glutamate; 
however, the reasons behind this are not known (Kimura, 2003).  The constant drive to 
improve the yield of glutamate has led to the initiation of molecular biological analyses, 
including novel genetic manipulations and proteomic analyses.  Significantly, the techniques 
being developed to improve the productivity of C. glutamicum in an industrial context may 
well aid in expanding our understanding of other corynebacterial species, including those 
pathogenic for humans and animals. In addition to C. glutamicum the closely-related non-
pathogenic bacterium Corynebacterium efficiens is also used in the food industry for the large-
scale production of glutamate. Unlike C. glutamicum, C. efficiens is capable of growing and 
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producing glutamate at 40°C. For the glutamate industry the thermostability of the organism is 
a valuable feature since it reduces the considerable cost of the cooling of C. glutamicum 
cultures, in order to dissipate the heat which builds up during the glutamate fermentation 
process (Nishio, et al.  2003).  
 
1.1.2 The pathogens 
 
1.1.2.1 Corynebacterium diphtheriae 
Corynebacterium diphtheriae is an important human pathogen, being the aetiological agent of 
the disease, diphtheria.  The first stage of C. diphtheriae infection in humans starts with 
colonisation of the throat. The organism generally gains entry following inhalation of aerosols 
from an infected person or an asymptomatic carrier. The first symptoms of the resulting 
highly-infectious, potentially-fatal, disease include malaise, low-grade fever, sore throat and 
loss of appetite. As the infection develops, a greyish membrane forms in the throat which can 
extend to the lungs.  The membrane, which consists of a complex of fibrin, bacteria and 
inflammatory cells, adheres to underlying tissue which, when attempts are made to physically 
remove the membrane, can bleed. In more serious cases, once C. diphtheriae infection has 
become systemic, a protein toxin, known as diphtheria toxin (DT), is produced which can 
cause damage to internal organs (Salyers & Whitt 1994). Experimentally, when large doses of 
DT were administered parenterally into susceptible animals, typical diphtheria-like systemic 
lesions were observed, including, myocarditis, polyneuritis, and focal necrosis in organs such 
as the liver, kidneys and adrenal glands (Holmes, 2000). Fortunately, as a result of a 
successful vaccination programme, diphtheria has been under control (with no significant 
outbreaks) for many years in developed countries; however, the disease has recently been 
making a remarkable return, specifically within Eastern Europe, where vaccine uptake has not 
been sufficient to maintain herd immunity (Golaz, et al. 2000). Vaccination is achieved by 
administering toxoided DT, a formalin-inactivated derivative which results in a protective 
antitoxic immune response in vaccinated individuals.  
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1.1.2.2 Corynebacterium ulcerans  
Another corynebacterial species, Corynebacterium ulcerans, has been identified, which is 
normally associated with disease in cows and domestic animals such as dogs and cats; 
however, in recent times, in addition to C. diphtheriae, C. ulcerans has also been implicated as 
a cause of diphtheria-like disease in humans (Gubler, et al. 1990; Lartigue, et al. 2005; Tiwari, 
et al. 2008).  
1.1.2.3 Corynebacterium jeikeium  
Another important pathogenic corynebacterial species is Corynebacterium jeikeium. This 
opportunistic pathogen causes septicaemia and endocarditis in immunocompromised humans, 
and attempts to combat infection are often without success due to the organism‘s resistance to 
a number of antibiotics (Balci, et al. 2002).    
 
1.2 Corynebacterium pseudotuberculosis 
 
Corynebacterium pseudotuberculosis is the aetiological agent of a variety of chronic and 
suppurative conditions in a number of mammalian species, most notably, caseous 
lymphadenitis (CLA) of small ruminants and ulcerative lymphangitis of horses (Hughes & 
Biberstein, 1959; Knight, 1969; Lopez, et al. 1966; Miers & Ley, 1980). In 1888 the French 
veterinarian, Edmond Isidore Etienne Nocard, first described an organism from a case of 
lymphangitis in a cow. Three years later, Hugo von Preisz isolated a similar bacterium from 
renal abbesses in a ewe (Preisz & Giunard 1891). The organism subsequently became known 
as the Preisz-Nocard bacillus. In 1894, Preisz described the organism in detail and branded it 
Bacillus pseudotuberculosis ovis, the name pseudotuberculosis, meaning ―false tuberculosis‖ 
derived as a result of the similarities between the lesions and the caseous nodules commonly 
observed during infections with Mycobacterium tuberculosis (Preisz, 1894).  However, in 
1911 Buchanan suggested abandoning the subspecies designation, resulting in the name B. 
pseudotuberculosis. Subsequently, several investigators observed the noticeably diphtheroid 
morphology of the organism (i.e. sharing similarities with Corynebacterium diphtheriae).  
Later, in the 1923 edition of the Bergey‘s manual, the organism was presented as 
Corynebacterium ovis, due to its frequent association with disease in sheep; however, by the 
sixth edition of ―the manual‖, the name had been officially changed back to Corynebacterium 
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pseudotuberculosis, due to the recognition that the organism caused disease in a range of 
animal species (Rogosa, et al. 1974).  
 
C. pseudotuberculosis is a facultative anaerobe and facultative intracellular pathogen. 
Dimensions of the organism vary from 0.55 by 0.40µm to 1.2 by 0.50µm (Hard, 1969a). 
When grown on blood agar, C. pseudotuberculosis produces pale grey colonies that are matt in 
appearance. Due to the waxy (high-lipid) nature of the cell wall, C. pseudotuberculosis 
colonies can be pushed along the agar surface, and tend to spatter when introduced to a flame 
(Quinn, et al. 1994). In liquid media, the bacterium has a tendency to form clumps; again, this 
is due to the high lipid content of its outer layer.  Significantly, cell wall lipids account for as 
much as 11.3% of the dry weight of the bacterial cell (Ioneda & Silva, 1979). 
 
1.2.1 Phenotypic characterisation 
 
Many early attempts were made to characterise strains of C. pseudotuberculosis by assessment 
of biochemical characteristics (Barakat, 1984; Biberstein, et al. 1971; Muckle & Gyles, 1982). 
Corynebacterium pseudotuberculosis is strongly catalase- and urease-positive and is able to 
ferment glucose, galactose, maltose and mannose (Brown & Olander, 1987). Interestingly, 
these biochemical traits are identical in isolates of C. pseudotuberculosis from different 
mammalian species, with the exception of the ability to reduce nitrate to nitrite.  It was 
originally reported that C. pseudotuberculosis isolates from horses and cattle were uniformly 
able to reduce nitrate, whereas isolates from sheep and goats were not. These developments 
led to the creation of the term ―biotype‖ whereby strains were separated into two distinct 
biotypes in an overly-simplistic attempt to label isolates from diseases in different host 
species. Non-nitrate reducing (or nitrate-negative) strains responsible for causing CLA in 
sheep and goats were assigned to biotype I, whereas nitrate-reducing (or nitrate-positive) 
strains responsible for causing infections in cattle and horses were assigned to biotype II 
(Biberstein, et al. 1971). Later studies involving the comparative biochemical characterisation 
and restriction endonuclease analysis of chromosomal DNA of C. pseudotuberculosis isolates 
demonstrated that the variation in the ability to reduce nitrate coincided with different 
restriction patterns, whereby nitrate-positive strains produced one pattern, while nitrate-
negative strains produced another. As a consequence, the terms ‗biovar equi‘ for nitrate-
positive strains and ‗biovar ovis‘ for nitrate-negative strains were coined (Songer, et al. 1988). 
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However, it has subsequently become apparent that the relationship between biotype/biovar 
and specific host type is not as clear-cut as was once thought.  In recent years, nitrate negative 
strains have been isolated from horses (Biberstein, et al. 1971; Connor, et al. 2000).  
Therefore, different approaches to characterising the relationships between isolates have been 
taken. Other methods of characterising strains have included serotyping (Barakat, 1984; 
Sutherland, et al. 1989) immunoblotting (Muckle, et al. 1992) and molecular characterisation 
(Connor, et al. 2000; Costa et al. 1998; Sutherland et al. 1996).  Interestingly, the molecular 
studies, although they were carried out using different methods of characterisation, are in 
agreement with regards to the grouping of nitrate-negative ovine and caprine isolates and the 
designation ―biovar ovis‖ (Biberstein, et al. 1971; Connor, et al., 2000; Muckle, et al., 1992). 
Using pulsed-field gel electrophoresis (PFGE), Connor et al. (2000) genotyped 50 UK isolates 
of C. pseudotuberculosis which included both sheep and horse isolates (Connor, et al. 2000). 
Pulsed-field gel electrophoresis using SfiI and SmaI restriction endonucleases identified six 
different pulsotypes within the clonally-related group of ovine and caprine isolates.  The 
results of that study led the authors to suggest that C. pseudotuberculosis isolates of ovine and 
caprine origin within the UK are clonally-related (Connor, et al. 2000). Furthermore, a later 
study addressed the molecular genotyping of a panel of multinational C. pseudotuberculosis 
isolates (Connor, et al. 2007). Unexpectedly, Connor et al. (2002) observed that, irrespective 
of their country of origin, ovine and caprine C. pseudotuberculosis isolates are clonally 
related, leading them to suggest that the differences in the manifestation of CLA in sheep and 
goats in different countries is more likely to be attributed to fundamental differences in the 
host species themselves, in addition to other factors such as animal age or environmental 
pressures (al-Rawashdeh & al-Qudah, 2000; Connor, et al. 2007). Significantly, these findings 
may have important implications with regards future vaccine development and vaccination 
policies.  
 
Significantly, transmission of C. pseudotuberculosis biovar equi strains from horses to sheep 
and goats grazing on the same pasture has not been shown to occur. In an experiment carried 
out by Brown et al. (1985) kid goats were experimentally infected intradermally with C. 
pseudotuberculosis strains originally isolated from goats or horses (Brown, et al. 1985). Five 
kids were administered a caprine-derived strain, whilst a further five were administered an 
equine-derived strain. At post mortem, those goats infected with the caprine strain were 
observed to have multiple lesions, both peripherally and in visceral locations. The goats that 
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received the equine strain had an initially more prominent reaction at the site of inoculation, 
but at the end of 4 months 1 animal had no evidence of diseases and the other 3 had minimal 
abscesses found only in the draining lymph node (Brown, et al. 1985).  Therefore, it would 
appear that, as originally postulated by Songer (1988), the two biovars have diverged to the 
extent that biovar equi strains cannot infect sheep and goats. Superficially, it would appear the 
same is not true of infection of horses and cattle with nitrate-negative strains.  However, the 
analysis of the nitrate-negative horse isolates conducted by Connor et al. (2000) revealed that 
it was genetically-distinct to the ovine and caprine isolates included in the same study, in 
addition to being distinct from other nitrate-positive horse isolates (unpublished data).  
Therefore, it would appear that there is a further ―type‖ of C. pseudotuberculosis in 
circulation, which does not correspond to those previously described (Connor, et al. 2000).  
 
1.2.2 Virulence factors 
 
Significantly, there has never been a report of an avirulent C. pseudotuberculosis strain.  
However, there is relatively little information available in the published literature regarding 
specific C. pseudotuberculosis factors that contribute to the organism‘s ability to colonise and 
persist within susceptible host species. The reasons for this are several-fold but stem, at least 
in part, from the sporadic research attention that C. pseudotuberculosis has received over the 
years. In addition, much of the existing literature supports several commonly-held hypotheses 
regarding C. pseudotuberculosis pathogenicity; one example being the involvement of 
mycolic acid in the ability of C. pseudotuberculosis to survive within macrophages. 
Significantly, this hypothesis was a result of early electron microscopy studies carried out at a 
time when our understanding of host and pathogen biology, and the host/pathogen interaction, 
was completely different to what it is nowadays.  These early experiments were conducted 
within the confines of the available methodologies and knowledge of the times, and thus far 
have not been substantiated by modern molecular methods. However, due to the many times 
these hypotheses have been cited throughout the subsequent years of research on C. 
pseudotuberculosis, they have become convincing fact. Nevertheless, it is potentially unsafe to 
assume that all resulting hypotheses concerning factors contributing to C. pseudotuberculosis 
virulence are correct. Despite this fact, the majority of modern C. pseudotuberculosis research 
has focused upon factors identified decades previously. In some cases these hypotheses have 
already been substantiated with modern molecular methods. The hypothesis which implicates 
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the Phospholipase D-exotoxin (PLD) as being an important virulence factor (Carne & Onon, 
1978) has since been substantiated with molecular methods (Hodgson, et al. 1992; McNamara, 
et al. 1994), however, there are still other putative virulence factors  which are yet to be 
proven. The absence of a genome sequence and suitable tools for the genetic manipulation of 
C. pseudotuberculosis has made it virtually impossible to identify other potential research 
targets until very recently. It is therefore understandable why there has not been a vast amount 
of research effort focused on the identification of novel virulence determinants, furthermore 
therein lays a reason why there is a lack of evidence to establish claims of previous ones.  
 
1.2.2.1 Mycolic acid 
As previously stated, the corynebacteria have a particularly complex cell wall structure, and 
like other members of the mycolata the cell wall has been implicated in the virulence of C. 
pseudotuberculosis (Carne, et al. 1956; Hard, 1972; Muckle & Gyles, 1983; Tashjian & 
Campbell, 1983). A lipid (subsequently thought to be mycolic acid) of C. pseudotuberculosis 
was shown to elicit cytotoxic properties (Carne, et al. 1956). Using petrol ether, Carne et al. 
(1956) extracted the lipid from C. pseudotuberculosis without impairing the viability of the 
organism. When injected intradermally in guinea pigs or rabbits, this toxic lipid caused 
clinical signs including local oedema, congestion and haemorrhagic necrosis (Carne, et al. 
1956). It is important to note that in this study there was no mention of the amount of lipid 
administered, which may have been far in excess of what would be encountered by the host 
during a natural infection. As a consequence these results must be interpreted with caution. In 
a further experiment, Carne et al. (1956) noted that leukocytes which had engulfed C. 
pseudotuberculosis prior to being maintained under tissue culture conditions, rapidly 
degenerated and died. Carne et al. (1956) subsequently concluded, that the capacity of C. 
pseudotuberculosis to resist digestion by phagocytes, contributed to the eventual formation of 
abscesses. Later, studies by Muckle and Gyles (1983) postulated that the virulence of any 
particular strain of C. pseudotuberculosis may be related to the cell wall lipid component of 
that strain. By extracting the lipid component of 25 different isolates of C. pseudotuberculosis 
and inoculating each into groups of mice, the researchers demonstrated that the strain with the 
greatest lipid content produced most abscesses (Muckle & Gyles, 1983).  While this work 
supported that of Carne et al. (1956), it is also possible that other cell-surface 
anchored/associated components were being extracted along with the lipid, and that some 
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other, as yet undetermined, factor may be responsible for the apparent differences in virulence 
observed between strains.   
 
 According to a later study, it is the high lipid content of the cell wall which allows C. 
pseudotuberculosis to evade digestion by cellular enzymes, and subsequently to persist as a 
facultative intracellular parasite (Hard, 1972); however, it is important to note that this 
hypothesis was based exclusively upon analyses of electron micrographs. It is entirely possible 
that other factors are associated with the organism‘s ability to survive within macrophages. 
For example, in the related Actinomycete M. tuberculosis, the mechanism by which this 
organism is able to survive killing within macrophages has been well-described at a molecular 
level. Most bacteria, once internalised by a macrophage, are destroyed by lysosomes; 
however, mycobacteria are capable of evading delivery to lysosomes, and hence are able to 
survive within macrophages. Interestingly, the ability of mycobacteria to avoid lysosomal 
degradation is only a trait observed with viable cells (Armstrong & Hart, 1971; Hasan, et al. 
1997); a phagosome which contains internalised dead bacteria rapidly becomes a 
phagolysosome, suggesting compounds synthesised by living mycobacteria impede the 
mechanisms by which phagosomes and lysosomes fuse (Pieters & Gatfield, 2002). Although it 
has yet to be the focus of research attention, it is entirely possible that a similar mechanism 
exists in C. pseudotuberculosis, and it should be recognised that this would not be identified 
by scrutiny of electron micrographs alone.  
 
A further study by Jolly (1965) demonstrated that, when brought into contact with C. 
pseudotuberculosis in vitro, murine macrophages usually only phagocytose a single organism 
(Jolly, 1965a); however, it was observed that bacterial multiplication was initiated 
immediately, and several generations were seen within 5 hours. Subsequently, it was reported 
that degeneration of infected macrophages occurred when the number of organisms reached 30 
or 40 (Jolly, 1965a). Later, using electron microscopy to look at the viability of phagocytosed 
C. pseudotuberculosis in caprine mammary macrophages, Tashjian and Campbell (1983) 
showed the bacteria not only survived in macrophages but that they remained viable (Tashjian 
& Campbell, 1983).  While the results of these studies clearly show that C. pseudotuberculosis 
is able to survive and replicate within macrophages, they do not prove the involvement of 
mycolic acid, and therefore further work is required to prove or refute the original hypothesis. 
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1.2.2.2 Phospholipase D 
Phospholipase D is a powerful exotoxin, secreted into the extracellular milieu by C. 
pseudotuberculosis.  It was first characterised by Carne in 1940, and has since been detected 
in all strains of C. pseudotuberculosis that have been recovered from infected mammalian 
species (Carne, 1940; Songer, et al. 1988). The closely-related Corynebacterium ulcerans is 
also known to produce PLD, and the proteins from the two species share 98 % similarity and 
80 % identity with each-other (McNamara, et al. 1995).  
 
Phospholipids form an important part of the surface membranes of all mammalian cells; 
hence, a bacterial enzyme with specific activity against them is likely to exert a significant 
effect upon the infected host (Batey, 1986). Bacterial phospholipases comprise a diverse group 
of enzymes produced by a variety of Gram-positive and Gram-negative bacteria. The enzymes 
manifest a range of effects in vivo and in vitro, from minor alterations in cell membrane 
composition and function, to lethality at low concentrations (Songer, 1997; Soucek, et al. 
1971; Titball, 1997). Phospholipases are able to hydrolyze one or more ester linkages in 
glycerophospholipids; the letters A-D are used to differentiate between phospholipases and to 
denote the specific phospholipid ester bond that is cleaved (Ansell, 1964). Specifically, PLD 
cleaves sphingomyelin into choline and ceramide-1-phosphate (Bernheimer, et al. 1980). 
Interestingly, an enzyme similar to PLD, showing comparable bioactivity, is found in the 
venom of the Loxosceles genus of spider. The causative toxin is known as sphingomyelinease 
D, and this observation demonstrates the ubiquitous nature of the phospholipase enzymes 
(Bernheimer, et al. 1985). 
 
In 1965, Jolly demonstrated that PLD was involved in the pathogenesis of C. 
pseudotuberculosis. The investigator showed that an antitoxin against PLD, which was in the 
form of serum from a horse which had received multiple injections of sub-lethal doses of 
toxin, was capable of eliminating toxin-induced vascular permeability in the skin of sheep 
which subsequently reduced the transport of bacteria to the local lymph nodes (Jolly, 1965c). 
Later, the potency of PLD was demonstrated in vivo, when high doses of the enzyme 
administered intravenously, intraperitoneally and subcutaneously, were observed to cause 
rapid death in laboratory rodents and gnotobiotic small ruminants (Hsu, et al. 1985; Muckle & 
Gyles, 1983). Significantly, these experiments were conducted using much higher 
concentrations of PLD than would normally be encountered during a natural infection, and for 
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this reason toxaemia is not typical of CLA in vivo (Yozwiak & Songer, 1993). Interestingly, in 
vitro, PLD causes lysis of sheep erythrocytes when grown in synergy with Rhodococcus equi 
cholesterol oxidase (Bernheimer, et al., 1980; Muckle & Gyles 1986; Prescott, et al. 1982). 
Moreover, an inhibitory affect on the haemolytic activity of staphylococcal β-toxin can be 
observed when erythrocytes are pre-treated with PLD (Souckova & Soucek, 1972). The toxin 
has been shown to cause dermonecrosis and increase vascular permeability by hydrolysis of 
vascular and lymphatic endothelial cell walls (Egen, et al. 1989; Songer, 1997).  As a result of 
these observations, PLD has been implicated in aiding the dissemination of C. 
pseudotuberculosis within the host (Batey, 1986). The increase in vascular permeability, 
(resulting from the hydrolysis of sphingomyelin), leads to leakage of plasma from small blood 
vessels at the site of infection into the surrounding tissues which then floods lymphatic spaces 
and allows the bacteria to be transferred to regional lymph nodes   (Carne, et al. 1956; Jolly, 
1965c; Onon, 1979).  
 
More recently, the C. pseudotuberculosis PLD gene was cloned, and subsequent sequence 
analysis revealed that it encoded a protein of 31.4 kDa (Hodgson, et al. 1990). When 
expressed in E. coli (under the control of its own promoter), the resulting protein had 
sphingomyelinease activity (Hodgson, et al. 1990). Hodgson et al. (1992) disrupted the 
chromosomally-located PLD-encoding gene from C. pseudotuberculosis, thus obtaining a 
PLD-deficient (Toxminus) strain (Hodgson, et al. 1992). Interestingly, when put into an 
experimental sheep model, virulence was reduced by at least two log doses, and these results 
clearly demonstrated that PLD contributes to the virulence of C. pseudotuberculosis 
(Hodgson, et al. 1992).  The investigators also noted that the wild-type bacteria persisted in 
the host for at least 18 weeks (the duration of the experiment), whereas the PLD
-
 mutant strain 
was resolved at the site of inoculation within a few weeks. In addition, the mutant bacteria 
could not be cultured from any of tissue samples obtained from challenged animals at 
necropsy. These results add to the seminal work on PLD with respect to virulence by 
suggesting that PLD contributes to the in vivo survival of C. pseudotuberculosis. Later, 
McNamara et al. (1994) also made a PLD-deficient mutant using allelic exchange mutagenesis 
to introduce a nonsense mutation in the wild-type chromosomal gene (McNamara, et al. 
1994).  When the resulting PLD-deficient strain was used in goat challenge studies, similar 
results to those previously observed by Hodgson et al. (1992) were seen, in that wild-type 
bacteria could be recovered from primary lesions and popliteal lymph nodes of infected goats, 
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whereas the PLD-deficient mutant could only be recovered from the inoculation site of one 
goat which had received a large (5×10
6
 cfu) inoculum of the
 
mutant. Although both 
investigators demonstrated that PLD affects the formation of abscesses and the subsequent 
survival and spread of the bacteria within the host, McNamara et al. (1994) suggested that 
further attenuation would be required before a PLD-deficient mutant strain could be used as a 
vaccine (McNamara, et al. 1994). This is because, at the site of inoculation, the abscessation 
of the goat which received the 5×10
6
 cfu inoculum was indistinguishable from that of the 
wild-type strain.   
 
1.2.2.3 Serine protease  
Walker et al. (1994) described the identification of a 40 kDa protein antigen from C. 
pseudotuberculosis (Walker, et al. 1994). The majority of native protein was found to reside in 
the culture supernatants, suggesting the 40 kDa protein was secreted, although there was also a 
suggestion that the protein may be non-covalently attached to the cell (Walker, et al. 1994). 
Significantly, sheep vaccinated with the 40 kDa antigen preparation in an aluminium 
hydroxide adjuvant, were protected against infection with C. pseudotuberculosis, exhibiting, 
an 82 % reduction in the proportion of infected sheep and a 98 % reduction in number of lung 
lesions. When compared to the levels of protection observed with the commercially available 
vaccines at the time of the publication, the researchers stated that their 40 kDa protein antigen 
vaccine compared favourably (Eggleton, et al. 1991a; Eggleton, et al. 1991b).  
 
A year later, researchers in the same laboratory cloned the 40 kDa protein structural gene and 
subsequent DNA sequence analysis revealed an ORF of 1,137 bp, encoding a protein of 379 
amino acids (Wilson, et al. 1995). Wilson et al. (1995) overexpressed the recombinant 40 kDa 
protein and subsequent biochemical analyses of both the recombinant and native protein 
revealed associated proteolytic activity. Furthermore, preliminary characterisation of the 
protein revealed that it had serine protease-type activity; however, there was no significant 
homology with previously published DNA or protein sequence data found in the databases at 
that time, leading the authors to suggest that it is a novel protein, possibly belonging to an 
uncharacterised subclass of serine proteases. Interestingly, protease activity could not be 
detected in culture supernatants; in fact, protease activity could only be detected after 
purification of the native protein. Since other serine proteases require conformational change 
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and cleavage modifications for maximal activity the authors suggest conversion of the inactive 
form to the active form of the protein may require conformational change and/or post-
translational modification (by an autocatalytic self cleavage process). The 40 kDa protein, 
characterised as having serine protease activity, was subsequently designated Corynebacterial 
protease 40 (cp40; acc. # U10424).  The function of the Cp40 is not known, and Wilson et al. 
(1995) alluded to the function by comparison with other characterised serine proteases, which 
have been shown to have roles in aiding intracellular survival, tissue destruction and helping 
bacteria to evade the host immune system (Maeda & Molla, 1989; Wilson, et al. 1995). The 
authors also suggested further characterisation of the serine protease is essential to allow an 
understanding of its contribution to pathogenesis (Wilson, et al. 1995).  
 
1.3 Caseous lymphadenitis  
 
Caseous lymphadenitis (CLA or CL) is a chronic, suppurative disease affecting farmed small 
ruminants, including sheep and goats, worldwide. CLA is caused by infection with C. 
pseudotuberculosis, and although rarely fatal, infections can last for most, if not all, of an 
animal‘s life.  If this infection is not managed, it can disseminate rapidly through a flock or 
herd, significantly affecting welfare and productivity as a result.  Rather than being an acute 
disease, CLA is a subtle, often-recurring complaint, classically associated with the formation 
of pyogranulomas which appear sporadically in various lymph nodes, in particular the 
superficial lymph nodes (i.e. those nodes which can be palpated externally, including the 
mandibular, parotid, inguinal, prescapular, retropharyngeal, popliteal and mammary lymph 
nodes) of infected animals (Valli and Parry, 1993). On occasion, internal lymph nodes (e.g. 
mediastinal, bronchial and lumbar lymph nodes) and visceral organs such as the liver, kidney, 
spleen, brain and most frequently the lungs are also affected (Batey, 1986; Hard, 1969a, 1972; 
Jensen, 1974; Jolly, 1965b; Jubb & Kennedy, 1970; Marsh, 1965). Lesions within superficial 
lymph nodes can be externally visible as distinct swellings, often accompanied by the loss of 
overlying hair, and these observations can be used in diagnosing the presence of CLA within a 
flock/herd.  In contrast, because lesions are hidden within affected animals, the visceral form 
of CLA is impossible to diagnose, unless at post mortem; however, signs of weight loss and 
ill-thrift are commonly observed in animals with CLA. In this respect, the visceral 
manifestation is thought to be an important factor contributing to the debilitating condition 
referred to as ―thin ewe syndrome‖ (Gates, et al . 1977).  
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1.3.1 Prevalence of CLA 
 
CLA is of major economic consequence to sheep producers in many parts of the world, 
including North and South America, Australia, New Zealand, Europe and South Africa, this 
global prevalence reflecting the major small ruminant farming areas (M. Smith & Sherman, 
1994; Williamson, 2001). The establishment of CLA infection within livestock, in particular 
sheep, has been an issue for decades in many countries. As early as the 1930s, CLA was 
recognised as ―extensively affecting the flocks of most mutton exporting countries‖ (Cesari, 
1930).   For some time it has been suggested that the origins of infection were in Europe, and 
that the global spread of C. pseudotuberculosis followed the exportation of sheep by the 18
th
 
century colonial powers. In particular, the Merino breed, which originated in Spain and was 
widely valued for its characteristics as a dual meat and wool animal, was first exported to 
South Africa and subsequently Australia and the Americas. This early exportation is thought 
to have assisted in the spread of C. pseudotuberculosis (Paton, 2000). It was therefore 
surprising, that the first case of CLA in the UK was not identified until 1990, when the disease 
was thought to have entered via an infected goat from Europe (Lloyd, et al. 1990). 
Unfortunately, since it was first identified CLA has become increasingly prevalent in the UK, 
with the last published prevalence report revealing that as many as 18 % of terminal sire 
breeds were affected by the disease (Baird, et al. 2001). In the years following the initial 
assessment of prevalence, incidences of disease have been reported the length and breadth of 
the British Isles, Northern Ireland and the Republic of Ireland. As a result, the prevalence 
report of 2001 is likely to be a significant under-representation of the current rate of infection, 
since rather than being a disease restricted to breeding animals alone, CLA has become well-
established within the national flock (Baird, et al. 2004).  
 
1.3.2 Economic consequences of CLA  
 
The Economic consequences of CLA are several.  Primarily, CLA is responsible for decreased 
post-slaughter meat yield from production animals, through the necessity to trim off infected 
lesions, or through outright carcase condemnation in severe cases. In addition, significantly 
decreased wool yields have been reported in CLA-affected animals in Australia, where it was 
shown over a 12 month period that sheep challenged with, but not vaccinated against, C. 
pseudotuberculosis produced 0.20 kg less clean wool than unchallenged controls (the annual 
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wool yield from a healthy sheep is ca. 4 kg) (Paton, et al. 1988); it is currently not known 
whether the same is also true of sheep in the UK.  A reduction in the reproductive efficiency 
of breeding stock, increased rates of culling and increased mortality of breeding stock are also 
important economic factors associated with C. pseudotuberculosis infection (Williamson, 
2001), not to mention reduced live weight gain due to ill thrift in infected animals.  
 
1.3.3 Pathogenicity and disease in sheep 
 
1.3.3.1 Primary infection  
Infection with C. pseudotuberculosis typically occurs via skin or mucus membrane wounds, 
such as those introduced by shearing.  The bacterium has also been reported to be able to 
penetrate through intact skin (Smith & Sherman, 1994); however, this observation is open to 
some criticism and further work would be required to prove or refute such a statement. 
Following entry into the host, C. pseudotuberculosis rapidly spreads to the local draining 
lymph nodes; it is here that multiple micro-abscesses or micro-pyogranulomas develop, and 
merge to form larger abscesses (Baird & Fontaine, 2007). The caseation observed within CLA 
lesions is thought to result from a constant cycle of phagocytosis, bacterial multiplication and 
cellular degeneration.  Pepin et al. (1991) studied the early phase of infection in lambs and 
reported that early pyogranulomas contained clumps of bacteria and cellular debris, in addition 
to a reasonably high proportion of eosinophils which gave the purulent core a slightly green 
tinge (Pepin, et al.1991a). Subsequently, the predominant cell type within the lesion became 
monocytes/macrophages; this stage was closely followed by encapsulation of the lesion 
(Pepin, et al. 1994). As the encapsulated pyogranulomas grow in size, there is a constant 
degradation and re-synthesis of the fibrous capsule around the expanding lesion. On dissection 
of a mature abscesses, an ‗onion ring‘ appearance is exhibited, which is typical of CLA 
(Batey, 1986; Hard, 1969b). As lymph node abscesses mature they can rupture through a 
fistula, draining infective purulent discharge into the environment (Williamson, 2001). The 
rupture of superficial lymph node abscesses can result in the release of many millions of 
bacteria (it has been estimated that each gram of pus contains between 1×10
6
 and 5×10
7
 cfu 
(Brown & Olander, 1987)) into the environment, which has been shown to contaminate pens, 
water buckets, shearing clippers, etc., thereby facilitating transmission of C. 
pseudotuberculosis to other susceptible animals. Furthermore, although unable to multiply, C. 
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pseudotuberculosis has been shown to be able to survive for long periods outside of the host, 
and the extent of this survival time is enhanced in the presence of particulate fomites such as 
wood, straw and faeces (Augustine & Renshaw, 1986; Williamson, 2001).  Significantly, 
viable C. pseudotuberculosis has been isolated from straw, hay and wood up to 8 weeks after 
inoculation with pus from a CLA lesion. Viable organisms have also been isolated up to 8 
months from soil, where it is thought that survival is enhanced by shaded, moist conditions 
and low temperatures (Augustine & Renshaw, 1986; Brown & Olander, 1987; Rizvi, et al. 
1997), such as could be argued to be prevalent within the British Isles. C. pseudotuberculosis 
has also been shown to survive in prepared commercial sheep dips for at least 24 hours (Nairn 
& Robertson, 1974), although this is no longer an issue in the UK since it is no longer a legal 
requirement to dip sheep. Once a ruptured abscess has healed over, it is not uncommon for 
further abscessation to occur within the same animal at the same or other sites, months or even 
years later. This reoccurrence of abscesses is likely to be a result of a previous infection in 
which the animal was unable to completely eliminate the infecting organism (Williamson, 
2001).   
 
As stated above, CLA occurs in both sheep and goats, and generally there are many 
similarities in the way that the disease manifests in both species. It is primarily the superficial 
lymph nodes that are affected, and, in both sheep and goats the visceral form of the disease is 
thought to occur less frequently but is more severe. Interestingly, the distribution and form of 
the CLA lesions in sheep and goats around the world have been described as ‗varying‘ by 
some authors (Batey, 1986; Brown & Olander, 1987; Rizvi, et al. 1997; Williamson, 2001). In 
Australia, the superficial lymph nodes of the shoulder and flank of sheep are the sites most 
commonly associated with CLA lesions; however, in the UK a different pattern is seen, 
whereby abscesses develop predominantly in the superficial lymph nodes of the head and neck 
(Baird, et al. 2001). Significantly, in other countries, this ―UK sheep‖ lesion pattern is more 
commonly associated with manifestation of CLA in goats, whereby the parotid lymph node is 
often affected, followed by the prescapular, and then by other nodes usually confined to the 
head and neck area (Brown & Olander, 1987).  
In Australia the visceral form of CLA is relatively rare, although, it is thought that the 
associated lung abscesses could be involved in transmission of C. pseudotuberculosis via the 
airways (Ellis, et al. 1987; Paton, et al. 1995; Stoops, et al.1984). In the USA, the visceral 
form of CLA is more widespread and is regarded as the most common cause of chronic 
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wasting disorder or thin ewe syndrome (Paton, 1997). Being a relatively new disease in the 
UK, there have been few reports of the extent of visceral infection; however, anecdotal 
evidence would suggest the prevalence of lung lesions in approximately 25 % of naturally-
infected animals, and this observation is borne out through the results of experimental 
challenges of sheep with a UK C. pseudotuberculosis strain (Fontaine, et al. 2006).  
 
1.3.3.2 Dissemination 
Once C. pseudotuberculosis has gained entry into a host animal, macrophages migrate to the 
invasion site and engulf the organism (Pepin, et al. 1991b).  As discussed previously, 
conclusive proof  is still required to confirm that the high lipid content of the C. 
pseudotuberculosis cell wall enables the bacterium to evade the action of lysosomal enzymes 
and subsequently survive within the macrophage phagosome (Carne, et al. 1956; Hard, 1972). 
However, whatever the actual method of intracellular survival, once engulfed, surviving 
intracellular organisms can rapidly multiply within macrophages, resulting in the degeneration 
and subsequent death of the infected cells, thereby releasing C. pseudotuberculosis to be 
engulfed by secondary macrophages (Batey, 1986; Hard, 1969a, 1972; Jolly, 1965b). The 
organism is then able to spread through the lymphatic system to secondary sites such as 
regional lymph nodes and internal organs including, the lungs, spleen and kidney, where new 
infectious foci are established (Batey, 1986; Hard, 1969a, 1972; Jolly, 1965b).  The 
dissemination process is thought to be aided by the inflammation that occurs as part of the host 
innate immune response, since in sheep, inflammation results in increased vascular 
permeability, which increases lymph flow, prostaglandin levels and polymorphonuclear cell 
numbers in efferent lymph fluid (Johnston, et al. 1979). As discussed above, it has also been 
suggested that vascular permeability, and hence dissemination of the infecting organism, is 
facilitated by the action of PLD (Carne, et al. 1956; Jolly, 1965c; Onon, 1979).  
 
Following dissemination of C. pseudotuberculosis within leukocytes, these immune cells are 
thought to be temporarily removed from the circulation by localisation in the lungs, liver and 
spleen. It is thought this occurs prior to redistribution to sites of predilection (Hay, 1982). 
Thakur et al. (1977) used whole body scans to follow isotype-labelled leukocytes. The 
researchers revealed a concentration of cells in the lung tissue, suggestive of pooling of blood 
or temporary entrapment of leukocytes (Thakur, et al. 1977). Batey (1986) suggested that the 
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work by Thakur et al. (1977) supports the observed incidence of C. pseudotuberculosis 
infection within different tissues. In particular, Batey (1986) postulated that retention of 
degenerating infected immune cells within the lungs of sheep is responsible for the subsequent 
development of micropyogranulomas, eventually, leading to fully-developed CLA abscesses 
within the lungs (Batey, 1986).   
 
1.4 C. pseudotuberculosis infection in other species 
1.4.1 C. pseudotuberculosis infection in horses 
 
Infection with C. pseudotuberculosis in horses causes ulcerative lymphangitis, an excoriating, 
suppurative inflammation of the lymphatic system. The condition, which is usually confined to 
the distal portion of the limbs of affected animals, is generally thought to be associated with 
poor husbandry practices, and is rarely encountered nowadays, except for in the USA (Brown 
& Olander, 1987). More recently in the USA, C. pseudotuberculosis has been reported as the 
causative-agent of a syndrome in horses known as Pigeon fever (synonyms; dry land 
distemper, Wyoming strangles, false strangles). Pigeon fever is recognised as a problem, 
particularly in the Western United States, and clinical signs of the disease include lameness, 
fever, weight loss and lethargy, in addition to the development of very deep abscesses and 
multiple sores along the midline and groin areas. In some cases the abscesses can spread to the 
back, and also develop internally. The disease was coined ―pigeon fever‖ due to the nature of 
the abscesses, which cause swellings on the pectoral muscles, which subsequently resemble a 
pigeon‘s chest (Brown & Olander, 1987; Hughes & Biberstein, 1959). In rare cases, C. 
pseudotuberculosis has been associated with cases of equine abortion (Miers & Ley, 1980; 
Rumbaugh, et al. 1978) and equine mastitis (Addo, et al. 1974).  
 
The observation that the majority of C. pseudotuberculosis infections in horses occur 
predominantly in the Western United States of America, has led to the suggestion that there 
may be a specific reason for this geographical clustering within the USA. Some authors have 
suggested that arthropod vectors in this area may have facilitated spread of the organism 
between horses (Knight, 1969; Miers & Ley, 1980). Spier et al. (2004) performed real-time 
PCR analyses of flies that were collected from an area which surrounded that inhabited by 
infected horses. The researchers demonstrated the presence of the C. pseudotuberculosis (as 
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determined by successful PCR amplification of the PLD-encoding gene) in a number of the 
samples, thereby implicating the flies in the carriage of this organism.  The most prevalent 
arthropod vector found to be carrying C. pseudotuberculosis was the housefly (Musca 
domestica), where around 20 % were shown to be carriers (Spier, et al. 2004).  
 
1.4.2 C. pseudotuberculosis infection in cattle 
 
Infections of cattle with C. pseudotuberculosis were previously thought to be exceptionally 
rare, with the only clinical case having been described in 1980; mastitis, arising through a 
laceration of the teat resulted in clinical signs including a swollen, hard and tender udder 
quarter, watery milk containing clots, fever, and severe weight loss (Adekeye, et al. 1980).  
Subsequently however, reports of infections of cattle have increased, although it is unknown 
whether this is as a result of increased prevalence or increased attention. Corynebacterium 
pseudotuberculosis has been isolated from cattle with ulcerative granulomatous lesions 
(Yeruham, et al. 2004), otitis (Duarte & Hamdan, 2004) and a visceral form of ulcerative 
lymphangitis (Shpigel, et al. 1993).  
 
Significantly, C. pseudotuberculosis lesions in the bovine host are distributed quite differently 
to those in the equine host, since only rarely do lesions occur on the limbs of cattle. In Egypt, 
C. pseudotuberculosis is the causative agent of an endemic disease of buffalo called 
oedematous skin disease (OSD), which is characterised by swellings and thickening of the 
skin in the hind or fore limbs, the belly and dewlap (Selim, 2001); lesions are usually 
associated with the drainage lymph nodes.  Oedematous skin disease primarily manifests 
during the summer months, although sporadic cases can develop throughout the year, which 
would implicate the involvement of a seasonally-occurring vector in the promotion of disease 
transmission.  
 
1.4.3 Zoonotic Infections  
 
Reports of C. pseudotuberculosis infections in humans are somewhat rare, but are usually 
associated with patients‘ occupations.  In particular, workers in regular contact with sheep 
(e.g. shepherds, shearers, abattoir-workers and butchers) are more likely to be affected (Baird 
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& Fontaine, 2007), and clinical signs include suppurative granulomatous lymphadenitis (Mills, 
et al. 1997). Significantly, there have been no fatal cases of C. pseudotuberculosis infection of 
humans reported. The first published case was in 1966 (Lopez, et al. 1966), and reports of 
subsequent cases have been sporadic (Goldberger, et al. 1981; Keslin, et al. 1979). Recently, 
the description of a case of necrotizing lymphadenitis in a 12 year old child was described 
(Join-Lambert, et al. 2006).  The child contracted the infection after having had contact with 
sheep whilst on holiday in rural France.  The organism that was isolated from the infection 
was nitrate-negative C. pseudotuberculosis isolate which was susceptible to a range of 
antibiotics in vitro. However, two separate treatments with amoxicillin/clavulanate were 
unsuccessful.  The infection increased in severity which prompted the use of intravenous 
antimicrobial therapy and the subsequent surgical resection of affected tissue. Intravenous 
antimicrobial therapy was continued for 4 months after the surgery followed by 6 months of 
oral therapy and after two years no relapse had occurred. In addition, a second report occurred 
in a 63 year old woman who was living in rural France. The first treatment introduced was 
antibiotherapy, which was followed by a second course of antibiotics. Unfortunately neither 
was able to clear the infection which left surgery as the only option for a cure (Hemond, et al. 
2009).  It has been suggested that human C. pseudotuberculosis infections are under reported 
in countries such as Australia where ovine CLA is particularly prevalent, since often affected 
human lymph node abscesses are not cultured after excision, and hence the causative agent of 
the infection is not determined (Baird & Fontaine, 2007).  
   
1.5 Antimicrobial therapy 
 
Although C. pseudotuberculosis isolates are routinely sensitive to a wide variety of 
antimicrobial compounds, the generally-held hypothesis is that it is extremely difficult, if not 
impossible, to successfully cure C. pseudotuberculosis-infected animals with antibiotics. 
There are two reasons for this; firstly, it is thought that the organism is protected from 
commonly employed antibiotics during stages of the infection when the bacteria are 
intracellular (Williamson, 2001).  Secondly, antibiotics are thought to be unable to penetrate 
the thick encapsulations around the typical pyogranulomas and the thick caseous pus within 
the lesion (Williamson, 2001).  Recently however, there have been reports of the successful 
use of antibiotics to cure sheep of infection with C. pseudotuberculosis (Senturk & Temizel, 
2006; Ural, 2008).  Senturk and Temizel (2006) used a combination of rifamycin and 
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oxytetracycline antibiotics to treat CLA in a naturally-infected sheep (2-3 years of age, 
weighing 54-61 kg). Rifamycin is often used to combat infections involving M. tuberculosis 
and Mycobacterium leprae since the antibiotic is known to kill susceptible intracellular 
bacteria. Senturk and Temizel (2006) took 10 CLA-affected animals, and over a period of 10 
days treated twice-daily with rifamycin, interspersed with injections of oxytetracycline at 
intervals of 3 days. The researchers observed a decrease in the size of CLA-lesions in the 
external lymph nodes and described the result as a clinical resolution of the lesions (Senturk & 
Temizel, 2006). However, the report did not describe how long the animals were apparently 
―disease free‖, and did not involve detailed post mortem analyses. Furthermore, the study used 
antibiotics not licensed for veterinary use, at least in the UK.  In a published, critical response 
to this study, it has been suggested that further and thorough studies are essential before 
antibiotic treatment of CLA cases becomes a viable alternative to culling (Baird, 2006). 
 
In a more recent study Ural et al. (2008) assessed the efficacy of kanamycin for controlling C. 
pseudotuberculosis infection in goats. The researchers demonstrated a statistically significant 
difference (p<0.05) in the clinical recovery of kanamycin-treated goats compared to a placebo 
group (Ural, 2008). These results suggested that the antibiotic was effective at reducing 
clinical signs of CLA in the goat model; however, as with the previous study by Senturk and 
Temizel (2006) the animals were not followed up for a significant period of time after they 
had apparently been cured.  In this study, it was entirely possible, and likely, that a 
recrudescence of infection would occur in kanamycin-treated animals, since the antibiotic 
cannot penetrate macrophages, and hence would have no access to C. pseudotuberculosis cells 
resident within macrophages at the time of treatment.   
 
1.6 Vaccines against C. pseudotuberculosis  
 
Interestingly, although there is very little known about the virulence mechanisms employed by 
C. pseudotuberculosis, there has been a substantial volume of work carried out with respect to 
the development of vaccines against infection with this organism. Historically, the use of 
cellular components, bacterin vaccines and the C. pseudotuberculosis PLD exotoxin have 
demonstrated some protection against experimental infection (Brodgen, 1995; Cameron, et al. 
1972; Jolly, 1965c).  Jolly (1965) demonstrated that PLD was able to confer some protection 
against C. pseudotuberculosis infection in sheep (Jolly, 1965c). Later, Cameron et al. (1972) 
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determined the ovine immune response to vaccination, following administration of an 
experimental vaccine composed of formalin-killed, whole cells of C. pseudotuberculosis 
(Cameron, et al. 1972). The researchers concluded that vaccination with the bacterin vaccine 
could protect sheep against the lethal effects of sub-acute infection but not against the 
formation of the lesions associated with chronic infections (Cameron, et al. 1972). 
Subsequently, attempts to develop an effective CLA vaccine concentrated on the use of whole 
cell vaccines or bacterins as it was generally considered that a toxoid vaccine would not be 
sufficient to confer protection against C. pseudotuberculosis due to the chronic nature of the 
infection in sheep.  
 
In Australia, since management strategies alone were found to be unable to prevent the spread 
of CLA, efforts to develop an effective vaccine were increased in the 1970s. As a result, 
further evidence demonstrating the ability of the C. pseudotuberculosis PLD exotoxin to 
protect against CLA was reported (Burrell, 1978; Nairn, et al. 1977); this influential work led 
to the development of the first commercial CLA vaccine, Glanvac™ (Eggleton, et al. 1991a).   
The Glanvac™ vaccine consists of a combined clostridial and corynebacterial components, 
including formalin-inactivated PLD obtained from filtered and concentrated C. 
pseudotuberculosis culture supernatants (Burrell, 1983).  The vaccine has been reported to 
confer statistically-significant protection against infection with C. pseudotuberculosis (Burrell, 
1983; Eggleton, et al. 1991a; Eggleton, et al. 1991b; Eggleton, et al. 1991c); however, Burrell 
(1983) stated that the culture supernatants used to prepare Glanvac™ contain other C. 
pseudotuberculosis antigens which vary from batch to batch (Burrell, 1983), and hence affect 
the efficacy of different vaccine batches.  Subsequent to the release of Glanvac™, there has 
been a steady flow of publications in which research groups have attempted to improve upon 
the level of protection obtained by focusing upon the development of alternative CLA 
vaccines.  Another reason for needing to improve upon the already significant protection 
achieved with Glanvac™, was as a result of the general requirement for a single dose vaccine  
(at present Glanvac™ requires lambs to be revaccinated 4 weeks after an initial vaccination).  
One way in which this has been attempted was through the use of live attenuated vaccines. 
Since PLD has been shown to be an important virulence factor of C. pseudotuberculosis 
(Carne & Onon, 1978) a group of researchers in Australia attempted to create a mutant 
derivative of the PLD-encoding gene in C. pseudotuberculosis, and test its ability to act as a 
live attenuated vaccine (Hodgson, et al. 1992). Hodgson et al. (1992) demonstrated that single 
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subcutaneous inoculation with 10
5 
cfu of the mutant strain (designated Toxminus), resulted in 
an absence of the clinical disease usually associated with wild-type C. pseudotuberculosis 
infection; however, at higher doses (10
7 
cfu) transient abscesses were observed at the site of 
inoculation. Later, in order to overcome these problems the same group evaluated the use of 
Toxminus as a live oral vaccine (Hodgson, et al. 1994). During this work Hodgson et al. 
(1994) postulated that by creating a pld
-
 strain, its usefulness as live oral vaccine was reduced 
since it no longer contained one of the major immunodominant antigens (Hodgson, et al. 
1994). In order to overcome this, the researchers subsequently used the Toxminus strain to 
introduce a plasmid borne copy of PLD which had been mutated in such a way that it secreted 
inactive PLD (Hodgson, et al. 1994). The PLD-encoding gene was toxoided by site 
specifically mutating PLD His-20 to Tyr, a substitution which had been shown previously to 
remove enzymatic activity (Haynes, et al. 1992). However, in contrast to subcutaneous 
vaccination of sheep with Toxminus, oral vaccination did not provide significant protection 
against challenge with wild-type C. pseudotuberculosis (Hodgson, et al. 1994). Using a goat 
infection model McNamara et al. (1994) also assessed the utility of a C. pseudotuberculosis 
pld
-
 variant as a live attenuated vaccine. The researchers mutated the PLD-encoding gene of a 
Whetten 1 goat strain of C. pseudotuberculosis by replacing it with an allele containing a 
nonsense mutation. Subsequently, virulence of the mutant strain (designated W1.31r1) was 
compared to wild-type by inoculating goats (McNamara, et al. 1994). The researchers 
demonstrated that the mutant bacteria had a greatly reduced ability to induce a clinical 
response in goats (McNamara, et al. 1994). However, neither of these C. pseudotuberculosis 
mutants have been suitable for use as live attenuated vaccines due to the infection at the sites 
of inoculation being indistinguishable to that of wild-type.   
 
Subsequent to the release of Glanvac™, other commercial CLA vaccines have been 
developed, including Case-Bac and Caseous D-T (Colorado Serum Laboratories; Denver, CO, 
USA) which are either based on killed whole-cell preparations or toxoided PLD.  However, 
these latter vaccines are of unproven efficacy and are unlicensed for use outside of their 
country of origin (USA). 
 
To date there is no routinely-licensed vaccine available in the UK for use against CLA.  
However, the production of a so-called ―autogenous‖ CLA vaccine is possible under an 
emergency license issued by the Veterinary Medicines Directorate (VMD). Autogenous 
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vaccines are adjuvanted bacterins derived from C. pseudotuberculosis isolates from flock 
outbreaks. These vaccines are only intended for use in animals on the holding in which the 
strain used to prepare the vaccine has derived (Fontaine, et al. 2006).  Unfortunately, however, 
in addition to the relatively high cost of preparation, there is very little data available to 
support the efficacy of these vaccines. Fontaine et al. (2006) assessed an experimental 
autogenous vaccine (formalin-killed C. pseudotuberculosis) and showed that it was sufficient 
to prevent the spread of the C. pseudotuberculosis challenge strain beyond the site of 
inoculation in an ovine experimental model of CLA. Although these results confirm that 
autogenous vaccination does confer significant protection, it is not known what the exact 
formulation of the commercial autogenous vaccine is, and whether an equivalent level of 
protection can be achieved with this vaccine, especially under field conditions.  In addition, it 
is unknown whether an autogenous vaccine will confer protection against infection with 
heterologous C. pseudotuberculosis strains.  In this respect, it has been shown by PFGE 
analysis that more than a single strain of C. pseudotuberculosis may be in circulation within a 
single flock at any given time, presumably due to multiple importations of the disease through 
purchase of new animals, etc. (Fontaine, et al. 2006).  
 
The ability of Glanvac™ to protect against experimental challenge with a heterologous UK C. 
pseudotuberculosis strain (heterologous because the PLD in Glanvac™ was derived from a 
different strain to that used for the challenge) was recently assessed, and this work described 
the only scientific investigation into the capacity of Glanvac™ to protect against the UK form 
of CLA (Fontaine, et al. 2006). It was demonstrated that, overall, the prevalence of C. 
pseudotuberculosis-infected loci was reduced within Glanvac™ immunised animals as 
compared to unvaccinated, challenged control animals; however, only one of six vaccinated 
animals appeared completely free from infection, while the others had infections at multiple 
internal loci. It was therefore concluded that Glanvac™ was not able to prevent the 
dissemination of the challenge strain beyond the primary site of infection; however, it was 
interesting to note that none of the vaccinated animals were found to have lung lesions 
(Fontaine, et al. 2006).  Glanvac™ was never licensed for use within the European Union; 
however, this has not prevented sheep producers from (legally) purchasing the vaccine from 
abroad and (illegally) administering it to their animals. This introduced a potential 
complication with respect to a newly-introduced CLA diagnostic test (so-called ―Elitest 
CLA‖; M. C. Fontaine, unpublished data), which is currently provided on a UK-wide 
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flock/group-testing basis by the Scottish Agricultural College (Perth Veterinary Centre, Bertha 
Park View, Perth, Perthshire, Scotland).  The test, described in a preliminary form by Fontaine 
et al. (2006), utilises a recombinant PLD protein to detect anti-PLD antibodies in sheep with 
CLA, using an ELISA-based procedure (Fontaine, et al. 2006).  Given that Glanvac™ is also 
PLD-based, there was the possibility that illegally-vaccinated animals would cause false-
positive reactions in the blood test, which would be unlikely to be explained due to lack of 
information regarding vaccine usage.  However, the purchase of the vaccine in the UK has 
recently become possible under an emergency license which may be issued by the VMDAs 
such, by removing the illegality of the use of Glanvac™, it is hoped that producers will be 
more likely to report the use of the vaccine when they sell-on their animals, so that prospective 
buyers can bear this in mind when deciding whether to undertake CLA blood-testing. 
 
As part of the same experiment involving the assessment of Glanvac™ in the UK, Fontaine et 
al. (2006) also assessed the efficacy of a recombinant PLD protein (rPLD) and a killed whole-
cell vaccine supplemented with rPLD to protect against infection with the homologous C. 
pseudotuberculosis strain. Significantly, the rPLD vaccine (which had been completely 
inactivated by treatment with SDS) induced a greater level of protection than had been 
observed with Glanvac™. Although it was acknowledged that the experimental rPLD vaccine 
was derived from the challenge strain (whereas Glanvac™ was not), the overall similarity 
between the PLD sequences in different C. pseudotuberculosis strains is so great that there 
was essentially nothing to discriminate between homologous and heterologous challenge in 
this case.  It would therefore seem that the recombinant derivative of PLD conferred greater 
protection than Glanvac™, which is in contrast to a previous study in Australia, whereby it 
was found that a recombinant, inactivated derivative of PLD did not induce the same level of 
protection in vaccinated animals as Glanvac™ did (Burrell, 1983).  In addition, the results of 
the Fontaine et al. (2006) study would tend to disprove the hypothesis that residual PLD 
activity in PLD-based vaccines is required for protection. In their study, Fontaine et al. (2006) 
also used a combined rPLD and formalin-killed whole cell vaccine, and demonstrated that this 
combination conferred 100% protection against experimental infection of sheep with C. 
pseudotuberculosis (Fontaine, et al. 2006).  
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1.7 Iron-regulated proteins as vaccines  
 
Iron is essential for life, and bacteria have developed numerous mechanisms by which they 
obtain it from their immediate environment.  As a result of the absolute requirement for it, 
interference with iron-acquisition mechanisms can lead to the death of the bacterial cell.  As a 
result,  the proteins involved in iron-acquisition have been targeted in the development of 
novel vaccines, and to date there have been several publications documenting the successful 
application of such vaccines (Banerjee-Bhatnagar & Frasch, 1990; Chhibber & Bajaj, 1995; 
Chibber & Bhardwaj, 2004; Gilmour, et al. 1991). Early studies, such as that conducted by 
Banerjee-Bhatnagar et al. (1990) described the potential use of iron-regulated proteins (IRPs), 
including a 70 kDa transferrin receptor, as components in a vaccine against group B 
meningococcal disease. The researchers noted that their vaccine, which was an outer 
membrane protein preparation from bacteria grown under low-iron conditions in order to 
induce expression of IRPs, induced significant levels of anti-IRP antibodies.  However, 
despite postulating the use of IRPs as a vaccine, and noting that IRPs are major outer 
membrane proteins expressed in vivo and are required for bacterial survival, the researchers 
did not assess vaccine efficacy in their study (Banerjee-Bhatnagar & Frasch, 1990). In 1991, 
Gilmour et al. assessed the efficacy of a vaccine containing Pasteurella haemolytica sodium 
salicylate extract (SSE) and IRPs (the latter having been induced by growth under low-iron 
conditions) in the protection against an experimental model of lamb pasteurellosis (Gilmour, 
et al. 1991). During the trial the group also tested a vaccine containing SSE only (previously 
shown to confer protection against a different strain of P. haemolytica). Interestingly, the 
researchers demonstrated significant protection (p <0.005) against P. haemolytica using the 
vaccine which incorporated both SSE and IRPs whereas the SSE only vaccine did not confer 
protection against the strain under investigation.  The researchers proposed that the enhanced 
protection observed with the SSE-IRP vaccine was as a direct result of the IRPs.  Furthermore, 
they also suggested that the IRPs may have enhanced the protective efficacy of their vaccine 
by stimulating the production of antibodies to antigens produced in vivo in response to 
naturally provoked iron depletion (Gilmour, et al. 1991).  
 
Subsequent to these initial reports, other groups have studied the use of IRPs as vaccine 
candidates. Using a rat infection model, Chibber and Bajaj (1995) investigated the 
immunogenicity of a polysaccharide-iron-regulated cell surface protein conjugate vaccine 
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against Klebsiella pneumoniae-induced lobar pneumonia (Chhibber & Bajaj, 1995). The 
vaccine was found to be highly protective in a rat infection model, influencing a decrease in 
bacterial counts by 3.17 log cycles (Chhibber & Bajaj, 1995). A much later publication 
described protection against infection in a mouse experimental model of peritonitis, elicited by 
iron-regulated outer membrane proteins (IROMPs) of Salmonella typhi (Chibber & Bhardwaj, 
2004). In that study the researchers used a conjugative vaccine consisting of S. typhi 
polysaccharide and IROMPs which had been prepared from the same strain.  The vaccine 
preparation was tested in male BALB/c mice, and following two vaccinations the animals 
were challenged intraperitoneally with 10
9 
organisms per ml of S. typhi. Quantitative bacterial 
counts determined from the spleens, Peyer‘s patches and livers of mice immunised with the 
conjugated vaccine demonstrated a 4-fold decrease in bacterial counts compared to 
unvaccinated mice (Chibber & Bhardwaj, 2004). The researchers noted that the conjugate 
vaccine elicited both a humoral and cell-mediated immune response. It was postulated that the 
higher antibody levels seen with the conjugate compared to the controls (where animals were 
separately immunised with each subunit component of the conjugate vaccine) may have 
contributed towards the protection against challenge, since antibodies against IROMPs have 
been shown to interfere with iron uptake, leading to protection of mice against infections 
(Banerjee-Bhatnagar & Frasch, 1990; Lucier, et al. 1996).  
 
A recent investigation by Aranda et al. (2009) employed a slightly different approach to study 
the protective capacity of iron-regulated proteins (Aranda, et al. 2009). The researchers 
created a double knockout of a Streptococcus suis strain to create a mutant which was 
deficient in both the zinc/manganese regulator (adcR) and the iron-uptake regulator (fur). The 
mutant strain, designated UA5002 AdcR
-
/ Fur
-
, overexpressed a set of immunogenic, cell-
surface proteins, which were able to confer significant protection against S. suis challenge in a 
mouse model of infection (Aranda, et al. 2009).  
 
1.8 Iron-homoeostasis      
 
Although iron is an essential requirement for most living organisms, unless its concentration is 
tightly-regulated it is highly toxic. Under physiological conditions, iron exists mainly in the 
extremely insoluble ferric form (Fe
3+
); however, in the presence of molecular oxygen, it reacts 
via the Fenton reaction to produce highly-reactive oxygen species (ROS), hydroxyl radicals 
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and ferryl iron (Touati, 2000).  Excess ROS (Greenberg & Demple, 1989) are detrimental to 
living organisms, resulting in DNA damage (Touati, 2000). Due to excess iron being highly 
toxic to the host as well as the pathogen, availability of iron within extracellular fluid and on 
the mucosal surfaces is highly restricted; in mammals this is achieved by sequestration of free-
iron by iron-binding glycoproteins. The predominant mammalian iron-binding protein in 
serum and extracellular fluid is transferrin, whereas lactoferrin dominates in mucosal 
secretions and milk (Andrews, et al. 2003; Wooldridge & Williams, 1993). Other important 
sources of iron within the host are haem-containing proteins, such as haemoglobin. It is 
estimated that serum contains as much as 1.56 mg/ml of iron (Burriel & Heys, 1997); 
however, much of this is not readily accessible to bacterial pathogens (Litwin & Calderwood, 
1993).   
 
For bacterial pathogens, the availability (or otherwise) of iron contributes to successful 
colonisation or clearance from the host.  As a result, one arm of the mammalian non-specific 
immune defence has evolved to exploit this iron requirement. During infection, iron 
availability is limited by the host in a process known as hypoferremia, which has been 
recognised as a component of the acute-phase response (Litwin & Calderwood, 1993; Otto, et 
al. 1992). The mechanisms of hypoferremia are poorly understood, however, it can be induced 
by intact microbes and certain microbial products such as endotoxin and mycolic acid, and is 
mediated through the increased release of various cytokines (interleukin-1 and tumour 
necrosis factor alpha in particular (Beutler & Cerami, 1987; Dinarello, 1984)). As a result, iron 
saturation in serum decreases concurrently with an increase in the level of transferrin, which 
binds free-iron, rendering it inaccessible (Litwin & Calderwood, 1993; Muller, et al. 1983; 
Weinberg, 1984). In addition, during the inflammatory response, the level of lactoferrin within 
the blood is also increased. The release of apo-lactoferrin by leukocytes occurs during 
degranulation and phagocytosis, which, in turn, increases the local concentration of lactoferrin 
at sites of infection (Leffell & Spitznagel, 1975; Wright & Gallin, 1979).  Interestingly, 
several studies have shown that animals whose serum levels of iron have been reduced by an 
iron-deficient diet, show increased resistance to bacterial infection.  Moreover, resistance to 
infection is reversed if the iron deficient host is injected with sufficient iron to restore levels to 
that of normal serum (Hart, et al. 1982; Puschmann & Ganzoni, 1977).  
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1.9 Genes Involved In Iron Sequestration  
 
Bacteria have evolved a number of diverse mechanisms which enable them to scavenge iron 
from their environment, whether it be in or out of a mammalian host.  Furthermore, because 
iron-limitation is such an important factor, the expression of many of these genes is regulated 
in direct response to the levels of environmental iron (Hantke, 2001). A common method of 
iron acquisition is through the production and secretion of low molecular weight, high-affinity, 
iron-scavenging molecules known as siderophores (which are discussed in detail in Chapter 
6).  
 
Significantly, bacteria which have been genetically-manipulated to be deficient in the 
biosynthetic or transport apparatus required for siderophore production and utilisation, are not 
always restricted in their ability to colonise and persist within the host.  This is because, in 
addition to siderophores, bacteria have also evolved other mechanisms of obtaining iron from 
their environment, which is somewhat unsurprising given the importance of iron to the cell.  
Certain bacteria possess ―siderophore-independent‖ mechanisms of iron acquisition, the best-
characterised of which involve the direct binding of the host iron-binding protein (e.g. 
transferrin, lactoferrin and haemoglobin) to substrate-specific receptors located on the outer 
membrane, prior to transport of the bound protein into the cell.  The receptors, Transferrin-
binding proteins (Tbps), involved in the binding of transferrin and lactoferrin have been well 
studied in Gram-negative pathogenic Neisseria and Haemophilus species (Mietzner & Morse, 
1994). The process of iron delivery is via a periplasmic-binding protein-mediated active 
transport mechanism involving the Ferric iron-binding protein (Fbp) (Mietzner & Morse, 
1994). In contrast, siderophore-independent mechanisms of iron acquisition are less well 
understood in Gram-positive bacteria.  In Mycobacterium avium subsp. paratuberculosis, an 
extracellular ferric reductase has been identified, which is able to remove iron from ferric 
ammonium citrate, ferritin and transferrin by reduction of the metal (Rodriguez & Smith 
2004). In C. diphtheriae, a study by Schmitt et al. (1997) demonstrated that the organism was 
able to utilise iron from haem and haemoglobin when in an iron-limited growth environment 
(Schmitt, 1997b). Later, several genes involved in haem utilisation were identified in C. 
diphtheriae (Schmitt, 1997b; Wilks & Schmitt, 1998), including hmuO, encoding the first 
bacterial haem oxygenase.  Subsequent work to assess the function of HmuO, by sub-cloning 
and expression of the protein in E. coli, revealed that the enzyme had haem-cleaving activity 
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and enabled C. diphtheriae to obtain iron from haem-containing compounds such as 
haemoglobin (Wilks & Schmitt, 1998).   
1.10 Microbial “sensing” of the environment  
 
In order to adapt to diverse niches, bacteria are required to sense and respond to their 
environment. Such environmental conditions include temperature, pH and ion concentration, 
including iron. The ―sensing‖ mechanism is achieved by bacterial regulatory proteins which 
adapt accordingly to changes in environmental conditions. Regulation occurs by both 
activation and repression of gene expression by so-called stand-alone transcriptional 
regulatory proteins (e.g. Zur (Smith, et al. 2008)) and by two-component regulatory systems 
(e.g. PhoR/S (Kocan, et al. 2006)). Stand-alone transcriptional regulatory systems involve a 
receptor protein forming a complex with a specific ligand (in the case of Zur, the ligand is zinc 
(Smith, et al. 2008)); subsequently, the receptor/ligand complex is able to function directly as 
a transcriptional activator or repressor by binding to specific promoters, which leads to the 
modulation of gene expression (Miller, et al. 2007). In contrast to the relatively simple stand-
alone regulators, two-component regulatory systems are more complex since they involve a 
membrane-bound sensor histidine kinase (the first component) which is required to 
phosphorylate a transcriptional activator (the second component) which is then able to regulate 
gene expression (Miller, et al. 2007).  Briefly, on stimulation by an extracellular signal the 
histidine kinase domain of the sensor protein is autophosphorylated. Signal transduction takes 
place when the phosphoryl group is transferred to the equivalent response regulator protein. 
Phosphorylation of the regulator protein subsequently adjusts its binding affinity for target 
promoter regions, and, as a result this affects the frequency of transcription of specific genes 
or operons (Graham, et al. 2002).  
 
Often, an interrelationship between groups of genes which are controlled by different 
regulatory proteins exists. In such situations, one regulator is able to exert an affect on the 
expression of another regulator, thus allowing the ―global‖ co-ordination of expression of 
multiple groups of genes required for multiple different processes and produced in response to 
varying environmental stimuli. Several examples of such ―global regulatory networks‖ have 
been described, one example being the Control of virulence Regulator‖ (CovR) of 
Streptococcus pyogenes. CovR is part of a two-component regulatory system (CovR/S) which 
negatively controls expression of both proven and putative virulence factors, including capsule 
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and cysteine protease (Graham, et al. 2002). The expression of these virulence-associated 
genes is regulated in response to growth phase and the external environment of the bacteria 
(Churchward, 2007).  The CovR/S system regulates, either directly or indirectly (by 
influencing the expression of genes encoding other transcriptional regulators), 15% of the 
genes within the S. pyogenes genome (Graham, et al. 2002).  
 
1.11 Iron-regulation in corynebacteria 
 
Very little is known about the differential expression of C. pseudotuberculosis genes in 
response to environmental iron concentrations (or any other condition for that matter); 
however, there has been a significant amount of research conducted on this subject in other 
corynebacteria, principally C. diphtheriae and C. glutamicum.  In C. diphtheriae, the principle 
virulence determinant is diphtheria toxin (DT), which the organism must produce in order for 
it to cause the severe respiratory disease, diphtheria.  Diphtheria toxin is an A-B toxin that 
catalyses the ADP-ribosylation of a host cell protein essential for protein synthesis (Salyers, 
1994). So called A-B toxins are composed of two parts, these being an enzymatically-active 
portion, and a receptor-binding portion (Salyers & Whitt 1994). In the case of DT, susceptible 
cells are killed by the toxin catalyzing ADP ribosylation of elongation factor 2 (EF 2), 
resulting in the inhibition of protein synthesis (Collier, 1967; Honjo, et al. 1971; Iglewski & 
Kabat, 1975). Significantly, DT is extremely toxic with a lethal dose of ca. 0.1 μg/kg body 
weight for humans and susceptible animals (Holmes, 2000).  
 
In 1936, Pappenheimer and Johnson demonstrated that the addition of low concentrations of 
iron to the growth medium resulted in the inhibition of DT production by C. diphtheriae 
(Pappenheimer, & Johnson 1936). It was later found that DT was expressed at maximal levels 
only during the ―decline phase‖ of the bacterial growth cycle, when iron becomes a growth 
rate-limiting substrate (Pappenheimer, 1955). It was noted some years ago that DT, despite 
being essential for the development of diphtheria, is not produced by all C. diphtheriae strains.  
Those strains without DT were generally regarded as nontoxigenic, and infections with these 
strains tended to manifest as superficial, self-limiting sore throat and cold-like symptoms.  
However, more recently there have been documented cases in which systemic disease has 
resulted from infection with a nontoxigenic C. diphtheriae isolate (Zasada, et al. 2005), and it 
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is currently thought that these nontoxigenic  isolates could act as a reservoir for the re-
emergence of toxigenic C. diphtheriae strains in the UK (De Zoysa, et al. 2005).  Uchida et al. 
(1971) demonstrated that rather than being a normal component of the C. diphtheriae genome, 
the DT structural gene, tox, was in fact carried by several corynebacteriophages, including the 
well characterised phage β (Uchida, et al. 1971).  Lysogeny of susceptible strains with tox-
carrying (tox
+
) corynebacteriophages was essential to allow production of DT; however, the 
expression of the tox gene itself was shown to be dependent on the physiological state of the 
host bacterial cell (Murphy, et al. 1974). Using an E. coli system to express DT from β-phage 
DNA, Murphy et al. (1974) proved that the synthesis of DT was not dependent on iron alone. 
The addition of iron to the medium had no affect on the synthesis of DT and other phage-
encoded proteins, whereas the addition of C. diphtheriae extracts resulted in differential 
expression of DT with and without iron supplementation (Murphy, et al. 1974).  Therefore, the 
expression of the tox gene was clearly shown to be dependent on the physiological state of the 
natural bacterial host.  
 
The observation that the physiology of toxigenic C. diphtheriae strains influenced tox 
expression led to the hypothesis that the organism carries a gene encoding an apo repressor, 
which, in the presence of iron, forms an active complex that specifically binds to the tox 
operator thereby blocking transcription of the gene (Murphy & Bacha 1979). This hypothesis 
was confirmed some time later when Boyd et al. (1990) and Schmitt and Holmes (1991) 
described the molecular cloning of an iron-dependent regulatory element; the chromosomally-
encoded Diphtheria toxin Repressor (DtxR) protein (Boyd, et al. 1990; Schmitt & Holmes, 
1991). The dtxR gene encodes a 226 aa polypeptide with a molecular weight of 25,316 kDa, 
which shares some homology to the E. coli Fur protein. In the presence of iron, DtxR was 
shown to bind to a specific DNA motif within the tox operator, preventing the binding of RNA 
polymerase to the tox promoter, thereby preventing transcription of tox.  However, in the 
absence of iron, DtxR was found to be unable to bind the tox operator; thus the iron-dependent 
transcription of tox was proven (Tao, et al. 1994). In addition to DT of C. diphtheriae, the 
expression of other bacterial toxins has also been shown to be repressed in the presence of 
iron. Examples include the Shiga toxin from Shigella dysenteriae type I (Van Heyningen & 
Gladstone, 1953), Shiga-like toxin I from E. coli (Calderwood & Mekalanos, 1987), and 
exotoxin A from Pseudomonas aeruginosa (Bjorn, et al. 1978).  
 
Chapter 1                                                                                                                   General Introduction 
 33 
 
1.12 DtxR-like proteins in other bacteria 
 
Since its discovery, DtxR has become the founding member of a rapidly expanding group of 
bacterial, metal-ion-dependent, regulatory proteins that have been identified in numerous 
Gram-positive and acid fast genera (Feese, 2001), including: Streptococcus (Jakubovics, et al. 
2000; Kitten, et al. 2000), Staphylococcus (Hill, et al. 1998), Bacillus (Que & Helmann, 
2000), Escherichia (Patzer & Hantke, 2001), Treponema (Hardham, et al. 1997),  
Streptomyces (Gunter-Seeboth & Schupp, 1995), Mycobacterium (Doukhan, et al. 1995) and 
Rhodococcus (Boland & Meijer, 2000). The DtxR-like transcriptional regulator has been 
characterised for some of these bacteria, and it has become apparent that they can be neatly 
divided into two distinct groups, defined by the ability of the regulator to exert an affect 
through the binding of either iron or manganese.  
 
Oram et al. (2004) assayed chromosomal DNA from 42 different corynebacterial strains, 
representing 33 different species, for the presence of a highly conserved region of the dtxR 
gene (Oram, et al. 2004). Interestingly, the researchers demonstrated that all strains tested 
incorporated this conserved region, including a strain of C. pseudotuberculosis, ATCC 19410 
(Oram, et al. 2004). Concurrently, a strain of C. pseudotuberculosis, isolated from a sheep in 
an outbreak of CLA in the Scottish Borders (Connor, et al. 2000), was assessed for the 
presence of a dtxR-like gene (Malloy, 2004); a ca. 0.3 kb PCR product was amplified from 
this strain using oligonucleotide primers based upon conserved regions within the dtxR genes 
of other sequenced corynebacteria, and subsequent analysis of sequence of the PCR product 
revealed that it encoded a fragment of a C. pseudotuberculosis gene sharing homology with 
the C. diphtheria dtxR gene.  However, despite these findings which suggest the presence of a 
dtxR-homologue in C. pseudotuberculosis, there has yet to be any report of the involvement of 
a DtxR homologue in the regulation of gene expression in this species.  
Following the sequencing of the C. glutamicum genome (Kalinowski, et al. 2003), and the 
subsequent discovery of a DtxR-like protein in this species, several studies ensued. DtxR was 
shown to be vital for the iron-dependent regulation of gene expression in C. glutamicum 
(Brune, et al. 2006; Wennerhold & Bott, 2006). By comparing the global gene expression of a 
dtxR deletion mutant with that of the wild-type using DNA microarrays Wennerhold and Bott 
(2006) determined the DtxR regulon of C. glutamicum (Wennerhold & Bott, 2006). 
Furthermore, a computer-based approach was used to identify putative DtxR binding sites in 
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the C. glutamicum genome. The results demonstrated that around 60 genes are likely to be 
controlled by DtxR in C. glutamicum, thus forming the DtxR regulon. In addition, since 
several of these genes themselves encode transcriptional regulators, such as ripA, it was 
postulated that a multitude of further genes are controlled indirectly by DtxR; hence, C. 
glutamicum DtxR was referred to as a ―master regulator‖ of gene expression (Wennerhold & 
Bott, 2006).   
 
The iron-dependent regulation of gene expression in other actinomycetes, such as M. 
tuberculosis, R. equi and R. erythropolis, occurs through the action of the global regulator, 
IdeR (Boland & Meijer, 2000; Rodriguez, et al. 2002). IdeR is a homologue of the C. 
diphtheriae DtxR protein (Boland & Meijer, 2000; Schmitt, et al. 1995; Tao, et al. 1994), and 
acts in the same way as DtxR, by binding to target DNA sequences in the presence of iron, 
resulting in the repression of gene expression. In M. tuberculosis, IdeR is an essential gene 
(Rodriguez, et al. 2002), however, the same is not true of its non-pathogenic relative M. 
smegmatis, where IdeR has been shown to be non-essential (Dussurget, et al. 1996).  
 
1.13 Overall objectives and aims of the study 
 
Currently there is limited scientific knowledge regarding C. pseudotuberculosis factors 
associated with virulence, and there is essentially nothing known about how these (and other) 
genes are regulated.  The availability of genome sequences has facilitated the expansion of 
knowledge in these areas for other pathogenic bacteria, including the corynebacteria; however, 
at the time the work described in this thesis was initiated, no genome sequence was available 
for C. pseudotuberculosis.  
 
 
Due to the importance of iron for bacterial viability, and the fact that mammalian host species 
restrict the bio-availability of iron, it was considered likely that low environmental iron 
concentrations would be a trigger for the switching on of the expression of C. 
pseudotuberculosis genes involved in host colonisation and persistence, including those 
associated with iron acquisition. This hypothesis was further strengthened by reports of iron-
dependent regulation of virulence gene expression (through DtxR) in the closely-related 
pathogen, C. diphtheriae, and also by the characterisation of the partial sequence of a gene 
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encoding a DtxR-like regulator in C. pseudotuberculosis (Malloy, 2004; Oram, et al. 2004).  
Therefore, with a view to identifying factors associated with C. pseudotuberculosis 
pathogenicity, the overall objective of this study was to determine the effects of iron on gene 
expression, both by analysis of the general response to varying environmental iron 
concentrations, but also by conducting a more in-depth investigation into the possible 
involvement of a DtxR-like transcriptional regulator. In addition to expanding our 
understanding of C. pseudotuberculosis phenotypes associated with growth in a low-iron 
environment (these phenotypes being of relevance to growth in vivo), and of a novel, potential 
C. pseudotuberculosis regulatory mechanism, it was also hoped that these studies would lead 
to the identification of novel virulence-associated determinants that could, in future, be 
exploited for the development of improved diagnostic and preventative reagents for CLA. 
  36 
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2.1 Chemicals 
 
Unless otherwise stated all chemicals were from purchased from Sigma-Aldrich (Sigma-
Aldrich Company Ltd., Dorset, UK), and restriction endonucleases and modifying enzymes 
were purchased from Promega (Promega UK Ltd.; Hampshire, UK). 
 
Sterilisation of media and reagents was achieved by autoclaving (121°C for 15 min) or by 
filtering.  In the latter case, small volumes were sterilised by passage through 0.2 μm pore 
diameter syringe filters (Millipore; Watford, UK), while larger volumes were drawn through 
0.2 µm Stericup
®
 filter units (Millipore) under vacuum.  
 
Oligonucleotide primers were synthesised to-order by Sigma-Genosys Ltd. (Haverhill, 
Suffolk, UK) or by Integrated DNA Technologies (Coralville, IA, USA), and are presented in 
Tables 2.3, 2.4, 2.5 and 2.6.  Stock solutions were prepared by reconstituting lyophilised 
primers to 100 μM in ddH2O. Oligonucleotides were subsequently stored at -20°C until 
required. 
 
2.2 Bacterial strains, plasmids and media 
2.2.1 Escherichia coli  
 
E. coli strains used for general cloning purposes (Table 2.1) were routinely cultured using 
Luria-Bertani (LB) medium or nutrient agar (Appendix one). For maintenance of plasmids 
(Table 2.2), media were supplemented with the appropriate antibiotics at the following 
concentrations: erythromycin (300 μg/ml), kanamycin (50 μg/ml), spectinomycin (100 μg/ml) 
or ampicillin (100 μg/ml ).  
 
2.2.2 Corynebacterium pseudotuberculosis 
 
The C. pseudotuberculosis isolate 3/99-5 used throughout this study was a virulent field 
isolate which originated from an outbreak of CLA in the Scottish Borders (Connor, et al., 
2000). The isolate is nitrate negative, which is typical of ovine isolates of C. 
pseudotuberculosis. This strain has been extensively studied in-house and has been used in the 
Chapter Two                                                                                                          Materials and Methods 
 38 
 
establishment of a standardised ovine experimental model of CLA.  As standard, C. 
pseudotuberculosis isolates were maintained on Brain Heart Infusion (BHI) agar (Oxoid Ltd.; 
Basingstoke, Hampshire, UK), or cultured in BHI broth (Oxoid) supplemented with 0.05% 
(v/v) polyoxyethylene sorbitane monooleate (Tween 80
®
) from a  filter-sterilised 20% (v/v) 
stock solution (Dubos & Middlebrook, 1948; McGinley, et al. 1985a; McGinley, et al. 1985b; 
Riley, et al. 1979). Both BHI broth and agar media were reconstituted as recommended by the 
manufacturer; however, the BHI medium was filter-sterilised prior to use rather than 
autoclaved as previous experience in our lab had shown improved growth of C. 
pseudotuberculosis in filtered medium. Prior to use, 0.05 % (v/v) filter-sterilised Tween 80
®
 
was added and the medium was subsequently referred to as BHIT.  
 
In addition to BHI media, a Corynebacterium chemically-defined medium (CCDM) was 
developed as part of this study (Chapter 3).  For ease of reference, the final, optimised recipe 
is presented here:  Each litre of CCDM consisted of 10.38 g/l RPMI-1640 (Sigma, R 8755), 86 
mM L-glutamic acid and 10 % (w/v) glucose.  Media components were dissolved in 900 ml 
ddH2O prior to adjusting the pH to 4.0 and supplementing with NaHCO3 to 23 μM final 
concentration.  The pH was then adjusted to 7.1 prior to the medium being made up to a final 
volume of 1 l.  The medium was subsequently stored at 4°C protected from light. Prior to use, 
the CCDM was supplemented with 0.05 % (v/v) filter-sterilised Tween 80
®
. Where required, 
BHI and CCDM were supplemented with the appropriate antibiotics, at the following 
concentrations: erythromycin (0.05 μg/ml), kanamycin (50 μg/ml), spectinomycin (100 μg/ml) 
and ampicillin (100 μg/ml). 
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Table 2.1 Bacterial strains  
 
Bacterial strain Genotype Source/Reference 
 
E. coli    
 
electroMax DH5α-E 
 
 
 
(F- φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rk-, mk+) gal- phoA supE44 λ- thi-1 
gyrA96 relA1) 
 
 
 
Invitrogen, UK 
One shot® TOP 10 chemically 
competent cells 
(F- mcrA Δ(mrr-hsdRMS-mcrBC) φ80lacZΔM15 
ΔlacX74 recA1 araD139 Δ(ara-leu) 7697 galU galK 
rpsL (StrR) endA1 nupG) 
Invitrogen, UK 
C. pseudotuberculosis 
 
3/99-5  
 
 
Nitrate-negative virulent field isolate  
 
 
(Connor, et al. 2000) 
C. pstb Δcp40 Serine protease (cp40) deletion derivative of C. 
pstb 3/99-5 
This study  
Cp- ΔdtxR Diphtheria toxin repressor (dtxR) deletion derivative 
of C. pstb 3/99-5 
This study 
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Table 2.2  Plasmid vectors  
Plasmid Description 
Selective 
antibiotic  
Source or reference Chapter 
Zero
®
 Blunt 
TOPO
®
 
Routine E. coli  cloning vector Kanamycin Invitrogen, UK.  5 
pCR
® 
II-TOPO
®
 Routine E. coli  cloning vector Kanamycin Invitrogen, UK. 5 
pCAW001 
Zero
®
 Blunt TOPO
®
 :: inverse PCR 
product from KpnI digested gDNA 
Kanamycin This study 5 
pCAW002 
Zero
®
 Blunt TOPO
®
 :: inverse PCR 
product from HindIII digested gDNA 
Kanamycin This study 5 
pCAW003 
Zero
®
 Blunt TOPO
®
 :: inverse PCR 
product from XbaI digested gDNA 
Kanamycin This study 5 
pSFKT2 Temperature sensitive shuttle plasmid Kanamycin ( Nakamura, et al. 2006) 4 
pG
+
host 9 Source of ermAM Em
r
 gene N/A (Maguin, et al. 1996) 4 
pSPZ lacZ reporter gene containing plasmid Spectinomycin (Oram, et al. 2006) 5/6 
toxP pSPZ :: tox promoter region Spectinomycin (Oram, et al. 2006) 5 
Irp3P pSPZ :: irp3 promoter region Spectinomycin 
R. K. Holmes personal 
communication 
5 
pCAW004 pSPZ :: sigB promoter region Spectinomycin This study 5 
pCAW005 pSPZ :: dtxR promoter region Spectinomycin This study 5 
pCAW006 pSPZ :: galE promoter region Spectinomycin This study 5 
pCAW007 pSPZ :: fagA promoter region Spectinomycin This study 5/6 
pCAW008 pSPZ :: cp40 promoter region Spectinomycin This study 5 
pCAW009 pSPZ :: ORF 02949 promoter region Spectinomycin This study 6 
pCARV001 pCARV ::224bp cp40 fragment Erythromycin This study 4 
pCARV002 pCARV ::432bp cp40 fragment Erythromycin This study 4 
pCARV003 pCARV ::750bp cp40 fragment Erythromycin This study 4 
pCARV004 pCARV ::1020bp cp40 fragment Erythromycin This study 4 
pCARV005 pCARV :: ∆cp40 Erythromycin This study 4 
pCARV006 pCARV :: ∆dtxR Erythromycin This study 5 
pCARV007 pCARV :: ∆02949 Erythromycin This study 6 
pWSK29 E. coli cloning/expression plasmid Ampicillin (Wang & Kushner, 1991) 5 
pWSK29/DtxR pWSK29 :: DtxR Ampicillin This study 5 
pEP2 
Shuttle vector E. coli and 
Corynebacterium 
Kanamycin (Messerotti, et al. 1990) 5 
pCAW010 pEP2 :: DtxR Kanamycin This study 5 
Chapter Two                                                                                                          Materials and Methods 
 41 
 
2.3 Measurement of Bacterial Growth  
 
The Bioscreen C system (Oy  Growth Curves Ab Ltd., Helsinki, Finland) was used to allow 
the automated measurement of bacterial growth characteristics based upon optical density 
measurements at user-defined wavelengths. Essentially, the apparatus is a computer-controlled 
incubator/reader/shaker which uses a unique micro-plate format (10 × 10 wells); with space 
for 2 plates it is possible to run 200 samples simultaneously. The optical density of bacterial 
cultures is recorded over a user-defined period of time and at user-defined time intervals.   
 
The Bioscreen C was used to assess C. pseudotuberculosis growth in a variety of media; 
however, a standard experiment was carried out as follows: Five ml of the desired medium 
was inoculated with a single colony of C. pseudotuberculosis and incubated overnight at 37°C 
with shaking at 225 rpm. The following day 250 µl was taken from a 6 ml aliquot of fresh 
medium and placed into micro-plate, in triplicate (media blank controls). The remaining 
medium was inoculated 1/100 with the overnight culture and a 250 μl aliquot was placed into 
the Bioscreen micro-plate, in triplicate. The machine was then programmed to measure and 
record the growth of the cultures in each well every 15 min, at 37° × 225 rpm. 
 
2.4 Nucleic Acid Extraction and Purification 
2.4.1  Small scale extraction and purification of plasmid DNA 
 
For routine analysis of recombinant clones, rapid extraction and purification of plasmid DNA 
from E. coli was performed using the QIAprep Spin Miniprep Kit (Qiagen; Qiagen Ltd., West 
Sussex UK.). The procedure was carried out according to the manufacturer‘s instructions and 
employs a modified alkaline lysis method (Birnboim & Doly, 1979) combined with the use of 
silica membrane-containing microcentrifuge spin columns to purify plasmid DNA. Briefly, a 5 
ml overnight culture of E. coli, propagated in LB broth containing an appropriate selective 
antibiotic, was centrifuged at 3, 893 × g for 15 min at 4°C. The resulting bacterial pellet was 
re-suspended in 250 μl of buffer P1, containing RNase, and subsequently transferred to a fresh 
microcentrifuge tube. Two hundred and fifty µl of buffer P2 was added to the solution and the 
tube was mixed thoroughly. Following this step, 350 µl of buffer N3 was added and mixed 
well by inverting of the tube. The tube was then centrifuged at 17, 970 × g for 10 min at room 
temperature in a microcentrifuge, and then the cleared supernatant was transferred to a 
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QIAprep spin column which was subsequently centrifuged, as before, for 1 min.  The column 
was washed with 750 µl of buffer PE and centrifuged twice for 1 min, as before, to ensure the 
complete removal of residual ethanol. The spin column was then placed into to a clean 
microcentrifuge tube and 30 μl of elution buffer (10 mM Tris-HCl, pH 8.0) was added directly 
to the surface of the silica membrane. The tube was then incubated for 1 min at room 
temperature before eluted plasmid DNA was collected in the microcentrifuge tube by 
centrifugation as before for 1 min.   
 
2.4.2 Large scale extraction and purification of plasmid DNA  
 
To provide large quantities of highly-pure plasmid DNA for procedures such as cloning, DNA 
sequencing, etc., the QIAprep Maxiprep Kit (Qiagen) was employed.  The principle of this 
procedure was identical to that of the miniprep procedure above (Section 2.4.1), whereby cells 
were lysed using a slightly modified version of the alkaline lysis method described by 
Birnboim and Doly (1979).  In addition, the use of spin columns was replaced by gravity flow 
columns, to ensure reduced contamination of plasmid preparations with E. coli chromosomal 
DNA.  So as not to overload the binding-capacity of the silica resin in the columns, a 
maximum of 100 ml of cultures of E. coli containing high-copy-number plasmids or 500 ml of 
cultures of E. coli containing low-copy-number plasmids was used. Briefly, a single colony of 
E. coli transformed with the desired plasmid was used to inoculate 5 ml of LB medium 
containing the appropriate selective antibiotic. After incubation overnight at 37°C × 225 rpm, 
the culture was diluted 1/500 into LB broth containing the appropriate antibiotic. This culture 
was incubated overnight, as before, prior to harvesting bacteria by centrifugation at 3, 893 × g 
for 15 min at 4°C. The bacterial pellet was thoroughly re-suspended in 10 ml of buffer P1, 
prior to the addition of 10 ml of buffer P2.  Subsequently, following thorough mixing of the 
tube contents by gentle inversion of the tube 4-6 times, cells were lysed during a 5 min 
incubation at room temperature. Finally, the lysate was neutralised by addition of 10 ml of 
chilled buffer P3; the tube contents were immediately mixed by gentle inversion 4-6 times, 
followed by incubation on ice for 20 min. The lysate was subsequently cleared by filtration 
through a 1 μM syringe filter (Millipore). A Qiagen-tip 500 (column) was equilibrated by the 
addition of 10 ml buffer QBT.  The filtered lysate was added to the equilibrated Qiagen-tip 
500 and allowed to empty by gravity flow. Subsequently, the column was washed twice with 
30 ml buffer QC prior to elution of plasmid DNA with 15 ml of buffer QF.  To precipitate 
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DNA, 10.5 ml of isopropanol was added to the eluate, and immediate centrifugation was 
conducted at 9,500 × g for 15 min at room temperature. The resulting DNA pellet was washed 
with 5 ml of 70 % (v/v) ethanol and centrifuged as above for 10 min.  Finally, the supernatant 
was carefully decanted and the pellet was allowed to air dry prior to re-suspension in a suitable 
volume of ddH2O.  
 
2.4.3  Extraction and purification of C. pseudotuberculosis genomic DNA 
 
Genomic DNA was harvested from cells from 5 ml overnight cultures of C. 
pseudotuberculosis, propagated in BHIT.  Cells were harvested by centrifugation at 3,893 × g 
for 15 min at 4°C. Immediately before use, 5 mg of lysozyme was dissolved in 500 μl of 
buffer P1 (Appendix one). In addition 2 µl/ml RNAse A (10 mg/ml) was added to the buffer 
P1/lysozyme solution which was subsequently used to re-suspend the cell pellet. Following 
incubation at 37°C for at least 1 hr, the cell suspension was transferred to a 1.5 ml tube 
containing ca. 500 μl of 10 μm diameter zirconium beads.  Homogenisation was then 
performed for 3 × 20 sec at a speed rating of 5.5 on a FastPrep® instrument (Q.Biogene; 
Middlesex, UK).  The tubes were then centrifuged briefly in at 17, 970 × g in a 
microcentrifuge and the supernatant was transferred to a fresh 1.5 ml microcentrifuge tube.  
Then, 5 mg proteinase K and 50 µl of a 10 % (v/v) solution of N-lauryl-sarcosine were added 
to the supernatant prior to a further overnight incubation at 55°C. Following this incubation, 
the DNA was extracted with 500 μl of phenol:choloroform:isoamyl alcohol (25:24:1); the 
solution was mixed by gently inverting the tube numerous times, and then centrifugation was 
performed at 17,970 × g for 5 min at room temperature. The top layer of the supernatant was 
transferred into a clean 1.5 ml microcentrifuge tube and a further round of extraction was 
carried out with cholorofom:isoamyl alcohol (24:1). Subsequently, the DNA was precipitated 
by addition of 2 volumes of absolute ethanol and 0.1 volumes of 3 M sodium acetate (pH 5.2). 
Precipitated DNA was harvested by centrifugation at 17,970 × g for 20 min at 4°C, and the 
resulting pellet was washed by addition of 500 μl of 70 % (v/v) ethanol and centrifuging as 
before for 10 min.  Finally, the ethanol was carefully decanted, and the DNA pellet was air–
dried prior to re-suspension in 50-100 μl of ddH20.  
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2.4.4 Isolation of genomic DNA for Colony PCR 
 
Two-hundred μl of well shaken Insta-Gene™ Matrix (Bio-Rad; Bio-Rad laboratories Ltd., 
Hertfordshire, UK.) was placed into a 1.5 ml microcentrifuge tube. Using a toothpick, a single 
colony of C. pseudotuberculosis was transferred into the Insta-Gene™ Matrix solution. The 
mixture was then vortexed briefly before being placed in a hot-block at 100°C for 8 min. The 
solution was then vortexed again prior to being centrifuged at 17, 970 × g for 3 min in a 
microcentrifuge. The DNA-containing supernatant was then transferred to clean 1.5 ml 
microcentrifuge tube, and between 3-20 μl was used as template in subsequent polymerase 
chain reactions.  
 
2.4.5 Extraction and purification C. pseudotuberculosis RNA  
 
C. pseudotuberculosis total RNA was extracted and purified based upon a method described 
by Huser et al. (2003) which employs the RNeasy mini kit (Qiagen) with some modifications 
(Huser, et al., 2003). Briefly, a single colony of C. pseudotuberculosis was used to inoculate 5 
ml of medium which was subsequently incubated at 37°C × 225 rpm overnight. The culture 
was diluted 1/100 into 5 ml of fresh medium and the bacteria were grown to mid log phase 
before being harvested at 3,893 × g at 4°C. The entire supernatant was removed and the pellet 
was immediately snap-frozen in a dry ice/ethanol bath. The pellet was then re-suspended in 1 
ml of RLT buffer (containing 10 µl of β-mercaptoethanol). To achieve 5×109 bacterial cells 
(previously shown to result in an optimal yield of RNA) a 500 µl aliquot of the suspension 
was taken and made up to 800 μl with RLT. The suspension was transferred to a screw cap 
tube containing ca. 500 µl of 10 μm zirconium glass beads. The beads/cells suspension was 
homogenised twice in the Fast prep® instrument (Q.Biogen) at a speed rating of 6.5 for 30 sec 
with a 5 min interval on ice. Following homogenisation the tube was centrifuged briefly in a 
microcentrifuge at 17, 970 × g to pellet the beads and cell debris. The supernatant, containing 
the RNA was transferred to a clean 1.5 ml tube and 250 μl of absolute ethanol was added and 
mixed by pipetting. The sample was then transferred to an RNeasy mini column and 
centrifuged for 15 sec at 10,000 × g. At this stage, on-column digestion of genomic DNA with 
DNase I was carried out using the RNase-free DNase set (Qiagen) according to the 
manufacturer‘s instructions.  Briefly, 350 µl of buffer RW1 was pipetted into the RNeasy mini 
column and centrifuged for 15 sec at at least 10,000 × g. Following this wash, 10 μl of DNase 
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I stock solution was added to 70 μl of buffer RDD and the solution was mixed gently by 
inverting the tube; this was then pipetted directly onto the membrane of the RNeasy column 
and incubated at room temperature for 15 min. The column was washed with 350 μl of buffer 
RW1 followed by centrifugation for 15 sec at 10,000 × g. Following the DNase I digestion the 
column was washed twice with 500 μl of buffer RPE, the first time by centrifuging for 15 sec 
at 10,000 × g and the second time for 2 min.  Subsequently, following removal of the RPE 
flow-through, the RNeasy mini column was further centrifuged, as before, to eliminate any 
carry-over of RPE buffer which may interfere with the amplification of cDNA from the RNA. 
The RNeasy mini column was transferred to a fresh 1.5 ml microcentrifuge tube, and total 
bacterial RNA was eluted from the column by adding 50 μl of RNase free water directly to the 
silica resin in the column and centrifuging for 1 min at 10,000 × g.   
 
Prior to using the purified mRNA in RT-PCR experiments, a further round of DNase I 
digestion was performed to ensure complete removal of contaminating DNA.  This was 
achieved using amplification grade DNase I (Invitrogen), according to the manufacturer‘s 
instructions.  Briefly,  1 µg of RNA was transferred to a 0.2 ml RNase-free tube, to which was 
added 1× DNase I reaction buffer and 1 U DNase I.  The reaction volume was made up to 10 
μl with RNase free water, and incubation was perfored at room temperature for 15 min. The 
DNase I was then deactivated by heating to 65°C for 10  min in the presence of  25 mM 
EDTA.  Subsequently, RNA was stored at -20°C for subsequent use. 
 
2.5 General DNA manipulations  
 
2.5.1 Restriction endonuclease digests 
 
Restriction endonuclease digestions were conducted, essentially as detailed in the 
manufacturer‘s supplied instructions.  Digests were performed in 1.5 ml microcentrifuge 
tubes, containing the appropriate  restriction endonuclease reaction buffer to 1× final 
concentration, a final concentration of  acetylated BSA of 0.1 μg/μl, an appropriate volume of 
ddH2O and ca. 5-10 U of restriction endonuclease per μg of DNA.  To minimise star activity, 
restriction digests were performed in sufficient volumes to ensure that the final concentration 
of glycerol (from the restriction enzyme storage buffer) was ≤10 % (v/v). Subsequently, 
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restriction digests were incubated at the recommended temperature for the enzyme for 
between 1-4 hrs.   
2.5.2 Dephosphorylation of DNA  
 
Shrimp alkaline phosphatase (SAP) was used to remove the phosphate groups of digested 
vector DNA to prevent re-circularisation of vector during ligation reactions.  
Dephosphorylation was performed in 30-50 µl reaction volumes, containing 1× SAP buffer 
and 1 U SAP per µg DNA. Reactions were incubated at 37°C for 15 min, prior to heat 
inactivation at 65°C.  
 
2.5.3 End-filling of DNA fragments  
 
The large (Klenow) fragment of DNA polymerase I (Invitrogen) was used to fill-in sticky-
ended restriction endonuclease termini or to remove the 3‘-adenine residue frequently 
incorporated into amplified DNA fragments during PCR with Taq polymerase. Reactions were 
conducted in 30 μl volumes, containing 1× React® 2 buffer (Invitrogen), 66 μM final 
concentration of each of dATP, dTTP, dCTP and dGTP, between 0.5-1.0 μg of DNA and 0.5 
U of Klenow polymerase (from a 0.5 U/μl stock solution prepared by diluting the enzyme in 
Klenow Dilution Buffer (Invitrogen)).  Reactions were mixed briefly by vortexing, centrifuged 
briefly at 17, 970 × g in a microcentrifuge, and then incubated for 20 min on ice.  
Subsequently, reactions were terminated by the addition of 0.6 μl of 0.5 M EDTA followed by 
heat-inactivation of the enzyme at 75°C for 20 min.  The resulting blunt-ended DNA was 
ready for use in blunt-cloning reactions. 
 
2.5.4 Ligation of DNA fragments 
 
Ligations were performed according to the traditional method employing T4 DNA ligase, or 
by using a Quick Ligation Kit purchased from NEB (New England Biolabs UK Ltd., 
Hertfordshire, UK). For the former method, ligation reactions were conducted in 20 μl 
volumes, containing 1× Ligase Buffer (containing ATP), a 1:9 ratio of vector:insert DNA and 
2 Weiss Units of T4 DNA ligase. Reactions were incubated overnight at 4°C in a chilled water 
bath, prior to heat inactivation of the ligase at 65°C for 10 min.   
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Quick ligations were conducted according to the manufacturer‘s supplied instructions.  
Briefly, for each ligation, 50 ng of vector DNA was combined with a 3-fold molar excess of 
insert in a clean 1.5 ml microcentrifuge tube and the mixture was made up to a final volume of 
10 μl. Ten μl of 1× Quick ligation reaction buffer was added to the tube. The tube was then 
vortexed briefly and 1 μl of Quick T4 DNA ligase was added and mixed again by vortexing. 
The reaction was centrifuged briefly at 17, 970 × g in a microcentrifuge at room temperature, 
and subsequently incubated at room temperature (25°C) for 5 min. Following incubation the 
reaction was chilled on ice. 
 
For both methods, where ligated DNA was to be used for subsequent bacterial 
transformations, the heat-inactivated ligation mixtures were de-salted by dialysing on 
Millipore VS membranes (Section 2.7.3).   
 
2.5.5 Polymerase Chain Reaction 
 
Polymerase Chain Reactions were conducted using different DNA polymerase enzymes 
according to the downstream applications for which amplified DNA was to be used, and PCR 
was routinely performed in 50 μl reaction volumes using 0.25 ml flat-topped PCR tubes 
(Elkay Lab Products (UK) Ltd; Hampshire, UK).  In addition, template DNA varied in 
concentration (and hence volume) according to source.  
2.5.5.1 KOD DNA Polymerase 
For amplification of DNA fragments for subsequent cloning, KOD Hot Start Polymerase 
(Novagen; Merck Chemicals, Nottingham, UK) was used, which generates PCR products 
without 3‘-overhangs (Mizuguchi, et al. 1999). PCRs routinely contained 1× Polymerase 
Buffer, 1.5 mM MgSO4, 0.2 mM each of dATP, dTTP, dCTG and dGTP, 0.3 μM of each 
oligonucleotide primer and 0.02 U/μl of KOD Hot Start Polymerase.  Thermal cycling was 
typically conducted for 95°C for 2 min as an initial denaturation step, followed by 30-40 
cycles of a 95°C for 20 sec denaturation step, a 10 sec annealing step (temperature dependent 
on primers) and a 70°C extension step (extension time dependent on length of target being 
amplified e.g 1min/kb).  
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2.5.5.2 Platinum Taq Polymerase 
For amplification of complementary DNA (cDNA) fragments, Platinum® Taq Polymerase 
(Invitrogen) was used according to the manufacturer‘s supplied instructions. Reactions 
routinely contained 1× PCR Buffer, 0.2 mM each of dATP, dTTP, dCTP and dGTP , 1.5 mM 
MgCl2, 0.2 μM of each primer and 1 U Platinum® Taq DNA polymerase. Thermal cycling 
regularly involved a preliminary denaturation step at 94°C for 2 min, followed by 25-35 cycles 
of a 94°C for 30 sec denaturation step, a 30 sec annealing step (temperature dependent on 
primers) and a 72°C extension step for 1 min per kb of target sequence).  A final extension 
step at 72°C for 10 min was then performed. 
2.5.5.3 Inverse PCR 
An ―inverse PCR‖ technique was used to amplify unknown regions of DNA flanking a known 
portion of the C. pseudotuberculosis dtxR gene (Ochman, Gerber, & Hartl, 1988). The 
protocol was essentially identical to standard PCR (Section 2.5.5.1), with the exceptions being 
the way that the template DNA was prepared and the fact that inverse PCR primers orientate 
in the opposite direction to conventional PCR primers (since they are based upon known DNA 
sequences and are used to amplify unknown upstream and/or downstream flanking sequences).  
Genomic DNA was digested to completion with a suitable restriction endonuclease (as 
determined by Southern hybridisation). Subsequently, the digested DNA fragments were gel 
purified (Section 2.7.1), and circularised by self-ligation with T4 DNA ligase in a 20 µl 
reaction containing 3 μg DNA (Section 2.5.4).  Finally, following heat-inactivation of the 
ligase, the DNA was de-salted by dialysis against ddH2O (Section 2.7.3).   
 
Inverse PCR was conducted as described in Section 2.5.5.3. A total of 1 μl of circularised 
genomic DNA was used as template in 50 μl reactions.  Thermal cycling was conducted for 30 
cycles, as described, using a primer annealing temperature of  56°C for 1 min and an extension 
temperature of 72°C for 2.5 min.   
 
For inverse PCR amplification of larger DNA fragments, following circularisation of genomic 
template DNA, long-range PCR was carried out using the Expand Long Template PCR system 
(Roche Diagnostics Ltd., West Sussex, UK.), which is designed to allow amplification of 
DNA fragments up to 20 kb in length.  For the work described in this thesis, the supplied 
―Buffer 1‖ was used, which is optimised for amplification of DNA fragments of ≤9 kb. Long-
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range inverse PCR was performed in 50 μl reactions, containing 20 μl of circularised DNA as 
template, 0.2 mM each of dATP, dTTP, dCTP and dGTP, 0.3 μM dtxR_inv(fwd) primer, 0.3 
μM dtxR_inv (rev) (Table 2.3), 1× Buffer 1 and 0.75 μl polymerase mix (3.75 U). Following a 
preliminary denaturation step at 94°C for 2 min, thermal cycling was conducted for 25 cycles, 
comprising a 94°C denaturation step for 10 sec, a 30 sec annealing step at 55.5°C and a 68°C 
extension step for 8 min.  Subsequently, amplified DNA fragments were purified as above 
(Section 2.7.1).  
2.5.5.4 Reverse Transcription-PCR (RT-PCR)  
Ribonucleic acid was reverse transcribed using SuperScript™ III First Strand Synthesis 
System (Invitrogen) following the manufacturer‘s instructions. Briefly, 19.2 ng of random 
hexamers, 769 μM of dNTP‘s cumulatively and 10 µl of DNase I-digested RNA solution, 
containing 1 μg of total RNA, were added to a nuclease-free 0.2 ml microcentrifuge tube. The 
solution was made up to a total volume of 13 μl with nuclease-free water and the mixture was 
heated to 65°C for 5 min, followed by incubation on ice for at least 1 min. Tubes were pulse 
centrifuged, following which First Strand buffer was added to 1× final concentration in 
addition to 40 U  RNaseOUT™ recombinant RNase inhibitor and 1 μl SuperScript™ III RT 
(or 1 µl nuclease free water for negative controls) for subsequent cDNA synthesis.  The 
solution was mixed by pipetting up and down and the tubes were incubated at 25°C for 5 min.  
Tubes were subjected to a further incubation at 50°C for 1 hr, followed by inactivation of the 
enzyme by heating to 70°C for 15 min.  
2.4.5.5 Quantitative real time reverse transcription PCR (qRT-PCR) 
Quantitative real time reverse transcription PCR was carried out using OMNiMix HS 
(TaKaRa Bio Inc., CA, USA), a pre-dispensed blend of reagents with hot start Taq 
polymerase, which are supplied as lyophilised beads and are specifically designed for use with 
the Cepheid SmartCycler
®
 system (Cepheid, CA, USA). Oligonucleotide primers were 
specific for the target gene(s) of interest (Table 2.6) and the probes (Table 2.7) included 5‘ 6-
carboxyfluorescein and 3‘ black hole quencher 1 modifications. Working stocks of primers 
and probes were made up to 10 µM and 2 μM, respectively.  The qRT-PCR procedure was 
performed according to the manufacturer‘s supplied instructions.  Briefly, a single OMNiMix 
HS lyophilised bead (sufficient for two 25 µl reactions) was reconstituted in 4 μl of each 
primer stock, 3 μl of probe stock and 48 μl of ddH2O.  Subsequently, 1 μl of cDNA (Section 
2.5.5.2) was added to each 24 μl aliquot of reconstituted OMNiMix, in smart-cycler tubes 
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(Cepheid, CA, USA) in a cold rack.  The resulting 25 μl reaction mixes contained 1.5 U of 
TaKaRa hot start polymerase, 200 μM dNTP mix, 4 mM MgCl2 and 25 mM HEPES pH 8.0, 
and care was taken to not touch or scratch the windows of the smart-cycler tubes (which can 
affect the fluorescence).  Immediately prior to thermal cycling, reactions were centrifuged 
briefly in a microcentrifuge at 17, 970 × g to remove air bubbles which can affect 
fluorescence; thermal cycling was conducted at 75°C for 75 sec followed by 50 cycles of 95°C 
for 5 sec and 59°C for 40 sec. During cycling, fluorescence was monitored and logged. The 
standard curve for each primer and probe set was determined prior to the actual cDNA 
reactions. The standard curve was achieved using 1 µg DNA diluted 10-fold in nuclease-free 
water to give a range of dilutions down to 1×10
-8
 μg DNA. 
 
2.6 Agarose gel electrophoresis  
2.6.1 Analysis of DNA samples  
 
PCR products, restriction endonuclease digests and other DNA samples were analysed by 
electrophoresis through agarose gels, using the Mini-Sub Cell GT Cell electrophoresis 
apparatus (BioRad).  Briefly, agarose gels were prepared, containing a range of molecular 
biology-grade agarose concentrations from 0.8-2.0 % (w/v) (depending on the size of DNA 
fragments to be analysed) in 0.5 × TAE buffer (Appendix one). The TAE was heated in a 
microwave oven until the agarose had completely melted, following which the molten agar 
solution was cooled to ca. 56°C prior to addition of GelRed (Cambridge Biosciences, 
Cambridge, UK) to 1:10,000. The solution was subsequently poured into a mini-gel casting 
tray, with a comb. The gel was allowed to set prior to submersion in an electrophoresis tank 
containing 0.5× TAE buffer.  Subsequently, DNA samples were prepared in a 1× final 
concentration of Blue/Orange loading dye (Promega), and loaded into wells in the gel. Each 
mini-gel was run at 100 V/cm until the dye-front had reached the end of the gel.  Then, DNA 
fragments were visualised over UV light using an AlphaImager (GRI AlphaInnotech; UK) gel 
documentation system, and linear DNA sizes were determined in comparison to a DNA ladder 
molecular weight marker (Promega).  
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Table 2.3 Miscellaneous oligonucleotide primers   
 
Primer Sequence (5’-3’)
*
 Target Reference 
dtxR_inv (fwd) TCGTAGATGGTCCGCA 
bp 2091-2106 C. 
pstb dtxR locus 
This study 
dtxR_inv (rev) TGGCTTAGATATCCACAAGG 
bp 2326-2345 C. 
pstb dtxR locus 
This study 
pCARV MCS F ACACAGGAAACAGCTATGACC 
bp 4594-4614 
pCARV vector 
This study  
pCARV MCS R AAACGACGGCCAGTGAAT 
bp 4679-4696 
pCARV vector 
This study 
dtxR 1 F AGCCCAAACCATTGAGGTAG 
bp 962-981 C. 
pstb dtxR locus 
This study 
dtxR 1 R TGTATGCGGCTGTACAGGAG 
bp 3838-3857 C. 
pstb dtxR locus 
This study 
∆dtxR AE 1 gtcgacAGGACTCAGAAGAACCACTA
a
 
bp 1006-1025 C. 
pstb dtxR locus 
This study 
∆dtxR AE 2 ctcgagATCTTTCATTTTCAACCTCTT
b
 
bp 2045-2065 C. 
pstb dtxR locus 
This study 
∆dtxR AE 3 ctcgagTAAAGGGTACCCACATGAAACT
b
 
bp 2735-2756 C. 
pstb dtxR locus 
This study 
∆dtxR AE 4 gtcgacGAGAAAACGAATGCAGCAG
a
 
bp 3777-3795 C. 
pstb dtxR locus 
This study 
∆dtxR DCO F ATCTAATTTCACCACCATAAAA 
bp 1788-1809 C. 
pstb dtxR locus 
This study 
∆dtxR DCO R GAAGAAAAGACCAAGTTTGTTA 
bp 3068-3089 C. 
pstb dtxR locus 
This study 
cp40 F cccgggGCACAGTGACCCAAGGA
c
 bp 4-20  Acc. # U10424 
cp40 0 224bp  cccgggAGAGCGGAAGTTATGCCTA
c
 bp  245-263  Acc. # U10424 
cp40 1 432bp cccgggCTGGAGCTTGTCTTTCCAA
c
 bp 450-468  Acc. # U10424 
cp40 2 750bp cccgggCGGAGTTCCATGTCTACG
c 
 bp 759-776  Acc. # U10424 
Cp40 4 1020bp cccgggCTGGCAGGAATTGATCTTG
c 
 bp 1041-1059  Acc. # U10424 
cp AE 1 gtcgacGCGGACTTTGTAAAGTTTGC
a
   
cp AE 2 ctcgagGCGTGAGACTGATCGAGG
b
 bp 217-234  Acc. # U10424 
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cp AE 3 ctcgagTTCACCACACTCAAACCGAC
b
 bp 1240-1259  Acc. # U10424 
cp AE 4 gtcgacGACCTTTTTGTTACCGTGC
a
   
∆cp40 DCO F CTTGCCCAGGATTAAATGC   
∆cp40 DCO R CGCCCGTGAGATTATTTTT   
dtxR pWSK29 A AGACAAACTCCGCGCCTAC 
bp 1766-1784 C. 
pstb dtxR locus 
This study  
dtxR pWSK29 B AACCTCGTGGCCTTGTTCG 
bp 2811-2829 C. 
pstb dtxR locus 
This study 
AE 249 1 gtcgacTATTTATCTGGTTCTCAACG
a
 
bp 4025-4044 
02949 locus 
This study 
AE 249 2 ctcgagGGAAGATCGATAAAACAAAG
b
 
bp 4956-4975 
02949 locus 
This study 
AE 249 3 ctcgagGGAAAGGATATATACATTGA
b
 
bp 8246-8265 
02949 locus 
This study 
AE 249 4 gtcgacGCACTATAAAACGCTATCAT
a
 
bp 9214-9233 
02949 locus 
This study 
Δ0249 DCO F CCCAACACTGATTAAGAAAGC 
bp 4789-4809 
02949 locus 
This study 
Δ0249 DCO R GCAACCAGAGTAGATGATCCT 
bp 8415-8435 
02949 locus 
This study 
dtxR_01 GTGAAGGATCTGGTCGATACC 
Degenerate 
primers 
(Malloy, 2004) 
dtxR_03 CCAGCGGCAGGCTTCGTCGTG 
Degenerate 
primers 
(Malloy, 2004) 
pCARV_MCS F ACACAGGAAACAGCTATGACC pCARV This study 
dtxR_SX R TGTATGCGGCTGTACAGGAG 
bp 3838-3857 C. 
pstb dtxR locus 
This study 
Erm_probe F TGGAAATAAGACTTAGAAGC 
bp 3303-3322 
pCARV  
This study 
Erm_probe R CGACTCATAGAATTATTTCC 
bp 4156-
4175pCARV 
This study 
dtxR_comp F AGACAAACTCCGCGCCTAC 
bp 1766-1784 C. 
pstb dtxR locus 
This study 
dtxR_comp R AACCTCGTGGCCTTGTTCG 
bp 2811-2829 C. 
pstb dtxR locus 
This study 
*
 oligonucleotide-incorporated restriction endonuclease recognition sites are indicated by lower-case letters and the suffixes a, 
b and c refer to SalI, XhoI and XmaI respectively. 
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Table 2.4 Sequencing primers for the C. pseudotuberculosis dtxR locus  
 
Primer Sequence (5’-3’) Target Reference 
M13 F CGCCAGGGTTTTCCCAGTCACGAC 
bp 452-475  inverse PCR 
product 
TOPO Blunt 
(Invitrogen) 
M13 R GAGCGGATAACAATTTCACACAGG 
bp 185-208 inverse PCR 
product 
TOPO Blunt 
(Invitrogen) 
pCAW004 1.0 AGCATAACACCGAATTG  This study 
pCAW004 2.0 GGTACCCACATGAAACTCCT 
bp 2740-2759 C. pstb dtxR 
locus 
This study 
pCAW004 1.1 TTCCATGGCTCGGATAAG 
bp 1188-1205 C. pstb dtxR 
locus 
This study 
pCAW004 2.1 GCAGGAGCATATGGAAG 
bp 3256-3272 C. pstb dtxR 
locus 
This study 
pCAW004 1.2 TCACCGATCTCTTGCACAA 
bp 7193-7211 C. pstb dtxR 
locus 
This study 
pCAW004 2.2 TCGTTTTCTCATCATGACA 
3786-3804 bp C. pstb dtxR 
locus 
This study 
pCAW004 1.3 GAATTTTTCGCTAACAAGC 
bp 6660-6678 C. pstb dtxR 
locus 
This study 
pCAW004 2.3 AAAGCTTCCCCACGGCT 
bp 4337-4353 C. pstb dtxR 
locus 
This study 
pCAW004 1.4 AGCAAGAAATTTCTCGAACT 
bp 6114-6133 C. pstb dtxR 
locus 
This study 
pCAW004 2.4 TGGATAGCGCGTCATGC 
bp 4870-4886 C. pstb dtxR 
locus 
This study 
pCAW004 1.5 ACCAAAGCGTTCTACGAGGT 
bp 5598-5617 C. pstb dtxR 
locus 
This study 
pCAW004 2.5 CTTGAGCACAGGCCAGT 
bp 5381-5397 C. pstb dtxR 
locus 
This study 
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Table 2.5 Primers for PCR amplification of promoter regions 
 
Primer Sequence (5’-3’)
 *
 Target Reference 
sigB P F  agatctTTGGGGCAACGATGGAGGT
a
 bp 601-619 C. pstb dtxR 
locus 
This study 
sigB P R gtcgacGCGACTTCCACGGTCAATCA
b
 bp 841-860 C. pstb dtxR 
locus 
This study 
dtxR P F agatctCGGAATTGACGAGTCTAA
a
 bp 1415-1432 C. pstb 
dtxR locus 
This study 
dtxR P R gtcgacTAGATGGTCCGCAGATAC
b
 bp 2086- 2103  C. pstb 
dtxR locus 
This study 
galE P F agatctAGAGCGGCGGCTTGTTGATG
a
 bp 2392-2411 C. pstb 
dtxR locus 
This study 
galE P R gtcgacCGGCTTCCTTATTGCCAGTAG
b
 bp 2849-2869 C. pstb 
dtxR locus 
This study 
fagA P F agatctTGGGATCTGGATGGAATAGAG
a
 bp 2774-2794 fagA gene Acc. # 
AF401634 
fagA P R gtcgacACCCAAAGCGTGCTTAAC
b
 bp 3268-3285 fagA gene Acc. # 
AF401634 
cp40 P F agatctGGATACGCCAAAGGAAAC
a
 cp40 gene  
cp40 P R gtcgacTTGCTGATCGCTCTTCTG
b
 bp 532-549 cp40 gene Acc. # U10424 
sid P F agatctTTGGAATTAGTCAAGTCCCT
a
 bp 4640- 4659 
ORF02949  
This study  
sid P R gtcgacATCATGGTAGCCAAGGCTA
b
 bp 4896-4914 ORF02949  This study  
*
 oligonucleotide-incorporated restriction endonuclease recognition sites are indicated by lower-case letters and the suffixes a 
and b refer to BglII and SalI respectively 
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Table 2.6 qRT-PCR primers 
 
Primer Sequence (5’-3’) Target Reference 
recA F TTGTGATGTTCGGCGTATCC bp 921-940 recA gene Acc. # U30387 
recA R ACTACCTTTAACCGCGTCCTGTT bp 973-995 recA gene Acc. # U30387 
sigB B F  CTTCCTTGCGACACTCTGACAT bp 1564-1585 C. pstb 
dtxR locus 
This study  
 
sigB d R CGAATTGTCGGCCAATTTG bp 1677-1695 C. pstb 
dtxR locus 
This study  
 
dtxR C F AACGTGACGGGCTCGTTGTA bp 2202-2221 C. pstb 
dtxR locus 
This study  
 
dtxR c R GCGAGGCGATGTTTACGCAT bp 2282-2301 C. pstb 
dtxR locus 
This study  
 
galE G F ACAAGTCTGCGCTACTTCAA bp 3232-3251 C. pstb 
dtxR locus 
This study  
 
galE a R GGCCTAAAGCAACTTGGAGAATT bp 3315-3337 C. pstb 
dtxR locus 
This study  
 
dtxR-galE F F ACGGTCGCGTGATTATTACG bp 2652-2671 C. pstb 
dtxR locus 
This study  
dtxR-galE b R GCTCCGCCGGTGACAA bp 2759-2774 C. pstb 
dtxR locus 
This study 
fagA F AGCGGTTGCACTGGCCGCAA bp 2157-2176 fagA gene Acc. # AF401634 
fagA R GTGCTCACAATCGCTTGCGCT bp 2277-2297 fagA gene Acc. # AF401634 
 
  
Chapter Two                                                                                                          Materials and Methods 
 56 
 
Table 2.7 qRT-PCR probes 
 
Probe Sequence (5’-3’)
a
 Target Reference 
recA AAGGACGGGCAGGATGCCATCG bp 949-970 recA gene Acc. # U30387 
sigB SB TGAACAAGACGTGATCAGAATGCGTTA bp 1616-1642 C. pstb 
dtxR locus 
This study  
dtxR DR TTCAAATGACGCCCACTGGGC bp 2241-2261 C. pstb 
dtxR locus 
This study  
galE GE ATCGGCGAAAATCGCGAAGTTGA bp 3274-3296 C. pstb 
dtxR locus 
This study  
dtxR-galE DG ACCTAGCTCACGCAGTACGAATCGAAGAAAT bp 2703-2733 C. pstb 
dtxR locus 
This study  
fagA  ATAGATGTAGCCATGGCATCA bp 2230-2250 fagA 
gene 
Acc. # AF401634 
a 5‘-6-carboxyfluorescein and 3‘–black  hole quencher 1 modifications 
 
2.6.2 Analysis of RNA samples 
 
To visualise total RNA, formaldehyde (FA) gels were prepared. Briefly, for each gel, 1.2 g of 
molecular biology grade agarose was added to 10 ml of 10× FA gel buffer (Appendix one) 
and the solution was made up to 100 ml with RNase-free water. The mixture was heated in a 
microwave to melt the agarose, following which the molten agarose was cooled to ca. 56°C 
prior to the addition of 1.8 ml of 37 % (12.3 M) formaldehyde and GelRed to 1: 10,000.  Gels 
were cast as above (Section 2.6.1), then submerged in an electrophoresis tank containing 1× 
FA gel running buffer.  Each gel was equilibrated in FA for at least 30 min prior to the 
addition of RNA samples; RNA samples were prepared in RNA loading buffer (Appendix 
one) to a final concentration of 1×, heated to 65°C for 5 min, then chilled on ice prior to gel 
loading. Subsequently, each mini-gel was run at 36 V/cm until the dye-front had reached the 
end of the gel.   
 
2.7 DNA Clean up 
2.7.1 DNA extraction from agarose gels  
 
Following electrophoresis through agarose gels, DNA bands were visualised over UV light (as 
described in section 2.6.1), prior to being excised using a clean scalpel blade, and placed into 
Chapter Two                                                                                                          Materials and Methods 
 57 
 
a clean 1.5 ml microcentrifuge tube. The weight of gel slices was determined (by subtracting 
the weight of an empty tube from the weight of a tube + gel slice) and 100 μl of 
GENECLEAN
®
 Turbo salt solution was added per 0.1 g of gel slice. Each gel slice/salt 
solution was incubated at 55°C for approximately 5 min (or until the gel had melted), aided by 
frequent vortexing. No more than 600 µl of DNA/salt solution was added to a GENECLEAN
®
 
Turbo cartridge and catch tube. The cartridge was centrifuged at 17, 970 × g for ca. 15 sec in a 
microcentrifuge, and then the flow-through in the catch tube was discarded.  Cartridge-bound 
DNA was washed by addition of 500 µl of GENECLEAN
®
 Turbo wash buffer, followed by 
further centrifugation at 17, 970 × g for 15 sec. Finally, the catch tube was emptied, and the 
cartridge was centrifuged for a further 4 min at 17, 970 × g to ensure there were no traces of 
ethanol contaminating the DNA. The GENECLEAN
®
 Turbo cartridge containing bound DNA 
was placed into a clean 1.5 ml microcentrifuge tube and 30 µl of ddH2O was added directly to 
the GLASSMILK
®
-embedded membrane. The tube was then incubated at room temperature 
for 5 min prior to a final centrifugation at 17, 970 × g for 1 min to elute the DNA.  
 
2.7.2 Isolation of DNA from PCR reactions and other enzymatic solutions 
 using GENECLEAN® Turbo Kit (Q. Biogene) 
 
In order to purify DNA from PCR and other enzymatic reactions, the GENECLEAN
®
 Turbo 
kit (Q. Biogene) was employed, according to the manufacturer‘s instructions. Briefly, DNA-
containing solutions were supplemented with 5 volumes of GENECLEAN
®
 Turbo salt 
solution. Subsequently, GENECLEAN
®
 Turbo cartridges and catch tubes were used to purify 
DNA, as described in Section 2.7.1, ensuring that no more than 600 µl of DNA/salt solution 
was added to each cartridge.  
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2.7.3 De-salting of ligations prior to transformation 
 
To reduce the risk of arcing during bacterial transformations involving electroporation, rapid 
dialysis of ligation reactions was performed to remove excess salts, using Millipore Type VS 
0.025 μM filter discs (Millipore). VS filter discs were placed (shiny-side–up) in Petri dishes 
containing ddH2O. After a brief wetting period, ligation reactions were pipetted carefully onto 
the centre of discs and allowed to sit for approximately 10 min at room temperature. 
Subsequently, ligation reactions were transferred to clean microcentrifuge tubes and either 
used immediately for bacterial transformation or stored at -20°C for subsequent use. 
 
2.8 Bacterial transformation  
 
2.8.1 Preparation of E. coli chemically-competent cells 
 
A 10 ml aliquot of LB broth containing the appropriate antibiotic was inoculated with a single 
colony of the E. coli strain to be transformed.  The culture was incubated overnight at 37°C × 
225 rpm, then diluted 1/100 into 100 ml of SOB medium (Appendix one). The culture was 
incubated at 37°C × 225 rpm for ca. 2 hrs, until an OD600nm of 0.3 was reached. The culture 
was then chilled on ice for 20 min prior to harvesting cells by centrifugation at 3,893 × g for 
10 min at 4°C. Cells were washed by re-suspension of the pellet in 20 ml of ice-cold, sterile 
Transformation Buffer (Appendix one), then harvested by centrifugation as previously stated.  
Cells were then re-suspended in 2.5 ml of ice-cold Transformation Buffer and incubated on ice 
for 30 min.  Subsequently, 90 µl of DMSO was then added. Finally, cells were incubated on 
ice for a further 10 min prior to the transfer of 100 μl aliquots into pre-chilled 0.2 ml 
microcentrifuge tubes.  Cell aliquots were snap frozen in a dry ice/ ethanol bath prior to being 
aliquoted and stored at -80°C.  
 
2.8.2 Transformation of E. coli  
2.8.2.1 Chemical transformation 
A 50-100 µl aliquot of chemically competent E. coli cells from section 2.8.1 or One shot
®
 
TOP 10 cells (Invitrogen) were taken from storage at -80°C and thawed on ice. The cells were 
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then mixed with 0.5-1 μg plasmid DNA and incubated on ice for 30 min. Subsequently, cells 
were heat shocked at 42°C for 45 sec prior to incubating on ice for a further 5 min. A 500-900 
µl aliquot of SOB (Appendix one) was added to the cell suspension, which was then 
incubated at 37°C × 225 rpm for 1 hr. Ten-fold serial dilutions of the transformed cells were 
then prepared in LB broth, and 100 μl aliquots were plated on agar media containing the 
appropriate antibiotics.  Finally, plates were incubated at 37°C until single colonies had 
developed.  
2.8.2.2 Electroporation 
An aliquot of electrocompetent E. coli ElectroMAX™ DH5α-E™ cells (Invitrogen, Paisley, 
UK) was removed from -80°C storage and thawed on ice. Subsequently, 1 μg of plasmid DNA 
was added to the defrosted cells and mixed by gently stirring with a pipette tip. The mixture 
was then incubated on ice for 10 min before being transferred into a pre-chilled, 0.1 cm 
electrode gap electroporation cuvette (Bio-Rad). The cells were electroporated in a Gene 
Pulser Xcell™ Electroporator (Bio-Rad) at 200 Ω, 25 μF and 2.0 kV, and immediately 
transferred to 500 μl of SOC medium in a sterile 1.5 ml microcentrifuge tube. Subsequently, 
the cell suspension was incubated at 37°C × 225 rpm for 1 hr. Following incubation the cell 
suspension was plated onto antibiotic containing LB nutrient agar prior to overnight 
incubation at 37°C.  
 
2.8.3 Preparation of electrocompetent C. pseudotuberculosis  
 
Electrocompetent C. pseudotuberculosis cells were prepared to facilitate transformation by 
electroporation.  Twenty ml of BHIT broth was inoculated with a colony of C. 
pseudotuberculosis, and the culture was incubated overnight at 37°C × 225 rpm.  
Subsequently, the culture was diluted 1/10 into 200 ml of BHI broth containing 2.5 % (w/v) 
glycine. The culture was incubated, as above, for ca. 4 hrs to an OD600nm of between 0.6-0.8, 
and then cells were harvested by centrifugation at 3,893 × g for 15 min at 4°C.  The cell pellet 
was gently re-suspended in 100 ml of ice cold, sterile electroporation buffer (15 % (v/v) 
glycerol, 0.01 % (v/v) Tween 20), and centrifugation was conducted as before; this washing 
procedure was carried out a total of 3 times.  Cells were then re-suspended in 1 ml of ice cold 
electroporation buffer, and 65 μl aliquots of the cell suspension were transferred into pre-
chilled 0.2 ml microcentrifuge tubes. Cells required for immediate transformation were stored 
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on ice, while those that were not required immediately were snap frozen in a dry ice/ethanol 
bath and stored at -80°C for future use.  
 
2.8.4 Transformation of C. pseudotuberculosis 
 
Plasmid DNA was introduced into C. pseudotuberculosis by electroporation. If competent 
cells were stored at -80°C, an aliquot was allowed to thaw gently on ice prior to use.  To an 
aliquot of cells was added 1 µg of highly-pure plasmid DNA, and the cells and DNA were 
mixed gently by stirring with a pipette tip. Following a ca. 15 min incubation on ice, the cells 
were transferred to a pre-chilled, 0.1 cm electrode gap electroporation cuvette (Bio-Rad), and 
electroporation was conducted in a Gene Pulser Xcell™ Electroporator (Bio-Rad) at 200 Ω, 25 
μF and 1.8 kV.  Immediately, cells were transferred to a 14 ml polypropylene Leighton tube 
containing 10 ml of room temperature BHIT, and incubated without agitation for 2 hrs at 37°C 
(or the permissive replication temperature for the plasmid). Cells were harvested by 
centrifugation at 3, 893 × g for 15 min at 4°C, and then re-suspended in 200 µl of BHIT. Ten-
fold serial dilutions of the transformed cells were prepared in PBS, prior to the plating of 100 
μl aliquots onto the appropriate media containing the necessary selective antibiotics. Finally, 
plates were incubated at a temperature permissive for plasmid replication until single colonies 
had developed.  
 
2.9 Southern hybridisation  
 
Southern hybridisation (blotting) was carried out using a standard capillary-transfer method. 
Briefly, restriction endonuclease digested DNA samples were separated by electrophoresis 
through a 20 cm × 15 cm, 2 % (w/v) agarose gel for 12 hrs at 50 V/cm.  Subsequently, DNA 
was depurinated by soaking the gel in 0.25 M HCl for no longer than 10-15 min. Four sheets 
of Whatman™ 3 MM paper (Whatman Ltd., UK) were cut to the size of the gel tray, ensuring 
a 5 cm overhang at each end. A sheet of Zeta-Probe Genomic Tested (GT) blotting membrane 
(Bio-Rad) was cut to the size of the gel tray, and pre-wet in ultra pure ddH2O for 5 min. The 
Whatman™ 3MM paper sheets were placed on an inverted gel casting tray which was then 
placed into the bottom of a deep dish and saturated with 0.4 M NaOH. To ensure good 
capillary transfer of DNA, bubbles were removed using a plastic pipette in a rolling motion 
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over the filter paper.  The gel was then carefully placed onto the filter paper; again bubbles 
were removed, and a small amount of 0.4 M NaOH was used to cover the gel to prevent it 
from drying out. Plastic laboratory wrap was used to cover the whole dish and a clean scalpel 
blade was used to cut a small gel sized window into the plastic wrap (thereby allowing the gel 
to be exposed but preventing the 0.4 M NaOH from evaporating elsewhere). The pre-wet Zeta-
Probe GT membrane was then placed over the gel surface and a further 2 pieces of filter paper 
were cut to the exact size of the gel, pre-wet, and placed onto the Zeta-Probe GT 
membrane/gel stack. A pile of pre-cut paper towels, a glass plate and a lead weight were 
placed on top of the membrane/gel stack and transfer was allowed to continue for 24 hrs.  
Following transfer, the membrane was separated from the gel, rinsed briefly in 2× SSC 
(Appendix one) and allowed to air dry. The DNA was cross-linked to the membrane by 
microwaving for 2 min on high in a 950 W microwave oven, ensuring constant turning to 
prevent scorching.  
 
2.9.1 Digoxygenin-dUTP (DIG) Labelling of DNA  
 
DNA probes used for Southern hybridisation experiments were labelled using the DIG high 
prime labelling and detection starter kit (Roche), according to the manufacturer‘s instructions. 
Briefly, approximately 1 μg linear or supercoiled template DNA was added to ddH2O to a 
final volume of 16 μl. The DNA was denatured by heating in a boiling water bath for 10 min 
followed by chilling in an ice water bath. The DIG High prime solution was mixed 
thoroughly, 4 μl was added to the denatured DNA, and the resulting mixture was vortexed and 
centrifuged briefly at 17, 970 × g. To achieve efficient labelling of DNA the mixture was 
incubated overnight at 37°C. The reaction was stopped by the addition of 2 µl of 0.2 M EDTA 
(pH 8.0) and by heating to 65°C for 10 min.   
 
2.9.2 Hybridisation  
 
Prior to use in hybridisations, DIG-labelled probes were denatured by boiling for 5 min in a 
boiling water bath before being chilled in an ice water bath. The Zeta-Probe GT membrane 
onto which DNA had been transferred was first pre-hybridised by placing it in a sealable tray 
and submerging it in hybridisation fluid. The fluid contained 0.25 M sodium phosphate (pH 
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7.2) and 7 % SDS. The membrane was incubated at 65°C for 30 min ensuring complete and 
even coating with the solution. Following pre-hybridisation the fluid was removed and 
replaced with fresh hybridisation fluid. The denatured DIG labelled probe (Section 2.9.1) was 
added to the hybridisation fluid and mixed by swirling. All bubbles were removed to avoid 
background noise on the blot. The tray was placed in a Hybaid hybridisation oven (Thermo-
Scientific, UK) overnight at 65°C with agitation.  Following the incubation the hybridisation 
fluid and probe were removed from the membrane which was washed twice in 20 mM sodium 
phosphate (pH 7.2), 5 % (w/v) SDS at 65°C for 30 min.  The membrane was then subjected to 
two further washes in 20 mM sodium phosphate (pH 7.2), 1 % (w/v) SDS at 65°C for 30 min.  
 
2.9.3 Immunological detection of DIG labelled probes 
 
Immunological detection of hybridised, DIG-labelled probes was carried out according to the 
manufacturer‘s instructions. Briefly, the hybridised membrane was rinsed in DIG washing 
buffer (Appendix one) and then incubated in 100 ml of 1× blocking solution (Appendix one) 
for 30 min at room temperature.  The blocking solution was removed and replaced with 20 ml 
of antibody solution (Anti-Digoxigenin-AP, diluted 1:10,000 in 1× blocking solution) at room 
temperature. The membrane was incubated for a further 30 min in antibody solution at room 
temperature. This solution was removed and the membrane was subjected to two 15 min 
washes in washing buffer. Following these washes, the membrane was equilibrated for 2-5 
min in 20 ml detection buffer. The developing solution was removed and the membrane was 
placed on laboratory plastic wrap, DNA-side-up. One ml of chemiluminescent substrate for 
alkaline phosphatase (CSPD) was added to the membrane which was immediately covered by 
a second piece of laboratory plastic wrap and all air bubbles removed. Excess liquid was 
squeezed out of the membrane which was then incubated at 37°C for 10 min to enhance the 
luminescent reaction. The membrane was then used to expose a piece of X-ray film (Kodak
®
 
X-Omat AR Film, Kodak, UK) for 15-20 min at room temperature. The X-ray film was then 
developed using an X-ray developer (Optimax 2010 X-Ray film processor; Protec GmbH & 
Co., Germany)  
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2.10 General Proteomic Techniques  
2.10.1 Isolation of exported proteins from C. pseudotuberculosis  
 
In order to observe differences in the exported protein profiles of C. pseudotuberculosis grown 
under high- and low-iron conditions (Chapter 3),  10 ml of CCDM was inoculated with single 
colony of C. pseudotuberculosis and grown overnight at 37°C × 225 rpm.. The overnight 
culture was diluted to an OD600nm of 0.1 in a total volume of 200 ml of iron-restricted CCDM 
and non-restricted CCDM in plastic disposable flasks (Nalgene, Rochester, NY, USA), and 
incubation was continued as before for ca. 7 hrs until log phase growth was reached. 
Discrepancies between the OD600nm of the cultures were adjusted by addition of CCDM to 
obtain equivalent cell numbers between the 2 cultures.  The cultures were transferred to 50 ml 
disposable Falcon polypropylene tubes (BD-Biosciences, Oxford, UK) and centrifuged for 15 
min at 3,893 × g and 4°C. The resultant supernatants were filter-sterilised to remove any cell 
debris, and supplemented with Complete protease inhibitor cocktail (Roche), to 1× final 
concentration, and stored on ice to prevent proteolytic degradation of the exported proteins. 
Subsequently, proteins were concentrated using Amicon Ultra-15-5K Mr cut-off centrifugal 
filters (Millipore), at 3,893 × g at 4°C.  The concentrated samples were then buffer-exchanged 
3 times in PBS (Appendix one).  Subsequently, the concentrated protein solutions were 
transferred to 1.5 ml microcentrifuge tubes and stored at -20°C until required.  
 
2.10.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
 PAGE) 
 
C. pseudotuberculosis exported proteins were visualised by SDS-PAGE using the Bio-Rad 
mini protean II apparatus (Bio-Rad). Glass plates were cleaned with isopropanol to remove 
any debris. The plates were then clipped into the gel casting stand and 10 % resolving gel 
mixture (Appendix one) was poured in between the two glass plates to about 2 cm from the 
top.  The resolving gel was covered with isopropanol whilst it was setting to provide a uniform 
interface between the resolving and stacking gels. Once the resolving gel had polymerised the 
isopropanol was poured off and the gel was rinsed with ddH2O. A 5 % stacking gel mixture 
(Appendix one) was poured onto the solid resolving gel and a Teflon comb was placed in 
between the plates. Once the stacking gel had polymerised, the comb was removed and the 
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apparatus was placed into the mini protean II electrophoresis tank. If only one gel was being 
run in the tank at a time, a blank cartridge was used to seal the inner chamber of the tank. Both 
the inner and outer chambers were filled with 1× running buffer (Appendix one). Five-10 µl 
of the exported protein samples were transferred to clean microcentrifuge tubes, and 1-2 µl of 
5 × SDS-PAGE sample loading buffer (Appendix one) was added to each. Samples were then 
boiled in a hot block for 5 min, centrifuged in a microcentrifuge at 17, 970 × g for 3 min, and 
loaded into the wells of the gel.  Protein Mr markers were chosen according to the type of 
post-staining technique to be used; SeeBlue
®
 Plus2 pre-stained standards (Invitrogen) were 
used for Coomassie staining or Mark 12
TM 
standards (Invitrogen) were used for silver staining. 
 
2.10.3 Visualisation of proteins in SDS-PA gels 
2.10.3.1 Colloidal Coomassie blue staining  
Electrophoresed proteins for LC-ESI-MS/MS analysis were stained with colloidal Coomassie 
brilliant blue (Genomic Solutions, MI, USA).  The gel was fixed in a solution of 40 % (v/v) 
methanol, 10 % (v/v) acetic acid for 30 min in a plastic tub. The gel was then stained 
overnight in 80 ml of colloidal Coomassie and 20 ml of methanol.  Prior to downstream 
protein analysis, gels were de-stained in 20 % methanol for at least 1 hr.  
2.10.3.2 Silver staining  
To allow greater staining sensitivity, silver staining of protein gels was carried out using the 
SilverQuest
TM 
Silver staining kit (Invitrogen) following the manufacturer‘s instructions. Each 
gel was rinsed in ddH2O and placed in a plastic tub containing 100 ml of fixing solution (40 % 
(v/v) ethanol, 10 % (v/v) acetic acid). The gel was microwaved on full power in a 950 W 
microwave oven for 30 sec, and immediately agitated at room temperature for 5 min on a 
rotary shaker. The fixative solution was removed, and the gel was placed in 30 % (v/v) ethanol 
and microwaved on high power for a further 30 sec and agitated again for 5 min at room 
temperature. The ethanol was decanted and 100 ml of sensitizing solution (30 ml ethanol, 10 
ml sensitizer and 60 ml ddH2O) was added to the tub containing the washed gel. The 
gel/sensitising solution was subjected to further microwaving on high power for 30 sec prior to 
agitation for 2 min. The sensitizing solution was decanted and the gel was washed twice in 
100 ml ddH2O; each wash step included 30 sec of microwaving and 2 min agitation at room 
temperature. Following these washes the gel was subsequently placed into 100 ml of staining 
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solution (1 ml stainer and 99 ml ddH2O), microwaved on high power for 30 sec and agitated at 
room temperature for 5 min. The staining solution was decanted and the gel was washed with 
100 ml of ddH2O for less than 1 min.  The gel was then placed into developing solution (10 ml 
developer, 1 ml of enhancer and 89 ml ddH2O) and incubated for 5 min at room temperature 
with agitation. Once the desired band intensity was achieved, 10 ml of stopper solution was 
added to the developer solution/gel and the gel was washed in ddH2O.  
 
2.10.4 Drying of SDS-PAGE Mini-Gel’s 
 
Mini-gels were dried using the DryEase® mini-gel drying system (Invitrogen) following the 
manufacturer‘s instructions. Briefly, 35 ml of Gel-Dry™ drying solution was added to the 
mini-gel which was incubated at room temperature for 15 min. Two sheets of cellophane were 
immersed in Gel-Dry™ and one sheet was then placed over the gel drying base. The Mini-gel 
was then placed on top of the pre-wet cellophane followed by the mini-gel and a further piece 
of pre-wet cellophane. Bubbles and wrinkles were removed from the gel and the top of the 
DryEase™ frame was clamped around the mini-gel. The apparatus was allowed to air dry for 
approximately 12 hrs.   
 
2.10.5 Western blotting 
 
Following separation by SDS-PAGE, proteins were immediately transferred to nitrocellulose 
membranes (BioRad). Briefly, the top left corner of the each membrane was removed to aid 
orientation post-transfer. The nitrocellulose membrane and two pieces of Whatman™ 3MM 
filter paper were pre-soaked in Tris-glycine transfer buffer (Appendix one), then the 
membrane and gel were placed in-between the two pieces of filter paper and two sponges. 
Using the Bio-Rad Mini Trans-Blot
TM
 apparatus, the gel was clamped into the assembly with 
the gel closest to the cathode core.  To keep the apparatus cool at high voltages an ice block 
and stir bar were placed in the tank, which was then placed on a magnetic stirrer.  The 
chamber was filled with 1× Tris-glycine transfer buffer and run at 400 mA for 30 min.  
 
Following transfer, the nitrocellulose membrane to which proteins were bound was blocked in 
1 % (w/v) Top-Block
TM
 (Fluka Chemical Corp. Buchs, Switzerland) for 1 hr.  The Top-
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Block
TM
 was then poured off and replaced with 15 ml of PBS containing 0.05 % (v/v) Tween 
20 (PBST) containing CLA-positive sheep sera diluted 1:500. The membrane was incubated 
with the sheep sera for 1 hr at room temperature on a rotary shaker, and then washed three 
times for 5 min in 15 ml of PBST on a rotary shaker. The membrane was then incubated in 15 
ml of PBST containing a 1:5,000 dilution of a horseradish peroxidise-conjugated mouse 
monoclonal anti-goat/sheep IgG antibody (clone GT-34; Sigma) for 1 hr, with shaking. The 
membrane was washed twice with PBST, as before, then incubated in 3,3‘-diaminobenzidine 
(DAB) substrate (prepared from a DAB tablet (Sigma) according to the manufacturer‘s 
instructions), at room temperature until bands were visible. The membrane was then rinsed 
with ddH2O and dried in filter paper.  
 
2.11 Allele replacement mutagenesis 
2.11.1 Targeted plasmid integration into the C. pseudotuberculosis   
 chromosome 
An individual colony of C. pseudotuberculosis which had been transformed with a pCARV-
based plasmid construct was grown in BHIT broth supplemented with 0.05 μg/ml 
erythromycin (Chapter 4). The culture was incubated at 25°C (the permissive replication 
temperature for the plasmid) × 225 rpm until, an OD600nm of 0.8 was reached.  The temperature 
of incubation of the culture was subsequently shifted to 37°C (the non-permissive replication 
temperature for the plasmid) for 6-9 generations (ca. 9 hrs). Ten-fold serial dilutions were then 
prepared in PBS containing 0.05 % (v/v) Tween 80
®
 and 100 μl aliquots of each dilution were 
plated onto BHI agar containing 0.05 μg/ml of erythromycin.  The plates were incubated at 
37°C until bacterial colonies had developed.  At this stage, bacteria resistant to erythromycin 
at 37°C were considered to have undergone a single homologous recombination event between 
plasmid and chromosomal sequences, resulting in the integration of the plasmid into the 
chromosome; although the temperature was not-permissive for plasmid replication, the 
integrated plasmid replicated along with the bacterial chromosome, allowing expression of the 
plasmid-encoded erythromycin resistance determinant. 
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2.11.2 Secondary cross-over mutagenesis 
 
A single co-integrate colony was inoculated into 5 ml BHIT supplemented with erythromycin, 
and the culture was incubated overnight at 37°C × 225 rpm.  Subsequently, the culture was 
serially-diluted down to 1.0×10
-5
 into a 5 ml volume of fresh BHIT (without erythromycin) 
and incubation was continued at 25°C (the permissive replication temperature for the 
plasmid). Once the culture had reached stationary phase, 10-fold serial dilutions were prepared 
in PBS containing 0.05 % (v/v) Tween 80
®
. Appropriate dilutions were plated onto BHI agar 
and incubated at 37°C until single colonies had developed. Subsequently, individual colonies 
were replica plated onto erythromycin-containing and erythromycin-free BHI agar plates to 
identify those which had undergone a secondary recombination event that caused excision of 
the plasmid from the chromosome, resulting in the loss of plasmid-encoded antibiotic 
resistance. 
 
2.11.3 Ampicillin enrichment of secondary crossover mutations  
 
To facilitate the identification of C. pseudotuberculosis secondary cross-over mutants which 
had undergone excision of pCARV-based constructs from the chromosome, a novel antibiotic 
enrichment procedure was devised. Allele-replacement mutagenesis was performed exactly as 
detailed in Sections 2.11.1 and 2.11.2 above.  However, following dilution to 1.0×10
-5
 and 
shifting of the incubation temperature to 25°C (Section 2.11.2) until the culture had reached 
stationary-phase, serial dilutions were not plated immediately.  Rather, the stationary-phase 
culture (containing secondary cross-over mutants) was further diluted 1:100 in 5 ml of BHIT, 
and incubated at 37°C until early log-phase growth (ca. OD600nm 0.4) was reached.  At this 
point erythromycin was added to the inhibitory concentration (0.05 µg/ml) and the culture was 
incubated for a further 2 hrs to allow expression of the plasmid-encoded erythromycin 
resistance gene. Finally, the culture was supplemented with ampicillin to 100 µg/ml, and 
incubation was continued at 37°C.  The OD600nm of the culture was measured regularly until 
growth was observed to be static.  At this point it was assumed that erythromycin-resistant 
cells (which still contained chromosomally-integrated plasmid) would have been killed by the 
bactericidal affect of the ampicillin, while the bacteriostatic affect of erythromycin upon non-
erythromycin-resistant cells (which had undergone plasmid excision from the chromosome) 
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would have protected these cells from the harmful effects of the ampicillin.  Subsequently, 
non-lysed cells were harvested by centrifugation at 3,893 × g for 15 min), and washed twice 
with PBS containing 0.05 % (v/v) Tween 80 to remove residual ampicillin. Ten-fold serial 
dilutions of the culture, which had been enriched in the proportion of plasmid excision 
mutants to non-excised plasmid integrants, were then prepared in PBS containing 0.05 % (v/v) 
Tween 80, and 100 μl aliquots were plated onto BHI agar.  Plates were incubated at 37°C to 
allow bacterial growth, and then single colonies were replica plated onto erythromycin-
containing and erythromycin-free BHI agar plates to allow identification of cells having 
undergone secondary cross-over events, resulting in the loss of plasmid (and hence 
erythromycin-resistance).  
 
2.12 β-galactosidase promoter-fusion assays  
 
A single colony of C. pseudotuberculosis, transformed with a pSPZ-derived construct 
(Chapter 5), was used to inoculate 5 ml of CCDM containing spectinomycin (100 µg/ml), and 
the culture was incubated overnight at 37°C × 225 rpm; cultures were prepared in triplicate.  
Subsequently, cultures were diluted to an OD600nm of 0.1, and incubated, as before, for ca. 6 
hrs until mid log-phase had been reached. The OD of each culture was recorded, and a 100 μl 
aliquot of each was then transferred to glass test tubes.  For each culture aliquot, bacteria were 
lysed by the addition of 900 μl of Z buffer (Appendix one), followed by 40 μl of 0.1 % (w/v) 
SDS and 150 μl of chloroform.  The tubes were then sealed with Parafilm (Pechiney Plastic 
Packaging, Chicago, IL, USA) and vortexed for 30 sec. To assess expression of the lacZ 
reporter gene, 200 μl of a 4 mg/ml solution of o-nitrophenyl-ß-D-galactoside (ONPG) was 
added.  Subsequently, tubes were incubated at room temperature to allow colour development 
for up to 1 hr depending on the speed of the colour change.  Enzymatic reactions were stopped 
by addition of 500μl of 1 M Na2CO3 to a final concentration of 0.5 M, and the length of 
incubation was recorded. The whole mixture was subsequently transferred to 2 ml tubes and 
centrifuged at 17, 970 × g for 5 min at room temperature. Following centrifugation, the upper, 
aqueous phase was transferred to a cuvette and the OD420nm was measured and recorded. 
Subsequently, the level of expression was determined, expressed in ―Miller units‖, according 
to the following equation: 1000 × (A420nm-1.75) ÷ (length of incubation) × cell volume (0.1 ml) 
× A600nm.   
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2.13 Siderophore Assay  
 
To allow quantification of siderophore in culture supernatants, a colourimetric microtitre plate 
assay was conducted.  Five ml cultures of C. pseudotuberculosis were propagated (in 
triplicate) in high- and low-iron-containing growth media for ca. 12 hrs at 37°C × 225 rpm 
until stationary growth-phase was reached.   Subsequently, cultures were diluted 1:10 in 
CCDM, in order to record an accurate OD600nm of each culture. Then, each neat culture was 
centrifuged at 3,893 × g for 20 min at room temperature, and the supernatants (containing 
siderophore) were decanted into clean tubes. Following this, 100 µl of each culture 
supernatant was transferred to individual wells of a 96-well, flat-bottomed microtitre plate 
(Nunc™, Rochester, NY, USA).  To allow quantification of siderophore, a standard curve was 
prepared using an 80 µM stock of EDDA. One hundred µl of the stock EDDA solution was 
transferred into 100 µl Tris-buffered saline (TBS), pH 7 (Appendix one) in wells B1 and C1 
of the microtitre plate. Then, 100 μl of TBS was added to wells B1 and C1, and serial 2-fold 
dilutions of the EDDA were prepared in TBS, across the plate from left to right. The final 100 
μl was discarded, resulting in duplicate rows, with each well containing 100 μl of EDDA 
solution at the following concentrations: 40 µM, 20 µM, 10 µM, 5 µM, 2.5 µM and 1.25 µM 
and again 40 µM, 20 µM, 10 µM, 5 µM, 2.5 µM and 1.25 µM in the remaining 6 columns 
resulting in a duplicated plate. Subsequently 100 µl of CAS assay buffer (Appendix Two) was 
added to each well and the plate was incubated at room temperature, in the dark, for 2 hrs.  
Following incubation, the OD630nm of each microtitre plate well was determined in a ELX 808 
ultra microplate-reader (Bio-Tek Instruments Inc. VT, USA) A result indicative of chelator 
presence turned the normally blue CAS assay buffer to pink, due to stripping the iron from the 
dye.  Subsequently, siderophore units were divided by OD600nm to correct differences in 
culture density. 
 
2.14 DNA Sequencing  
 
Automated sequencing of DNA was carried out by the Moredun Proteomics Facility (Moredun 
Research Institute) on a Mega BACE sequencer (Amersham Biosciences) using sequence 
specific  primers (Table 2.4).  
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2.15 Computational analyses 
 
Basic DNA sequence analyses, including mapping of restriction endonuclease recognition 
sites, open reading frame (ORF) predictions, translation and multiple DNA and protein 
sequence alignments were carried out using the Clone Manager Professional Suite Version 8 
(Sci–Ed Scientific Ltd., Cary, NC, USA). In addition, translated C. pseudotuberculosis ORFs 
were identified by comparison with sequences resident in the National Center for 
Biotechnology Information (NCBI) non-redundant database, using the Basic Local Alignment 
Search Tool (BLAST), accessed via the NCBI WWW portal (http://www.ncbi.nlm.nih.gov). 
 
2.16 Statistical analyses  
 
Data was analysed and graphs were drawn using Microsoft
®
 Office Excel 2003 (Microsoft
®
; 
CA. USA). Significant differences were assessed by the Student‘s t- test and ANOVA, which 
were performed using the Minitab
®
 15.1 software (Minitab™, UK). All errors bars that are 
shown throughout this are a result of the standard deviation of the mean.  Statistical advice 
was provided by Dr Mintu Nath and Jill Sales at Biomathematics and Statistics Scotland 
(BioSS; University of Edinburgh, Kings Buildings, Edinburgh, Scotland).  
 
2.17 Proteomic data interrogation 
 
Proteins were identified following a match of at least two peptides, those peptides with lower 
scores were inspected manually and only included if a series of 4 or more continuous y or b 
ions were observed.  Obtaining matches to a number of peptides from a single protein provides 
a very high level of confidence that the results are correct.  Results obtained from proteomic 
studies were analyzed using Mascot™ software21 (Matrixscience, London, U.K.), SwissProt 
(Swiss Institute of Bioinformatics), NCBInr databases (National library of Medicine and 
National Institutes of Health) and an in-house Mascot database derived from C. diphtheriae, 
C. efficiens and C. glutamicum genomes.  
  71 
 
 
 
 
 
 
 
 
Chapter Three 
Investigation of the effects of environmental iron on 
Corynebacterium pseudotuberculosis
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3.0 Introduction 
 
Iron is an essential element which is required by the majority of living organisms, an 
exception being some lactobacilli (Archibald, 1983). It contributes to numerous vital 
biological processes, including respiration, the trichloroacetic acid cycle, oxygen transport, 
gene regulation and DNA biosynthesis (Andrews, et al. 2003).  Iron is the fourth most 
abundant metal in the Earth‘s crust, implying that there is a plentiful supply; however, under 
physiological conditions iron exists in an extremely insoluble ferric form. Furthermore, as part 
of the host‘s innate defence against invading microorganisms, free-iron is bound by host iron-
binding proteins such as transferrin and lactoferrin. In order to cause infection, bacteria need 
to multiply; however, in order to multiply they need to acquire essential nutrients, including 
iron.  Bacteria generally require 10
-7
 to 10
-5
 M of iron to achieve optimal growth (Andrews, et 
al. 2003), however, in the mammalian host, the concentration of free-iron is normally around 
10
-18
 M which is far below the required level (Bullen, et al. 1978). Therefore, due to its 
general unavailability, microorganisms have evolved a number of mechanisms to obtain iron 
from their environment, and these mechanisms are often closely-linked to virulence (Litwin & 
Calderwood, 1993).   
 
Host iron-binding proteins are varied; the majority of iron being bound by hemoproteins such 
as haemoglobin. Ferritin, another host-iron binding protein, is involved in iron storage and 
detoxification. Interestingly, ferritin analogs are found in bacteria, where they are known as 
bacterioferritin, and are also involved in the storage of intracellular iron (Mietzner & Morse, 
1994; Theil, 1987). Haemoglobin and ferritin are intracellular iron sources, being found within 
host cells, while transferrin and lactoferrin are extracellular. Transferrin is responsible for 
transporting extracellular iron between cells, and circulates in the plasma and lymphatic fluids 
(Welch, 1992), while lactoferrin tends to be associated with mucosal secretions and 
phagocytic granules (Welch, 1992) (Mietzner & Morse, 1994). Lactoferrin and transferrin are 
also involved in the first line of defence against invading microorganisms by binding 
extracellular free-iron.  At decreased pH, lactoferrin retains its affinity for iron, whereas iron is 
dissociated from transferrin at pH <4.5 (Welch, 1992) (Mietzner & Morse, 1994).  The 
primary function of lactoferrin is to act as an inhibitor of microbial growth, but unlike 
transferrin it is not thought to be involved in eukaryotic iron transport (Mietzner & Morse, 
1994).   
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Bacteria use several different mechanisms to sequester iron. The type of iron sequestration 
employed largely depends on the bacterium in question. The iron/haem acquisition systems in 
bacteria can generally be separated into two groups; the first involves direct contact between 
the source of iron and the bacterial surface, while the second mechanism involves compounds 
(known as siderophores), that are secreted by the bacteria into the extracellular medium to 
scavenge iron (Wandersman & Delepelaire, 2004).  
 
In order to become a successful pathogen, an organism is required to ―sense‖ its environment 
and respond quickly to environmental changes by modulating the expression of relevant 
genes. Environmental factors including pH, osmolarity, temperature and amino acid 
concentration, all exert an effect on bacterial gene expression including those genes associated 
with virulence (Miller, et al. 1989). It is not surprising then that being an essential requirement 
for growth, the concentration of environmental iron is also ―sensed‖ by bacteria.  In C. 
pseudotuberculosis, the sensing of environmental iron concentrations and the concomitant 
effect on pathogenesis is not yet fully understood. Billington et al. (1992) identified the so-
called ferric iron acquisition genes (fag) operon, comprising three genes (fagABC) shown to 
be involved in iron acquisition. These genes were subsequently associated with C. 
pseudotuberculosis virulence (Billington, et al. 2002). However, to-date there has been no 
other published research on the requirement of iron or its potential link to gene expression 
(and therefore virulence). Interestingly, iron has been shown to play a very important role in 
the regulation of expression of virulence genes in the closely related human pathogen C. 
diphtheriae, and there has been a plethora of work carried out in this area.   
 
Upon infection with a microorganism, and as part of the innate defence mechanism, the host 
specifically limits free-iron. This shift from a high to low-iron environment is an important 
environmental signal for bacteria to coordinate the regulation of gene expression (Litwin & 
Calderwood, 1993), and it is a signal which is interpreted in each of two ways; primarily, the 
bacterium recognises that it must acquire iron, but secondly it recognises that it has entered a 
hostile environment (i.e. the host) and must initiate attempts to colonise and persist. 
Subsequently, in addition to iron-acquisition genes, the expression of many genes involved in 
virulence are also regulated in response to environmental iron concentration. With this in 
mind, it was thought likely that by assessing the influence that iron had on C. 
pseudotuberculosis gene expression, it might eventually be possible to identify novel 
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phenotypes, which could be the focus of further study in order to discover specific factors 
contributing to the pathogenicity of the organism. There is no doubt that the natural host is the 
best system in which to study an organism; however, this environment is very complex, and 
hence it is difficult to dissect the multiple, often subtle influences that are exerted upon the 
pathogen by multiple host factors.  Therefore, for the purposes of this study, a preliminary aim 
was to develop a defined growth medium, which would allow significant in vivo conditions to 
be mimicked.  Using such a medium, it was anticipated that environmental iron concentrations 
could be altered so as to assess the outcome on growth and gene expression (determined by 
observation of phenotypes and assessment of changes in protein profiles) of C. 
pseudotuberculosis.  
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3.1 Results 
3.1.1 Development of a chemically defined medium to investigate iron- 
 regulation of gene expression C. pseudotuberculosis 
 
A major objective of the work described in this chapter was to develop a chemically-defined 
medium (CDM) which would support the rapid growth of C. pseudotuberculosis, and, in 
which the concentrations of specific growth factors, including iron, could be easily and 
accurately manipulated.  Furthermore, to facilitate downstream proteomic analyses, it was 
important that the CDM contained as few contaminating proteins as possible. Significantly, an 
effective CDM was an essential resource, required for all subsequent experiments on the iron-
regulation of gene expression, described throughout this thesis.  
 
3.1.2 Growth Characteristics of C. pseudotuberculosis in rich media 
 
In order to define optimal growth conditions that could subsequently be exploited in the 
development of a CDM, it was important to determine the definitive growth of C. 
pseudotuberculosis in a rich, undefined medium. Routinely, corynebacteria are grown in Brain 
Heart Infusion broth (BHI). This undefined medium is very rich and provides all the necessary 
nutrients for the bacterium to flourish; however, the presence of contaminating proteins in the 
BHI could potentially result in background noise in proteomic analyses. In addition, and more 
importantly, the exact composition of the medium is unknown with respect to the abundance 
of specific growth factors and nutrients. The growth of C. pseudotuberculosis in BHI (typical 
results are shown in Figure 3.1) reached an OD600nm of 1.8 after 15 hr, and this was used as the 
gold standard level of growth to compare the success of the subsequently developed CDM.  
 
Due to the waxy nature of the Corynebacterium cell wall, polyoxyethylene sorbitane 
monooleate (Tween 80
®
), a non-ionic surfactant and emulsifier, is typically added to liquid 
cultures to prevent the bacteria clumping (Dubos & Middlebrook, 1948; McGinley, et al. 
1985a; McGinley, et al. 1985b; Riley, et al. 1979). Furthermore, Tween 80
®
 also serves as a 
metabolite, subsequently enhancing growth (Dubos & Middlebrook, 1948). The addition of 
0.05 % (v/v) Tween 80
®
 to liquid cultures became a standard procedure throughout this thesis.  
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Figure 3.1 Typical growth curve of C. pseudotuberculosis 3/99-5 in BHIT broth at 37°C with 
constant shaking.  
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3.1.3 C. pseudotuberculosis chemically defined medium  
 
A CDM which has been successfully used in the culture of the closely-related organism 
Corynebacterium renale (VanEseltine, et al. 1978), was used as a guide to help determine the 
composition of a C. pseudotuberculosis CDM.  Significantly, many previously described 
CDM, including the one mentioned above, are composed of a remarkably complex blend of 
inorganic salts, amino acids and vitamins. Such media are time-consuming to prepare and 
frequently suffer from inconsistencies in performance due to their complex nature and the 
increased likelihood of errors during preparation.  Hence, in order to ensure consistency in the 
quality of the CDM, in addition to facilitating ease of preparation, the utility of commercially 
available cell-culture media as a base for a novel C. pseudotuberculosis CDM was determined. 
The evaluation of two commercially available media, Hanks Balanced Salt Solution (HBSS; 
Sigma-Aldrich, UK, catalogue no. H 8264), and Roswell Park Memorial Institute medium 
1640 (RPMI-1640; Sigma-Aldrich, UK, catalogue no. R 8755) were carried out to assess their 
ability to support the growth of C. pseudotuberculosis. Table 3.1 compares the ingredients of 
the CDM (VanEseltine, et al., 1978), RPMI-1640 Sigma-Aldrich, UK, catalogue no. R 8755 
and HBSS Sigma-Aldrich, UK, catalogue no. H 8264).  
 
Initially, growth of C. pseudotuberculosis in HBSS was assessed. Unfortunately, this medium 
was found not to be able to support the growth of the organism, and after 24 hr incubation the 
OD600nm of the culture was <0.1. The second cell culture medium to be evaluated was RPMI-
1640. The RPMI-1640 medium, although it contains some amino acids, is typically used in 
conjunction with a further preparation which provides supplementary amino acids.  The 
addition of the supplement increased the concentration of amino acids in the RPMI-1640 
which had the affect of substantially improving growth over RPMI-1640 alone (data not 
shown). Also, the addition of a carbon source (glucose) was found to be essential (data not 
shown), as RPMI-1640 contains only 2 g/L of glucose whereas the published CDM contained 
10 g/L (VanEseltine, et al., 1978). Another addition to the RPMI-1640 was 12 g/L of L-
glutamic acid. Again, this was to increase the concentration to mimic that of the published 
CDM (VanEseltine, et al., 1978). Significantly, the addition of 10 μM manganese and zinc 
chloride respectively, made no difference to the growth of C. pseudotuberculosis in the newly 
developed CDM (data not shown).  
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Them modified/supplemented RPMI-1640 medium was subsequently designated 
―Corynebacterium Chemically-Defined Medium (CCDM). In order to confirm that CCDM 
could reproducibly support the growth of C. pseudotuberculosis, single colonies were picked 
from BHI agar plates and used to inoculate CCDM.  Following incubation for 24 hr, the 
results clearly demonstrated that the novel CCDM was capable of sustaining growth of C. 
pseudotuberculosis (data not shown). In addition, growth experiments were carried out using 
overnight C. pseudotuberculosis cultures, propagated in CCDM to inoculate fresh CCDM.  
Following incubation for 24 hr, sub-cultured C. pseudotuberculosis had reached an OD600nm of 
1.6; a typical growth curve is presented in Figure 3.2. This showed that the CCDM contained 
sufficient nutrients/growth factors such that C. pseudotuberculosis was not relying on 
intracellular stores during primary culture. In addition, the final OD600nm was almost 
equivalent to the gold standard BHI.  
Chapter Three                                                                                                                                Results 
 79 
 
Table 3.1 Comparison of growth media ingredients 
 
Component RPMI-1640 (cat no. R 
8755)* 
g/L 
CDM (VanEseltine) 
g/L 
HANKS (cat no. H 8264) 
g/L 
Inorganic salts 
Ca(NO3)2•4H2O  
0.1 0.065 0.185 
MgSO4 (anhydrous) 0.04884 0.021 0.097 
KCl  0.4 0.4 0.4 
KH2PO4  - 0.68 0.06 
NaHCO3  - 0.5 0.35 
NaCl  6.0 6.2 8.0 
Na2HPO4 (anhydrous) 0.8 2.8 0.045 
Amino acids 
L-Arginine  
 
0.2 (10) 
 
- 
 
- 
L-Asparagine (anhydrous)  0.05 (2.8) - - 
L-Aspartic Acid 0.02 (1.0) - - 
L-Cystine•2HCl 0.065 (2.5) 0.05 - 
L-Glutamic Acid  0.02 (1.0) 12.7 - 
L-Glutamine  0.3 - - 
Glycine  0.01 (0.5) - - 
L-Histidine  0.015 (0.75) - - 
Hydroxy-L-Proline  0.02 (1.0) 0.5 - 
L-Isoleucine  0.05 (2.5) - - 
L-Leucine 0.05 (2.5) - - 
L-Lysine•HCl  0.04 (2.0) - - 
L-Methionine  0.015 (0.75) 0.03 - 
L-Phenylalanine 0.015 (0.75) - - 
L-Proline  0.02 (1.0) - - 
L-Serine  0.03 (1.5) - - 
L-Threonine  0.02 (1.0) - - 
L-Tryptophan  0.005 (0.25) - - 
L-Tyrosine - (1.16) - - 
L-Tyrosine•2Na•2H2O  0.02883 - - 
L-Valine  
 
0.02 (1.0) - - 
Vitamins 
D-Biotin  
0.0002 0.0004 - 
Choline Chloride 0.003 - - 
Choline Bitartrate  - - - 
Folic Acid  0.001 - - 
myo-Inositol 0.035 0.5 - 
Niacinamide 0.001 - - 
p-Amino Benzoic Acid  0.001 - - 
D-Pantothenic Acid•½Ca  0.00025 - - 
Pyridoxine•HCl 0.001 - - 
Riboflavin  0.0002 - - 
Thiamine•HCl 0.001 0.01 - 
Vitamin B-12 
 
0.000005 - - 
Other 
D-Glucose  
 
2.0 
 
10 
 
- 
Glutathione (reduced)  0.001 - - 
HEPES - - - 
Phenol Red•Na - - - 
*Values in parentheses relate to  RPMI amino acid solution 
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Figure 3.2 Typical growth curve of C. pseudotuberculosis 3/99-5 in CCDM  
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3.1.4 Modulating the iron content of CCDM  
 
With the intention of using the CCDM as a tool to investigate iron-regulation of gene 
expression in C. pseudotuberculosis, the next and most critical step was to determine suitable 
high- and low-iron growth conditions. Importantly, it was necessary to obtain a high-low iron 
differential which had an effect on gene expression, while maintaining growth at a level 
sufficient to provide adequate cell density for subsequent analyses. The literature 
accompanying the RPMI-1640 (which was purchased in powdered form) and the other 
chemicals added to create CCDM did not state that iron was present. However, the observation 
that C. pseudotuberculosis was able to grow in CCDM meant that there were either traces of 
iron present, or that the organism did not require iron for growth. In order to prevent the 
leaching of iron from contaminated glassware, plastic containers were used during preparation 
of the CCDM. Therefore, the most likely scenario was that minor contamination with iron was 
a result of the water and/or commercial chemicals used to prepare the CCDM.  
 
The growth of C. pseudotuberculosis in CCDM was comparable to that in BHI. However, 
because only trace (contaminant) levels of iron were present, it was thought possible that the 
addition of further iron to the CCDM potentially could improve the growth of C. 
pseudotuberculosis. To determine the effect of iron on the growth of the organism, CCDM 
was supplemented with ferric chloride (FeCl3) to 1 μM, 10 μM and 100 μM final 
concentration, and the outcome on the growth of C. pseudotuberculosis was assessed (Figure 
3.3). Interestingly, the addition of FeCl3 did not improve the growth of C. pseudotuberculosis.  
Interpreting this result led to the conclusions that either sufficient contaminating iron was 
present in CCDM to promote growth, or that C. pseudotuberculosis did not require iron for 
growth. 
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Figure 3.3 Growth of C. pseudotuberculosis in CCDM supplemented with varying 
concentrations of FeCl3. CCDM (  ), CCDM + 1 μM FeCl3 ( ), CCDM + 10 μM FeCl3 ( ), 
CCDM + 100 μM FeCl3 ( ). For ease of interpretation, data is plotted on a linear scale. 
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To determine whether C. pseudotuberculosis requires iron for growth, the iron-load in CCDM 
was reduced by addition of the powerful iron-chelator, 2‘, 2‘ dipyridyl (subsequently referred 
to as dipyridyl).  Corynebacterium chemically defined medium was supplemented with a 
range of concentrations of dipyridyl from 200-450 µM (final concentration).  The results of 
these experiments are presented in Figure 3.4 where it is apparent that with increasing 
dipyridyl concentration, there is a concomitant decrease in growth of C. pseudotuberculosis. 
Therefore, it was assumed that C. pseudotuberculosis did require iron for growth, and that 
contamination of the CCDM with trace amounts of iron was sufficient to allow growth of the 
organism.  In the course of assessing the outcome of supplementing CCDM with dipyridyl, a 
suitable low-iron growth medium was determined, based upon the observation that a 300 μM 
final concentration of dipyridyl resulted in a reduction of growth to a maximum OD600nm of ca. 
1.0. This level of growth was deemed sufficient to have reduced the growth satisfactorily to 
exert an effect on iron-dependent gene expression, while allowing sufficient bacterial growth 
to provide material for downstream analyses.    
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Figure 3.4 Growth of C. pseudotuberculosis in CCDM supplemented with varying 
concentrations of the iron chelator dipyridyl.  CCDM ( ), CCDM + 200 μM (  ), 250 μM ( ), 
300 μM (  ), 350 μM (  ),  400 μM (  ), 450 μM ( ), dipyridyl. For ease of interpretation, data is 
plotted on a linear scale. 
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3.1.5 Concentration of metal ions in C. pseudotuberculosis growth media 
 
In order to determine the levels of metal ions present in the CCDM, it was analysed in 
comparison to BHI, both with and without the addition of Tween 80
®
. Inductively Coupled 
Plasma Mass Spectrometry (ICP-MS) analyses were performed by staff at the Analytical 
Services Department of the Scottish Agricultural College (Bush Loan, Penicuik, Midlothian, 
Scotland) on a Perkin Elmer Optima 4300DV mass spectrometer. The ICP-MS procedure is 
highly sensitive and capable of determining the concentrations of a range of metals, and is 
based on coupling together inductively coupled plasma as a method of producing ions which 
are separated and detected using a mass spectrometer.   However, it is unable to measure iron 
concentration accurately below 230 μg/ml. The results of ICP-MS analyses are presented in 
Table 3.2, and clearly show that all assessed metal ions were reduced in quantity in CCDM-
based media as compared to BHI.  Unfortunately however, the concentration of iron in CCDM 
was too low to be quantified, being below the limit of sensitivity of 230 μg/ml, so it was not 
possible to determine the relative concentrations of iron in CCDM as compared to dipyridyl-
treated CCDM. As expected, the addition of Tween
80
 did not have a significant effect on the 
composition of the media. 
 
Table 3.2. ICP-MS analysis of C. pseudotuberculosis growth media 
 
 BHI BHI + 
(Tween 80) 
CCDM CCDM + 
(Tween 80) 
CCDM + 
dipyridyl  
Sulphur 127  123 36.3 35.5 33.8 
Magnesium  18.9  18.6 7.95 8.10 7.71 
Calcium 20.7  20.6 13.9 13.9 13.2 
Aluminium 356  340 <80.0 <80.0 <80.0 
Iron 866  843 <230 <230 <230 
Manganese 275  270 <4.0 <4.0 <4.0 
Copper <11.0  <11.0 <11.0 <11.0 <11.0 
Zinc 827  822 <9.0 <9.0 <9.0 
Phosphorus 597000  598000 167000 170000 162000 
Cadmium <14.0 <14.0 <14.0 <14.0 <14.0 
Chromium 20.0 19.9 <13.0 <13.0 <13.0 
Nickel <30.0 <30.0 <30.0 <30.0 <30.0 
Lead <110 <110 <110 <110 <110 
Boron  224 220 <45 <45 <45 
Units of concentration are μg/ml except sulphur, magnesium and calcium which are mg/ml. Analyses were carried out by the 
Analytical Services Department of the Scottish Agricultural College  
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3.1.6 C. pseudotuberculosis acquisition of iron from host iron-binding proteins  
3.1.6.1 Transferrin 
In order determine whether C. pseudotuberculosis was able to acquire iron from the host iron-
binding protein, transferrin, 1 mg/ml of holo (iron-saturated)-transferrin was added to aliquots 
of CCDM, with and without a final concentration of 300 μM dipyridyl (Figure 3.5). No 
difference in the growth profile was observed following the addition of transferrin to CCDM 
without dipyridyl, suggesting that the CCDM alone contains sufficient iron to support the 
growth of the organism. In contrast, the addition of holo-transferrin to dipyridyl-supplemented 
CCDM resulted in the restoration of growth, after a ca. 5 hr lag-phase, from the previously 
observed OD600nm of ca. 1.0 to the CCDM-equivalent OD600nm of ca. 1.6. This data suggests 
that C. pseudotuberculosis is able to sequester iron from transferrin. 
 
To further demonstrate the capacity of C. pseudotuberculosis to acquire iron from transferrin, 
CCDM was supplemented with apo (iron-free)-transferrin, which has a high-affinity for iron. 
As can be seen in Figure 3.6, C. pseudotuberculosis was still able to grow in CCDM 
supplemented with 1mg/ml of apo-transferrin, although the final OD600nm was slightly lower 
than observed in CCDM supplemented with dipyridyl and holo-transferrin (or CCDM alone). 
These results are consistent with the preliminary sequestration of free-iron by transferrin, 
followed by the acquisition of transferrin-bound iron by C. pseudotuberculosis. In addition, 
these results further demonstrate that C. pseudotuberculosis is able to acquire iron from 
transferrin.  
3.1.6.2 Lactoferrin 
An equivalent experiment to that described for transferrin was conducted, whereby aliquots of 
CCDM (with and without dipyridyl) were supplemented with lactoferrin to 1 mg/ml. It should 
be noted that the lactoferrin used in this experiment, which was purchased from Sigma-
Aldrich, was obtained from bovine colostrum, and it was not possible to ascertain from the 
manufacturer‘s accompanying data whether it was the apo- or holo-form.   
 
Following the supplementation of cultures with lactoferrin a preliminary lag in growth of ca. 5 
hr was observed (Figure 3.7), following which growth proceeded at a rate slower than 
observed in CCDM, but faster than in CCDM supplemented with dipyridyl.  The final OD600nm 
of lactoferrin supplemented cultures was ca. 1.6, equivalent to growth in CCDM. These data, 
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which were equivalent to the growth of C. pseudotuberculosis in CCDM supplemented with 
dipyridyl and holo-transferrin, revealed that the organism was able to acquire iron from 
lactoferrin. 
3.1.6.3 Haemoglobin 
To further investigate the ability of C. pseudotuberculosis to utilise host iron binding proteins 
as sources of iron, CCDM was supplemented with haemoglobin to a final concentration of 1 
mg/ml. Unfortunately the addition of haemoglobin to the CCDM resulted in solubility issues, 
and these experiments were not pursued further. 
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Figure 3.5 Growth of C. pseudotuberculosis 3/99-5 in CCDM supplemented with dipyridyl and 
transferrin. CCDM ( ), CCDM + 300 μM dipyridyl ( ), CCDM + 1 mg/ml holo-transferrin ( ), 
CCDM + 1 mg/ml holo-transferrin + 300 μM dipyridyl ( ). For ease of interpretation, data is plotted on a 
linear scale. 
 
  
 
 
 
 
 
 
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
0 5 10 15 20 25 30
O
D
6
0
0
Time in Hrs
Chapter Three                                                                                                                                Results 
 89 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Growth of C. pseudotuberculosis 3/99-5 in CCDM supplemented with varying 
concentrations of apo-transferrin. CCDM ( ), CCDM + 5 μM (  ),10 μM (  ), 15 μM (  ), 
20 μM (  ), 25 μM  ( )  apo-transferrin. For ease of interpretation, data is plotted on a linear scale. 
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Figure 3.7 Growth of C. pseudotuberculosis 3/99-5 in CCDM supplemented with lactoferrin.  
CCDM  (  ), CCDM + 300 μM dipyridyl (  ), CCDM + 1 mg/ml lactoferrin ( ). For ease of 
interpretation the graph is presented on a linear scale.  
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3.1.7 Environmental iron-dependent production of exported proteins  
 
The successful development of CCDM, and the determination of high- and low-iron growth 
conditions, provided the opportunity to investigate the effect of variation in environmental 
iron concentration on gene expression, as determined by the observation of differences in 
protein profiles from C. pseudotuberculosis grown under different conditions.  As a 
preliminary investigation, C. pseudotuberculosis was cultured to mid exponential growth-
phase in high- and low-iron-containing CCDM. Culture volumes were scaled up in order to 
obtain enough material for subsequent analyses. However, it was observed that when using 
500 ml flasks containing 100 ml of culture volume, the observed OD600nm of the high-iron 
culture reached approximately 3.0, while that of the low-iron culture reached approximately 
1.5. This difference in growth between the Bioscreen (high-iron 1.6 and low-iron 1.0) and 
culture flask final OD600nm was consistently reproducible and most likely derived from 
different levels of aeration between the two culture methods. However, despite differences in 
the final OD600nm values, the growth profiles were identical between methods; only the final 
OD varied.  
 
The culture supernatants containing C. pseudotuberculosis exported proteins were normalised 
by diluting the high-iron culture to an equivalent OD600nm to the low-iron culture; hence 
equivalent cell numbers/ml were obtained. An equivalent volume of each culture supernatant 
was supplemented with protease inhibitors to prevent protein degradation prior to being 
concentrated and buffer-exchanged in PBS using 5 kD Mr cut-off centrifugal filters.  
Subsequently, equal volumes of the concentrated protein preparations were separated by SDS-
PAGE, and visualised by silver staining.  
 
To allow optimal separation of both large and small proteins, the protein preparations were 
analysed on both 6 % and 10 % gels (Figure 3.8). As can be seen from Figure 3. 8, it would 
appear that there was more protein present in the low-iron derived sample compared to that of 
the high-iron derived sample. Given that the culture volume had been normalised by cell 
number, and the CCDM contained no contaminating protein, one could hypothesise that the 
apparent increase in protein production is a result of iron stress. 
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 Panel A)  
 
 
Panel B)  
 
 
Figure 3.8 Supernatant proteins derived from C. pseudotuberculosis 3/99-5 cultures.  Shown are  
examples of a 6 % SDS- PA gel (panel A) and a 10% SDS-PA gel (panel B). In both panels samples correspond 
to proteins derived from high- (lane 1) and low- (lane 2) iron growth conditions.  A Mark 12™ standards 
(Invitrogen) molecular weight marker (M) was used.  
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3.1.8 Western blot analysis of C. pseudotuberculosis exported proteins  
 
Following growth of C. pseudotuberculosis under high and low-iron conditions in-vitro, an 
experiment was carried out to ascertain whether any of the exported proteins were produced in 
vivo.  Pooled sera from sheep known to have CLA (hence, infected with C. 
pseudotuberculosis), were used to probe the C. pseudotuberculosis exported protein 
preparations by Western blot analysis (Figure 3.9). Proteins elaborated from C. 
pseudotuberculosis grown under high- and low-iron conditions were separated through a 10 % 
SDS-PA gel and transferred to a nitrocellulose membrane prior to conducting Western blots. 
As can be seen in Figure 3.9, no proteins were recognised in a negative control Western blot 
conducted using sera from CLA-free sheep.  In contrast, several proteins were recognised in 
the blot probed with CLA-positive sera, in sample lanes containing proteins isolated from 
bacteria grown under both high- and low-iron conditions.  Significantly, several of the bands 
appeared to be the same between each preparation; however, in addition there were other 
bands which were either less abundant or completely absent from the high-iron culture.  
Furthermore, there was evidence of one band being more abundant in the high-iron culture.      
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Figure 3.9 Western blot analysis of C. pseudotuberculosis exported proteins.  Primary antibodies 
to probe membrane-bound proteins were either pooled serum samples from sheep with CLA (panel A) or from 
sheep naïve to C. pseudotuberculosis (panel B).  Sample lanes correspond to exported proteins obtained from 
cultures propagated in CCDM (Lane 1) or CCDM containing 300 μM dipyridyl (Lane 2). Molecular weight 
markers (M) were SeeBlue® Plus2 (Invitrogen).  
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3.1.9 Preliminary proteomic analyses  
 
In an attempt to identify C. pseudotuberculosis exported proteins, a preliminary proteomic 
investigation was conducted. Corynebacterium pseudotuberculosis was cultured under low-
iron conditions. Subsequently, exported proteins were separated through a 10 % SDS-PA gel 
and visualised by staining with colloidal Coomassie blue (Figure 3.10). Five unique bands 
(i.e. bands that weren‘t apparent in the exported proteins isolated from high-iron growth 
conditions) were excised and analysed by liquid chromatography, electrospray ionisation, 
tandem mass spectrometry (LC-ESI-MS/MS)(Batycka, et al. 2006).   
 
At the time this work was conducted, there was no C. pseudotuberculosis genome available; 
hence, successful identification of proteins from the MS-analysed peptides was dependent on 
similarity with proteins in the publicly-available databases. Interrogation of Mascot databases 
compiled from publicly-available protein sequences revealed a significant Molecular weight 
search (Mowse) score with two published C. pseudotuberculosis protein sequences (Figure 
3.10).  The first of these proteins, with a Mowse score of 301, and matching peptides across 
37% of the published sequence was identified as phospholipase D (Accession no. L16587).  
The second of the proteins, with a Mowse score of 104, and matching peptides across 10 % of 
the published sequence, was the C. pseudotuberculosis serine proteinase, Cp40 (Accession no. 
U10424).   
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Panel A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Panel B 
 
Corynebacterium 
Hits 
Identifier 
(GI) 
Origin Mowse 
Score 
No. of 
peptides 
matched 
% 
coverage 
Band 
Serine proteinase 531383 C. pseudotuberculosis 104 4 10 D 
Phospholipase D 
precursor  
289914 C. pseudotuberculosis 301 7 37 B, C 
N.B. Bands A and E resulted in no significant hits within the publicly available databases 
 
Figure 3.10 Colloidal Coomassie stained (10 %) SDS-PA gel, showing C. pseudotuberculosis 
3/99-5 exported proteins purified from cultures cultivated under high- (lane 1) and low-iron (lane 
2) growth conditions. The letters A-E identify the bands that were subsequently excised and analysed by LC-
ESI-MS/MS. (Panel A). Significant hits with C. pseudotuberculosis through NCBI databases (Panel B)   
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3.2 Discussion 
 
In most labs, C. pseudotuberculosis is routinely cultured in/on BHI, which is a rich medium; 
however, BHI originates from animal extracts, and as such, it contains proteins which could 
complicate downstream proteomic analyses. Therefore, utilising BHI for the purposes of this 
project was not an option, which led the requirement to develop a chemically-defined medium 
(a CDM being defined as a medium consisting of purified ingredients, the exact composition 
of which is known).   Although a major focus of the work described in this chapter was to 
develop such a CDM, its purpose was simply to facilitate downstream experiments in which 
the iron-dependent regulation of gene expression in C. pseudotuberculosis could be studied.  
Therefore, the presentation of extensive growth data acquired during the development of the 
CDM has been deliberately restricted to the minimum required to highlight the performance of 
C. pseudotuberculosis in the subsequently developed medium, CCDM.  In order to develop a 
CDM it is desirable to have prior knowledge of the growth requirements of the organism for 
which the CDM is required. Fortuitously, there was a published recipe for CDM for another 
actinomycete, C. renale (VanEseltine, et al. 1978). Significantly, the ingredients previously 
recommended for the successful growth of Corynebacterium (VanEseltine, et al. 1978) 
revealed similarities to commercial cell culture media. It was therefore the intention to 
examine the growth of C. pseudotuberculosis in two cell culture media, HBSS and RPMI-
1640. The use of a commercial cell culture medium was appealing for two reasons. Firstly, the 
constituents would be consistent, and therefore batch to batch variation would be negligible. 
Secondly, cell culture media are purchased in the form of pre-prepared powders, which are 
reconstituted in water. Thus, utilising a commercially-available cell culture medium as a base 
for a CDM required less time and effort to prepare compared to the laborious task encountered 
when generating a CDM from individual components.   
 
The CDM was evaluated by comparing the maximum growth of C. pseudotuberculosis in the 
novel medium, to the maximum growth in BHI, the gold standard (allowing an OD600nm
 
of 1.8 
to be reached in Bioscreen C experiments).  The first cell culture medium to be assessed was 
HBSS. Unfortunately, this medium was not able to support the growth of C. 
pseudotuberculosis. In contrast, the constituents of RPMI-1640 were similar in many ways to 
the components of previously reported corynebacteria CDM. As a result, an RPMI-1640-based 
medium was chosen for further development. Typically, for eukaryotic cell culture, RPMI-
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1640 is supplemented with a further complement of amino acids. Again, this mixture comes 
pre-prepared, hence is very easy to use, simply being added to the re-suspended RPMI-1640 
medium. The addition of the amino acid supplement resulted in a final amino acid 
concentration similar to that of the previously reported CDM. However, further optimisation 
was required in order to improve the RPMI-1640-based medium such that it was similar in 
composition to the CDM developed by VanEseltine et al (1978); in particular, the levels of 
glucose and L-glutamic acid were increased. The resulting CDM designated Corynebacterium 
CDM (CCDM) was successfully shown to support the growth of C. pseudotuberculosis. 
Significantly, the maximum OD600nm of C. pseudotuberculosis grown in CCDM in Bioscreen 
C experiments was 1.6; a favourable result, given that the maximum OD600nm in BHI was 
OD600 1.8.  Interestingly, when cultures were scaled-up to allow the provision of proteins for 
mass spectrometric analyses, it became apparent that a larger culture vessel resulted in cultures 
reaching a much higher cell density (as determined by OD600nm values). Corynebacterium 
pseudotuberculosis is a facultative anaerobe, able to grow under aerobic and anaerobic 
conditions; however, in hindsight this result is perhaps not surprising as the oxygen tension of 
cultures is known to be important for other actinomycetes, even those that are facultative 
anaerobes. For example, Moore and James (1982) recognized that Mycobacterium bovis BCG 
requires a sufficient oxygen tension to support logarithmic phase growth in vitro; 
consequently, growth was dependent on the depth of the culture (Moore & James, 1982).   
 
The main objective of the work presented in this chapter was to recreate in vitro, the low-iron 
conditions faced by C. pseudotuberculosis in vivo. At the time this study began, very little was 
known about the C. pseudotuberculosis requirement for iron. Preliminary experiments using 
dipyridyl were conducted to determine whether removal of medium-containing iron resulted in 
a decrease in growth rate, and eventual cessation of growth at higher concentrations of 
dipyridyl.  The results of these experiments showed that removal of increasingly more iron 
resulted in a decreasing ability of C. pseudotuberculosis to grow.  However, although 
dipyridyl is a strong chelator of iron, it is acknowledged that it also binds other transition 
metals.  In this respect, although it was considered most likely that iron-chelation was 
affecting growth, there was a slight possibility that removal of other transition metals, such as 
manganese and zinc, were affecting the ability of C. pseudotuberculosis to grow in chelated 
CCDM.  In order to assess the importance of iron over other transition metals experiments 
examining the interaction between C. pseudotuberculosis and transferrin or lactoferrin were 
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performed.  Clearly, the results presented in Figures 3.5, 3.6 and 3.7 reveal that C. 
pseudotuberculosis is able to acquire iron from transferrin and lactoferrin, allowing a 
restoration of growth to an equivalent OD600nm to that observed in un-chelated CCDM.  Since 
lactoferrin and transferrin only bind host iron, these experiments provided the necessary 
evidence to show that the reduction in growth induced by supplementing CCDM with 
dipyridyl was a direct result of the reduction in availability of iron.   
 
In addition to proving that C. pseudotuberculosis requires iron for growth, these experiments 
also provided evidence of one of the means by which C. pseudotuberculosis is able to acquire 
iron from the host, which is of relevance since transferrin is present within lymphatic fluid and 
blood, and may therefore serve as a major source of iron for the organism.  Following the 
addition of transferrin to dipyridyl-treated CCDM, the growth of C. pseudotuberculosis was 
restored to a level equivalent to that in CCDM alone; however, there was a slower transition to 
logarithmic-phase of growth. It was considered likely that the slow transition was a result of 
the bacterium sensing the low-iron environment and adjusting accordingly, in order to acquire 
iron from transferrin. However, it is also possible that it was due to a requirement for the pH 
of the culture to drop (observed during bacterial growth), allowing the release of iron from 
transferrin, as has been described elsewhere (Welch, 1992) (Mietzner & Morse, 1994).  
However, in vivo the pH would not be expected to drop in a similar manner to that observed in 
in vitro culture, and it is possible, therefore, that localised reduction in pH, such as may be 
observed as a result of H
+
 transport across the cell membrane, may be responsible for the iron 
release.  In order to test this hypothesis, however, further work would be required to determine 
the physical interaction of C. pseudotuberculosis with transferrin.   
 
Corynebacterium pseudotuberculosis has also been associated with cases of mastitis in sheep, 
goats and cows, most likely through introduction of the organism to the mammary gland 
following rupture of supra-mammary lymph node abscesses.   Lactoferrin is the principle iron-
binding protein in milk, and is similar to transferrin except that it has a 300-fold greater 
affinity for iron. Furthermore, lactoferrin is usually less than 10 % iron saturated (Bezwoda & 
Mansoor, 1989; Mietzner & Morse, 1994). Interestingly, the addition of lactoferrin to CCDM 
resulted in a similar C. pseudotuberculosis growth pattern to that seen previously when 
dipyridyl-treated CCDM was supplemented with apo-transferrin (Figures 3.6 and 3.7), in that 
the transition from lag to exponential growth phase was slow.  There could be several reasons 
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for this, one of them being that the lactoferrin, being less than 10 % saturated, acts in the same 
way as apo-transferrin by binding the iron in the CCDM prior to C. pseudotuberculosis 
scavenging the iron back.  This would support the hypothesis that the slow transition between 
growth phases is due to the bacteria sensing their low-iron environment and modulating gene 
expression of iron acquisition genes accordingly.  Significantly, the release of iron from 
lactoferrin has been shown not to be affected by pH (Welch, 1992; Mietzner & Morse, 1994), 
and, as such it is likely that C. pseudotuberculosis uses some other, as yet undefined method 
for obtaining iron from this molecule.  In addition, it may well be that an equivalent 
mechanism is also employed by the organism to obtain iron from transferrin.  Significantly, 
both lactoferrin and transferrin are known to be bacteriostatic (Weinberg, 1993), and restrict 
bacterial growth by limiting iron availability; however, some bacterial pathogens have evolved 
methods to retrieve iron from host iron binding proteins, thus permitting growth once more 
(Ratledge & Dover, 2000).  
 
In the course of the current study, a preliminary attempt was made to address the question of 
whether differences in the ability of C. pseudotuberculosis isolates from different host species 
were better or less able to acquire iron from transferrin or lactoferrin.  A preliminary 
experiment was conducted to determine the differences in the ability of an ovine-derived 
(3/99-5) and bovine-derived strain of C. pseudotuberculosis to utilise transferrin and 
lactoferrin as a source of iron.  Unfortunately, the clumping of the bovine isolate during 
growth, even in high concentrations of Tween 80, interfered with the ability to accurately 
measure growth, either by OD-based measurements or plate counts, and also made it difficult 
to compare results between the two strains, and for this reason the results are not presented in 
this thesis.  However, the results did tend to suggest that the bovine strain preferred lactoferrin 
as a source of iron (data not shown); however, clearly more work is required to prove or refute 
this preliminary observation.    
 
Whilst studying the effect of iron-chelation on the growth of C. pseudotuberculosis, it became 
apparent that the CCDM contained a sufficient amount of iron to support growth, and that 
addition of further iron made no difference to growth (until higher concentrations were 
reached when toxicity issues arose). Significantly, this work has highlighted that C. 
pseudotuberculosis is not a particularly fastidious organism, and is able to grow well in the 
presence of very little iron. It is likely the presence of trace amounts of iron in CCDM was 
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either a consequence of contamination of the RPMI-1640 components themselves, or of the 
water used to re-suspend the medium. The use of Chelex 100 (Sigma) may have provided a 
more consistent means of controlling iron content within CCDM; however, preliminary 
attempts to do this were time-consuming and problematic, and for this reason dipyridyl was 
used instead.   
 
This thesis contains the first report of the acquisition of iron from transferrin and lactoferrin by 
C. pseudotuberculosis.  As mentioned above, the mechanism(s) by which the organism 
acquires iron from these molecules has not yet been determined, and no attempt has been 
made to address this issue in the work presented in this thesis. However, in C. diphtheriae the 
acquisition of iron from transferrin has been shown to be siderophore-dependent (Schmitt, 
1997b).   A mutant of C. diphtheriae (designated HC1) which lacks a siderophore uptake 
mechanism was unable to utilize transferrin as an iron source. Furthermore, other C. 
diphtheriae siderophore transport mutants were also unable to obtain iron from holo-
transferrin (Schmitt, 1997b). It may be that, like C. diphtheriae, C. pseudotuberculosis also 
requires siderophore to utilize transferrin-bound iron. However, to date there has been no 
published evidence of a siderophore produced by C. pseudotuberculosis.  In this respect, the 
assessment of siderophore by C. pseudotuberculosis was conducted as part of the work carried 
out towards this thesis, and these results are presented in their entirety in Chapter 6, alongside 
a more thorough discussion of siderophore-dependent iron acquisition. 
 
In general, little is known about siderophore-independent iron-uptake systems; however, more 
information exists for some bacteria than others. Besides siderophore, other mechanisms by 
which bacteria utilize transferrin and lactoferrin-bound iron have been described, and include 
receptor-mediated transport systems specific for host-iron complexes (Andrews, et al. 2003). 
However, the ability to acquire iron from transferrin and lactoferrin in a siderophore-
independent manner has been mainly studied in the Gram-negative species, Neisseria 
(Cornelissen & Sparling, 1994). Species in this genus have independent transferrin and 
lactoferrin receptors, which facilitate binding of these molecules at the bacterial cell-surface 
and allow iron to be stripped, resulting in the extracellular release of the (intact) iron-free 
transferrin or lactoferrin molecule (Andrews, et al. 2003). Another method that some bacteria 
employ to exploit iron sources in-vivo, is to convert extracellular ferric iron into the more 
usable ferrous iron (Andrews, et al. 2003). The enzyme involved in this is ferric reductase, and 
Chapter Three                                                                                                                                Results 
 102 
 
ferric reductase activity has been identified in several bacteria including E. coli (Cowart, 
2002). At low pH (~4.5) iron can be easily mobilised from transferrin (Mietzner & Morse, 
1994). Subsequently, bacteria have evolved mechanisms to reduce the environmental pH and 
retrieve iron from transferrin. As yet, it is not possible to confirm which method C. 
pseudotuberculosis employs in order to utilise transferrin and lactoferrin-bound iron, however, 
this is an interesting field of investigation that could result in the identification of potential 
novel virulence determinants in C. pseudotuberculosis.     
 
Haem is the most abundant source of iron in the mammalian host. Interestingly, the closely 
related human pathogen C. diphtheriae is known to scavenge iron directly from haem by 
employing haem oxygenase, HmuO (Schmitt, 1997b). It may be that C. pseudotuberculosis 
shares a similar mechanism in order to exploit haem-containing proteins as an iron source. 
However, being a facultative intracellular parasite able to survive in macrophages, (where the 
principle iron sources utilised are ferritin and the transferrins) it may be that C. 
pseudotuberculosis does not require the use of haem (an extracellular source of iron). The 
ability of C. pseudotuberculosis to utilise iron from haem sources was investigated, 
unfortunately, without success. When CCDM was supplemented with haem there were 
solubility issues, which subsequently resulted in a lack of bacterial growth. Given more time, 
this would be an interesting area to explore. In order to do this it would be necessary to 
solubilise the haem in a suitable solvent, prior to supplementation of CCDM.  
 
As part of the work presented in this chapter, the affect of environmental iron availability on 
C. pseudotuberculosis gene expression and hence protein production, was investigated. During 
this preliminary work, only exported proteins (those found in culture supernatant) were 
analysed and no attempt was made to assess differences in cell wall-anchored proteins; 
primarily this was due to the fact that the failure to identify C. pseudotuberculosis proteins by 
MS-based approaches rendered obsolete the requirement to assess cell wall material following 
disappointing results with secreted proteins. However, it was known at the start of this project 
that the addition of Tween 80
®
 to the C. pseudotuberculosis cultures would likely have an 
affect on C. pseudotuberculosis, as has been described previously in relation to cell 
morphology (Chevalier, et al. 1988). In addition, it is highly likely that surface-associated 
proteins would also have been removed from the cell surface by the action of the detergent; 
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hence, although referred to as ―exported proteins‖, they included a range of proteins both 
associated and un-associated with the cell surfaces.   
 
Interestingly, the exported protein profile of C. pseudotuberculosis cultured in low-iron 
CCDM differed significantly to that of cells cultured in high-iron medium. Furthermore, the 
concentration of proteins exported was much higher under low-iron conditions compared to 
high-iron. While it remains to be proven, it may be that the increased concentration of proteins 
demonstrated under low-iron conditions, was due to bacterial sensing of the extracellular 
environment, resulting in attempts to acquire more iron through the up-regulation of genes 
involved in iron acquisition, and the down-regulation of genes involved in iron storage, such 
as ferritin and bacterioferritin (both ferritin and bacterioferritin have been shown to be up-
regulated under high-iron conditions in M. tuberculosis (Rodriguez, et al. 2002)).  
 
The exported proteins from bacteria grown in high- and low-iron media were analysed by 
Western blot. Pooled sera from CLA-positive sheep detected a number of bands in both 
protein preparations, however a clear difference was observed between the actual bands that 
were recognised.  These results indicated that at least some of the proteins in the ―exported‖ 
fraction were produced in vivo.  Furthermore, infected sheep obviously produced antibodies 
against these proteins, some of which were differentially produced between high- and low-iron 
growth conditions.  Those proteins which were produced in greater amounts in high-iron 
medium may well have been associated with iron storage (such as bacterioferritin, although 
the size of the bands in relation to the reported size of iron storage proteins was not 
compared), while those over-produced in low-iron medium may well have been associated 
with iron-acquisition.  A significant fact that can be concluded from these results is that iron-
limitation, in vivo, is clearly an environmental signal to which C. pseudotuberculosis responds, 
resulting in changes in gene expression leading to the production or up-/down-regulation of 
specific proteins.  Significantly, while ―immunogenicity‖ does not necessarily correlate with 
―protectivity‖, it would be interesting to determine what these differentially-produced, 
immunogenic proteins are, since they could form the basis of targets for the development of 
novel therapeutics.   
 
While sufficient to demonstrate that differences in environmental iron concentrations were 
able to induce differential protein production (and hence gene expression) in C. 
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pseudotuberculosis, another objective of the work conducted towards this thesis was to 
identify novel C. pseudotuberculosis ―factors‖ that may contribute to virulence.  Therefore, it 
was decided to conduct more in-depth analyses of differentially-produced proteins using a 
previously described mass spectrometric technique.  As described in the results, the ability to 
identify C. pseudotuberculosis proteins from MS data was hampered by the absence of a 
relevant database to interrogate with the MS data.  In addition, a significant flaw in the 
experimental design was noticed after-the-fact, in that the only bands excised from SDS-PA 
gels for subsequent analysis were from proteins obtained from cultures grown under low-iron 
conditions. In order to confirm that iron was implicated in inducing differential protein 
production, equivalent bands from cultures grown under low- and high-iron conditions should 
have been excised and analysed, to allow direct comparison of results. In addition, it is 
generally recognised that each apparently single band in a one-dimensional gel can actually 
contain many different proteins.  Therefore, a positive identification of a protein from a 1D gel 
does not prove that the differentially-produced protein was identified, only that a protein 
within that particular band had been identified.  In this respect, it is of relevance that one of the 
two C. pseudotuberculosis proteins identified by MS analysis in this study was PLD 
significantly, the pld gene has previously been shown not to be iron-regulated (Billington, et 
al. 2002), suggesting that the MS-derived observation made in this study was incorrect.  
Published information pertaining to the second identified protein, Cp40, is scarce, and up-
regulation of expression of the cp40 gene has not been described under low-iron conditions.  
Therefore, it was unknown at this stage in the study whether the MS prediction of Cp40 as the 
product of an iron-regulated gene was correct (although work presented in Chapter 5 
eventually proved that it was not).  Irrespective of whether or not the finding was correct, 
further work would be required to provide conclusive proof in favour of the observation.  
Alternatively, a more appropriate analytical method (such as 2D gel electrophoresis to identify 
differentially-produced proteins, or a quantitative MS approach) could be employed to more 
accurately determine differences in the protein profiles from bacteria grown under high- and 
low-iron conditions.  However, advances in other areas of this project, presented in the 
following chapters, led to the decision not to pursue this line of investigation any further, 
partly due to lack of time, but particularly due to the lack of a genome sequence with which to 
build a meaningful database for interrogation with MS data. 
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Chapter Four  
Site-Directed Mutagenesis of Corynebacterium pseudotuberculosis  
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4.0 Introduction 
 
To date, genetic manipulation of C. pseudotuberculosis has been limited in comparison to 
other more frequently studied corynebacterial species.  This has, in part, been due to the lack 
of an available genome sequence, limiting the number of potential mutagenesis targets, in 
addition to a lack of mutagenesis tools. Mutagenesis of putative virulence genes from 
pathogenic bacteria is a very powerful tool in molecular bacteriology. Mutant derivatives that 
are deficient in the expression of specific genes can be successfully created, and subsequently 
analysed in vitro or preferably in vivo, thereby providing definitive answers to the contribution 
of specific genes to virulence (i.e. fulfilling ―molecular Koch‘s postulates). To-date, mutants 
of C. pseudotuberculosis have been constructed, using transposon (Tn) mutagenesis (Dorella, 
et al. 2006) and allele exchange mutagenesis (Billington, et al. 2002; Hodgson, et al. 1992; 
McNamara, et al. 1994; Simmons, et al. 1997). Targeted (site-directed) allele-exchange is by 
far the most useful of the two approaches. However, the technique as it has been applied to C. 
pseudotuberculosis, is imprecise, complicated and difficult to reproduce. 
 
Site-directed, allele-exchange mutagenesis is a technique which may be used to introduce 
specific changes into known chromosomal gene(s); such changes can range from a single 
nucleotide substitution to deletion of most, if not all, of a gene coding sequence.  The process 
involves homologous recombination (also known as Campbell-type recombination), which is a 
natural phenomenon that allows species to adapt more quickly to their environment by 
speeding up the process of evolution; this occurs by recombination between two DNA 
molecules which share identical (or highly-similar) nucleotide sequences within the region to 
be recombined. Subsequently, both molecules break at an equivalent site within the same 
region, then complementary base-pairing results in the ligation of one molecule to the other, 
resulting in a ―crossover‖ or ―strand-exchange‖. In nature, homologous recombination has 
been described as a means of adaptive evolution in several bacterial species.  For example, 
some Streptococcus suis strains have been shown to possess a type-II restriction-modification 
system (designated SsuDAT1I) which other strains lack (Sekizaki, et al. 2001b). Comparison 
of the nucleotide sequence between strains possessing and lacking SsuDAT1I system revealed 
that the SsuDAT1I system had originally inserted into the S. suis chromosome via illegitimate 
recombination and was subsequently transferred among S. suis strains by homologous 
recombination (Sekizaki, et al. 2001a; Sekizaki, et al. 2001b). Takamatsu et al (2002) suggest 
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that a series of genetic exchanges, illustrated by the SsuDAT1I system, may also be occurring 
in other genes and, that this process has been an important factor in the evolution of S. suis, a 
bacterium in which different strains exhibit various combinations of virulence markers 
(Takamatsu, et al. 2002); the authors provide evidence to suggest that the sly gene (encoding 
suilysin, a haemolysin) was acquired by a series of gene transfers and subsequently spread 
among strains, and that this type of transfer is a common occurrence in S. suis (Takamatsu, et 
al. 2002).  
 
In experimental practice, a wild-type chromosomal gene may be swapped with an in vitro-
constructed, mutated derivative by recombination between homologous DNA sequences 
flanking the gene/region of interest in both the wild-type chromosomal gene and a mutant 
derivative of that gene.  The DNA containing the mutagenised gene may be single- or double-
stranded in form; however, the process is facilitated if the mutated gene is cloned into a 
suitable plasmid.  In this way the plasmid may be easily manipulated prior to delivery into the 
target bacterial population by transformation of competent cells (either naturally-competent or 
induced, e.g. by electroporation), or alternatively by conjugation.  In addition, carriage of 
mutated genes on a plasmid facilitates a two-step allele-replacement process, as discussed 
below. 
 
Plasmids used for allele-replacement must ultimately be removed from the bacterial host after 
the desired mutation has been constructed, and hence these plasmids are usually (but not 
always) designed in such a way as to be removed in a straight forward manner.  Some are 
simply plasmids which do not possess an origin of replication compatible with the target 
bacterial species, and hence they are not able to replicate. However, non-replicative vectors 
are problematic, since, in general, the frequency of homologous recombination is very low, 
and they are therefore only suitable for use in bacteria that can be transformed to a high 
frequency (Biswas, et al. 1993). Other more sophisticated plasmids overcome the problem of 
low transformation efficiencies by being able to replicate in the target host, but only under 
certain specific conditions (e.g. normally only under a particular permissive temperature, 
(Hashimoto & Sekiguchi, 1976)). Introduction of a conditionally-replicative suicide vector 
into a single bacterial cell can allow the propagation of a large population of daughter cells, all 
of which will contain the plasmid if the cells are grown under permissive conditions. With 
such large starting populations of transformed cells, the likelihood of rare homologous 
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recombination events occurring is increased, especially since it has been reported that 
replication of the plasmid itself stimulates homologous recombination (Noirot, et al. 1987).  
Alternatively, some plasmids are designed to be able to induce the death of host cells in a 
controllable manner.  For example, some carry the sacB gene encoding a sucrose transporter 
which is lethal in some Gram-positive bacteria (Jager, et al. 1992).  Often plasmids used for 
allele replacement are referred to as ―suicide vectors‖, alluding to the fact that they can be 
removed from the bacterial population essentially, at will.   
 
Under permissive conditions, conditionally-replicating plasmids are able to replicate 
autonomously in the cytoplasm of the host cell, where they are stably maintained by antibiotic 
selection, permitted by a plasmid-encoded antibiotic-resistance gene. The majority of 
conditionally-replicating plasmids are temperature-sensitive (Ts), in that they are only able to 
replicate at a specific incubation temperature, normally below a critical cut-off temperature.  
In Ts vectors, the gene encoding the protein responsible for plasmid replication is mutated 
(either naturally or by artificial means such as by hydroxylamine mutagenesis) such that the 
resulting protein becomes unstable (and non-functional) at elevated temperatures (Humphreys, 
et al. 1976).  As such, by shifting the incubation temperature of cultures containing Ts 
plasmids from a permissive to non-permissive temperature, the ability of the plasmid to 
replicate is lost.  At this point, the plasmid is no longer segregated into daughter cells at cell 
division, and is rapidly lost from the bacterial population.  As a result, the net effect is the loss 
of the antibiotic-resistance phenotype from the cell population.   
 
Traditionally, a large proportion of targeted allele-replacement experiments have attempted 
gene replacement with a concurrent, double-crossover process, whereby strand exchange 
between plasmid- and chromosome-borne sequences occurs simultaneously at the 5‘- and 3‘-
regions flanking the target gene; the result is a direct swapping of the target gene with the 
mutated derivative. Significantly, because of the extremely low frequency of recombination 
events, a concurrent double-crossover event is highly unlikely, so identification of the desired 
mutants is normally facilitated by the introduction of a mutation in the form of a gene 
disruption with an antibiotic-resistance cassette, which allows direct selection for cells 
carrying the mutation.  Experimentally, while a double-crossover is the most direct approach 
to mutagenesis, the low chance of occurrence combined with the nature of the induced 
mutation is such that other approaches are more favourable.   
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An alternative means of using homologous recombination to achieve gene replacement is by 
using a two-step process. This involves selecting for cells having undergone an initial 
recombination event (so-called ―co-integrants‖), in which the plasmid carrying the mutated 
gene has been integrated into the chromosome (Figure 4.1).  At this stage, the plasmid 
replicates along with the chromosome, and expression of the plasmid-borne antibiotic-
resistance marker takes place, even under conditions not-permissive for replication of the 
plasmid in cytoplasmic form.  Once a Ts plasmid has integrated into the chromosome, a 
second recombination event can occur, which results in the excision of the plasmid (Figure 
4.2).  This process is facilitated by incubation of co-integrants at the permissive temperature 
for plasmid replication, which causes the integrated plasmid to become unstable, increasing 
the likelihood of excision (Biswas, et al. 1993); this is in contrast to non-replicating plasmids, 
which can be difficult to excise (Nakamura, et al. 2006; Schwarzer & Puhler, 1991). 
Subsequently, plasmid-integrant cells having undergone a second recombination event are 
selected for, in which the plasmid is excised from the chromosome.  As presented in Figures 
4.1 and  4.2, whether this two-step recombination procedure results in the wild-type or mutant 
gene being left in the chromosome depends on whether successive recombination events occur 
at opposite ends of the target gene (to generate a mutant) or  at equivalent ends (to retain the 
wild-type gene).   
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Figure 4.1 Schematic representation of single crossover integration (SCO) 
An SCO results in the integration of the plasmid into the chromosome, resulting in a co-integrant. The crossover 
event can happen between homologous regions flanking either side (A or B) of the mutated region. The end at 
which the crossover event takes place determines whether the integrated plasmid lies upstream (co-integrate A) 
or downstream (co-integrate B) of the wild-type target gene.  
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Figure 4.2 Schematic representation of secondary or double crossover (DCO) 
DCO is the second step in the two step recombination procedure. Using co-integrate B as an example (Figure 
4.1) it is possible to observe that there are two likely outcomes.  Recombination at the opposite end from that that 
led to initial plasmid integration results in the plasmid excising, carrying with it the wild type gene and leaving 
the mutant derivative in the chromosome.   
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In recent years, a number of C. pseudotuberculosis genes have been cloned and sequenced 
including pld (Hodgson, et al. 1990; Songer, et al. 1990), aroQ (Simmons, et al. 1997), cp40 
(Wilson, et al. 1995) and fagABC (Billington, et al. 2002). Significantly, in order to fulfil 
molecular Koch‘s postulates, several investigators have attempted to construct C. 
pseudotuberculosis mutants, deficient in the production of specific (putative) virulence-
associated proteins. Unfortunately however, allele-replacement mutagenesis of C. 
pseudotuberculosis has proven to be extremely problematic, as a result of which reports of 
success have been limited. To-date, the only successful reports of site-directed mutagenesis in 
C. pseudotuberculosis have involved non-replicative suicide plasmids (Billington, et al. 2002; 
Hodgson, et al. 1992; McNamara, et al. 1994; Simmons, et al. 1997). Hodgson et al. (1992) 
constructed a pld-deficient mutant of C. pseudotuberculosis by targeted mutagenesis of the pld 
gene. A recombination plasmid was constructed by cloning a fragment of pld (which had part 
of the gene deleted and replaced with an erythromycin resistance gene) into the plasmid pEP2 
(Zhang, et al. 1994). The resulting plasmid (pBTB58) was used to transform wild-type C. 
pseudotuberculosis by electroporation. Subsequently, C. pseudotuberculosis isolates 
containing the recombination plasmid, were transformed with pEP3, which contains the same 
origin of replication as pEP2 but harbours a different antibiotic resistance gene. To maintain 
the plasmid pEP3 and promote the loss of pBTB58 by exploiting plasmid incompatibility, the 
investigators sub-cultured cells containing both plasmids. Finally, a mutant was identified in 
which a double-crossover recombination event had incorporated the erythromycin gene into 
the chromosome resulting in a disruption of pld and the subsequent loss of pBTB58 from the 
cell.  While undoubtedly successful, this indirect and inefficient approach necessitated the 
insertion of a selectable marker into the chromosome, and also left the mutant containing a 
plasmid (pEP3) with an antibiotic-resistance gene which it previously did not have.    
 
McNamara et al. (1994) constructed a mutant derivative of pld in vitro, into which a frame-
shift deletion had been introduced; subsequently, the mutant construct was used to replace the 
wild-type chromosomal gene with the mutant derivative.  To create their mutant strain, the 
authors used an E. coli plasmid vector, unable to replicate in C. pseudotuberculosis.  The 
resulting recombinant plasmid, designated pJM11ar, contained the erythromycin-resistance 
gene from the plasmid pNG2 (a C. diphtheriae plasmid that is functional in both E. coli and C. 
pseudotuberculosis (Serwold-Davis & Groman, 1986)), and the mutated pld. The plasmid was 
integrated into the chromosome of C. pseudotuberculosis by homologous recombination, and 
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in the absence of antibiotic selective pressure the integrated plasmid resolved from the 
chromosome (and was subsequently lost from the cell), creating the pld-deficient mutant. 
Using a similar approach, Simmons et al. (1997) created a mutant C. pseudotuberculosis strain 
in which the aroQ gene, encoding the 3-dehydroquinase enzyme involved in aromatic amino 
acid biosynthesis, was insertionally inactivated by introduction of a mutant derivative of the 
gene interrupted with an erythromycin resistance cassette (Simmons, et al. 1997).  More 
recently, Billington et al. (2002) constructed a fagB-deficient mutant of C. pseudotuberculosis, 
the gene being thought to be involved in the acquisition of iron. In order to create the 
mutation, a chloramphenicol resistance gene was used to disrupt fagB in vitro, the resulting 
mutant gene was cloned into the non-replicative plasmid pJGS102, and allele-replacement was 
performed to replace the wild-type fagB gene with the insertionally inactivated derivative 
(Billington, et al. 2002).   
 
As summarised above, the majority of the limited allele-replacement studies conducted in C. 
pseudotuberculosis thus far have involved the use of a non-replicative plasmid to achieve the 
desired mutations.  As such, these studies were subject to the inherent limitations of the 
mutagenesis approach employed; primarily low frequencies of recombination resulting in poor 
efficiency of mutant creation.  Significantly, it is perhaps for this reason that all but one study, 
namely that of McNamara et al. (1994), involved creating mutations by disrupting the coding 
sequence of target genes by insertion of a selectable marker to facilitate downstream 
identification of the desired mutants.  The use of such a strategy is flawed for two reasons; 
primarily this type of mutation can induce polar effects on the transcription or translation of 
downstream genes (especially those in an operon), such that the resulting mutant phenotype 
may not actually be due to a mutation in the target gene, but due to altered expression of some 
other, undetermined gene.  The inactivation of non target genes can occur by polar termination 
(Berg, 1996), and the promoters of the selectable marker genes can also alter the expression of 
adjacent genes in the chromosome (Wang & Roth, 1988). In addition, inclusion of antibiotic 
resistance markers into bacterial pathogens increases the risks associated with biosecurity, and 
if the bacterium being mutagenised is intended for use in food manufacturing or as a live, 
attenuated vaccine, it is imperative that no antibiotic resistance marker(s) remain in the 
chromosome at the end of the mutagenesis procedure.   
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Over the years, some of the most extensive work into factors affecting homologous 
recombination in Gram-positive bacteria has been conducted at l‘Institute Nationale de 
Recherche Agronimique (INRA), in France. A broad Gram-positive-host-range, Ts derivative 
of a lactococcal plasmid was used by Biswas et al. (1993) to investigate the integration of 
different sized homologous fragments into the L. lactis chromosome.  The Ts vector, pG
+
host 
5, used in the study was shown to have potential use as a delivery vector in many Gram-
positive bacterial species (Maguin, et al. 1992); however, it has been reported that the use of 
the pG
+
host plasmids may be extended to other Gram-positive bacteria but plasmid 
replication, thermosensitivity, background integration and level of drug resistance must be 
determined in each new host (Biswas, et al. 1993).  Significantly, pG
+
host 5, which at one 
time was commercially-available, was found to be inherently unstable, and a new derivative, 
pG
+
host 9 was created in its place (Maguin, et al. 1996). This vector has been used with great 
success in the targeted mutagenesis of numerous genes in numerous Gram-positive species 
(e.g. (Fontaine, et al. 2003)); unfortunately however, the vector was shown to be unable to 
replicate in C. pseudotuberculosis (M. C. Fontaine, personal communication).   
 
Compared to C. pseudotuberculosis, methods of allele-replacement mutagenesis in other 
corynebacterial species are more advanced.  Of the various approaches taken to-date, the most 
versatile system was reported by Nakamura et al. (2006), who exploited the C. glutamicum 
cryptic plasmid, pBL1 (Santamaria, et al. 1985) and the E. coli cloning vector, pK1, to 
construct the C. glutamicum/E. coli shuttle vector, pSFK6.  Subsequently, pSFK6 was 
subjected to in vitro mutagenesis using hydroxylamine, prior to being introduced into C. 
glutamicum. The investigators then isolated a mutant plasmid which was stably maintained at 
26°C but not at 34°C; following sequence analysis, the mutation thought to be responsible for 
the temperature-sensitivity of the plasmid was identified within the gene encoding the protein 
responsible for plasmid replication. Using site-directed mutagenesis the investigators were 
able to construct a plasmid carrying only this mutation (rather than numerous, random, 
hydroxylamine-induced mutations) which was then cloned into pSFK6, and the resulting Ts 
plasmid was designated pSFKT2. Subsequently, Nakamura et al. (2006) successfully used 
pSFKT2 to create a deletion in the glutamate dehydrogenase gene of C. glutamicum.    
 
For the purposes of facilitating downstream experiments in this study, it was necessary to 
obtain a means of creating unmarked, in-frame deletion mutants of C. pseudotuberculosis, 
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rather than mutants containing insertionally-inactivated genes.  The primary reason for this 
was to ensure that any changes in the phenotype, pathogenicity, etc. of the mutants was due to 
the imposed mutations rather than downstream polar effects.  Furthermore, because it was 
anticipated that the method would be employed both in this project, but subsequently as a 
general molecular biological tool in the laboratory in which this project was conducted, an 
efficient and reproducible method was desirable, to ensure rapid progress and to avoid the 
problems associated with the use of non-replicative plasmid vectors.  Following a review of 
the available literature pertaining to allele-replacement mutagenesis systems in C. 
pseudotuberculosis and other actinomycetes, it was felt that the pSFKT2 Ts vector previously 
used in C. glutamicum (Nakamura, et al. 2006) would be most suitable.  For this reason, 
efforts were made to adapt this system of mutagenesis for use in C. pseudotuberculosis.      
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4.1 Results 
4.1.1 Construction and utilisation of pCARV in C. pseudotuberculosis  
 
A Ts plasmid vector, pSFKT2, (a kind gift from J. Nakamura, Dept. of Bioengineering, Tokyo 
Institute of Technology, Nagatsuta, Midori-ku, Yokohama, Japan)(Nakamura, et al. 2006) 
previously designed for use in C. glutamicum was successfully used to transform 
electrocompetent C. pseudotuberculosis. The pSFKT2 plasmid, which carries a kanamycin 
resistance determinant, was shown to be able to replicate in C. pseudotuberculosis at the 
permissive temperature of 26°C, as determined by recovering transformed cells at 26°C on 
BHI agar plates (with kanamycin).  Subsequently, colonies deriving from transformed cells 
were picked and sub-cultured onto fresh BHI agar plates (with kanamycin) and incubated at 
37°C for 4 days.  The absence of any bacterial growth from these plates indicated that the 
plasmid was temperature-sensitive at the elevated temperature of 37°C, and also indicated that 
non-specific integration of pSFKT2 into the C. pseudotuberculosis chromosome was not 
occurring. Interestingly, when cells transformed with pSFKT2 were cultured at 26°C on BHI 
agar containing kanamycin an irregular colony morphology was observed, in that they were 
slightly raised, and had a more crenated and less waxy appearance than normally encountered 
with wild-type C. pseudotuberculosis (Figure 4.3).  
 
The reason for kanamycin inducing an irregular C. pseudotuberculosis colony morphology 
was unknown.  However, in order to alleviate this problem, which could not be ruled out as 
being detrimental to the bacterium, it was decided to replace the kanamycin resistance gene of 
pSFKT2 with another antibiotic resistance determinant.  Importantly, in order to facilitate a 
novel enrichment process (discussed in Section 4.1.4), a resistance determinant against a 
bacteriostatic antibiotic was desirable; hence the kanamycin gene was swapped with an 
erythromycin resistance gene. This was achieved by excising a ca. 2.7 kb HpaI/StuI fragment 
from pSFKT2, which contained the kanamycin resistance gene, but also contained two open 
reading frames (ORF 2 and 3; (Nakamura, et al. 2006)).  Subsequently,  the ermAM 
erythromycin resistance gene from pG
+
host 9 (Maguin, et al. 1996), a kind gift of E. Maguin, 
Laboratoire de Gènètique Microbienne, INRA, Jouy-en-Josas, France), was obtained by 
digesting the vector with BamHI; the resulting ca. 1.1 kb DNA fragment was blunt-ended, and 
cloned into HpaI/StuI digested pSFKT2. The resulting ca. 5,666 bp recombinant plasmid, 
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designated pCARV (for Corynebacterium Allele Replacement Vector; Figure 4.4), was 
propagated in E. coli for preparation of stocks for downstream experiments.  The pCARV 
vector was shown to be capable of replication in C. pseudotuberculosis in the presence of 
erythromycin at 26°C, and, despite the deletion of ORFs 1 and 2, pCARV retained its 
temperature sensitivity at 37°C. Furthermore, non-specific chromosomal integration of 
pCARV was not apparent in C. pseudotuberculosis.  
 
 
 
 
 
 
         
   
Figure 4.3 Corynebacterium pseudotuberculosis colony morphology. 
Plasmid-containing C. pseudotuberculosis was cultured on BHI agar containing either kanamycin (panel A) or 
erythromycin (panel B). Plasmid-free C. pseudotuberculosis cultured on BHI agar without antibiotics exhibited 
identical colony morphology to that in panel B (data not shown).   
 
 
  
A B 
Chapter Four                                                                                                                                  Results 
 118 
 
 
 
 
 
 
Figure 4.4 Cloning strategy for the construction of pCARV 
A ca. 2.7 kb HpaI/StuI fragment from pSFKT2, which contained the kanamycin resistance gene, but also 
contained two open reading frames (ORF 2 and 3) was excised. Subsequently, the ermAM erythromycin 
resistance gene from pG
+
host 9 was obtained by digesting the vector with BamHI; the resulting ca. 1.1 kb DNA 
fragment was blunt-ended and cloned into the HpaI/StuI digested pSFKT2. The resulting 5,666 bp recombinant 
plasmid was designated pCARV (Corynebacterium Allele Replacement Vector).   
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rep
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4.1.2 Chromosomal integration of pCARV-based constructs 
 
The suitability of pCARV as an allele-replacement mutagenesis vector in C. 
pseudotuberculosis was assessed, initially by determining the relationship between the length 
of homologous sequences and the resulting frequency of homologous recombination.  This 
was facilitated by creating a series of recombinant pCARV-based constructs containing 
varying-sized fragments of the C. pseudotuberculosis cp40 gene ((Wilson, et al. 1995); acc. # 
U10424).  The cp40 gene fragments were amplified by PCR using olignucleotide primers that 
incorporated XmaI restriction endonuclease recognition sites to facilitate downstream cloning 
of PCR products into XmaI-digested pCARV (Table 2.3).  PCR was conducted using C. 
pseudotuberculosis 3/99-5 genomic DNA as template, using the primers cp40 F and 
cp40_0_224 to amplify a 224 bp fragment, the primers cp40 F and cp40_1_432 to amplify a 
432 bp fragment, the primers cp40 F and cp40_2_750 to amplify a 750 bp fragment, and the 
primers cp40 F and cp40_4_1020 to amplify a 1,020 bp fragment of the cp40 gene.  The 
resulting recombinant plasmids were designated pCARV001, pCARV002, pCARV003 and 
pCARV004, respectively.  To facilitate downstream experiments in C. pseudotuberculosis, 
large-scale, highly-pure preparations of the plasmids were obtained from cultures of E. coli 
transformed with each plasmid.   
 
The approach to mutagenesis adopted in this study was a two-step process involving the 
chromosomal integration of plasmid constructs, followed by a secondary plasmid excision step 
(as discussed above).  However, for the experimental assessment of the pCARV mutagenesis 
system, by creating recombinant plasmids containing fragments of the wild-type cp40 gene, no 
attempt was being made in the first instance to create mutant C. pseudotuberculosis strains; 
rather the intention was only to measure the rate of homologous recombination driving the 
integration and subsequent excision of the recombinant plasmids from the chromosome.  As a 
first step, the rate of integration of the pCARV-based vectors into the C. pseudotuberculosis 
chromosome by homologous recombination (giving rise to so-called bacterial ―co-integrates‖) 
was determined. Plasmid integration was conducted as described in Section 2.11.1, and the 
integration frequency of each plasmid construct was calculated according to the following 
equation: (100 ÷ total cell number) × erythromycin-resistant cells. The results of triplicate 
experiments revealed an average integration frequency of 1.81×10
-1
, 2.23×10
-1
, 2.80×10
-1
 and 
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4.75×10
-1
 for pCARV001, pCARV002, pCARV003 and pCARV004 respectively.  
Significantly, as presented in Figure 4.5, the rate of plasmid integration increased linearly 
with increasing length of homologous sequences. 
 
4.1.3 Secondary crossover recombination  
 
Single C. pseudotuberculosis colonies, deriving from cells with integrated pCARV-based 
constructs, were used as the starting point for the next experimental phase.  A second 
recombination event between homologous vector-borne and chromosomal sequences drives 
the excision of the vector from the chromosome. The experimental procedure detailed in 
Section 2.11.2 was followed, and the resulting excision frequency of each of the plasmid 
constructs from the C. pseudotuberculosis chromosome was determined, according to the 
equation: (100 ÷ total number of colonies) × number of erythromycin resistant colonies. The 
data from triplicate experiments is presented in Table 4.1, and it is readily apparent that, 
although the general trend was undoubtedly an increase in excision rate with increasing length 
of homologous sequences, the variability within the triplicate experiments for each particular 
construct was extensive. 
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Figure 4.5 Integration rates of pCARV-based constructs containing cp40 fragments into the C. 
pseudotuberculosis chromosome by homologous recombination  
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Table 4.1 pCARV001-004 plasmid excision rates  
 
Size of insert (bp) Percentage Excision Rate 
224 0-13 % 
432 0-50 % 
750 2-54 % 
1,020 23-69 % 
 
 
4.1.4 Application of a novel enrichment method to isolate secondary crossover 
 mutants 
 
Although the assessment of the plasmid excision rate revealed a frequency of recombination 
much higher than observed for initial plasmid integration (the reasons for this are discussed in 
section 4.2), it was felt that a means of enriching cultures to increase the chance of identifying 
mutants having undergone a secondary recombination event would be a useful tool.  Such an 
enrichment process would be particularly useful in cases where very short lengths of 
homologous sequence were available to drive homologous recombination, where the resulting 
rate of plasmid excision would be low.  Therefore, a novel enrichment process was developed 
which exploited the erythromycin resistance determinant in pCARV, which was deliberately 
used to replace the kanamycin resistance determinant of pSFKT2 (Section 4.1.1).   
 
To test the hypothesis, the series of pCARV constructs pCARV001-004, were screened both 
with and without enrichment (Tables 4.1 and 4.2).  The enrichment method was made 
possible by the observation that different antibiotics are either bactericidal or bacteriostatic.  
Erythromycin, which is a macrolide antibiotic, acts by inhibiting translocation of peptidyl 
tRNA from the A to the P site on the ribosome by binding to the 50S ribosomal subunit of 70S 
rRNA.  This has the affect of interfering with the production of functionally useful proteins, 
resulting in bacteriostasis until such time as the erythromycin is removed from the bacterium‘s 
environment. In contrast, ampicillin is a bactericidal beta-lactam antibiotic which acts as a 
competitive-inhibitor of the transpeptidase enzyme, which is required for bacterial cell wall 
synthesis (AHFS Drug information® 2006, 2006 ed, American Society of Health-System 
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Pharmacists). The outcome of this competition is the inhibition of the formation of cross-links 
in the peptidoglycan layer (the third and final stage of bacterial cell wall synthesis), which 
ultimately leads to cell lysis; significantly however, due to its mode of action, the antibiotic is 
only effective against actively-growing cells. 
 
For ease of reference, the preliminary enrichment method developed as part of this thesis is 
presented in Chapter 2, Section 2.11.3. During the culture steps required to allow 
downstream identification of mutants having undergone plasmid excision from the 
chromosome, a large proportion of the bacterial co-integrate population will not have 
undergone plasmid excision. Significantly, these cells retain pCARV-encoded erythromycin 
resistance, while those that have lost the plasmid become sensitive to the antibiotic.  
Therefore, following the normal culturing process to allow plasmid excision, cultures were 
diluted into fresh medium containing erythromycin, and incubated at 37°C (the non-
permissive temperature for plasmid replication) for a period of time sufficient to allow 
expression of the resistance gene and the subsequent growth of resistant cells (with a 
concurrent inhibition of the growth of non-resistant cells).  Subsequently, cultures were 
supplemented with ampicillin, which only affected actively-growing cells, i.e. the undesired 
co-integrates.  Cultures were monitored by measuring optical density, until the OD600nm had 
dropped to its lowest point and had become stable.  Subsequently, cultures were washed to 
remove antibiotics, and 10-fold serial dilutions were replica-plated onto either antibiotic-free 
BHI agar plates, or BHI agar containing erythromycin.  Subsequently, the numbers of colonies 
deriving from cells having undergone excision events was determined as a percentage of the 
total bacterial population.  The results of these calculations are presented in Table 4.2, where 
it is evident that the novel ampicillin-enrichment procedure significantly increased the 
likelihood of identifying cells having undergone secondary crossover events. This was most 
evident for the pCARV-based constructs containing the shortest cp40 fragments; for example, 
cells having undergone excision of the 224 bp-containing construct, pCARV001, had 
increased from a maximum of 13 % of the population without enrichment to 73 % following 
enrichment.    
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Table 4.2 pCARV001-004 plasmid excision rates following ampicillin enrichment  
 
Size of insert (bp) 
Proportion of population having undergone plasmid 
excision 
224 25-73 % 
432 43-97 % 
750 45-89 % 
1,020 48-81 % 
 
4.1.5 Site-directed mutagenesis of the C. pseudotuberculosis cp40 gene 
 
Having determined the suitability of the pCARV plasmid as a system of allele-replacement 
mutagenesis of C. pseudotuberculosis, based upon the ability to integrate and excise the 
plasmid from the bacterial chromosome, the next logical step was to obtain conclusive proof 
that the vector could be used to deliver in vitro-constructed mutations into target chromosomal 
genes, to generate clean, well-defined, isogenic mutant strains, free from foreign plasmid 
sequences within the chromosome.  To this end, a deletion derivative of the cp40 gene was 
constructed by first amplifying the 5‘- and 3‘-chromosomal regions flanking cp40 from C. 
pseudotuberculosis genomic DNA using the primers cpAE1 and cpAE2 (―Fragment 1‖, 
upstream 5‘-region) and cpAE3 and cpAE4 (―Fragment 2‖, downstream 3‘-region). The 
Fragment 1 amplicon comprised 1,032 bp of upstream flanking sequence including the first 10 
bp of the C. pseudotuberculosis cp40 gene, while Fragment 2 comprised 919 bp of 
downstream flanking sequence, containing the last 122 bp of the cp40 gene.  Significantly, the 
length of both fragments was equivalent (at 1,042 bp and 1,041 bp for Fragment 1 and 
Fragment 2, respectively), so as not to bias a higher rate of homologous recombination at one 
end of the cp40 gene. The two PCR amplicons were digested with XhoI (enabled by the 
enzyme recognition site having been engineered into the primers cpAE2 and cpAE3) and 
ligated to each other (3‘-Fragment 1 to 5‘-Fragment 2), prior to reamplification of the ca. 2.1 
kb fragment by PCR with the primers cpAE1 and cpAE4.  The result was the creation of a 
derivative of cp40 (designated ∆cp40) which contained an in-frame deletion that had 
effectively removed ca. 1,000 bp of the intact, wild-type gene.  Subsequently, the ∆cp40 gene 
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was cloned into pCARV, facilitated by the SalI restriction endonuclease recognition site 
engineered into primers cpAE1 and cpAE4. The resulting recombinant plasmid, designated 
pCARV005, was subsequently propagated in E. coli DH5α, prior to being introduced into C. 
pseudotuberculosis by electroporation.  Then, allele-replacement, followed by ampicillin-
enrichment, was conducted as described in Chapter 2, Section 2.11, prior to the identification 
of erythromycin-sensitive isolates, having lost pCARV005 from the chromosome. A total of 
10 erythromycin-sensitive isolates were screened to determine whether recombination had 
resulted in either the wild-type cp40 or the mutant ∆cp40 derivative gene being left in the 
chromosome.  Genomic DNA was extracted from each of the isolates, and PCR was 
conducted using the primers Δcp40 DCO F and Δcp40 DCO R; it was anticipated that a 1,299 
bp fragment would be amplified from isolates containing the wild-type gene, while a 292 bp 
fragment would be amplified from ∆cp40-containing isolates.  Amplified PCR products were 
analysed by agarose gel electrophoresis (Figure 4.6). Of the 10 isolates, 9 were confirmed as 
having excised pCARV005 from the chromosome, as determined by the amplification of only 
a single DNA fragment corresponding to the wild-type or mutant phenotype.  In contrast, a 
single isolate was identified as still containing chromosomally-integrated pCARV005, as 
determined by the presence of both the 1,299 bp and 292 bp bands.  Of the 9 plasmid excision 
isolates, a 1,299 bp fragment was amplified from 4, confirming that primary and secondary 
recombination events had occurred at equivalent loci, resulting in plasmid excision and the 
wild-type gene being left in the chromosome.  In contrast, a 292 bp fragment was amplified 
from 5 of the 9 isolates, confirming that primary and secondary recombination events had 
occurred at opposite loci, resulting in plasmid excision and the mutant gene being left in the 
chromosome.   
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Figure 4.6 PCR analysis of C. pseudotuberculosis secondary-crossover mutants  
PCR products visualised following electrophoresis through a 1 % (w/v) agarose gel.  Lanes correspond to 1kb 
marker (M), co-integrate (Lane 1), ∆cp40 (Lanes 2, 3, 7, 8 and 9), wild-type cp40 (Lanes 4, 5, 6 and 10)., and C. 
pseudotuberculosis wild-type control PCR (Lane 12).  
 
M    1   2   3    4    5   6    7   8     9   10  11  12 
1 kb 
250/253 bp  
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4.2 Discussion 
 
In order to fulfil molecular Koch‘s postulates, i.e. confirming the contribution of a specific 
gene product to the pathogenicity of an organism, it is essential that efficient and straight-
forward method(s) are available to allow manipulation of target gene(s) within the organism of 
interest, without the need for excessive and extensive experimentation. Until the work 
described in this chapter was conducted, no such system of genetic manipulation existed for C. 
pseudotuberculosis.  As discussed in Section 4.0, above, limited reports of targeted genetic 
manipulation of this organism have been forthcoming (e.g. (Billington, et al. 2002; Hodgson, 
et al. 1992; McNamara, et al. 1994; Simmons, et al. 1997)); however, these have all been 
conducted using low-efficiency, non-replicative plasmid vectors, or have exploited plasmid 
incompatibility, and hence  these systems are not ideal when  a high-throughput process of 
mutant generation is required. Furthermore, the majority of these mutagenesis studies have 
focused upon creating gene disruptions through insertion of antibiotic resistance cassettes, an 
approach that facilitates the identification of allele-replacement mutants through antibiotic 
selection.  However, it is generally accepted that such an approach is unfavourable due to the 
possibility of downstream polar effects which may affect the expression of other gene(s) in 
addition to the target gene. 
 
In general, the need to create C. pseudotuberculosis mutants has been limited, primarily 
because of the lack of information pertaining to valid targets for mutagenesis.  However, as 
part of the work presented in the following chapters of this thesis, the availability of a means 
of creating well-defined mutations within target genes was absolutely essential to allow 
experimental progress.  In addition, while not the focus of the current study, the genome of the 
virulent UK C. pseudotuberculosis strain, 3/99-5, was being sequenced as part of a parallel 
project within the same laboratory.   Therefore, there was a clear requirement for a highly-
efficient mutagenesis system downstream of the analysis of the genome sequence, since it was 
anticipated that a range of suitable mutagenesis targets would be identified, allowing a 
thorough analysis of the role of these targets in the virulence of the organism.  A pre-requisite 
for such a mutagenesis system was that it was based upon a conditionally-replicating plasmid 
to circumvent problems associated with low-transformation frequencies.  In addition, it was 
essential that the system be relatively rapid and reproducible.  It was the intention that the 
creation of clean, in-frame deletion mutants would be the preferred approach in this study, and 
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hence no extraneous DNA sequences (including the mutagenesis plasmid itself) could remain 
within the bacterium (either within the chromosome or the cytoplasm) following mutagenesis. 
Given this approach, it was considered likely that the downstream identification of the desired 
mutants could be a time-consuming process, and hence the need for a suitable means of 
enriching for the required mutants was desirable.   
 
Taking all of these factors into account, it was apparent that none of the pre-existing C. 
pseudotuberculosis mutagenesis systems were applicable. Previous work in the same 
laboratory had assessed the suitability of the pG
+
host 9 broad-host-range, allele-replacement 
vector for use in C. pseudotuberculosis; however, the plasmid had been shown not to replicate 
in this actinomycete host (M. Fontaine, personal communication).  Significantly, while the 
work described in this thesis was being conducted, a manuscript detailing the development of 
a temperature-sensitive plasmid, pSFKT2, for allele-replacement mutagenesis of C. 
glutamicum was described (Nakamura, et al. 2006). This plasmid was derived from 
hydroxylamine mutagenesis of a parent plasmid. The plasmid pSFKT2 was generously 
donated by J. Nakamura.  Preliminary analyses revealed that the plasmid was able to be used 
to transform C. pseudotuberculosis, conferred resistance to kanamycin at 25°C (the permissive 
temperature for plasmid replication), was unable to replicate at 37°C, and did not integrate 
non-specifically into the C. pseudotuberculosis chromosome.  
 
Despite preliminary indications that pSFKT2 would be suitable for use with C. 
pseudotuberculosis, it was noticed that colonies of C. pseudotuberculosis grown on BHI agar 
containing kanamycin exhibited an unusual morphology. A similar observation had been made 
previously within the same laboratory, using a different plasmid which also carried a 
kanamycin-resistance marker (M. C. Fontaine, personal communication), and it was therefore 
decided that the kanamycin marker in pSFKT2 would be changed.  Significantly, this decision 
enabled two further distinct issues to be addressed, which led to the creation of pCARV.  
Primarily, the choice of replacement antibiotic resistance marker was made so as to facilitate a 
downstream enrichment process for mutant recovery.  In addition, the overall size of pSFKT2 
was reduced by removal of sequence encoding 2 ORFs (designated ORF 2 and ORF 3), which 
had previously been shown to be non-essential for plasmid replication (Goyal, et al. 1996).  
The deletion was anticipated to have the effect of increasing transformation efficiencies with 
the derivative plasmid, in addition to increasing plasmid stability, and as expected, deletion of 
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ORF 2 and ORF 3 appeared to make no difference to the ability of the plasmid to replicate in 
C. pseudotuberculosis.  Furthermore, deletion of unnecessary sequences was conducted in 
order to reduce the metabolic load that the plasmid imposed upon the host cell.  Metabolic 
load can be defined as the proportion of the host cell‘s resources, either in the form of energy 
or raw materials such as amino acids, that are required to maintain and express foreign DNA, 
as either RNA or protein, in the cell (Glick, 1995). A certain amount of cellular energy is 
needed to maintain a plasmid in the host cell, and increasing plasmid size requires increasing 
amounts of cellular energy (Cheah, et al. 1987; Glick, 1995).  Significantly, the observed 
colony morphology of C. pseudotuberculosis containing pCARV was equivalent to wild-type 
C. pseudotuberculosis, suggesting that erythromycin was exerting a less-harsh effect on cells.   
 
It has been previously reported that a log-linear relationship between length of homologous 
sequence and the frequency of chromosomal integration, exists in Lactococcus lactis (Biswas, 
et al. 1993) and Lactobacillus sake (Leloup, et al. 1997); log-linear models postulate a linear 
relationship between independent variables, e.g. the length of homologous sequence, and the 
logarithm of the dependent variable (such as frequency of chromosomal integration). The 
integration frequencies observed in Lactococcus and Lactobacillus were similar, but were 
observed over a specific range of homologous sequence lengths, where short sequence lengths 
were (unsurprisingly) found to be a rate-limiting factor for recombination.  In L. lactis, Biswas 
et al. (1993) observed a log-linear relationship between frequency of integrations per cell and 
length of homology over sequence lengths between 356 bp and 2,552 bp, whereby integration 
frequencies of between 10
-5
 and 10
-2
 were observed. The authors noted a minimum threshold 
length of 330 bp for efficient homologous recombination, and further reported that, with 
fragments larger than 2,552 bp, recombination frequencies appeared to plateau.  Similarly in 
L. sake, Leloup et al. (1997) observed a log-linear relationship between homologous sequence 
length and integration frequency for DNA fragments in the range of 0.3 kb to 1.2 kb, whereby 
integration frequencies of between 10
-5
 to 10
-3
 were recorded.  In addition, these investigators 
reported an almost constant recombination rate for larger inserts. Interestingly, the integration 
rates in C. pseudotuberculosis observed in the present study were somewhat higher than 
previously reported, being in the range of 2×10
-1
 to 5×10
-1
; however, a log-linear relationship 
between homologous sequence length and integration frequency was also observed (Figure 
4.5).  Although the results from the studies performed with different bacteria appear similar, it 
is not possible to make direct comparisons due to the different systems used in each study. In 
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addition to the different organisms, a different plasmid was used in each case, and the target 
genes were also not equivalent; all of these factors could have affected the observed 
integration rates (Biswas, et al. 1993). Other studies investigating the integration of different 
sized homologous fragments have been carried out in Bacillus subtilis  (Michel & Ehrlich, 
1984) and E. coli (Michel & Ehrlich, 1984), however, these studies reported linear or 
exponential integration frequencies, rather than log-linear.  
 
Interestingly, previous studies in B. subtilis have shown that recombination between 
homologous chromosomal DNA sequences are stimulated when an active plasmid replicon is 
integrated in their proximity (Noirot, et al. 1987). There are two main replication mechanisms 
observed in plasmids, these being theta type and rolling circle (RC) (del Solar, et al. 1998). 
Noirot et al. (1987) reported that an active rolling circle replicon that has integrated into the 
bacterial chromosome can stimulate homologous recombination between flanking repeated 
sequences between 20 to 450 times more than a non-replicating plasmid (Noirot, et al. 1987). 
Biswas et al. (1993) showed that, in L. lactis, in the absence of replication of the integrated 
plasmid, secondary homologous recombination was less than 0.25 %, which is consistent with 
the excision frequency seen in L. lactis when a non-replicating plasmid was used (Leenhouts, 
et al. 1991). Furthermore, as already alluded to above, it has been postulated that the type of 
replication mechanism employed by the plasmid plays a significant role in the rate of 
recombination (Biswas, et al. 1993; Noirot, et al. 1987). Noirot et al. (1987) postulated that 
the single-stranded DNA generated during rolling circle-type plasmid replication plays a role 
in the initiation of the recombination process. Later, Biswas et al. (1993) published findings 
which agreed with the previous hypothesis. In addition, Morel-Deville and Erhlich (1996) 
demonstrated that theta-replication had only a moderate effect on influencing recombination 
rate as compared to rolling circle replication (Morel-Deville & Ehrlich, 1996), presumably due 
to the observation that with theta-type replication there are no single-stranded intermediates, 
resulting in a greater stability of integrated plasmids (Tsuchida, et al. 2008). In their studies in 
Lactococcus, Biswas et al. (1993) observed between 1-40 % gene replacement when direct 
selection was not available (i.e. a selectable marker was not inserted into the target gene), 
whereas between 50-98 % was observed when selection for the replaced gene was available; 
these variable but high recombination rates were attributed to rolling circle replication of the 
integrated plasmid. Significantly, the plasmid, pCARV, used during this investigation derived 
from pSFKT2, contains an origin of replication from the C. glutamicum cryptic plasmid, pBL1 
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(Santamaria, et al. 1985), which is known to replicate via a rolling circle mechanism 
(Fernandez-Gonzalez, et al. 1994). The rates of secondary recombination driving plasmid 
excision in C. pseudotuberculosis in this study were between 0-69 %, dependent upon the 
length of homologous sequence.  Therefore, it is tempting to hypothesise that the replication 
mechanism of pCARV influences the apparently high, but variable rates of excision, given 
that plasmid co-integrants were cultured in the absence of antibiotic selection and at a 
temperature permissive for plasmid replication, in order to enhance the recombination rate; 
this fortuitous factor enhances the suitability of this vector for use in allele-replacement 
experiments.  
 
Mutations within genes that are important to the survival of the bacteria can be extremely 
difficult to isolate; however, methods of enriching for the required mutant have been 
described.  One of the most popular methods in Gram-positive bacteria is the use of the sacB 
gene as a counter-selectable marker on a plasmid (Oram, et al. 2006; Pelicic, et al. 1997; 
Pelicic, et al. 1996a, 1996b, 1996c; Schafer, et al. 1994). This enrichment process employs the 
B. subtilis sacB gene, encoding levansucrase, the expression of which is lethal to Gram-
positive bacteria in the presence of 10 % (w/v) sucrose. Therefore, growth on sucrose can be 
used as a means to eliminate co-integrates (or those that have retained plasmid DNA). This 
enrichment process has also been successfully applied to enrich for C. glutamicum and C. 
diphtheriae allele-replacement mutants (Oram, et al. 2006; Schafer, et al. 1994). As an 
alternative approach during this investigation, a novel method of enriching secondary-
crossover cultures was developed, in order to increase the likelihood of identifying the desired 
mutants.  This method, which relies upon the allele-replacement plasmid encoding a 
bacteriostatic antibiotic-resistance marker, is equally as applicable to the pCARV mutagenesis 
system described here as it is to any other allele-replacement vector, as long as that vector 
carries a bacteriostatic antibiotic-resistance marker.  Significantly, given that the rate of 
secondary crossover using pCARV is already naturally high, due to the rolling circle 
replication of the plasmid, it could be argued that the ampicillin-enrichment method would be 
even more suitable for use with low-efficiency mutagenesis systems, such as non-replicative 
allele-replacement plasmids.  Given the extremely low rate of recombination with these 
vectors, any means of enriching cultures to facilitate mutant identification would be a distinct 
advantage.  In addition, the inclusion of such an enrichment method would arguably negate the 
need to use antibiotic-resistance markers to create disruptions in target genes. Irrespective of 
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its applicability to other systems, when combined with the pCARV mutagenesis system the 
ampicillin-enrichment procedure offers an extremely powerful tool to render the identification 
of secondary crossover mutants a routine procedure, rather than necessitating tedious replica-
plating procedures to screen many colonies for an erythromycin-sensitive phenotype.  In this 
study, homologous recombination between sequences as short as 224 bp was assessed.  The 
ampicillin-enrichment process is particularly well-suited for inclusion when short sequence 
lengths are available for recombination, although the minimum number of homologous bases 
required to drive homologous recombination in C. pseudotuberculosis was not assessed in this 
study. 
 
Although successful, the ampicillin-enrichment procedure presented here is only in a 
preliminary form, and could still benefit from some improvement; however, there was not 
sufficient time available in the current study to pursue this further. The most likely way of 
fine-tuning the procedure would be with respect to the length of time the secondary-crossover 
cultures are incubated in the presence of ampicillin.  Despite a drop and subsequent levelling-
off of the OD600nm, it is apparent that a number of erythromycin-resistant co-integrants still 
remained at the end of the process (as evidenced by a <100 % mutant recovery rate).  
Therefore, further rounds of culture dilution and incubation in ampicillin-containing medium 
may well improve the process further.  Irrespective, there can be no doubt that the enrichment 
process, even in its current form, is a powerful addition to the normal allele-replacement 
process.  The process is generally applicable to the enrichment of cultures to allow subsequent 
identification of almost any gene mutation; however, there are potential side-effects resulting 
from the use of the procedure that could prove deleterious in some rare instances (as discussed 
in Chapter 5).     
During this study, a mutant derivative of C. pseudotuberculosis was constructed, which was 
deficient in the production of Cp40, through the introduction of an in-frame deletion within 
the cp40 gene.  While it would be interesting to study this mutant further, since Cp40 has been 
implicated in C. pseudotuberculosis virulence (Walker, et al. 1994; Wilson, et al. 1995), there 
was not sufficient time available to pursue this further.  Rather, the generation of the mutant 
was used to prove that the pCARV mutagenesis system, in combination with the ampicillin-
enrichment procedure were capable of achieving the desired result in a timely and 
uncomplicated manner.  It can be concluded therefore, that the system described here provides 
a high-efficiency means of generating clean mutations within specific target genes (or 
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genomic regions).  The use of a Ts vector negates the requirement for a high transformation 
frequency, since incubation of a single transformed cell under conditions permissive for 
plasmid replication can provide a large population of daughter cells, all containing the same 
plasmid.   
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Chapter Five 
 
The Iron Dependent Regulatory Protein DtxR of  
Corynebacterium pseudotuberculosis  
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5.0 Introduction 
 
Knowledge available regarding virulence mechanisms in C. pseudotuberculosis is limited. 
However, by comparison the information available regarding its close relatives, including C. 
diphtheriae and C. glutamicum, is immense. This is due, in part, to the availability of relevant 
genome sequences. The influence of the environment on bacterial gene expression has been 
well-studied for many bacteria.  This is particularly true of the affect of environmental iron 
concentration on the expression of C. diphtheriae genes, including virulence genes (discussed 
in Chapter 1). In C. diphtheriae the principal virulence determinant is diphtheria toxin (DT), 
encoded by the tox gene which is carried by tox
+
 corynebacteriophages; however, the 
regulatory protein responsible for controlling the expression of tox in response to 
environmental iron concentration is the product of a chromosomally-located gene, dtxR, which 
encodes the so-called Diphtheria Toxin Repressor (DtxR).  
 
In the presence of iron, DtxR combines with Fe
2+
 resulting in a conformational change that 
allows
 
it to bind to specific sequences within the promoter-encoding regions of target genes. 
Binding of the DtxR/Fe
2+
 complex to the promoter region subsequently impedes RNA 
polymerase from binding to the promoter; thus, transcription is prevented.  In contrast, under 
conditions of low environmental iron, DtxR is unable to bind Fe
2+
, and subsequently is 
restricted to a conformation that is incapable of binding to target DNA sequences.  As a result, 
transcription of target genes is permitted.  A similar regulatory protein is known to exist in E. 
coli.  The protein, known as Fur, is similarly capable of modulating the expression of target 
genes in response to environmental iron concentrations.  However, despite an equivalent role, 
it is interesting to note that DtxR is not able to control the expression of Fur-regulated genes, 
and vice versa.  This was demonstrated through the observation that Fur was unable to 
regulate β-galactosidase expression from a tox promoter-lacZ transcriptional fusion, and DtxR 
was incapable of regulating the expression of the outer-membrane proteins of a Fur-deficient 
strain of E. coli (Boyd, et al. 1990). Despite their lack of interchangability, the two proteins 
share 25 % amino acid homology (Tao, et al. 1994), and DtxR and Fur have therefore been 
designated the prototypes of two different types of bacterial iron-dependent regulatory 
proteins (Holmes, 2000).  
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The crystallographic structure of the C. diphtheriae DtxR protein has been determined (Qiu, et 
al. 1995). The elucidation of this structure has increased understanding of the basis of iron 
induced DtxR activation and DNA binding.  The DtxR protein in C. diphtheriae consists of 
three domains. Domain 1 contains a classic helix-turn-helix DNA-binding motif which spans 
amino acids 1 to 73 (Qiu, et al. 1995) (Schiering, et al. 1995). Amino acids 74 to 140 make up 
the second domain which is required for dimerization and metal binding. The third domain, 
consisting of amino acids 141 to 226 has a topology resembling SH3 domains consistent with 
signal transduction proteins (Qiu, et al. 1996). SH3 domains are β-sheet-rich structures, 
originally identified in eukaryotic Src proteins, which modulate metal-binding and regulation 
(Pohl, et al. 1999). Once it has bound iron, DtxR undergoes a conformational change which 
assists the binding of a second iron molecule to the complex. The dimeric complex is thus 
stabilised and is subsequently able to bind to the operator sequence of specific DtxR regulated 
genes, thereby preventing RNA polymerase binding to the promoter region of the gene (Tao, 
et al. 1994).  DtxR binds to 19 bp operators with the consensus sequence 5'-
TWAGGTTAGSCTAACCTWA- 3', where W = A or T and S = C or G (the consensus 
sequence is in essence a perfect 9 bp palindrome interrupted by a single C or G nucleotide 
(Schmitt & Holmes, 1994; Tao & Murphy, 1994)).  
 
Both C. pseudotuberculosis and C. ulcerans are known to produce DT when lysogenised with 
a tox-containing corynebacteriophage. Furthermore, these corynebacteria, like C. diphtheriae, 
produce DT in an iron-dependent manner (Maximescu, et al. 1974; Wong & Groman, 1984). 
There have been several cases of C. ulcerans causing diphtheria-like disease in humans 
(Gubler, et al. 1990; Lartigue, et al. 2005; Tiwari, et al. 2008). In the UK, isolation of any 
toxigenic Corynebacterium, including C. pseudotuberculosis and C. ulcerans, requires 
notification of local and national communicable disease control agencies (Efstratiou & 
George, 1999). By analogy with C. diphtheriae, control of expression of DT in C. ulcerans 
and C. pseudotuberculosis is likely to be controlled by a DtxR-like protein (Oram, et al. 
2004).   
 
In 1995, Oguiza et al. identified a dtxR homologue in the non-pathogenic Brevibacterium 
lactofermentum (B. lactofermentum has since been reclassified as C. glutamicum ATCC 13869 
(Liebl, et al. 1991) (Usuda, et al. 1996), and this is how it will subsequently be referred to 
throughout this thesis). The dtxR gene (accession no. L35906) shared homology with dtxR of 
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C. diphtheriae. The authors subsequently hypothesised that a family of DtxR-like regulatory 
elements may be present in other corynebacteria (Oguiza, et al. 1995). In keeping with this 
hypothesis, a fragment of a dtxR-homologue was subsequently identified in C. 
pseudotuberculosis (Malloy, 2004; Oram, et al. 2004). Oram et al. (2004) used PCR to 
determine the presence of dtxR homologues within the genomes of 42 different 
corynebacterial isolates, representing 33 different species including both pathogenic and 
saprophytic organisms.  The investigators identified dtxR-homologues in all 42 species of the 
genus Corynebacterium, including C. pseudotuberculosis (Oram, et al.  2004).   
 
In C. diphtheriae, iron-activated DtxR is not only involved in the regulation of DT but it is 
also involved in the regulation of other genes implicated in the acquisition and storage of iron. 
Following the identification of a functional siderophore in C. diphtheriae (Russell, et al. 
1984), expression of the genes involved in biosynthesis and transport of the siderophore were 
shown to be regulated by DtxR (Kunkle & Schmitt, 2005).  Another DtxR-regulated gene, 
hmuO, encoding a haem oxygenase enzyme, was identified in C. diphtheriae by Schmitt 
(1997).  Haem oxygenase enzymes catalyse the release of iron from haem, resulting in the 
oxidation of haem to biliverdin and CO (Schmitt, 1997a, 1997b). The HmuO enzyme of C. 
diphtheriae shares a high degree of homology with eukaryotic haem oxygenase enzymes 
(Schmitt, 1997b).  Significantly, HmuO has been shown to be at least partially responsible for 
the utilisation of iron from haem in C. diphtheriae (Kunkle & Schmitt, 2007). Expression of 
hmuO is activated by the presence of haem and haemoglobin in the environment, but DtxR is 
responsible for its repression. In addition to controlling the expression of siderophore-related 
genes and hmuO, DtxR has recently also been shown to regulate genes involved in the 
oxidative stress response of C. diphtheriae (Oram, et al. 2002). 
 
A significant body of work has led to the recognition of DtxR as a transcriptional regulator of 
iron metabolism in C. diphtheriae (Schmitt & Holmes, 1994; Tai, et al. 1990) and C. 
glutamicum (Brune, et al. 2006; Wennerhold & Bott, 2006). However, in C. glutamicum, 
DtxR has also been shown to regulate the expression of other regulatory components 
(Wennerhold, et al. 2005), and thus is involved in a global regulatory network. The Regulator 
of iron proteins, RipA, represses the expression of metabolism proteins, such as aconitase (an 
iron-containing protein) in C. glutamicum, however the RipA-encoding gene is itself regulated 
by DtxR in an iron-dependent manner.  As a consequence, in C. glutamicum, DtxR has been 
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shown to be a ―master regulator‖ of iron-dependent gene expression (Wennerhold, et al. 
2005), although the same scenario has yet to be proven for other corynebacteria.   
 
In addition to its more well-recognised role as a repressor, it is interesting to note that in C. 
glutamicum, DtxR has also been shown to be able to activate the expression of some genes; 
this observation is analogous to the IdeR regulatory protein in M. tuberculosis (Gold, et al. 
2001; Wennerhold & Bott, 2006; Brune, et al. 2006). Wennerhold and Bott (2006) and Brune 
et al. (2006) identified a number of genes that, in a C. glutamicum dtxR-deficient mutant 
strain, showed decreased levels of mRNA for several genes, therefore suggesting that 
expression of these genes was up-regulated by DtxR (Brune, et al. 2006; Wennerhold & Bott, 
2006). The genes identified included those encoding proteins which are involved in the 
assembly and repair of iron-sulphur clusters as well as genes involved in iron storage and 
oxidative stress.   
 
As discussed previously in Chapters 1 and 3, as part of the innate defence against invading 
microorganisms the mammalian host specifically limits the concentration of circulating iron in 
an attempt to combat microbial infection. Therefore, the ―sensing‖ of environmental iron 
concentrations by microbes is an indicator of whether or not they have gained entry into a host 
animal.  As a result, the expression of virulence genes (i.e. genes that are essential for a 
pathogenic microbe to colonise and persist within a host) is often linked to environmental iron 
concentrations. Significantly, the introduction of a synthetic construct into M. tuberculosis, 
resulting in constitutive expression of C. diphtheriae dtxR, caused reduced virulence in a 
mouse model of tuberculosis (Manabe, et al. 1999). The most likely explanation for this 
observation was that DtxR was interfering with the normal M. tuberculosis iron-dependent 
response in vivo.  Interestingly, the DtxR-like regulator shown to exist in M. tuberculosis 
(Doukhan, et al. 1995) is actually the so-called iron dependent regulator, IdeR (Schmitt, et al. 
1995), discussed above, and it is significant that both DtxR and IdeR appear to be functionally 
interchangeable, and are therefore members of the same family of proteins.     
 
In C. pseudotuberculosis, it is interesting to note that the most well-documented virulence 
factor, PLD, was shown by one research group not to be expressed in an iron-dependent 
manner (Billington, et al. 2002). The same group also identified the C. pseudotuberculosis 
fagABC operon, encoding ferric iron acquisition genes (Billington, et al. 2002).  Significantly, 
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Billington et al. (2002) showed that the expression of the fag genes occurred in an iron-
dependent manner in-vitro. Furthermore, a putative DtxR-like binding locus was identified 
just upstream of the first gene in the fag operon, although at that time a functional DtxR 
homologue had yet to be confirmed in C. pseudotuberculosis. The authors constructed a 
fagB(C) mutant, which showed reduced virulence when compared to its isogenic, wild-type 
parent in an experimental model of CLA in goats. Although tantalisingly close to proving the 
involvement of a DtxR-like regulator in the expression of the fag genes, Billington et al. 
(2002) did not pursue this research further.  
 
Brune et al. (2006) carried out a series of experiments in order to understand the regulatory 
network of DtxR in C. glutamicum. In order to achieve this, the investigators used a series of 
methods including transcriptomics, bioinformatics, in vitro assays and comparative genomics. 
Subsequently, the DtxR protein of C. glutamicum was recognised as having a major role in 
controlling genes involved in iron metabolism. Generally, DtxR in C. glutamicum was shown 
to act as a repressor of genes involved in iron uptake and utilisation, and an activator of genes 
involved in iron storage and DNA protection (Brune, et al. 2006).  Interestingly, the DtxR 
binding loci of some repressed genes were situated within the deduced promoter region, 
whereas the DtxR binding loci of some activated genes were located upstream of the promoter 
region. Due to the observation that decreased expression of these activated genes occurred in a 
DtxR-deficient C. glutamicum mutant (as measured by DNA microarray hybridisation and 
real-time RT-PCR), Brune et al. (2006) hypothesised that the location of the DtxR binding loci 
of the activated genes was more consistent with an activating function of the DtxR protein 
(Brune, et al.  2006; Madan Babu & Teichmann, 2003).  
 
The complete genome sequence of C. diphtheriae NCTC 13129 has become publicly available 
relatively recently (Cerdeno-Tarraga, et al. 2003).  Analysis of the sequence surrounding the 
dtxR gene revealed a gene encoding an RNA sigma (σ) factor, sigB, located 224 bp upstream 
and a gene encoding UDP-galactose-4-epimerase, galE, 22 bp downstream of dtxR (Cerdeno-
Tarraga, et al. 2003).  The σ-factor, SigB, is thought to have homology with σ70-type factors, 
which are known to be involved in bacterial stress responses (Oram, et al. 2006). It was 
previously noted that the galE gene of C. glutamicum shared homology with C. diphtheriae 
galE (Boyd, et al. 1990; Oguiza, et al. 1996a), the deduced amino acid sequences of both 
sharing significant homology with UDP-galactose 4-epimerases from other Gram-positive 
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genera (Oguiza, et al. 1996a). The actual function of the protein encoded by galE in C. 
diphtheriae has not yet been determined; however, UDP-galactose and UDP-glucose of other 
bacteria are substrates for the production of exopolysaccharides on the surface of the cell.  
 
The lack of understanding in relation to C. pseudotuberculosis virulence mechanisms has 
hindered the understanding of disease pathogenesis and hence the development of new CLA 
vaccines. Using the wealth of information available regarding the close relatives of C. 
pseudotuberculosis it was thought possible that a comparative study could be undertaken; 
however, it was considered likely, due to species divergence (and the fact that C. glutamicum 
is non-pathogenic) that an informed selection exercise (essentially a fishing-exercise) to 
determine the presence of other corynebacterial virulence genes in C. pseudotuberculosis 
would be problematic with a low chance of success.  In contrast, the involvement of DtxR in 
the regulation of gene expression in C. diphtheriae and C. glutamicum, combined with the 
suggestion of a DtxR-like regulator in C. pseudotuberculosis (Malloy, 2004) (Oram, et al. 
2004) and a putative DtxR-binding motif identified upstream of the C. pseudotuberculosis fag 
operon (Billington, et al. 2002), suggested that focusing research on the equivalent regulator in 
C. pseudotuberculosis would be a means of identifying information regarding virulence 
mechanisms in this organism. Therefore, the work in this chapter aimed to characterise the 
dtxR locus of C. pseudotuberculosis and to determine whether it functioned as a regulator of 
gene expression.   
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5.1 Results  
The work described in this chapter was conducted simultaneously with that presented in the 
next chapter. Interestingly, during the laboratory work described in Chapter 6 it became 
apparent that, although the CCDM ―high-iron‖ growth medium described in Chapter 3 was 
sufficient to support maximal growth of C. pseudotuberculosis in culture, the level of iron in 
the medium was insufficient to permit full repression of iron-responsive genes. Therefore, it 
became necessary to increase the concentration of available iron in the CCDM by 
supplementing with FeCl3 to 10 μM final concentration (Figure 5.1). This new ―high-iron‖ 
medium, which supported an equivalent level of bacterial growth in culture but ensured 
minimal expression of iron-responsive genes, became the de facto high-iron growth medium 
used to generate the data presented in this and the following chapter.  
 
5.1.1 Characterization of a C. pseudotuberculosis chromosomal locus 
 containing dtxR 
 
Previously in our laboratory, a 312 bp fragment of a dtxR-homologue was identified in C. 
pseudotuberculosis (Malloy, 2004). To determine the rest of the sequence of the dtxR-
homologue, and to characterise the chromosomal locus in which the gene lay, inverse PCR 
(iPCR) was employed (Figure 5.2), which is a technique designed by Ochman et al. (1988) to 
amplify unknown DNA sequences that flank a region of known sequence (Ochman, et al. 
1988).  
 
In the first instance, to determine which restriction endonucleases would generate 
chromosomal DNA fragments containing the dtxR-like gene, of an optimal size for iPCR, a 
Southern blot was performed. Several restriction endonucleases were chosen based on their 
ability to cut relatively frequently within GC-rich DNA sequences. C. pseudotuberculosis 
3/99-5 genomic DNA was digested to completion with either KpnI, SpeI, NdeI, HindIII, 
BamHI, XbaI, BglII, PstI, EcoRI or  NcoI, and separated by agarose gel electrophoresis prior 
to Southern blot analysis.  The blot was hybridised with a DIG-labelled probe consisting of the 
original 312 bp dtxR PCR product identified by Malloy (2004), and 3 restriction 
endonucleases producing fragments of a size suitable for subsequent amplification by PCR 
were identified (Figure 5.3).  
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As presented in Figure 5.3, the restriction endonucleases KpnI, HindIII and XbaI generated 
genomic DNA fragments of ca. 0.9 kb, 3 kb, 6.5 kb respectively, which contained the dtxR-
like gene; these were considered to be of a suitable size for PCR amplification. Significantly, 
Southern blot analysis also confirmed the presence of a single copy of the dtxR homologue on 
the C. pseudotuberculosis chromosome (Figure 5.3).  Having identified appropriate restriction 
endonucleases to generate optimally-sized DNA fragments, fresh genomic DNA was digested 
to completion with KpnI, HindIII, and XbaI.  Subsequently, linearised genomic DNA 
fragments were circularised by ligation to create templates for inverse PCR.   
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Figure 5.1 Analysis of the affect of iron on C. pseudotuberculosis growth. C. pseudotuberculosis 
3/99-5 was cultured in CCDM ( ), CCDM supplemented with 2‘,2‘-dipyridyl to 300 μM final concentration 
( ), or CCDM supplemented with dipyridyl and FeCl3 to 10 μM final concentration (  ). Despite 
supplementing chelated CCDM with a 10-fold greater amount of FeCl3 than had been used previously, growth of 
C. pseudotuberculosis in the iron-restored medium was still equivalent to that in CCDM alone.  
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Figure 5.2  Schematic representation of inverse PCR  
The inverse PCR method (Ochman, et al. 1988) uses straightforward PCR; however, oligonucleotide primers are 
orientated in the reverse direction to that used normally. The template is a restriction fragment (in this example 
the restriction endonuclease is XbaI) that has been self-ligated to form a circular piece of DNA. Amplicons are 
subsequently cloned and sequenced thereby allowing identification of unknown sequence surrounding a known 
DNA sequence  
 
Fwd 
Rev 
XbaI 
XbaI 
Reverse  Forward 
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Figure 5.3 Southern blot analysis of C. pseudotuberculosis 
Samples in lanes 1-10 correspond to C. pseudotuberculosis genomic DNA digested with KpnI, SpeI, NdeI, 
HindIII, BamHI, XbaI, BglII, PstI, EcoRI and NcoI, respectively. M is indicative of 1 kb DNA ladder 
(Invitrogen), and the 312 bp PCR product containing a fragment of the dtxR-homologue was included as a 
positive control (lane 11).  The probe corresponded to a DIG-labelled, 312 bp fragment of the C. 
pseudotuberculosis putative dtxR-like gene. 
 
 
 
 
 
 
M   1      2     3    4      5    6      7    8      9     10   11   M 
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Inverse PCR was conducted using the primers dtxR_inv (fwd) and dtxR_ inv (rev) (Table 2.3).  
Amplified blunt-ended DNA products were separated through a 1 % (w/v) agarose gel, stained 
with gel red and visualised over UV light (Figure 5.4).  DNA bands were excised and cloned 
into pCR
®
Blunt II TOPO
®
. The resulting recombinant plasmids (designated pCAW001, 
pCAW002, and pCAW003, respectively) were analysed by restriction endonuclease digestion  
and sequenced, in the first instance, using the M13 forward and reverse primers (Table 2.4) 
which annealed either side of the pCR
®
Blunt II TOPO
®
 multiple cloning site. The new DNA 
sequences were used to design further sequencing primers, and so on until the inserts in each 
of the 3 recombinant plasmids had been sequenced.   
 
From the sequencing data obtained, the region of the C. pseudotuberculosis chromosome 
surrounding the original 312bp dtxR-homologous sequence was assembled (Figure 5.5). The 
DNA sequences amplified by iPCR from KpnI and HindIII digested DNA were all present 
within the larger 6.5kb XbaI iPCR product. By sequencing all 3 plasmid constructs it was 
possible to confirm the integrity of the assembled chromosomal region. Open reading frames 
(ORFs) were identified within the sequences and subsequent BLAST analysis of the 6.5 kb C. 
pseudotuberculosis contig. revealed homology with C. diphtheriae (acc. # NC_002935)  dtxR 
(locus tag DIP1414), galE (locus tag DIP1415), and 2 conserved hypothetical proteins of C. 
diphtheriae. In addition, a partial ORF sharing homology with the sigB (locus tag DIP1413) of 
C. diphtheriae was present upstream of the ORF encoding the DtxR homologue.  Additionally, 
a partial ORF, which shared homology with a putative helicase of C. diphtheriae (locus tag 
DIP1418) was identified at the 3‘-end of the 6.5 kb contig.   
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Figure 5.4 Inverse PCR products 
Sample lanes correspond to 1 kb marker (M), the HindIII iPCR product (ca. 3kb) (lane 1) and the KpnI iPCR 
product (ca. 900bp) (lane 2).   
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Figure 5.5 Schematic representation of the C. pseudotuberculosis locus containing the dtxR-
homologue 
The ca. 6.5 kb fragment generated by inverse PCR using XbaI-digested C. pseudotuberculosis genomic DNA. 
The blue square indicates the previously-determined 312 bp region of the dtxR-homologous gene upon which the 
inverse PCR primers were designed.   
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Interestingly, an identical gene order with a high overall level of sequence homology was 
observed between the locus of C. pseudotuberculosis containing the dtxR-homologous gene 
and other sequenced corynebacteria. The translated products of the C. pseudotuberculosis 
ORFs were compared with the equivalent proteins from C. diphtheriae and C. glutamicum.  
Significantly, subsequent to the inverse PCR work, and as part of a separate project in the 
same laboratory, the C. pseudotuberculosis 3/99-5 genome was partially sequenced. 
Fortuitously, although the genome had not been analysed in any great depth, one of the several 
available contigs was found (by BLAST analysis) to contain the sequence corresponding to 
the dtxR-like region amplified by iPCR.  Subsequently, it was possible to obtain the 5‘-region 
of the sigB homologue of C. pseudotuberculosis which was lacking in the 6.5 kb iPCR 
fragment.  The translated product of the sigB homologue was subsequently found to share a 
high level of homology with C. diphtheriae and C. glutamicum, with 92% identity and 97% 
similarity with SigB of C. diphtheriae, and 89% identity and 95% similarity with that of C. 
glutamicum. The sequence of the DtxR-like protein of C. pseudotuberculosis shared 79% 
identity and 87% similarity with C. diphtheriae and 74% identity and 84% similarity with C. 
glutamicum. The GalE homologue of C. pseudotuberculosis shared 81% identity and 90% 
similarity with that of C. diphtheriae and 78% identity and 87% similarity with C. 
glutamicum. For the sake of this study, only the sigB, dtxR and galE genes were a focus of 
comparisons, since previous work carried out by Oram et al. (2006) on C. diphtheriae had 
identified these genes as being linked and therefore worthy of further analysis in C. 
pseudotuberculosis (Oram, et al., 2006).    
 
The DtxR-like protein of C. pseudotuberculosis was aligned with the DtxR proteins of C. 
diphtheriae and C. glutamicum (Figure 5.6).  The sequence encoding the predicted DNA-
binding domain (domain 1) lay within a region of generally-high sequence conservation, 
particularly between C. pseudotuberculosis and C. diphtheriae.  Similarly, domain 2, required 
for dimerization of DtxR, was also highly conserved between all three corynebacteria. 
Interestingly, however, domain 3 was highly variable between all three species.  
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DtxR protein cp       MKDLVDTTEMYLRTIYELEEEGVTPLRARIAERLDQSGPTVSQTVARMERDGLVVVASDR 
DtxR protein cg       ---------MYLRTIYELEEEGIVPLRARIAERLEQSGPTVSQTVARMERDGLVHVSPDR 
DtxR protein cd       MKDLVDTTEMYLRTIYELEEEGVTPLRARIAERLEQSGPTVSQTVARMERDGLVVVASDR 
                               *************  ********** ******************* *  ** 
 
 
 
DtxR protein cp       SLQMTPTGRALATAVMRKHRLAERLLTDIIGLDIHKVHDEACRWEHVMSDEVERRLVDVL 
DtxR protein cg       SLEMTPEGRSLAIAVMRKHRLAERLLTDIIGLDIHKVHDEACRWEHVMSDEVERRLVEVL 
DtxR protein cd       SLQMTPTGRTLATAVMRKHRLAERLLTDIIGLDINKVHDEACRWEHVMSDEVERRLVKVL 
                      ** *** ** ** ********************* ********************** ** 
 
 
 
DtxR protein cp       EDVTRSPFGNPIPGLDELGVSIKKKEGPGKRAVDVARATPRDVKIVQINEILQVDSDQFQ 
DtxR protein cg       DDVHRSPFGNPIPGLGEIGLDQADEPDSGVRAIDLPLGENLKARIVQLNEILQVDLEQFQ 
DtxR protein cd       KDVSRSPFGNPIPGLDELGVGNSDAAVPGTRVIDAATSMPRKVRIVQINEIFQVETDQFT 
                       ** *********** * *         * *  *          *** *** **   **  
 
 
           
DtxR protein cp       ALIDAGIRIGTTVTLSDVDGRVIITHGEKTVELIDDLAHAVRIEEI-- 
DtxR protein cg       ALTDAGVEIGTEVDIINEQGRVVITHNGSSVELIDDLAHAVRVEKVEG 
DtxR protein cd       QLLDADIRVGSEVEIVDRDGHITLSHNGKDVELIDDLAHTIRIEEL-- 
                       * **    *  *      *     *    *********  * *     
 
Figure 5.6 
Clustal Wallace multiple alignment of C. pseudotuberculosis (cp), C. glutamicum (cg) and C. diphtheriae (cd) DtxR protein.  
The predicted domains are labeled 1-3. Regions of homology are indicated by a star. Blue highlighter indicates homology between C. pseudotuberculosis 
and C. diphtheriae only, green indicates homology between C. pseudotuberculosis and C. glutamicum only and pink indicates homology between C. 
glutamicum and C. diphtheriae only. Domain 1 - classic helix-turn-helix DNA binding-motif (amino acids 1-73 in blue lines). Domain 2 - Required for 
dimerisation of DtxR and contains binding sites for two Fe
2+
 ions per monomer (amino acids 74-140 in red lines), (Also shown is the Cys-102). Domain 3 
- shares homology with SH3 domains found in some eukaryotic signal transduction proteins (amino acids 141-266 in black lines).  
Domain 1  
Domain 2  
Domain 3  
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5.1.2 Analysis of expression of genes within the C. pseudotuberculosis locus 
containing the dtxR-homologue 
 
Having identified the locus containing a dtxR-homologue, it was essential to determine 
whether the dtxR-like gene was actually expressed in C. pseudotuberculosis. In the first 
instance this was achieved by PCR amplification of the original 312 bp fragment of the gene 
with the primers dtxR_01 and dtxR_03 (Table 2.3), using reverse-transcribed mRNA extracted 
from a log-phase culture of C. pseudotuberculosis.  As expected, a fragment of the correct size 
was successfully amplified from the reverse transcribed mRNA, while absence of genomic 
DNA contamination was confirmed by the failure to amplify a product from non-reverse-
transcribed mRNA (Figure 5.7); therefore, expression of the dtxR-like gene was confirmed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 The 312bp transcript of the C. pseudotuberculosis dtxR gene amplified by RT-PCR 
Gel lanes correspond to 100 bp DNA ladder (M), 312 bp fragment of the dtxR-like gene amplified from reverse-
transcribed mRNA (Lane 1) and control reaction using non-reverse-transcribed mRNA (Lane 2).   
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Having confirmed the expression of the dtxR-homologue by RT-PCR, an experiment was 
conducted to determine whether C. pseudotuberculosis contained a functional DtxR regulator.  
This was achieved using the plasmid pSPZ (Oram, et al. 2006), containing a promoterless lacZ 
gene, a spectinomycin resistance gene and a stable pNG2 replication origin for C. diphtheriae, 
to study the outcome of environmental iron concentrations on the expression of known C. 
diphtheriae DtxR-regulated genes by measurement of β-galactosidase production.  Previously 
created pSPZ constructs were obtained from Prof. R. K. Holmes (University of Colorado at 
Denver and Health Sciences Centre, School of Medicine, Dept. of Microbiology, Aurora, 
Colorado, USA), which comprised the promoter-containing regions of the tox (Oram, et al., 
2006) and irp3 (R. K. Holmes, personal communication) genes cloned upstream of the 
promoterless lacZ gene in pSPZ. These constructs were introduced into wild-type C. 
pseudotuberculosis by electroporation, and promoter activity was assessed by measuring β-
galactosidase activity under high- and low-iron culture conditions. Significantly, as shown in 
Figure 5.8 lacZ expression was found to be up-regulated under conditions of low-
environmental iron for both the tox and irp3 promoters in C. pseudotuberculosis (the data 
shown is representative of 3 distinct experiments). The data was statistically analysed using a 
paired t-test, the outcome of which confirmed that environmental iron concentration was 
exerting a highly significant effect upon the level of expression of irp3 (p=0.011).  
Furthermore, the expression of tox also appeared to be affected by iron concentration (albeit to 
a lesser extent than irp3), although variability in the data over subsequent experiments resulted 
in fairly large error-bars, with the result that statistical analysis only suggested a trend towards 
significance (p= 0.068). While these results confirmed the presence of a DtxR-like regulator in 
C. pseudotuberculosis, they only circumstantially implicated the product of the dtxR-like gene 
in this process.  Therefore, further experiments were required to confirm (or refute) whether 
the product of this gene was a functional regulator of gene expression.  
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Figure 5.8 Assessment of the affect of environmental iron concentration on the expression of 
tox- and irp3-promoter/lacZ fusions in C. pseudotuberculosis.  Promoter fusion assays were 
undertaken to determine whether the expression of genes encoding known C. diphtheriae iron-regulated genes 
were regulated in response to environmental iron concentrations when in C. pseudotuberculosis. Statistical 
analyses using a paired t-test confirmed that environmental iron concentration was exerting a highly significant 
effect upon the level of expression of irp3 (p= 0.011); tox also appeared to be affected by iron concentration 
albeit to a lesser extent than irp3 (p= 0.068). Bars correspond to low-iron (   ), high-iron (   ).  
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 5.1.3 Assessment of the involvement of C. pseudotuberculosis DtxR in the 
iron-dependent regulation of tox  
 
To confirm the involvement of the product of the C. pseudotuberculosis dtxR-homologue in 
the iron-dependent regulation of known DtxR-regulated C. diphtheriae genes, a further 
promoter fusion assay was carried out in E. coli DH5α, using the pSPZ construct containing 
the tox promoter.  E. coli DH5α was transformed with either the pSPZ construct alone or with 
that construct in addition to pWSK29/DtxR, which contained the C. pseudotuberculosis dtxR-
like gene cloned into pWSK29 (Wang & Kushner, 1991). Using the PCR primers dtxR_comp 
F and dtxR_comp R (Table 2.3) a 1063 bp fragment which started 291 bp upstream of the 
dtxR-like gene (so as to include the promoter region) and finished 96 bp downstream of dtxR, 
was amplified. The amplicon was sub-cloned into pCR
®
II-TOPO
®
 vector (Table 2.2) to create 
pCR
®
II-TOPO
®
/dtxR. Subsequently, a ca. 1063 bp fragment was excised from the pCR
®
II-
TOPO
®
/dtxR construct using the restriction endonuclease EcoRI. The 1063 bp fragment, 
which included the full dtxR gene and promoter region, was then blunt-end ligated into a 
similarly digested pWSK29 vector to create pWSK29/DtxR (Table 2.2). Promoter fusion 
assays were carried out under high- and low-iron growth conditions as previously. This 
experiment was only conducted on a single occasion (with triplicate samples); therefore, rather 
than subjecting the data to statistical analysis equivalent to that described above (which 
corresponded to data gathered in triplicate on 3 different occasions), the level of repression of 
the tox promoter under high- and low-iron growth conditions was determined by calculating 
the repression ratio (low-iron/high-iron). The repression ratio was calculated in order to 
highlight the differential expression of tox when DtxR is present. In the presence of DtxR the 
repression ratio was 2.12; however, when DtxR was absent the repression ratio was markedly 
lower at 0.89. These results confirm that the C. pseudotuberculosis DtxR-homologue was 
capable of regulating a known C. diphtheriae DtxR regulated gene in an iron-dependent 
manner (Figure 5.9). Given its equivalent function, for ease of nomenclature the C. 
pseudotuberculosis dtxR-homologue will henceforth be referred to as dtxR. 
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Figure 5.9 Assessment of C. pseudotuberculosis DtxR regulation of tox.  
A further promoter fusion assay was carried out in E. coli DH5α, using the pSPZ construct containing the tox 
promoter (toxP).  E. coli DH5α were transformed with the pSPZ construct, while a further transformant was 
obtained by introduction of the pSPZ construct in addition to pWSK29/DtxR, which contained the C. 
pseudotuberculosis dtxR-like gene cloned into pWSK29. Bars correspond low-iron + DtxR (   ), high-iron + DtxR 
(   ), Low-iron - DtxR (green dashes), high-iron - DtxR (blue dashes).  In the presence of DtxR the tox promoter 
was differentially expressed (repression ratio of 2.12) whereas when DtxR was absent the repression ratio was 
markedly reduced (0.89).  
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5.1.4 Analysis of expression of the genes within the C. pseudotuberculosis 
dtxR chromosomal locus 
 
Having proven the involvement of C. pseudotuberculosis DtxR in the control of expression of 
a C. diphtheriae DtxR-regulated gene, experiments were conducted to investigate the 
expression of the genes within the C. pseudotuberculosis dtxR-containing region. This was 
done with a view to determining whether DtxR was involved in regulation of its own 
structural and surrounding genes, as has been described for the Fur regulator in Helicobacter 
pylori and Neisseria meningitidis (Delany, et al. 2003; Delany, et al. 2002). In order to assess 
the transcription of the C. pseudotuberculosis sigB, dtxR and galE genes, promoter fusions 
were constructed. In Figure 5.10 is presented a schematic representation of the dtxR locus of 
C. pseudotuberculosis, indicating the upstream regions which were used in promoter fusion 
assays. To determine the promoter activity of sigB, a 261bp fragment (derived from the 
ongoing genome sequence project) was amplified using the primers sigB_ P_F and sigB_ P_R 
(Table 2.5), and cloned upstream of the lacZ reporter gene in pSPZ.  Similarly, fragments of 
690bp and 479bp were cloned into pSPZ from sequences upstream of dtxR and galE using 
primers dtxR_P_F and dtxR_P_R, and galE_P_F and galE_P_R respectively. The resulting 
plasmids were designated pCAW004, pCAW005 and pCAW006 respectively. The fragment 
upstream of dtxR incorporated approximately 690bp so as to include the intergenic region 
between sigB and dtxR. The constructs were subsequently introduced into wild-type C. 
pseudotuberculosis and the promoter activity was determined by measuring β-galactosidase 
activity (Figure 5.11). The results indicated that a functional promoter lay upstream of sigB, 
and also upstream of dtxR; however, in contrast, there was no detectable promoter activity 
upstream of galE. Furthermore, despite the evidence of functional sigB and dtxR promoters, 
there was no evidence of environmental iron concentration exerting an effect upon the level of 
expression of these genes, as determined by there being no difference in the level of β-
galactosidase production under either condition. A paired t-test was employed to statistically 
analyse the data, which confirmed that there was no evidence to implicate iron concentration 
in the regulation of gene expression of sigB (p=0.507), dtxR (p=0.293) or galE (p=0.448).  
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Figure 5.10 Schematic representation of the C. pseudotuberculosis dtxR locus.  
Intergenic sequences which were assessed for the presence of functional promoters are highlighted.  
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Figure 5.11 Determination of functional promoters within the dtxR chromosomal locus, using 
pSPZ/ lacZ fusions. Promoter fusion assays were undertaken to determine whether the expression of the genes 
within the C. pseudotuberculosis dtxR locus were regulated in response to environmental iron concentrations.  A 
paired t-test was employed to statistically analyse the data, which confirmed that there was no evidence to 
implicate iron concentration in the regulation of gene expression of sigB (p= 0.507), dtxR (p= 0.293) or galE 
(p=0.448).  Bars correspond to Low-iron (    ) and high-iron (   ).  
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To further assess the expression of the sigB, dtxR and galE genes in C. pseudotuberculosis, 
quantitative reverse transcription PCR (qRT-PCR) was used to determine the relative 
transcript abundance of these genes. For qRT-PCR, RNA was extracted from bacterial cells 
harvested from exponentially-growing cultures of C. pseudotuberculosis 3/99-5, grown under 
either high- or low-iron conditions; each experiment was conducted in triplicate.  
Oligonucleotide primers were designed to amplify transcripts from sigB, dtxR, the dtxR-galE 
intergenic region and galE (Figure 5.12).  Primers for the sigB transcript annealed 226 bp 
upstream of the 3‘ end of sigB (B, d with blue probe in Figure 5.12).  To amplify the dtxR 
transcript, primers were designed to anneal 145 bp downstream of the 5‘ end of dtxR (C, c 
with red probe in Figure 5.11).  A transcript spanning the intergenic region of dtxR-galE was 
also measured, whereby primers annealed 82 bp upstream of the 3‘ end of dtxR and 
incorporated 200 bp of galE (F, b with yellow probe in Figure 5.12). Finally, the galE gene 
transcript was measured using primers which annealed 483 bp downstream of the 5‘ end of 
galE (G, a with green probe in Figure 5.12).  Transcript abundance was measured relative to 
the housekeeping gene recA (accession no. U30387). In addition, fagA (accession no. 
AF401634), the expression of which had previously been shown to be down-regulated under 
high-iron growth conditions (Billington, et al., 2002), was used as positive control. 
 
A graphical representation of the qRT-PCR results is presented in Figure 5.13. A statistical 
paired t-test analysis of the results of qRT-PCR experiments demonstrated no statistically-
significant difference between the expression of either sigB (p=0.414), dtxR (p=0.452) or galE 
(0.356) under high- or low-iron growth conditions. In general, sigB was only expressed at low 
levels under both growth conditions.  Interestingly, galE was observed to be co-transcribed 
with dtxR, consistent with the failure to identify a functional galE promoter in promoter fusion 
assays.  In contrast, qRT-PCR data revealed a significant difference (p=0.003) between the 
expression of fagA under high- and low-iron growth conditions; transcription of fagA had 
increased 16-fold under low-iron compared to high-iron conditions.  
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Figure 5.12 Schematic representation of the C. pseudotuberculosis dtxR chromosomal locus 
highlighting the locations of qRT-PCR primer and probe binding sites.   
Primers that were designed to amplify sigB transcripts annealed 226 bp upstream of the 3‘ end of sigB (B, d with 
blue probe.  To amplify dtxR transcripts, primers were designed to anneal 145 bp downstream of the 5‘ end of 
dtxR (C, c with red probe). Transcripts spanning the intergenic region of dtxR-galE were also measured, 
whereby primers annealed 82 bp upstream of the 3‘ end of dtxR and incorporated 200 bp of galE (F, b with 
yellow probe). The galE gene transcripts were measured using primers which annealed 483 bp downstream of 
the 5‘ end of galE (G, a with green probe).   
 
 
 
 
 
 
 
 
 
 
5’ 3’ 
sigB dtxR galE 
B C 
c a 
G F 
 b d 
Chapter Five                                                                                                                                   Results  
 161 
 
 
 
 
 
 
 
 
 
Figure 5.13 Relative transcript abundance of genes within the C. pseudotuberculosis dtxR 
chromosomal locus. The expression of each gene within the C. pseudotuberculosis dtxR locus was analysed 
following extraction of mRNA from cells cultured in high- and low-iron media. Statistical analysis of the data 
provided evidence to suggest that there was no significant difference between expression of sigB (p=0.414), dtxR 
(p=0.452) or galE (p=0.356) when grown under low- or high iron conditions. However, there was a significant 
difference between the expression of fagA under low-iron compared to high-iron conditions (p=0.003).  Bars 
correspond to low-iron (  ) and high-iron (   ). 
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Previously, Oram et al. (2006) demonstrated that in C. diphtheriae, sigB, dtxR and galE are 
transcribed as a polycistronic message (i.e. exist in an operon structure) (Oram, et al. 2006). 
Taking into account the similarities already seen between the dtxR loci of C. diphtheriae and 
C. pseudotuberculosis, it was thought likely the same operon structure also existed within the 
dtxR locus of C. pseudotuberculosis. Therefore, to determine whether sigB was expressed as 
part of a polycistronic mRNA, sigB-dtxR-galE transcription was analysed by conventional RT-
PCR.  Using the primers sigB_ B_ F and galE_ a_ R (Table 2.6), it was possible to amplify an 
expected sized fragment of ca. 2 kb, from mRNA isolated from C. pseudotuberculosis cells 
harvested in exponential growth-phase (Figure 5.14).  In contrast, an equivalent band was not 
amplified in a control reaction containing non-reverse-transcribed mRNA.  Therefore, this 
result confirmed the existence of a transcript spanning sigB-dtxR-galE, and hence proved the 
co-expression of all 3 genes. 
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Figure 5.14 Detection of sigB-dtxR-galE transcripts using RT-PCR 
Samples correspond to 1kb DNA ladder (M), the sigB-dtxR-galE transcript (Lane 1) and an equivalent negative 
control reaction using non-reverse-transcribed mRNA as template (Lane 2)   
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 5.1.5 Iron-dependent expression of other C. pseudotuberculosis genes 
 
Using promoter fusion assays, experiments were undertaken to determine whether the 
expression of genes encoding published C. pseudotuberculosis virulence factors were 
regulated in response to environmental iron concentrations.  With the exception of pld (the 
phospholipase D-encoding gene shown previously not to be expressed in an iron-dependent 
manner (Billington, et al. 2002)), the only virulence-related genes available in the NCBI 
sequence repository were fagA and the serine protease-encoding gene, cp40 (accession number 
U10424). As stated above, the fagA gene had already been shown by Billington et al. (2002) 
to be regulated in response to environmental iron concentrations, and this result had been 
corroborated by the data presented in Section 5.1.4. Computational analysis of the fagA and 
cp40 nucleotide sequences was performed, in order to determine whether either of the genes 
contained a putative DtxR-binding motif. Significantly, a putative DtxR-binding motif 
(TTAGTTTAGGCTAAACTGG) was identified 122 bp upstream of the first nucleotide of 
fagA, corroborating a previous report (Billington, et al. 2002).  Furthermore, cp40 was also 
observed to contain a putative DtxR-binding motif (GAAGTTATGCCTACCGTAA), 
although it was located 34 bp within the start of the gene, which was not consistent with the 
location of other DtxR-binding motifs in other genes.     
 
Promoter fusions of fagA and cp40 were constructed in pSPZ and the resulting recombinant 
plasmids were designated pCAW007 and pCAW008 respectively. This was achieved by 
cloning a 511 bp fragment corresponding to 211 bp within the 5‘ end of the gene to 300 bp 
upstream of fagA and a 488 bp fragment corresponding to 161 bp upstream of cp40.  Even 
though fagA had already been shown to be expressed in an iron-dependent manner through 
qRT-PCR analysis (Section 5.1.4), it was included here as a positive control. The two 
plasmids were used to transform wild-type C. pseudotuberculosis, and β-galactosidase 
production was measured under high- and low-iron growth conditions (Figure 5.15). A paired 
t-test was applied to statistically analyse the data and, as expected, fagA was found to be 
expressed in an iron-dependent manner (p=0.013), corroborating previous qRT-PCR results. 
However, no significant difference in β-galactosidase production was detected under high- and 
low-iron growth conditions, in bacteria containing the cp40 promoter fusion vector (p= 0.103).    
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Previously, it had been possible to prove the involvement of C. pseudotuberculosis DtxR in 
the iron-dependent control of expression of C. diphtheriae tox, using E. coli as an 
experimental host (Section 5.1.3). By calculating the repression ratio it was possible to see 
that in the presence of DtxR the tox promoter was being repressed under high iron with a 
repression ratio of 2.12, whereas when DtxR was absent the repression ratio was less markedly 
less at 0.89. These experiments were conducted during a working visit to the laboratory of 
Prof. Randall Holmes at the University of Colorado at Denver and Health Sciences Centre, 
School of Medicine, Dept. of Microbiology, Aurora, Colorado, USA. With respect to fagA, 
although the results obtained thus-far had proven the differential expression of the gene in 
response to iron concentration, and a putative DtxR-binding motif had been identified 
upstream of the gene, the actual involvement of C. pseudotuberculosis DtxR in regulating 
fagA expression had yet to be proven.  To achieve this objective, it was decided to undertake 
an equivalent experiment to that conducted previously in America, using E. coli as a ―DtxR-
deficient‖ host in which promoter fusion assays could be conducted in the presence/absence of 
a plasmid-encoded copy of the C. pseudotuberculosis dtxR-like gene.  However, attempts to 
replicate the conditions of the assay back in the UK were, unfortunately, unsuccessful.  
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Figure 5.15 Iron-dependent regulation of gene expression of genes encoding published C. 
pseudotuberculosis virulence factors 
Promoter fusion assays were undertaken to determine whether the expression of genes encoding published C. 
pseudotuberculosis virulence factors were regulated in response to environmental iron concentrations.  Statistical 
t-tests confirm fagA is differentially expressed with respect to iron (p= 0.013), whereas cp40 is not (p=1.03). Bars 
correspond to low-iron (   ), and high-iron (   ). 
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5.1.6 Construction of a dtxR-deficient mutant strain of C. pseudotuberculosis 
 
Due to the inability to assess the role of C. pseudotuberculosis DtxR using a plasmid-based 
system in E. coli, it was decided to generate a dtxR-deficient mutant of C. pseudotuberculosis 
3/99-5 so that the expression of putative DtxR-regulated genes could be compared in the 
mutant and isogenic, wild-type parent strains. In order to create the mutant strain, the targeted 
allele-replacement mutagenesis system described in Chapter 4 was used. In the first instance, a 
deletion derivative of the C. pseudotuberculosis dtxR gene was constructed in vitro.  PCR with 
the primers ΔdtxR_AE_1 and ΔdtxR_AE_2 (Table 2.3) was used to amplify a 1,022 bp 
fragment from immediately upstream of dtxR, which included the first 9 bp of the 5‘ end of the 
dtxR gene.  Likewise, PCR using the primers ΔdtxR_AE_3 and ΔdtxR_AE_4 was used to 
amplify a 1,020 bp fragment from immediately downstream of dtxR, which included the last 3 
bp of the 3‘ end of the dtxR gene. The two fragments were then ligated together (using the 
incorporated XhoI site), and the ca. 2 kb ligation product was amplified by PCR using primers 
ΔdtxR_AE_1 and ΔdtxR_AE_4; the resulting mutant gene, comprising a deletion of the 
majority of the dtxR coding sequence, was designated ΔdtxR. The ΔdtxR amplicon was then 
cloned into SalI digested pCARV (facilitated by primer-encoded restriction endonuclease 
recognition sites), and the resulting vector, designated pCARV006, was used to transform C. 
pseudotuberculosis. Subsequently, the plasmid-borne ΔdtxR was used to replace the wild-type 
chromosomal gene by homologous recombination.  In the first instance, bacterial cells having 
undergone integration of pCARV006 into the chromosome were identified by virtue of their 
resistance to erythromycin at 37°C (the non-permissive temperature for plasmid replication). 
These intermediary mutants (containing both chromosomal wild-type and plasmid-borne 
mutant dtxR genes) were analysed by PCR using primers pCARV_MCS F and dtxR_SX R 
(Table 2.5), specific for the vector and the insert (Figure 5.16).  It was expected that if 
homologous recombination had occurred upstream of the ΔdtxR construct that a ca. 2,500 bp 
fragment would be amplified, corresponding to the region spanning the mutant gene; however, 
if recombination had occurred downstream of ΔdtxR then a ca. 3,000 bp fragment would be 
amplified, corresponding to the region spanning the wild-type gene.  Significantly, due to the 
inclusion of the vector-specific pCARV_MCS F primer, a product could only be amplified 
from genomic DNA containing integrated plasmid. The data presented in Figure 5.16 revealed 
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that homologous recombination was occurring successfully between homologous 
chromosomal and plasmid-borne sequences present on either side of ΔdtxR.     
 
 
 
 
 
 
 
Figure 5.16 Analysis of single-crossover intermediate mutants of C. pseudotuberculosis.  Cells 
having undergone chromosomal integration of pCARV006 were analysed by PCR to determine at which side of 
ΔdtxR recombination was occurring. Sample lanes correspond to 1 kb DNA ladder (M), co-integrants arising 
through recombination at the 5‘-end of ΔdtxR (Lanes 1 and 3) or the 3‘-end of ΔdtxR (Lanes 2, 4, 5, 6 and 7).   
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A single colony deriving from a cell in which pCARV006 had integrated into the chromosome 
was used to inoculate a quantity of BHI containing erythromycin. The culture was 
subsequently grown to stationary phase at 37°C × 225 rpm.  The culture was then diluted (to 
1×10
-5
) in BHI and incubated at the permissive temperature for the plasmid (26°C), without 
any antibiotic selection. During this incubation, the ability of the integrated plasmid to 
replicate at the lowered temperature caused it to become unstable in the chromosome, driving 
its excision; subsequently, the absence of antibiotic selection resulted in the excised plasmid 
being lost from cells.  In keeping with the allele replacement protocol developed in chapter 4, 
ampicillin enrichment of cells which had undergone secondary cross-over events was carried 
out in order to reduce the number required to be replica plated. Following ampicillin 
enrichment, 10-fold serial dilutions of the resulting culture were then plated on BHI agar and, 
following incubation, single colonies were replica plated onto BHI agar with and without 
antibiotic selection (allowing identification of cells from which the plasmid had excised). 
Subsequently, a number of colonies were identified which derived from cells in which a 
secondary cross-over event had occurred.  Single colonies were screened by PCR with the 
primers ΔdtxR_DCO_F and ΔdtxR_DCO_R, which spanned the region of the chromosome 
containing dtxR; it was anticipated that a wild-type chromosomal dtxR gene would give rise to 
a 1,259 bp fragment, while the ΔdtxR gene would give rise to a fragment of 559 bp. 
Unfortunately, in all cases, PCR screening led only to the identification of cells having excised 
the plasmid to leave the wild-type gene in the chromosome (data not shown). Despite repeated 
attempts to obtain a dtxR-deficient mutant, only the wild-type strain could ever be recovered, 
despite using low-iron growth media to prevent iron-toxicity.  However, it was subsequently 
decided to omit the ampicillin-enrichment step, and at that point it became possible to isolate a 
mutant derivative containing the ΔdtxR gene in the chromosome.  
 
The mutant C. pseudotuberculosis strain, designated Cp-ΔdtxR, was checked to ensure that the 
dtxR deletion was as expected.  Genomic DNA extracted from the wild-type or the Cp-ΔdtxR 
mutant was used as template in PCR reactions using the primers ΔdtxR_DCO_F and 
ΔdtxR_DCO_R (Table 2.3).  As expected, these primers resulted in the amplification of a 
1,259 bp fragment from the wild-type strain; however, the equivalent PCR product for the 
ΔdtxR strain was ca. 0.7 kb shorter, confirming the deletion within the chromosomal dtxR 
gene (Figure 5.17).  In addition to PCR analysis, Southern blots were also performed, using 
probes specific for either galE or the erythromycin-resistance gene of pCARV (Figure 5.18).   
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Figure 5.17 PCR analysis of the region across dtxR in C. pseudotuberculosis wild-type and Cp-
ΔdtxR strains 
Sample lanes correspond to 1 kb DNA ladder (M), dtxR from the wild-type strain ca. 1.2 kb (Lane 1) and ΔdtxR 
from the Cp-ΔdtxR strain ca.0.6 kb (Lane 2)    
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Figure 5.18 Southern Blot analysis of C. pseudotuberculosis wild-type and Cp-ΔdtxR genomic 
DNA 
Sample lanes correspond to dtxR from the wild-type strain (Lane 1), ΔdtxR from the Cp-ΔdtxR strain (Lane 2) 
and pCAW002 (positive control) (Lane 3).   
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Genomic DNA from the Cp-ΔdtxR mutant and wild-type parent strains was digested to 
completion with HindIII (a previous Southern blot had revealed that HindIII produced a 
chromosomal fragment which contained both the dtxR and galE genes, and this observation 
was corroborated by in silico restriction analysis of the ca. 6.5 kb dtxR contig). As a result of 
the deletion within the dtxR gene of the mutant strain, probing with galE revealed a difference 
in size between the wild-type and mutant of ca. 0.7 kb; the mutant being smaller.  In order to 
confirm that pCARV had been completely excised from the chromosome of the Cp-ΔdtxR 
mutant, and had subsequently been lost from the cell due to incubation at a temperature non-
permissive for plasmid replication, the same HindIII-digested genomic DNA was probed with 
the DIG-labelled erythromycin-resistance gene from pCARV. As expected, no hybridisation 
was observed, confirming that the plasmid was absent (data not shown). 
 
In order to ensure that no polar affects had occurred on the transcription of other genes in the 
sigB-dtxR-galE operon, RT-PCR analysis was carried out as it had been previously for the 
analysis of the transcription of these genes in the wild-type strain.  Messenger RNA was 
extracted from exponential-phase cultures of the wild-type and Cp-ΔdtxR strains, and RT-PCR 
was conducted using the primers sigB_B_F and galE_ a_R to detect the presence of a sigB-
dtxR-galE transcripts. As expected, transcripts were detected in mRNA from both strains; 
however, the Cp-ΔdtxR transcript was ca. 0.7 kb smaller than that of the wild-type, 
corresponding to the size of the deletion within dtxR (Figure 5.19). No transcripts were 
detected in Cp-ΔdtxR mutant or wild-type parent mRNA that had not been reverse transcribed, 
confirming the absence of genomic DNA contamination.  
 
In addition to the genomic and transcriptional analyses of the Cp-ΔdtxR mutant strain, 
phenotypic differences between it and the isogenic wild-type parent were also observed.  
When grown on high-iron-containing medium, the colony size of the Cp-ΔdtxR mutant 
appeared to be small in comparison with those of the wild-type parent grown on the same 
medium. Furthermore, preliminary experiments were conducted to assess the tolerance of the 
mutant versus wild-type to H2O2 exposure. Briefly, stationary phase C. pseudotuberculosis 
cultures were plated as a lawn onto BHI agar plates containing 100 μM of 2‘, 2‘-dipyridyl. A 5 
mm Whatman™ filter disc was placed directly onto the centre of each plate, and 10 μl of 30 
%, 3 % or 0.3 % hydrogen peroxide (diluted in ddH2O) was pipetted directly onto each filter 
disc.  Subsequently, plates were incubated at 37°C for 48 hrs to allow bacterial growth and the 
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zone of growth inhibition surrounding the filter discs was measured. Although sufficient time 
was not available to undertake a thorough analysis, preliminary results suggested that the Cp-
ΔdtxR mutant survived less-well than the wild-type in a hydrogen peroxide inhibition assay 
(data not shown).  
 
5.1.7 Analysis of C. pseudotuberculosis DtxR regulation of target genes 
 
As stated above, in order to unequivocally determine the involvement of DtxR in the iron-
dependent regulation of C. pseudotuberculosis genes, cp40 and fagA, promoter fusion assays 
were carried out using the wild-type and Cp-ΔdtxR mutant strains as hosts for plasmid 
constructs.  This experiment meant it was possible to directly compare the extent of repression 
of each gene when DtxR was present (wild-type) and absent (Cp-ΔdtxR). The C. 
pseudotuberculosis strains were transformed with the promoter fusion plasmids pCAW007 
and pCAW008 and subsequent differences in the level of β-galactosidase production from 
each construct, under high- and low-iron growth conditions, was recorded for each strain 
(Figure 5.20). A paired t-test was used to compare the expression of fagA and cp40 under 
high- and low-iron growth conditions in the Cp-ΔdtxR mutant strain. The results suggest there 
was not a significant difference between the expression of fagA (p=0.086) or cp40 (p=0.329) 
under high or low-iron growth conditions. These results indicated that the absence of DtxR 
affected the influence of iron on repression of the iron-regulated fagA gene expression. In 
addition ANOVA was employed to statistically analyse the difference between the two strains 
(wild-type and Cp-ΔdtxR).  The analysis provided statistical evidence to suggest that there was 
a significant difference in gene expression of fagA in wild-type compared to Cp-ΔdtxR 
(p=0.005).  This suggested that, as predicted, the absence of DtxR had an effect on iron-
dependent regulation of fagA gene expression under differential iron growth conditions. The 
difference between the level of expression of fagA under high-iron conditions was greater than 
the difference under low-iron conditions (wild-type mean at high-iron was 0.87 +/- 0.06 and 
Cp-ΔdtxR high-iron was 1.42 +/- 0.06, compared to wild-type at low-iron which was 1.35 +/- 
0.06 and Cp-ΔdtxR at low-iron was 1.54 +/- 0.06) which indicated an interaction effect 
between strain and iron. In contrast, the statistical evidence suggested that there was no 
difference (p=0.290) between cp40 gene expression in wild-type or Cp-ΔdtxR, and that the 
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difference in expression of cp40 in wild-type compared to Cp-ΔdtxR was similar at both high 
and low levels of iron.   
 
5.1.8 Complementation of the C. pseudotuberculosis dtxR mutant  
 
The pEP2 vector (Radford & Hodgson, 1991) was used to provide a plasmid-borne copy of the 
wild-type C. pseudotuberculosis dtxR gene. This was achieved by performing an EcoRI digest 
on the previously constructed pWSK29/dtxR (Table 2.2), thereby excising the full C. 
pseudotuberculosis dtxR gene and its promoter region, which was subsequently cloned into 
EcoRI-digested pEP2; the resulting construct was designated pCAW010 (Table 2.2). This 
construct was used to transform Cp-ΔdtxR and thereby provide an in trans copy of a fully-
functional C. pseudotuberculosis DtxR protein. Under high- and low-iron conditions the 
growth of the complemented mutant was compared to that of the wild-type parent strain and 
the uncomplemented Cp-ΔdtxR mutant (Figure 5.21). Significantly, the growth of the 
complemented mutant under high-iron conditions was restored to that of wild-type, confirming 
that deletion of the dtxR gene had given rise to the observed phenotype. Preliminary analyses 
demonstrated that sensitivity to hydrogen peroxide was also restored to wild-type levels (data 
not shown).  
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Figure 5.19 Determination of the presence of sigB-dtxR-galE polycistronic mRNA in C. 
pseudotuberculosis wild-type and Cp-ΔdtxR strains 
Sample lanes correspond to 1 kb DNA ladder (M), sigB-dtxR-galE transcript from wild-type cDNA with and 
without reverse transcriptase (Lanes 1 & 2) and sigB-dtxR-galE transcript from Cp-ΔdtxR cDNA with and 
without reverse transcriptase (Lanes 3 & 4). 
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Figure 5.20 Assessment of DtxR-regulation of C. pseudotuberculosis genes  
The Cp-ΔdtxR strain was used as a host for pCAW007 and pCAW008 in a promoter fusion assay. Beta-
galactosidase activity was measured and Miller units were calculated to determine the expression of fagA and 
cp40 under high- and low-iron conditions under the control of the Cp-ΔdtxR mutant host. A paired t-test indicated 
that expression of fagA in Cp-ΔdtxR was not differentially expressed (p=0.086) and nor was cp40 (p=0.329) 
implicating DtxR in the regulation of fagA. Bars correspond to low-iron (   ) and high-iron (   ) growth conditions. 
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Figure 5.21 Growth of C. pseudotuberculosis wild-type, Cp-ΔdtxR and Cp-ΔdtxR + DtxR strains 
under high- and-low iron conditions 
The graph corresponds to wild-type grown under high-iron conditions ( ), wild-type grown under low-iron 
conditions ( ), Cp- ΔdtxR grown under high-iron conditions ( ), Cp- ΔdtxR grown under  low-iron 
conditions ( ),  Cp- ΔdtxR + DtxR grown under  high-iron conditions  ( ), Cp- ΔdtxR + DtxR grown 
under  low-iron conditions ( ) 
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 5.1.9 Transition metal activation of C. pseudotuberculosis DtxR  
 
In vitro, DtxR of both C. diphtheriae and C. glutamicum have been shown to bind transition 
metals other than iron (namely zinc and manganese), resulting in an effect on the ability of 
DtxR to regulate gene expression (Qiu, et al. 1995; Tao, et al. 1995).  To determine whether 
C. pseudotuberculosis DtxR was also activated by other transition metal ions, the fagA 
promoter fusion vector, pCAW007, was introduced into wild-type C. pseudotuberculosis 3/99-
5 and the transformed strain was cultured with and without zinc and manganese (for the 
purpose of this study, in addition to iron, only the transition metals zinc and manganese were 
assessed). Following transformation with pCAW007, wild-type C. pseudotuberculosis was 
cultured in CCDM containing 10 μM (final concentration) of either zinc, manganese or iron 
(as a positive control) in addition to CCDM alone to determine background levels of DtxR 
repression through binding of metal ions already in the medium. The low-ion medium was 
prepared in the same way as it had been throughout this thesis by adding 300 μM of dipyridyl 
to CCDM (Figure 5.22).  In order to compare the level of repression that resulted from the 
different metal ions, the ―repression ratio‖ was calculated by dividing the mean Miller units 
observed under CCDM with 300μM dipyridyl (low-ion) conditions by the mean Miller units 
observed under high-ion for each metal-ion and CCDM only as a control. The results of these 
experiments revealed that, in this in vitro assay, manganese was able to activate DtxR 
(repression ration of 2.6), although iron was clearly the more potent metal ion (repression 
ration of 3.3).  In contrast, there appeared to be little repression of DtxR in the presence of 
zinc, with a repression ratio of 1.8 which was less than that observed in CCDM only 
(repression ratio of 2.0).  
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Figure 5.22 Promoter fusion assay to determine the efficiency of zinc and manganese in the 
activation of DtxR and subsequent repression of the fagA promoter 
The fagA promoter fusion vector, pCAW007, was introduced into wild-type C. pseudotuberculosis 3/99-5. The 
transformed strain was grown under low-ion conditions (CCDM with the addition of 300 μM dipyridyl    ), and 
high-ion (10 μM final concentration of manganese, zinc and iron  ); CCDM was included as a control to 
determine the level of background repression.  The repression ratio (indicated above the bars) was calculated by 
dividing the mean Miller units under low-ion conditions by the mean Miller units under high-ion for each metal-
ion and CCDM only as a control. The repression ratio highlights the extent of the repression on the fagA 
promoter in the presence of different metal ions. The background level of repression seen with CCDM alone was 
2.0, zinc showed a repression ratio of 1.8, manganese was 2.6 and iron, which was the most potent repressor had 
a repression ratio of 3.3. 
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5.2 Discussion  
 
Previously in our laboratory a 312 bp fragment, of what has now been confirmed in this study 
to correspond to the dtxR gene of C. pseudotuberculosis, was amplified by PCR cloned, and 
sequenced. Using that novel sequence, a strategy for the inverse PCR amplification of the 
remainder of the gene and the surrounding chromosomal region was devised, resulting in the 
recovery of a ca. 6.5 kb fragment containing homologues of the sigB, dtxR, galE and helicase 
genes described previously in other sequenced corynebacteria, including C. diphtheriae 
(Cerdeno-Tarraga, et al. 2003) and C. glutamicum (Oguiza, et al. 1996b) (Kalinowski, et al. 
2003). Interestingly, a similar gene arrangement has been observed for two of the genes in the 
locus in the other actinomycetes, M. tuberculosis, M. smegmatis, and Rhodococcus  equi, 
whereby a sigB gene has been shown to lie immediately upstream of ideR, the equivalent of 
dtxR (Boland & Meijer, 2000; Doukhan, et al. 1995). Interestingly, in R. equi, unlike M. 
tuberculosis and M. smegmatis, a galE gene also lies immediately downstream of dtxR. The 
similarities within this locus indicate that the linkage, of sigB and dtxR (ideR) at least, is 
highly-conserved among members of the order Actinomycetales.  The reason for the linkage 
of sigB and dtxR (ideR) is currently unknown; however, Doukhan et al. (1995) suggest a 
functional significance (Doukhan, et al. 1995).   
 
The predicted C. pseudotuberculosis DtxR protein sequence has been shown to share ca. 70 %  
homology with C. glutamicum DtxR, and 90 % homology with that of C. diphtheriae.  In 
addition to this high level of sequence homology, alignment of the sequences of the 3 proteins 
has revealed that domains 1 and 2, which are involved in DNA- and metal ion-binding 
respectively (Qiu, et al. 1995) (Schiering, et al. 1995), are highly conserved between all three 
species, particularly C. pseudotuberculosis and C. diphtheriae (Figure 5.6). Domain 3 of 
DtxR is known to contribute ligands to the metal binding site in domain 2. Furthermore, 
domain 3 is predicted to control the activity of the protein at specific promoters (Love, et al. 
2004; Oram, et al. 2005). Interestingly, domain 3 was highly variable between C. 
pseudotuberculosis, C. diphtheriae and C. glutamicum, an observation which has been 
reported previously for comparisons between sequenced corynebacteria (Oram, et al. 2005). 
Oram et al. (2005) discovered DtxR domain 3 in C. diphtheriae contains immunodominant 
epitopes, and is required for full repression of tox in an E. coli reporter system. However, it is 
not required for DNA binding in vitro (Oram, et al. 2005).  Oram et al. (2005) also suggested 
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that, in some members of the DtxR family, the variability within the third domain potentially 
affects the intra-molecular interactions that this domain has with domains 1 and 2.  
Furthermore, Oram et al. (2005) reported that the biological activity, which is a result of 
domain 3 interactions, is also variable and subsequently species-specific roles for the third 
domain of these transcriptional regulators is, as yet, undefined (Oram, et al. 2005).     
 
In vitro, DtxR, including that of C. pseudotuberculosis during this work, has been shown to be 
capable of binding several different metal ions, resulting in the conformational change that 
permits the protein to act as a repressor of gene expression.  However, in vivo DtxR would 
appear to be almost entirely iron-specific (Groman & Judge, 1979). In in vitro studies, DT 
production in C. diphtheriae did appear to be repressed in the presence of manganese; 
however, a 1,000-fold higher concentration of manganese than iron was required to achieve 
the same level of repression (Groman & Judge, 1979).  It had previously been discovered that 
the Cysteine residue at amino acid 102, (Cys-102) is involved in heavy metal ion activation of 
DtxR (Tao & Murphy, 1993). Later, using site-directed mutagenesis, Geudon et al. (2003) 
investigated the effect of substituting specific amino acids on the metal ion specificity of DtxR 
and MntR (a manganese dependent DtxR-homologue). The investigators made changes to the 
two variable residues in the metal-sensing site, and subsequently converted DtxR to a 
manganese responsive regulator (Guedon & Helmann, 2003). Furthermore, the researchers 
were also able to make the manganese responsive MntR protein responsive to iron in a similar 
way.  These results suggest that the Cys-102 residue is responsible for the specificity of C. 
diphtheriae DtxR for iron, in vivo (Guedon & Helmann, 2003).  Oram et al. (2004) reported 
that the highly conserved sequence of the Corynebacterium DtxR-like proteins that they had 
investigated, exhibited a much higher overall homology to iron-responsive members of the 
DtxR family, than to those that are responsive to manganese (Oram, et al. 2004).  One can 
postulate then, that due to the high degree of homology between C. pseudotuberculosis DtxR 
and C. diphtheriae DtxR and, given that the same Cys residue resides at amino acid position 
102 in C. pseudotuberculosis, it is likely that DtxR of C. pseudotuberculosis is iron-specific in 
vivo.  Certainly, the results of the analyses of the affect of different transition metal ions on C. 
pseudotuberculosis DtxR function in the laboratory environment proved that iron was the 
preferred transition metal.  However, even though manganese also resulted in the repression of 
target gene expression, it is worth noting that the levels of accessible manganese within the 
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natural host (i.e. sheep/goats) is likely to be significantly less than the equivalent levels of 
iron. 
 
The conservation of the dtxR locus in the genus Corynebacterium is rather interesting; one 
could hypothesise that this region has been highly conserved due to its importance to the 
survival and fitness of the bacteria in question.  However, a recent publication by Nakamura et 
al. (2003) suggests that the integrity of the genomes of sequenced corynebacteria is due to the 
absence of the recBCD genes. The authors believe the absence of the RecBCD pathway in 
corynebacteria could have prevented frequent genome inversions, giving rise to greater 
genomic stability and hence the likelihood that gene order will be conserved over stretches of 
the genome (Nakamura, et al. 2003).      
 
Having identified the conserved nature of the dtxR locus of C. pseudotuberculosis and that of 
other sequenced corynebacteria, the next logical step in this study was the investigation of the 
functionality of the protein. In order to confirm the ability of C. pseudotuberculosis to regulate 
known C. diphtheriae DtxR regulated genes, the promoter regions of two known DtxR 
regulated genes which had previously been fused to a lacZ reporter gene in pSPZ (toxP and 
irp3P) (Oram, et al. 2006)(Holmes R.K. personal communication). Interestingly, when toxP 
and irp3P were introduced into wild-type C. pseudotuberculosis and grown under high- and 
low-iron conditions, both the tox and irp3 promoters were found to be regulated in response to 
environmental iron concentrations (Figure 5.8). Although the expression of tox was only 
found to show a trend towards significance (p=0.068) between low- and high-iron growth 
conditions in C. pseudotuberculosis, it is likely this was due to the relatively low levels of 
expression observed with this promoter, which subsequently led to high variability within the 
data. Given a larger data set, it is possible that the differential expression of tox would have 
been more evident. Significantly however, the expression of tox in the natural host, C. 
diphtheriae, has also been shown to be relatively low (Oram, et al. 2006).  
 
Despite proving iron-dependent expression of DtxR-regulated C. diphtheriae genes in C. 
pseudotuberculosis, the above experiment did not confirm the involvement of C. 
pseudotuberculosis DtxR in this regulation.  For this reason, a further experiment was 
conducted, using E. coli as a DtxR-deficient host to assess the capacity of the product of the 
recombinant C. pseudotuberculosis dtxR gene to repress expression from the tox promoter. 
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Significantly, C. pseudotuberculosis DtxR was able to repress the tox promoter in an iron-
dependent manner, proving that C. pseudotuberculosis and C. diphtheriae DtxR proteins are 
functionally compatible. It is also interesting to note that the DtxR homologues of C. 
glutamicum, M. tuberculosis (IdeR) and R. equi (IdeR) are also able to repress the C. 
diphtheriae tox promoter in an iron-dependent manner in an E. coli host (Boland & Meijer, 
2000; Oguiza, et al. 1995; Schmitt, et al. 1995). These prior observations, combined with the 
results of this study, demonstrate the conservation between the functions of these important 
proteins.  
 
Oram et al. (2004) previously assayed chromosomal DNA of 42 different isolates of 
Corynebacterium, including a C. pseudotuberculosis strain, for the presence of a dtxR gene.  
The portion of the genes assessed contained the sequence encoding domains 1 and 2 (the 
helix-turn-helix DNA-binding motif and the metal ion binding site). Interestingly, the 
investigators noticed an extremely high level of conservation in the region of the dtxR genes 
that they tested, leading them to postulate that these iron-dependent gene regulators are under 
strong selective constraints (Oram, et al. 2004).  However, whether this statement is true, 
considering the fact that corynebacteria appear to be unable to undergo significant genetic 
rearrangements, due to the lack of recombination enzymes (Nakamura, et al. 2003), remains to 
be determined, since the strong selective constraints postulated may simply be an inability to 
change. 
 
To further characterise the C. pseudotuberculosis dtxR locus, investigation of the 
transcriptional regulation of dtxR and surrounding genes was explored. This was achieved 
using two methods, firstly, by the use of promoter fusion assays to identify regions possessing 
promoter activity within the locus, and secondly by using qRT-PCR, to asses the relative 
transcript abundance of the genes within the dtxR locus. The promoter fusions, constructed by 
cloning fragments from immediately upstream of sigB, dtxR and galE respectively, into the 
pSPZ lacZ fusion vector and introducing the constructs into wild-type C. pseudotuberculosis, 
confirmed the presence of promoters for both the sigB and dtxR genes; however no promoter 
was identified upstream of galE, suggesting that no promoter is present for this gene. It is not 
surprising that the galE gene does not possess its own promoter in C. pseudotuberculosis since 
there is only a 15 bp gap between the 3‘ end of dtxR and the 5‘ end of galE. The results 
observed in this study are in agreement with those reported previously for C. diphtheriae 
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(Oram, et al. 2006), whereby only two promoter regions were identified within the dtxR locus 
of that organism. In the course of their study, Oram et al. (2006) used promoter fusion assays 
and RNase protection assays to determine the position of the promoters and equivalent to the 
situation in C. pseudotuberculosis, the C. diphtheriae promoters were only found upstream of 
sigB and dtxR.  
 
In C. diphtheriae, galE is co-transcribed with dtxR (Oram, et al. 2002; Oram, et al. 2006). The 
resulting mRNA is said to be bicistronic, implying the promoter region of dtxR produces a 
single mRNA molecule that encodes two separate gene transcripts, dtxR and galE. The co-
transcription of dtxR and galE has also been recognized in other actinomycetes. For example, 
Oguiza et al. (1996) investigated the transcriptional analysis of the dtxR and galE genes of C. 
glutamicum ATCC 13869. In nutrient rich broth, the researchers demonstrated that these genes 
formed part of an operon that is actively transcribed as a bicistronic mRNA. They also 
reported that dtxR-homologue could be expressed as a monocistronic transcript under certain 
conditions (Oguiza, et al. 1996a). In R. equi, IdeR (the DtxR homologue) shares greater 
homology with M. tuberculosis (75%) than with C. diphtheriae (57%); however, the 
organisation of the genes in the locus in which the IdeR structural gene lies was observed to be 
more similar to that  of C. diphtheriae, in that there was a galE gene just downstream of ideR 
(Boland & Meijer, 2000). Furthermore, Boland et al. (2000) postulated that, due to the small 
sequence gap between ideR and galE in R. equi, these genes too are likely to be co-transcribed 
(Boland & Meijer, 2000). In C. glutamicum ATCC 13032, the order of genes in the dtxR locus 
is the same as that of C. diphtheriae and C. pseudotuberculosis; it is therefore likely that dtxR 
and galE are also co-transcribed in C. glutamicum.  
 
Reasons for the co-transcription of dtxR and galE are unclear; however, galactose is an 
important component in corynebacterial cell wall biosynthesis, since the galactan in 
arabinogalactan, which is an integral cell wall component, is a polymer of galactose (Dover, et 
al. 2004). Furthermore, in C. diphtheriae, transcription of dtxR occurs constitutively at a low 
level (Schmitt & Holmes, 1991). Being required for cell wall biosynthesis, one could argue 
that galactose is constantly required by the cell; in short, galE is required to manufacture 
galactose, galactose is essential in the construction of the cell wall, and therein lays the 
requirement for galE to be constitutively expressed. If two genes are constitutively expressed 
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it makes sense for them to be co-transcribed as this results in less of a burden on the bacterial 
cell‘s resources.  
 
To verify the results seen with the promoter fusion assays, qRT-PCR was subsequently 
employed to assess the expression of the genes in the C. pseudotuberculosis dtxR locus. 
Interestingly, the galE transcript was apparently less abundant than that of the co-transcribed 
dtxR-galE. In a similar experiment carried out in C. diphtheriae, Oram et al. (2006) previously 
suggested that if galE can be transcribed both from a promoter in the dtxR-galE intergenic 
region and also by extension of dtxR-specific transcripts that initiate further upstream, then the 
transcripts detected with the galE probe should be more abundant than the transcripts detected 
by the dtxR-galE intergenic probe (Oram, et al. 2006). Therefore, by analogy it is possible to 
propose that C. pseudotuberculosis galE is co-transcribed with dtxR, similarly to the scenario 
in C. diphtheriae.  
 
In C. diphtheriae and C. glutamicum, co-transcription of both sigB-dtxR and dtxR-galE has 
been described (Oguiza, et al. 1996a, 1996b; Oram, et al. 2006). However, in C. diphtheriae, 
co-transcription of sigB-dtxR-galE has also been described (Oram, et al. 2006).  In the current 
study, an equivalent C. pseudotuberculosis polycistronic message was detected, proving that 
the transcription of genes within the C. pseudotuberculosis dtxR locus is closely similar to 
those of the equivalent locus in C. diphtheriae.  In contrast however, it is interesting to note 
that, although the arrangement of the sigB-ideR genes in Mycobacterium sp. is similar to that 
of Corynebacterium, the genes are not co-transcribed in this species (Smith, et al. 1998) (Lee, 
et al. 2008). Therefore, there are clearly differences in the expression of these genes among 
members of the order Actinomycetales. 
 
Larisch et al. (2007) demonstrated that SigB of C. glutamicum is implicated in the regulation 
of gene transcription during the transition from exponential- to stationary-growth phase 
(Larisch, et al. 2007). Furthermore, Oram et al. (2006) discovered that, in C. diphtheriae, sigB 
transcripts were more abundant following changes in several environmental conditions, 
including exposure to acid, cold, heat, ethanol and SDS; this suggested a possible role for 
SigB in the C. diphtheriae response to environmental stress conditions (Oram, et al. 2006). 
Similar results were seen in the closely related Brevibacterium flavum, where expression of 
sigB was significantly enhanced after exposure to several different stress conditions 
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(Halgasova, et al. 2001).  It is possible SigB of C. pseudotuberculosis is also involved in the 
regulation of gene expression during the transition to stationary-growth phase, or perhaps 
more appropriately in protection of the cell under conditions of environmental stress (such as 
the nutrient limitation associated with the shift towards stationary-growth phase). The co-
transcription of sigB and dtxR could be a means of facilitating the cell‘s preparation for the 
environmental changes that ensue at stationary phase of growth. Certainly, with respect to 
nutrient limitation, it is highly likely that environmental iron concentration will be low; 
therefore, DtxR may need to up regulate iron sequestration genes and down regulate iron 
storage genes.   
 
The E. coli Fur protein is, like DtxR, an iron-dependent transcriptional regulator. Interestingly, 
in some bacteria, such as Helicobacter pylori and Neisseria meningitidis,  the expression of 
the Fur-encoding gene has itself been shown to be autoregulated in response to environmental 
iron concentrations (Delany, et al. 2003; Delany, et al. 2002). Delany et al. (2002) suggested 
that this type of negative feedback loop is critical in the homeostasis of iron. Since it is such 
an important element, essential, yet toxic to bacteria in large quantities, intracellular 
concentrations of iron are required to be tightly regulated; fine tuning via a negative feedback 
loop dampens the extremes of responses (Delany, et al. 2002). It is well documented that DtxR 
and Fur, although undertaking the same activity, are actually very different proteins. It was 
therefore decided to determine whether C. pseudotuberculosis dtxR, like fur, is autoregulated 
in response to environmental iron concentration. In order to determine whether DtxR of C. 
pseudotuberculosis was able to regulate expression of its own structural gene in an iron-
dependent manner, both the promoter fusion assays and qRT-PCR experiments were carried 
out using bacteria cultured under high- and low-iron conditions.  Interestingly, and in 
agreement with the results of studies carried out with C. diphtheriae (Oram, et al. 2006), the 
two putative promoters upstream of sigB and dtxR did not appear to be regulated in response 
to environmental iron concentration in C. pseudotuberculosis. It therefore seems that, unlike 
Fur in some bacteria, DtxR is not autoregulated in response to iron, at the very least not in 
either C. diphtheriae or C. pseudotuberculosis.  
 
Having assessed the transcription of genes within the C. pseudotuberculosis dtxR locus, the 
involvement of DtxR in the regulation of other target genes was studied.  The promoter 
regions of two previously published C. pseudotuberculosis genes (fagA and cp40) were 
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investigated in promoter fusion assays, in order to determine whether they were expressed 
differentially under high- and low-iron growth conditions. Previously, Billington et al. (2002) 
identified a DtxR-like binding motif upstream of fagA, although the authors made no attempt 
to study the potential involvement of DtxR (or a DtxR-homologue) in the regulation of this 
gene (Billington, et al. 2002). Billington et al. (2002) using promoter fusion assays did 
however show that fagA was expressed in response to environmental iron concentrations. The 
results of the promoter fusion assay carried out during this investigation are in agreement with 
the results of Billington et al. (2002). Moreover, the results of the qRT-PCR experiments 
conducted during this study, whereby fagA transcript was observed to be 16-fold higher under 
low-iron growth conditions as compared to high-iron conditions, also support these results.   
 
In addition to fagA, another C. pseudotuberculosis gene, cp40, was also assessed to determine 
whether it was expressed in response to environmental iron conditions. The cp40 gene encodes 
a 40 kDa protein that shares homology with serine proteases (Wilson, et al. 1995). Wilson et 
al. (1995) undertook a study whereby immunodominant proteins produced by C. 
pseudotuberculosis during infection of sheep were identified. Cp40 was shown to be one of 
the first C. pseudotuberculosis proteins to which sheep responded immunologically.  
Subsequently, vaccination of sheep with recombinant Cp40 was found to partially-protect 
against subsequent challenge with C. pseudotuberculosis.  On the basis of these observations, 
Cp40 has been implicated as contributing to disease pathogenesis, although no role for this 
protein has yet been defined.  Since DtxR is known to regulate the expression of virulence 
genes in other bacteria, it was thought possible that the same may be true of cp40 in C. 
pseudotuberculosis; this hypothesis was strengthened by the identification of a putative DtxR-
binding motif within the 5‘-region of the cp40 gene. Despite this hypothesis, however, the 
results of this study confirm that the expression of cp40 is not regulated by DtxR, nor is it 
affected by variations in iron-concentration through an alternative regulatory mechanism. Of 
significance, it is worth noting that DtxR-binding motifs are normally found within the 
promoter-containing region upstream of DtxR-regulated genes, and not within the genes 
themselves; however, the presence of a predicted DtxR-binding domain so close to the 5‘-end 
of cp40 made a convincing case for further study.    
 
To unequivocally prove the involvement of DtxR in the iron-dependent regulation of C. 
pseudotuberculosis genes, a mutant derivative of C. pseudotuberculosis 3/99-5 was 
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constructed, which was deficient in production of DtxR.  The mutant, designated Cp-ΔdtxR, 
was derived from the deletion of a ca. 699 bp portion of dtxR. The generation of a C. 
pseudotuberculosis dtxR mutant proved to be significantly more difficult than was initially 
anticipated; however, in retrospect the difficulties experienced are perhaps not so surprising. 
Previous efforts to construct a cp40 deletion mutant of C. pseudotuberculosis 3/99-5, using the 
allele-replacement mutagenesis procedure described in Chapter 4, were successful, with the 
desired mutant strain being constructed quickly and without problems. It was therefore rather 
perplexing as to why, using the same method, the isolation of a dtxR mutant became such an 
ordeal. Several hypotheses were considered in order to explain why a dtxR deletion derivative 
of C. pseudotuberculosis could not be obtained. Firstly, it was thought possible that the dtxR 
gene was essential, and if this were the case then all attempts to construct a deficient mutant 
would be pointless. Confusingly, evidence was found to be available in the published literature 
to both corroborate and refute this hypothesis. On the one-hand, investigators were reportedly 
unable to construct an ideR-deficient derivative of M. tuberculosis, unless a fully-functional 
copy of the gene was expressed in trans (Rodriguez, et al. 2002). Substantiating this train of 
thought, further evidence hinting at the fact that a dtxR mutation in C. pseudotuberculosis may 
be lethal was derived from a report by Oram et al. (2004), whereby it was suggested that a 275 
bp fragment of the dtxR-homologue of C. pseudotuberculosis shared more homology with 
Mycobacterium ideR than that of other corynebacterial species (Oram, et al., 2004). 
Previously, dtxR of C. diphtheriae was thought to be an essential gene; however, Oram et al. 
(2002) conclusively demonstrated that the gene was not essential by isolating a viable 
transposon insertion mutant that was unable to produce DtxR (Oram, et al. 2002). The 
researchers subsequently created an in-frame dtxR deletion derivative of C. diphtheriae 
(Oram, et al. 2006). Furthermore, a dtxR deletion mutant was also isolated from C. 
glutamicum (Wennerhold & Bott, 2006) (Brune, et al. 2006), and an ideR deletion mutant was 
isolated from the non-pathogenic Mycobacterium smegmatis (Dussurget, et al. 1996). Given 
the similarity between the C. pseudotuberculosis and C. diphtheriae dtxR loci determined 
throughout the course of this study, it was considered likely that, as with C. diphtheriae, the 
dtxR gene of C. pseudotuberculosis was also not essential.  
 
A second hypothesis for why a C. pseudotuberculosis dtxR mutant could not initially be 
obtained was that a dtxR deletion mutant of C. pseudotuberculosis would be more sensitive to 
iron toxicity than its wild-type parent, and therefore a mutant strain would be less likely to 
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survive under high-iron growth conditions.  Both C. diphtheriae and C. glutamicum dtxR 
mutants were observed to grow more slowly under high-iron conditions, suggesting that iron 
toxicity was a problem (Oram, et al. 2006; Wennerhold & Bott, 2006). Similarly, Brune et al. 
(2006), in the construction of their dtxR-deletion derivative of C. glutamicum, suggested that a 
dtxR mutation resulted in a conditionally lethal phenotype depending on the amount of iron 
that is supplied in the medium (Brune, et al. 2006). Similar results have also been seen in other 
Gram-positive species.  For example, in Streptococcus equi subspecies equi, a deletion in 
eqbA (a dtxR-homologue) resulted in a small colony phenotype when grown on high-iron 
medium (Heather, et al. 2008); the researchers hypothesised that the small colony phenotype 
was due to iron toxicity which was, in turn, due to a lack of regulation of genes involved in 
iron sequestration.  In order to overcome the potential issue of iron toxicity, the chelator, 2‘, 2‘ 
dipyridyl, was added to the BHI medium used to culture C. pseudotuberculosis during 
attempts to mutagenise dtxR.  Chelation of excess iron within the growth medium has been an 
approach that has been successfully used to prevent the toxic affects of iron on iron-sensitive 
dtxR-homologue deletion derivatives of other bacteria, and has been achieved through the use 
of (for example) chelex-100 (Dussurget, et al. 1996), nitrilotriacetic acid (NTA) (Heather, et 
al. 2008) and ethylenediamine-N, N-diacetic acid (EDDA) (Oram, et al. 2006).  However, 
despite these reports in the literature, it was extremely frustrating when, even after the addition 
of an iron chelator, the isolation of a dtxR-deficient C. pseudotuberculosis mutant was still not 
possible.   
 
Although it had previously been successfully used to facilitate the recovery of a C. 
pseudotuberculosis mutant in which the cp40 gene had been deleted, the constant difficulties 
in isolating a dtxR mutant led to the scrutiny of the allele exchange method itself.  During the 
isolation of a dtxR mutant and in order to potentially improve the likelihood of isolating a 
mutant, ampicillin enrichment of secondary cross-over cultures was employed (Chapter 4). 
Significantly, ampicillin enrichment of secondary crossovers had previously been used, with 
great success, to enhance the recovery of mutants. Since this novel ampicillin enrichment 
protocol had not caused problems with the recovery of a cp40 mutant strain, it was not 
considered likely to cause problems with the recovery of mutants of any other gene.  However, 
it subsequently became apparent that the enrichment method may inadvertently have been the 
source of the problem.  The ampicillin-enrichment process, described in detail in Chapter 4, 
utilises ampicillin to kill erythromycin-resistant cells still harbouring the pCARV mutagenesis 
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plasmid within the chromosome. Recently Kohanski et al. (2007) investigated the mode-of-
action of three major classes of bactericidal antibiotics including β-lactams, of which 
ampicillin is a member.  β-lactams are cell-wall synthesis inhibitors, and interfere with normal 
cell wall biosynthesis, inducing cell death through lysis.  However, Kohanski et al. (2007) 
proposed that a side-effect of the normal route of killing resulted in an alternative phenomenon 
which is fundamental to all classes of bactericidal antibiotics.  This mechanism involves the 
release of harmful hydroxyl radicals from lysed cells; these radicals are normally formed 
intracellularly as a function of metabolism-related NADH depletion, leaching of iron from 
iron-sulphur clusters, and subsequent stimulation of the Fenton reaction (Fe
2+
 + H2O2 → Fe
3+
 
+ HO
-
 + HO) (Kohanski, et al. 2007). This leaching of iron results in increased intracellular 
free-iron which, subsequently, via the Fenton reaction, results in the generation of oxygen 
radicals and oxidative stress (Imlay, et al. 1988) (Kohanski, et al. 2007).  It is well 
documented that bacteria which are unable to produce iron-regulatory proteins are in fact more 
susceptible to oxidative stress than their wild-type counterparts (Touati, 2000). Deregulation 
of the control of iron acquisition/uptake in mutants of iron regulatory proteins produces iron 
overload which, via the Fenton reaction in an aerobic environment, generates ferryl and 
hydroxyl radicals leading to increased oxidative stress (Dussurget, et al. 1996; Touati, 2000). 
Such oxidative stress susceptibility has been documented in iron-dependent regulatory mutants 
of several Gram-positive bacteria, including C. diphtheriae (Oram, et al. 2002), M. smegmatis 
(Dussurget, et al. 1996) and M. tuberculosis (Rodriguez, et al. 2002). In addition, the same 
phenomenon has been observed in some Gram-negative species, including E. coli, whereby 
deletion of the fur gene resulted in hypersensitivity to oxidative stress (Touati, et al. 1995).  
 
Both DtxR and Fur play a role in protecting the cell from oxidative stress (Touati, et al. 1995) 
(Oram, et al. 2002). The primary role of the Fur regulated DNA-binding proteins of starved 
cells (Dps) from E. coli is to protect DNA from the combined affects of ferrous iron and H2O2 
which result in the production of hydroxyl free radicals via the Fenton reaction (Martinez & 
Kolter, 1997; Zhao, et al. 1991). The Dps protein catalyses oxidation of ferrous iron to ferric 
iron by hydrogen peroxide, and thereby prevents hydroxyl radical formation via the Fenton 
reaction. In E. coli, Dps is induced in response to oxidative or nutritional stress. Furthermore, 
in M. tuberculosis iron-rich environments prompt the up-regulation of iron storage molecules 
to increase mechanisms of protection against iron-mediated oxidative damage (Rodriguez & 
Smith, 2003). When grown under high-iron conditions, M. tuberculosis up-regulates 
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bacterioferritin (bfrA) and ferritin (bfrB), both of which are involved in iron storage, and 
catalase peroxidase (katG) which catalyses the dismutation of hydrogen peroxide into water 
and molecular oxygen (Rodriguez & Smith, 2003).  In C. diphtheriae, it has been predicted 
that the starvation-inducible Dps is regulated via DtxR (Yellaboina, et al. 2004). DtxR-
regulated Dps in C. diphtheriae (Yellaboina, et al.  2004), C. glutamicum (Wennerhold & 
Bott, 2006), and presumably also C. pseudotuberculosis, plays a role in protection from 
oxidative stress. It is therefore likely that a deletion in the dtxR gene of these species would 
result in the deregulation of Dps, resulting in a mutant that is more susceptible to oxidative 
stress. Therefore, it is possible that the free radicals released into the culture medium 
following ampicillin-induced lysis of C. pseudotuberculosis cells resulted in the unexpected 
(and unwanted) killing of the very cells that the ampicillin treatment was supposed to enrich 
for; hence, the only excision mutants ever identified corresponded to the wild-type dtxR 
genotype.  Certainly, by omitting the ampicillin-enrichment step, and by utilising a low-iron 
growth medium during allele-replacement experiments, the desired dtxR-deficient mutant was 
finally isolated very quickly thereafter. 
 
During preliminary hydrogen peroxide inhibition assays, the dtxR-deficient strain was found to 
be hypersensitive to H2O2, as compared to its wild-type parent strain (data not shown).  This 
data would tend to support the free-radical killing hypothesis with respect to the previous 
inability to isolate a dtxR-deficient mutant. Interestingly, up-regulation of ideR was detected in 
M. tuberculosis-infected macrophages (Hobson, et al. 2002). Rodriguez and Smith (2003) 
postulated that the induction of IdeR could contribute to the bacterial response to macrophage 
oxidative defence mechanisms (Rodriguez & Smith, 2003).  Oxidative defence mechanisms or 
‗the oxidative burst‘ occurs following ingestion of bacteria by a macrophage.  Following 
ingestion, bacteria are compartmentalised into a phagosome. The macrophage undergoes a 
burst of oxygen consumption which is a result of an NADPH oxidase complex (Iyer, 1961; 
Sbarra and Karnovsky, 1959); NADPH oxidase catalyses the reduction of oxygen at the 
expense of NADPH, resulting in the production of superoxide and other highly reactive 
oxidising agents. The resulting reactive oxygen species are essential for killing a number of 
microorganisms (Steinbeck, et al. 1992) (Chanock, et al. 1994) (Hampton, et al. 1998). C. 
diphtheriae DtxR (Oram, et al. 2002) and M. smegmatis IdeR (Dussurget, et al. 1996) mutants 
have been shown to be more susceptible to oxidative stress. Since C. pseudotuberculosis 
causes infection by surviving within macrophages and disseminating throughout the host‘s 
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lymphatic system, it follows that a C. pseudotuberculosis dtxR mutant would potentially be 
unable to survive the macrophage oxidative burst; however, further experiments are required 
to support this hypothesis.   
 
Analysis of C. pseudotuberculosis DtxR regulation of fagA and cp40 genes was conducted in 
order to unequivocally implicate the DtxR regulator in the iron-dependent expression of 
putative C. pseudotuberculosis virulence genes. Statistical analyses (ANOVA) provided 
strong evidence to suggest that, under differential iron concentrations, fagA gene expression 
was affected by the presence/absence of a functional DtxR protein. In contrast, statistical 
evidence suggested that cp40 gene expression was not significantly different in wild-type or 
Cp-ΔdtxR under differential iron concentrations. These data corroborate the previous results 
seen in wild-type experiments whereby the fagA gene was expressed differentially under high- 
and low-iron growth conditions; however, cp40 was not. Therefore, it was apparent that DtxR 
was intimately involved in the iron-dependent regulation of fagA, but was not with cp40. 
Interestingly, although a t-test performed to assess the levels of fagA expression in the mutant 
strain under high- and low- iron conditions did not reveal a statistically-significant difference, 
it was noted that the level of expression under high-iron conditions was consistently slightly 
lower than the equivalent in low-iron conditions, suggesting that some DtxR-independent 
regulatory mechanism may also affect the expression of this gene. (Figure 5.20). In this 
respect, it should be noted that similar reports of DtxR(or DtxR-like)-independent regulation 
of expression of DtxR-regulated genes has been reported for close relatives of C. 
pseudotuberculosis.  In M. smegmatis, inactivation of IdeR resulted in only partial 
derepression of siderophore biosynthesis (Dussurget, et al. 1996). Dussurget et al. (1996) 
suggested the existence of a second repressor, going on to hypothesise that, due to the 
importance of iron, it is very likely that a second repressor exists. In C. diphtheriae, Oram et 
al. (2006) have suggested that iron-dependent regulation in C. diphtheriae is due to both 
DtxR-dependent and DtxR-independent mechanisms, however to-date it is unclear what the 
DtxR-independent mechanism(s) might be (Oram, et al. 2006). Given the similarities 
encountered throughout the course of this study, it is possible that the same DtxR-independent 
regulation reported in C. diphtheriae is also occurring in C. pseudotuberculosis; however, the 
statistical analysis carried out during this project suggests the residual repression is not 
significant (at the 95 % confidence limit). Therefore, in C. pseudotuberculosis at least, it may 
be that the suggestion of iron-dependent differential expression in Cp-ΔdtxR maybe just an 
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artefact.  Previous reports in other bacteria based their conclusions as to the involvement of 
another (non-DtxR) iron-responsive regulatory mechanism on non-statistical methods; 
therefore, it is currently unclear whether an alternative regulator (which would presumably 
form part of a global regulatory network) actually exists or not. 
 
In order to attempt to supplement the results obtained from reporter gene assays conducted in 
the dtxR-deficient mutant strain, equivalent assays were conducted following complementation 
of the mutant with a functional dtxR gene. The full C. pseudotuberculosis dtxR gene and its 
promoter were cloned into pEP2 (Radford & Hodgson, 1991) (a small plasmid able to 
replicate in C. pseudotuberculosis) and the resulting construct (designated pCAW010) was 
used to transform the dtxR-deficient mutant. Unfortunately, following transformation of the 
complemented mutant with the promoter fusion constructs, it became apparent that there was a 
problem when antibiotic selection was imposed to maintain the two plasmids within the 
bacterial population. Addition of either kanamycin (for the pEP2-based construct) or 
spectinomycin (for the pSPZ-based construct) permitted growth of cultures, however, when 
both antibiotics were added at the same time, bacteria were unable to grow. Subsequently, it 
became apparent that pEP2 (Radford & Hodgson, 1991) and pSPZ (Oram, et al. 2006) contain 
the same stable replication origin from the plasmid pNG2 (Messerotti, et al. 1990). Plasmids 
containing the same origin of replication are generally considered incompatible (Austin & 
Nordstrom, 1990; Nordstrom & Austin, 1989; Novick, 1987), resulting in an inability of such 
plasmids to stably co-exist within a single bacterial cell.  Partly because of competition for 
growth factors, cells containing smaller plasmids tend to have a growth advantage over cells 
containing their larger counterparts. Of relevance to the experiments described here, pSPZ is 
approximately 10 kb in size, compared to pEP2 which is around 3kb. No efforts were made in 
the current study to determine which plasmid was being lost most rapidly; however, it seems 
logical that the pEP2-based construct would be preferentially-retained because of its smaller 
size.   Although it would have been possible to utilise a different, compatible plasmid, 
sufficient time was not available to pursue this work. Despite the inability to use the 
complemented dtxR-deficient mutant to perform promoter fusion assays, it was possible to 
observe the affect of complementation on the ability of the mutant to grow under high- and 
low-iron conditions. Significantly, following complementation, the growth of the mutant was 
restored to that of its wild-type parent under both high- and low-iron conditions (Figure 5.21).  
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In vivo, C. diphtheriae DtxR regulates gene transcription in response to changes in iron 
concentrations; however, in vitro DtxR is able to bind to specific DNA sequences in the 
presence of other transition metal ions including, cadmium, cobalt, manganese,  nickel and 
zinc (Schmitt & Holmes, 1993, 1994; Tao, et al. 1992). During this study, the ability of DtxR 
to utilise manganese and zinc in place of iron was tested. In order to achieve this, the ability of 
DtxR to bind to the fagA promoter region (and hence regulate transcription) was assessed in 
the presence of these different transition metal ions.  Interestingly, in the presence of 
manganese, DtxR was able to repress fagA expression; however, zinc did not have an 
equivalent affect.  Despite the ability to utilise manganese, the presence of iron resulted in a 
more potent repression of fagA expression.  This observation is in keeping with a previous 
report for C. diphtheriae, in which it was demonstrated that DtxR in complex with Fe
2+ 
was 
the most potent inhibitor of DT production and therefore bound more strongly to DtxR loci 
(Groman & Judge, 1979) (Figure 5.22).  Moreover, in C. diphtheriae, cobalt, nickel and 
manganese were all found to inhibit DT toxin production at a concentration that did not inhibit 
bacterial growth. However, Tao et al. (1992) demonstrated that in order for zinc to repress 
toxin production it required a 10-fold increase in concentration compared to iron; 
significantly, this 10-fold increase in concentration resulted in bacterial growth inhibition (Tao 
& Murphy, 1992). The repression ratio calculated for zinc (1.8) was below that of the CCDM 
(2.0) (Figure 5.22), which was employed to calculate background repression; one can 
postulate that the low level of repression observed with zinc could be due to the zinc inhibiting 
growth or exerting a toxic effect upon the cell, or may simply be because zinc is not bound by 
C. pseudotuberculosis DtxR.  
 
In summary, the work described in this chapter has highlighted the usefulness of a 
comparative approach when trying to understand the pathogenesis of a bacterium that has not 
yet been sequenced (although as a result of an ongoing sequencing project, during the later 
stages of this PhD study a partial genome sequence became available).  Using the vast amount 
of knowledge available regarding the involvement of iron in the regulation of virulence genes 
in the important human pathogen C. diphtheriae as a starting block, it has been possible to 
begin unravelling the iron-regulatory mechanisms of C. pseudotuberculosis. This work has 
shown that there are many similarities with regards to the iron-dependent regulation of gene 
expression by DtxR in C. pseudotuberculosis and C. diphtheriae. The confirmation of C. 
pseudotuberculosis DtxR as a regulator suggests that the expression of numerous other C. 
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pseudotuberculosis genes will be under DtxR control.  Since many of the genes under DtxR 
control are associated with virulence in other bacteria, the same will likely be true of C. 
pseudotuberculosis.  As such, the identification of these genes could have a dual outcome by 
increasing our understanding of how C. pseudotuberculosis causes disease, but also by 
providing potential targets for the development of diagnostic assays and/or vaccines.   
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Chapter Six 
Identification of a Corynebacterium pseudotuberculosis 
Siderophore 
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6.0 Introduction  
 
In oxygen-containing environments, the availability of iron is limited. For the invading 
microorganism, this problem is confounded by the mammalian host‘s ability to further deplete 
available iron as part of its innate defence mechanism against infection. To counteract this 
defence, in order to successfully colonise and persist within their selected host, pathogenic 
microorganisms have developed mechanisms that enable them to sequester iron from host-iron 
binding proteins; one of the most common mechanisms being through the production of 
siderophores. Siderophores are low molecular weight (<1 kDa) chelating agents, which are 
synthesised by many bacteria and fungi in response to low-iron growth conditions (Neilands, 
1995); their high affinity for ferric iron makes these molecules very efficient at fulfilling the 
micro-organism‘s iron requirements.  
 
The biosynthesis of siderophores can occur via two different mechanisms; and the mechanism 
employed depends on the type of siderophore being synthesised. Siderophores can be divided 
into three main classes, these being catecholates (which include phenolates (Miethke & 
Marahiel, 2007)), hydroxamates and carboxylates, although more recently mixed types have 
been identified, such as Mycobactin T of M. tuberculosis, which is a phenolate-hydroxamate 
(Miethke & Marahiel, 2007) siderophore. In general siderophores are synthesised either 
dependently or independently of a nonribosomal peptide synthetase (NRPS) (Miethke & 
Marahiel, 2007). NRPSs are multi-modular enzymes that produce peptide products of a 
particular sequence without an RNA template, rather, the order of NRPS domains specifies the 
order of monomeric amino acids activated and incorporated (Crosa & Walsh, 2002). NRPSs 
are responsible for the assembly of thousands of natural peptides yielded by a wide range of 
microorganisms (Marshall, et al. 2002). NRPS-dependent siderophore biosynthesis has been 
studied in detail in several human pathogens, examples of which include enterobactin 
(catecholate) synthesis in E. coli, and yersiniabactin (phenolate) synthesis in Yersinia (Crosa 
& Walsh, 2002). NRPSs have been shown to be partially involved in the synthesis of 
hydroxamate and carboxylate siderophores; however, generally these types of siderophores are 
assembled by NRPS-independent siderophore (NIS) mechanisms (Miethke & Marahiel, 2007).  
An example of a well studied hydroxamate NIS is aerobactin. The aerobactin gene cluster 
consists of five genes, four of which (iucABCD) direct aerobactin synthesis, with the fifth 
(iutA) encoding the siderophore receptor protein (de Lorenzo, et al. 1986), involved in uptake 
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of siderophore from the extracellular environment. Significantly, some siderophores which are 
synthesised via NRPS-independent mechanisms have been implicated in virulence (Miethke & 
Marahiel, 2007), an example being aerobactin, which is thought to be a key virulence factor in 
many pathogenic strains of E. coli ( Warner, et al. 1981; Gibson & Magrath, 1969).     
 
On arrival at the bacterial cell surface there are several mechanisms by which a siderophore‘s 
iron load can be transferred into the cell. One such mechanism is through reduction, whereby 
siderophore-bound Fe
3+
 undergoes a reaction  catalysed by free-extracellular or membrane-
bound ferric reductases (Miethke & Marahiel, 2007), resulting in its conversion into the 
ferrous state, a form which is readily usable by the bacterial cell, and one which results in the 
release and subsequent recycling of the siderophore. The second and most common 
mechanism for siderophore-bound iron uptake is by the import of the iron-siderophore 
complex into the cytosol.  Due to the differences in cellular structure, uptake of siderophores 
occurs by different mechanisms in Gram-negative and Gram-positive bacteria. In Gram-
negative bacteria, because of the presence of an outer membrane (OM) siderophore uptake 
occurs via a two-step process.  Firstly, prior to transport across the OM into the periplasmic 
space, the iron-siderophore complex is bound by an OM receptor molecule. Then with the help 
of the TonB complex (The TonB complex ―transduces‖ proton-motive energy to the receptor 
to allow substrate translocation (Miethke & Marahiel, 2007)), the receptor-bound siderophore 
is released into the periplasm. Subsequently, the complex binds to a specific periplasmic 
receptor of an inner membrane ABC transporter (a transmembrane protein that functions in the 
transport of a wide variety of substrates across extra- and intracellular membranes) prior to 
transportation across the cytoplasmic membrane into the cytoplasm (Schneider & Hantke, 
1993) (Brown & Holden, 2002). Ironically, although siderophore uptake by Gram-positive 
bacteria could be considered simpler due to the absence of an OM, the process is actually less-
well understood. In Gram-positive bacteria, the cell wall-located siderophore-binding receptor 
is generally considered to be a lipoprotein which is anchored into the cytoplasmic membrane 
through an N-terminal lipid moiety (Schneider & Hantke, 1993; Kunkle & Schmitt, 2005). 
Subsequent transport of the siderophore through the cytoplasmic membrane requires the 
involvement of an ABC-type transporter (Schneider & Hantke, 1993; Kunkle & Schmitt, 
2005).  
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Once siderophore-bound iron has been delivered into the cell it must be removed from the 
siderophore into the cytosol, and it is generally thought that there are two mechanisms of iron-
release. Firstly, similarly to the release of iron extracytoplasmically, the reduction of 
siderophore-bound Fe
3+
 to Fe
2+
, by intracellular ferric reductases, followed by the spontaneous 
release or competitive sequestration of the reduced species can occur (Miethke & Marahiel, 
2007). A second mechanism is a result of ferrisiderophore (iron-laden siderophore) hydrolysis. 
During this process specialised enzymes are employed to hydrolyse the ferrisiderophore 
thereby releasing its iron load.  However, hydrolytic iron release results in the destruction of 
the siderophore scaffold; hence, it is more costly to the cell compared to ferrisiderophore 
reduction, whereby the siderophore can be re-secreted (Cooper, et al. 1978; Miethke & 
Marahiel, 2007).  
 
More than 25 years ago, the presence of an extracellular factor that promoted the uptake of 
iron in C. diphtheriae was discovered (Russell & Holmes, 1983).  Following this finding, 
further work provided evidence to show that, under low-iron growth conditions C. diphtheriae 
produced a siderophore (Russell, et al. 1984). A year later, Russell et al. (1984) identified a 
siderophore-deficient mutant of C. diphtheriae which did not produce siderophore; however, 
although the mutant, referred to as HC6, did not produce siderophore, it was found to be able 
to utilise exogenous aerobactin (Russell, et al. 1984). A siderophore which is synthesised by 
one bacterium but opportunistically utilised by another is referred to as a xenosiderophore. In 
order to utilise xenosiderophores, a bacterium must possess ferric-chelate reductases and/or 
uptake systems for siderophores not synthesised by themselves (Miethke & Marahiel, 2007). 
Russell et al. (1984) postulated that the C. diphtheriae siderophore and aerobactin may be 
transported by a similar mechanism (Russell, et al. 1984), although the mechanism of 
transport of the C. diphtheriae siderophore or the xenosiderophore had not been identified.  
Significantly, much later Wennerhold and Bott (2006) alluded to the fact that C. glutamicum, 
strain ATCC 13032, likely employs siderophore produced by other microorganisms to acquire 
iron (Wennerhold & Bott, 2006); hence, the utilization of xenosiderophores may be a common 
feature among the corynebacteria.    
 
The discovery of the C. diphtheriae siderophore initiated a significant amount of downstream 
work. In 1997, Schmitt et al. characterised a lipoprotein, for which the structural gene, irp1, 
shared homology with genes involved in iron acquisition and was shown to be regulated by 
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DtxR (Schmitt, et al. 1997). Although potentially associated with iron-acquisition, the 
researchers demonstrated that Irp1 was unable to complement either  a HC6 siderophore-
deficient mutant, or other C. diphtheriae mutants defective in iron uptake, designated HC1, 
HC3, HC4 and HC5 (Cryz, et al. 1983).  Irp1 was also shown not to affect siderophore 
production or regulation in the strains tested (Schmitt, et al. 1997). Qian et al. (2002) later 
sequenced the irp1 operon and demonstrated that it encoded a C. diphtheriae ABC transport 
system, the function of which has yet to be elucidated. Irp1 was subsequently designated 
Irp1A and shown to share homology with FhuD from B. subtilis; however, the Irp1 operon 
could not complement the defects in siderophore-dependent iron transport in the HC1, HC3, 
HC4 and HC5 mutants (Qian, et al. 2002). Significantly, Qian et al. (2002) noted that the irp1 
operon was not present in the genome of C. diphtheriae NCTC 13129; thereby demonstrating 
that the ABC transport system is not present in all strains of C. diphtheriae (Qian, et al. 2002). 
Concurrently, Qian et al. (2002) identified a further iron regulated operon irp6ABC. Both irp1 
and irp6 operons demonstrate gene organisation typical of ABC transport systems for Gram-
positive bacteria; however, there is no significant homology between the lipoprotein receptors 
Irp6A and Irp1A, even in the N-terminal signal sequences (Qian, et al., 2002). Irp1B and 
Irp1C proteins each share 30 % homology with Irp6B whereas Irp6C and Irp1D share 34 % 
homology (Qian, et al. 2002). Interestingly, clones containing the irp6 genes were shown to 
complement the deficiency in growth and siderophore regulation in the HC1, HC4 and HC5 
iron uptake mutant strains (Qian, et al. 2002).  As a consequence, the investigators 
hypothesised that the irp6 operon encodes an ABC transporter which is involved in the high 
affinity siderophore-dependent uptake in C. diphtheriae (Qian, et al. 2002).  
 
To-date, the structure of the C. diphtheriae siderophore has yet to be determined, and it is not 
actually known whether C. diphtheriae produces more than one siderophore (Kunkle & 
Schmitt, 2005; Allen & Schmitt, 2009).  However, Kunkle and Schmitt (2005) recently 
identified a genetic locus associated with siderophore biosynthesis and transport in C. 
diphtheriae (Kunkle & Schmitt, 2005). The investigators conducted a BLAST analysis of 
predicted open reading frames within the sequenced genome of C. diphtheriae strain, NCTC 
13129 (accession # NC_002935), and subsequently identified a gene (locus tag DIP0586), the 
predicted product of which shared homology with the aerobactin biosynthetic enzymes IucA 
and IucC. This gene, referred to as ciuE, also lay downstream of four other genes, designated 
ciuA, ciuB, ciuC and ciuD (DIP 0582-DIP 0585), the predicted products of which shared 
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significant homology to ABC-type iron transport systems (Kunkle & Schmitt, 2005). Kunkle 
et al. (2005) noticed that the ciuE gene appears to be a fusion of two iucC/iucA-like genes. 
Somewhat confusingly, the authors reported that the predicted product of ciuE shows similar 
relatedness to both IucA and IucC in both halves of the protein; furthermore, there is not a 
significantly higher amino acid similarity to either IucA or IucC in either the N-terminal 
region or C-terminal section of CiuE (Kunkle & Schmitt, 2005). With regards to CiuE of C. 
diphtheriae, which appears to be a fusion protein, it is not known whether the protein has two 
distinct enzymatic activities within the single peptide (Kunkle & Schmitt, 2005).  Since CiuE 
shared significant homology with the aerobactin biosynthesis proteins, IucA and IucC, the 
investigators wanted to determine whether CiuE was involved in the synthesis of a C. 
diphtheriae siderophore; subsequently, an in-frame ciuE mutant was constructed in two C. 
diphtheriae strains and siderophore production was assessed. A significant decrease in the 
production of siderophore was observed in both CiuE-deficient strains of C. diphtheriae, 
although siderophore production equivalent to the wild-type parent strains could be restored 
by complementation with a fully-functional copy of ciuE.  It was therefore proven 
conclusively that ciuE is a siderophore biosynthesis gene (Kunkle & Schmitt, 2005). 
Interestingly, Kunkle and Schmitt (2005) provided evidence to suggest, that the irp6 operon, 
previously thought to be involved in high-affinity siderophore-dependent uptake in C. 
diphtheriae (Qian, et al. 2002), was not necessary for the uptake of the ciuE product, through 
the observation that an irp6A mutant was still able to utilise C. diphtheriae siderophore.  
However, a ciuA mutant was not able to uptake the siderophore, providing strong evidence for 
the involvement of ciuA in siderophore transport in C. diphtheriae.  In contrast to the previous 
observation that an irp6A mutant was not able to utilise aerobactin, supplementation of the 
CiuA-deficient mutant strain with aerobactin restored growth.  These results suggested to the 
researchers that Irp6A is in fact essential for the uptake of aerobactin but not C. diphtheriae 
siderophore, and CiuA is essential for C. diphtheriae siderophore uptake but not that of 
aerobactin (Kunkle & Schmitt, 2005).  
 
Schmitt et al. (1997b) demonstrated that the C. diphtheriae siderophore uptake mutant HC1 
(Cryz, et al. 1983), unlike the wild-type parent strain, was unable to obtain iron from 
transferrin, although it was able to obtain iron from haem and haemoglobin (Schmitt, 1997b). 
The ability of C. diphtheriae to utilise haem has been shown to be via a siderophore-
independent mechanism (Schmitt, 1997b; Bibb, et al. 2005), and it was subsequently 
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suggested that the acquisition of iron from transferrin in C. diphtheriae is dependent on a 
functional siderophore uptake system (Schmitt, 1997b).  As part of the work described in this 
thesis, the ability of C. pseudotuberculosis to utilise transferrin-bound iron was established 
(Chapter 3).  By analogy with the work by Schmitt et al. (1997b), it was considered entirely 
possible that a functional siderophore may also be associated with the ability of C. 
pseudotuberculosis to acquire iron from transferrin; however, to date there has been no 
siderophore detected in this organism.  Subsequently, the aim of the work described in this 
chapter was to determine the potential involvement of siderophore in C. pseudotuberculosis 
iron acquisition.    
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6.1 Results  
6.1.1 Production of siderophore by C. pseudotuberculosis 
 
A CAS assay was performed (Schwyn & Neilands, 1987) in order to ascertain whether C. 
pseudotuberculosis produces a siderophore when subjected to low-iron growth conditions. 
Production of siderophore was assessed by calculating ―siderophore units‖ using a standard 
curve of known EDDA concentrations (ranging from 1-20 μM), per absorbance of the culture 
(EDDA Eq/OD600nm) (Figure 6.1). Significantly, results of preliminary experiments, presented 
in Figure 6.1, revealed that the low-iron conditions previously determined in Chapter 3 
resulted in a considerable amount of siderophore being produced by C. pseudotuberculosis. In 
CCDM (characterised as the high-iron growth medium in chapter 3) the production of 57.06 
EDDA Eq/OD600nm was observed as compared to 222.04 EDDA Eq/OD600nm of siderophore 
produced in CCDM containing dipyridyl (low-iron growth conditions).   
 
The affect of supplementing CCDM with different concentrations of iron was investigated.  
Increasing concentrations of FeCl3 were added to the CCDM, and with increasing 
concentration came a concurrent decrease in siderophore production.  Addition of FeCl3 to 
final concentrations of 1 μM, 5 μM and 10μM, resulted in the production of 33.8, 3.39 and 
1.97 EDDA Eq/OD600nm of siderophore, respectively. This data revealed that, although the 
addition of further iron had no affect on the level of C. pseudotuberculosis growth (as 
compared to CCDM alone; Chapter 3, Figure 3.3), the near complete termination of 
siderophore production was not observed until the medium contained 10 μM FeCl3. The 
inverse relationship between iron concentration and siderophore production suggested that 
siderophore production is regulated by extracellular iron concentration. At this point it was 
considered possible that, if it was necessary to supplement CCDM to a final concentration of 
10 μM FeCl3 in order to terminate siderophore production, the same may well be true in order 
to regulate other genes which are expressed in an iron-dependent manner.  
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Panel A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 CAS assay for the detection of C. pseudotuberculosis siderophore production 
Panel A) Production of siderophore by C. pseudotuberculosis was assessed following growth in either CCDM, 
CCDM deferrated by addition of 2‘,2‘-dipyridyl to 300 μM (CCDM-Fe), or CCDM supplemented with varying 
amounts of FeCl3. Samples were analysed in duplicate in a microtitre plate assay, and production of siderophore 
was evidenced by the formation of an orange-pink colour.  Sample lanes correspond to CCDM (   ), CCDM
-Fe
 (  ), 
CCDM + 1 μM FeCl3 (   ), CCDM + 5 μM FeCl3 (   ) and CCDM + 10 μM FeCl3 (   ). Panel B) Standard curve.  
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6.1.2 Optimal growth conditions for the study of iron-dependent regulation of 
gene expression 
 
Following the identification of optimal low- and high-iron conditions, the CAS assay was 
performed a further 3 times to ensure that meaningful results were obtained (Figure 6.2). Each 
time, consistent levels of siderophore production were observed in either high- or low-iron 
medium, confirming the observation of siderophore production, and also confirming the iron-
dependent nature of production.  A paired t-test was employed to statistically analyse the data. 
The analyses provided evidence to suggest there was a statistically significant difference 
between the amount of siderophore produced under low-iron conditions compared to the 
amount of siderophore produced under high-iron  conditions (p=0.011).  
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Figure 6.2 Siderophore production by C. pseudotuberculosis under low- and high-iron growth 
conditions  
This figure illustrates an average of three CAS assay experiments in which C. pseudotuberculosis was grown 
under low iron (CCDM with 300 μM 2‘, 2‘ dipyridyl) and high iron (CCDM with 10 μM FeCl3) conditions. Bars 
correspond to low-iron (   ), high-iron (   ), and the difference in the level of expression was statistically 
significant (p= 0.011).  
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6.1.3 C. pseudotuberculosis chromosomal siderophore-encoding locus 
 
As mentioned in Chapter 5, towards the end of this PhD study, the near complete sequence of 
the C. pseudotuberculosis 3/99-5 genome became available.  Next Generation sequencing was 
conducted using a Roche 454 sequencing apparatus (GS-FLX Instrument) by 454 Life 
Sciences (Branford, Connecticut, USA). Subsequently, the sequence provider assembled 
sequence reads into 8 contiguous sections, comprising an estimated ca. 98 % of the complete 
C. pseudotuberculosis genome.  The subsequent (and ongoing) analyses of this genome 
sequence, including gap-closure, are being conducted as part of a separate project, and will not 
be discussed here. However, ORF predictions and a preliminary genome annotation was 
conducted by staff of the Bioinformatics Unit within the Moredun Research Institute, and the 
annotated sequence was made available as a means of attempting to link a specific 
chromosomal locus (or loci) to the observed siderophore-producing phenotype.   
 
Analysis of the annotated gene list led to the identification of a 3,390 bp open reading frame, 
designated here as ORF02949 (Figure 6.3).  The translated product of this ORF shared 52 % 
identity and 68 % similarity over its entire length with the previously published siderophore 
biosynthesis-encoding gene, ciuE of C. diphtheriae strain NCTC 13129 (locus tag DIP0586). 
A protein of 1,129 amino acids was predicted using the Clone Manager 9 software package.  
Analysis of the region immediately upstream of ORF02949 revealed a further 4 predicted 
ORFs, designated ORF02945 (905 bp), ORF02946 (563 bp), ORF02947 (1,031 bp) and 
ORF02948 (821 bp) (Figure 6.3).  Significantly, the translated product of each of these 4 open 
reading frames shared homology with ABC-type iron transport systems, the translated product 
of each ORF corresponding to a periplasmic binding protein (a possible lipoprotein (Kunkle & 
Schmitt, 2005)), 2 permease components and an ATPase component, respectively. 
Comparison of the putative C. pseudotuberculosis siderophore transporter proteins with the 
previously described C. diphtheriae Ciu ABC-type siderophore transporter (Kunkle & 
Schmitt, 2005) revealed significant homology. The translated product of ORF02945 shared 76 
% identity and 84 % similarity across its entire length with C. diphtheriae CiuA (locus tag 
DIP0582). The translated product of ORF02946 shared 66 % identity and 82 % similarity with 
C. diphtheriae CiuB (locus tag DIP0583), the translated product of ORF02947 shared 75 % 
identity and 87 % similarity with C. diphtheriae CiuC (locus tag DIP0584), and the translated 
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product of ORF02948 shared 69 % identity and 84 % similarity with C. diphtheriae CiuD 
(locus tag DIP0585). 
 
Despite a significant level of sequence conservation between the equivalent siderophore-
encoding loci of C. pseudotuberculosis and C. diphtheriae, it was apparent that there had been 
some divergence of sequence between the two species.  During their analysis of the C. 
diphtheriae NCTC 13129 genome sequence, Cerdeno-Tarraga et al (2003) revealed 13 regions 
which were absent in the non-pathogenic C. glutamicum and C. efficiens (Cerdeno-Tarraga, et 
al. 2003). Analysis of these regions led to the identification of anomalies in nucleotide 
composition, such as G+C content, and led to the speculation that they encoded pathogenicity 
islands (Cerdeno-Tarraga, et al. 2003). Significantly, it was observed that some of these 
islands encoded iron-uptake systems and a potential siderophore biosynthesis system.  
However, it is unfortunate that the Ciu-encoding locus of C. diphtheriae was not characterised 
until a few years later, and although likely, it is not stated that the siderophore biosynthesis 
system identified by Cerdeno-Tarraga et al. (2003) is that encoding the Ciu locus. What is 
interesting is that analysis of the chromosomal region immediately flanking the C. 
pseudotuberculosis siderophore-encoding locus revealed a putative open reading frame, which 
shared homology with transposase IS3510b for C. jeikeium. Analysis further upstream and 
downstream revealed that the C. pseudotuberculosis siderophore-encoding locus lay in an 
entirely different region of the chromosome than the (possible) equivalent locus in C. 
diphtheriae, and it would therefore appear, at least from preliminary analysis, that the 
acquisition of siderophore by both of these species has occurred as a result of independent 
bacteriophage lysogeny events, at different locations within the chromosome.   
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Figure 6.3 Schematic representation of the C. pseudotuberculosis and C. diphtheriae 
siderophore loci  
The C. pseudotuberculosis locus (panel A) incorporates the putative siderophore biosynthesis gene homologue 
(ORF02949), and demonstrates the predicted DtxR binding locus (shown in red). Also within the locus are ORFs 
02945-02948 which share significant homology to an ABC-type transport system. The 309 bp region upstream of 
ORF02949 that was used in subsequent promoter fusion assays is indicated by the black bar. The C. diphtheriae 
locus (panel B) incorporates the siderophore biosynthesis gene (ciuE), and the predicted DtxR binding locus 
(shown in red).  The genes ciuA-ciuD are thought to encode an ABC-type transport system (Kunkle & Schmitt, 
2005). 
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6.1.4 Complementation of a C. diphtheriae siderophore-deficient mutant with 
C. pseudotuberculosis siderophore 
 
Given the predicted divergence in sequence, it was thought interesting to establish whether the 
C. pseudotuberculosis siderophore was functionally homologous to that encoded by ciuE of C. 
diphtheriae. Supernatant from cultures of C. pseudotuberculosis grown in high-iron growth 
medium (containing no siderophore) and low-iron growth medium (containing un-purified 
siderophore) were used to supplement a C. diphtheriae ciuE-knockout strain (S. L. Zajdowicz 
personal communication) to determine whether the growth of the mutant (which was unable to 
grow under low-iron growth conditions) could be restored. The siderophore bioassay was 
carried out in collaboration with Dr S. L. Zajdowicz in the Department of Microbiology, 
University of Colorado at Denver and Health Sciences Centre, whilst on a working visit to 
Prof. Randall Holmes‘ lab.  Corynebacterium diphtheriae strain C7(-) ΔciuE was grown in an 
80:20 mixture of PGT medium (Oram, et al., 2002) (with 10 g/L casamino acids) and CHI 
broth (chelex resin-treated Heart Infusion broth) for 18 h. Heart Infusion broth with Tween
80
,  
containing 60 μM EDDA to chelate iron, was inoculated with  C. diphtheriae strain C7(-) 
ΔciuE to a final concentration of 106 bacteria/ml. An overlay of 1% (w/v) agarose containing 
0.01% triphenyltetrazolium chloride was added, and wells were cut into the agar plate. Sample 
containing 25 μl of each siderophore-containing sample was added to the wells and growth 
stimulation was measured after incubation for 18 h at 37°C. An example of a bioassay is 
shown in Figure 6.4 where supernatant containing siderophore from cultures of C. 
pseudotuberculosis propagated in either CCDM, CCDM containing 300μM dipyridyl, or 
CCDM containing 1 μM FeCl3 or 10 μM FeCl3 is shown. A sample of C. diphtheriae 
siderophore, which was in the form of supernatant taken from a culture of C. diphtheriae 
grown under low-iron conditions, was used as a positive control. As shown, supplementing the 
C. diphtheriae CiuE mutant with supernatant from wild-type C. pseudotuberculosis grown in 
low-iron medium resulted in a restoration of the ability of the C. diphtheriae mutant to grow 
under iron-restricted conditions; however, in contrast, supplementing the mutant with the 
high-iron medium did not result in the restoration of growth. These results suggest that the 
siderophore produced by C. pseudotuberculosis under low-iron growth conditions is similar 
enough in terms of function to be useable by C. diphtheriae.   
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Figure 6.4 Complementation of a C. diphtheriae C7 (-) ΔciuE with C. pseudotuberculosis 
siderophore containing supernatant  
Sample wells correspond to supernatant from cultures of C. pseudotuberculosis propagated in CCDM (1), CCDM 
containing 300μM dipyridyl (2), CCDM containing 1 μM FeCl3 (5) and CCDM containing 10 μM FeCl3 (3).  A 
positive control was included corresponding to siderophore-containing supernatant obtained from a culture of C. 
diphtheriae propagated under low-iron growth conditions (4).  Growth of the mutant strain is apparent by the 
presence of a brown colony surrounding each respective well. 
3
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6.1.5 Analysis of expression of the C. pseudotuberculosis putative 
 siderophore-encoding gene  
 
A 309 bp DNA fragment containing 271 bp of the chromosomal region upstream of the 
putative C. pseudotuberculosis siderophore biosynthesis gene (ORF02949), and 4 bp into the 
5‘-end of the gene itself (Figure 6.3), was amplified by PCR using the primers Sid_P_F and 
Sid_P_R (Table 2.5), and cloned into the promoterless lacZ reporter gene plasmid, pSPZ 
(Oram, et al., 2006). The resulting construct, designated pCAW009, which was considered 
likely to have incorporated the promoter-containing region of the C. pseudotuberculosis gene, 
was introduced into wild-type C. pseudotuberculosis, and β-galactosidase activity resulting 
from expression of the promoterless lacZ gene under the control of an ORF02949 promoter 
was subsequently measured under high- and low-iron growth conditions. The use of 
pCAW007, the fagA containing construct, which was previously proven to be regulated by 
DtxR in Chapter 5, was employed as a positive control in these experiments.  Assays were 
performed in triplicate on three separate occasions, and results confirmed that a functional 
promoter-encoding sequence was present within the cloned 309 bp fragment (Figure 6.5). 
Moreover, the promoter was observed to drive expression of the lacZ reporter gene in an iron-
dependent manner, since under high-iron growth conditions β-galactosidase activity was 
significantly less than that observed under low-iron conditions. Statistical analyses (by way of 
a paired t-test) corroborated this with evidence to suggest that a statistically significant 
difference (p=0.018) existed between expression of ORF02949 under low-iron conditions 
compared to expression under high-iron conditions.  While these results confirmed the iron-
dependent expression of the putative siderophore-encoding gene, it was not clear whether 
DtxR was involved in the iron-dependent regulation of this gene in C. pseudotuberculosis, 
equivalent to DtxR control of ciuE expression in C. diphtheriae (Kunkle & Schmitt, 2005). 
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Figure 6.5 Iron-dependent regulation of C. pseudotuberculosis putative siderophore 
biosynthetic gene expression 
The putative promoter containing region of ORF02949 was fused to promoterless lacZ, and β-galactosidase 
production was measured under high- and low-iron conditions in wild-type C. pseudotuberculosis.  The fagA 
gene, previously been shown to be regulated in an iron-dependent manner was included here as a positive control. 
Bars correspond to low-iron (  ) and high-iron (   ), and ORF02949 was found to be differentially expressed in 
response to iron in a statistically significant manner (p=0.018).  
-0.5
0
0.5
1
1.5
2
pSPZ fagA ORF02949
M
e
a
n
 M
ill
e
r 
u
n
it
s
 (
lo
g
1
0
)
Chapter Six                                                                                                                                     Results  
 214 
 
6.1.6 Involvement of DtxR in the regulation of the C. pseudotuberculosis 
 putative siderophore-encoding gene 
 
Further analyses were conducted in order to determine whether DtxR was involved in the 
regulation of expression of the C. pseudotuberculosis putative siderophore-encoding gene. In 
order to identify putative DtxR-binding loci in C. pseudotuberculosis genes, the software 
package ―fuzznuc‖, available through the European Molecular Biology Online Software Suite 
(EMBOSS; http://bioweb2.pasteur.fr/docs/EMBOSS/fuzznuc.html) was used to search for 
specific nucleic acid motifs within the C. pseudotuberculosis 3/99-5 chromosomal region 
corresponding to ORFs 02945-02949.  The search was conducted using the C. diphtheriae 
consensus DtxR-binding motif, 5‘-TWAGGTWAGSCTWACCTWA-3‘, where W = A or T 
and S = C or G.  To allow for divergence between species, up to five mismatches were 
allowed in the search, which was conducted by staff of the Moredun Bioinformatics Unit.  
Significantly, a DtxR-like binding motif (sequence 5‘-TAAAGGTAGCCTTGGCTAC-3‘) was 
identified immediately (20 bp) upstream of the putative siderophore biosynthesis gene, 
ORF02949 (Figure 6.3).  Furthermore, a DtxR-like binding motif (sequence 5‘-
TTAGGTTTGCTTTGCATAC-3‘) was identified immediately (29 bp) upstream of the 
putative ABC-transporter gene, ORF02945 however due to lack of time the promoter region of 
this gene was not analysed for DtxR-dependent  regulation.  
 
In order to confirm whether the promoter upstream of ORF02949 was regulated by DtxR in an 
iron-dependent manner, a promoter fusion assay was conducted using the DtxR-deficient C. 
pseudotuberculosis strain (Cp-ΔdtxR) as a host for pCAW009 (Figure 6.6). As a positive 
control, the fusion construct containing the C. pseudotuberculosis fagA promoter, pCAW007, 
was also used to transform the Cp-ΔdtxR strain. If expression of the putative siderophore-
encoding gene was under the control of DtxR in C. pseudotuberculosis, then it would be 
expected that there would be no difference between the levels of expression of the lacZ gene 
in pCAW009 in the DtxR-deficient host strain under high- and low-iron conditions. The 
average results obtained from 3 promoter fusion experiments are presented in Figure 6.6. A 
paired t-test was employed to analyse the difference between expression of ORF02949 under 
high- and low-iron growth conditions in the DtxR-deficient host strain Cp-ΔdtxR. The results 
provided evidence to suggest that there was no significant difference in expression (p= 0.240), 
implicating DtxR in the regulation of this gene. In addition, an ANOVA was employed to 
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compare the expression of ORF02949 between wild-type and Cp-ΔdtxR. The ANOVA 
provided statistical evidence to suggest there was a significant difference in gene expression of 
ORF02949 in wild-type as compared to Cp-ΔdtxR (p=0.009). Furthermore, the difference in 
expression of ORF02949 between wild-type and Cp-ΔdtxR was greater under high-iron 
growth conditions, compared to the expression in the two strains under low-iron growth 
conditions. Expression of ORF02949 in wild-type under high-iron conditions was 0.982 +/- 
0.08 compared to expression in the Cp-ΔdtxR under high-iron conditions which was 1.316 +/- 
0.08; these results indicated an interaction effect between the strain and iron.  
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Figure 6.6 Assessment of DtxR-regulation of C. pseudotuberculosis putative siderophore 
biosynthetic gene expression.  
The pCAW009 (containing ORF02949) construct was used to transform Cp-ΔdtxR and β-galactosidase 
expression was measured under high- and low-iron conditions. Again, pCAW007 (fagA) was included as a 
positive control since it had previously been shown to be regulated in an iron-dependent manner (Chapter 5).  
Bars correspond to low-iron (    ) and high-iron (   ). A paired t-test indicated that expression of ORF02949 was 
not differentially expressed (p= 0.240) in the mutant Cp-ΔdtxR strain implicating DtxR in the regulation of the 
putative siderophore biosynthesis gene.   
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6.1.7 Construction of a putative siderophore-deficient mutant of C. 
 pseudotuberculosis  
 
Using the allele-replacement method previously developed during this work (Chapter 4), 
attempts were made to construct a mutant of C. pseudotuberculosis 3/99-5, deficient in 
ORF0249; in this way it was hoped that the involvement of this gene in C. pseudotuberculosis 
siderophore production would be confirmed. Using the PCR primers AE_249_1 and 
AE_249_2 (Table 2.3) a 951 bp fragment was amplified from immediately upstream of 
ORF0249 which included the first 65 bp of the 5‘ end of ORF0249. Similarly PCR primers 
AE_249_3 and AE_249_4 (Table 2.3) were used to amplify a 988 bp fragment from 
immediately downstream of ORF0249 which included the last 53 bp of the 3‘ end of 
ORF0249. The two fragments were then ligated together (using the incorporated XhoI site); 
the ca. 2 kb product was amplified by PCR using primers  AE_249_1 and AE_249_4 and the 
resulting mutant gene  product was designated ΔORF0249.  The Δ02949 deletion derivative 
was cloned into SalI digested pCARV (facilitated by primer-encoded restriction sites) and the 
resulting recombinant plasmid, designated pCARV007, was used to transform C. 
pseudotuberculosis. Subsequently, an attempt was made to replace the wild-type, 
chromosomal ORF02949 gene with the plasmid-borne ΔORF0249 by homologous 
recombination, as described in Chapter 2.  Bacterial cells which were assumed to have 
undergone chromosomal integration of pCARV007 were identified by virtue of their ability to 
grow in the presence of erythromycin at 37°C (the non-permissive temperature for plasmid 
replication). A single colony deriving from a cell in which pCARV007 had integrated into the 
chromosome was used to inoculate a quantity of BHI medium containing erythromycin. 
Subsequently, the second stage in the mutagenesis protocol was conducted in order to obtain a 
derivative of C. pseudotuberculosis in which the wild-type gene had been replaced with 
ΔORF0249. Using primers Δ0249_DCO_F and Δ0249_DCO_R (Table 2.3), a number of 
colonies which had derived from cells in which the pCARV007 plasmid had excised were 
screened by PCR. Unfortunately PCR carried out on the cells in which the plasmid had 
excised did not result in an amplicon of the correct size, confirming that a mutant had not been 
obtained. Unfortunately however, due to lack of time in this final stage of the project, it was 
not possible to pursue the construction of the mutant any further. 
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6.2 Discussion  
In Chapter 3 of this thesis, results pertaining to the ability of C. pseudotuberculosis to utilise 
transferrin-bound iron were presented. In addition, a previously published study revealed that 
the related human pathogen, C. diphtheriae, requires a functional siderophore to obtain iron 
from transferrin (Schmitt, 1997b). Taken together, it was thought possible that these 
observations might be linked, and that C. pseudotuberculosis may therefore also produce a 
siderophore; however, despite decades of research attention, no siderophore had previously 
been reported for this organism.   The aim of the work presented in this chapter was therefore 
to determine whether C. pseudotuberculosis produces a siderophore; if, having successfully 
demonstrated siderophore production, the next objective was then to use a comparative 
approach in order to identify the genes responsible for the siderophore biosynthesis.   
 
In order to detect a functional siderophore, CAS assays were carried out. The CAS assay 
(Schwyn & Neilands, 1987) provides a useful, straight-forward and relatively rapid method of 
detection of all types siderophore; hence, it is a powerful tool to allow screening for this 
phenotypic attribute, either on solid media or in liquid assays, and no prior knowledge of the 
type of siderophore an organism produces is required. The assay is based on the colour change 
that occurs during the transfer of ferric ion from its intense blue complex to the siderophore, 
resulting in an orange-pink colour.  In order to ensure the best chance of detecting a 
siderophore, C. pseudotuberculosis was initially grown in CCDM supplemented with 300 μM 
(final concentration) of dipyridyl, the so-called ―low-iron growth medium‖ utilised throughout 
the work described in this thesis.  In this way, a liquid CAS assay, assessing serial-dilutions of 
culture supernatant, allowed the detection of a C. pseudotuberculosis siderophore (Figure 
6.1). Significantly, the work described here is the first documentation of a siderophore 
produced by this organism.   
 
The siderophore, aerobactin, into which much research has been conducted, has been shown to 
be synthesised by a NRPS-independent (NIS) pathway, and utilises two siderophore 
synthetase enzymes, IucA and IucC (de Lorenzo, et al. 1986) (Challis, 2005). Other 
siderophores produced via NIS biosynthesis pathways include vibrioferrin of Vibrio 
parahaemolyticus, staphylobactin of Staphylococcus aureus and anthrachelin of Bacillus 
anthracis (Challis, 2005), and it is interesting to note that each of these pathways utilises at 
least one enzyme with significant sequence similarity to the aerobactin siderophore 
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synthetases (IucA and IucE ) (Challis, 2005). It is perhaps of relevance that often, pathogens 
that biosynthesise siderophore via a NRPS-independent pathway require a functional 
siderophore to achieve full virulence (Miethke & Marahiel, 2007; Challis, 2005). An example 
of this has been reported for the porcine pathogen, Bordetella bronchiseptica, whereby strains 
that are unable to produce the NIS siderophore, alcaligin, are apparently reduced in virulence 
in swine (Register, et al. 2001). 
 
Recently, a gene (designated ciuE) sharing significant homology to the genes encoding 
aerobactin biosynthesis enzymes IucA and IucC, was identified in C. diphtheriae (Kunkle & 
Schmitt, 2005). IucA and IucC are the prototypes of NRPS-independent siderophore 
synthetases that catalyse aerobactin synthesis; significantly, all known NRPS-independent 
siderophore synthesis pathways utilise at least one enzyme with high sequence similarity to 
the aerobactin synthetases (Challis, 2005; Miethke & Marahiel, 2007). Immediately upstream 
of ciuE was reported the presence of four genes, designated ciuA, ciuB, ciuC and ciuD 
(thought to be in an operon structure), the predicted products of which have significant 
similarities to ABC-type iron transport systems. The ciuA gene encoded a protein which was 
similar to other iron uptake proteins of Gram-positive bacteria; in particular, lipoproteins; the 
ciuB and ciuC genes were predicted to encode the permease components of an ABC transport 
system while ciuD shared similarities to the ATPase component (Kunkle & Schmitt, 2005).  
Subsequently, Kunkle and Schmitt (2005) created an in-frame deletion derivative of the ciuE 
and ciuA genes in C. diphtheriae (Kunkle & Schmitt, 2005).  The researchers demonstrated 
that deletion of 95 % of the ciuE gene resulted in a significant decrease in siderophore activity 
relative to wild-type strains under low-iron growth conditions, indicating that the ciuE mutant 
has a defect in siderophore production. However, the presence of a plasmid carrying a 
functional copy of the ciuE gene resulted in wild-type levels of siderophore being produced, 
providing strong evidence for the role of CiuE in siderophore biosynthesis.  Additionally, a 
deletion in the ciuA gene resulted in a severe defect in iron uptake and the ability to obtain iron 
from C. diphtheriae siderophore, implicating this protein in the transport of siderophore.  
 
The utilisation of the hydroxamate xenosiderophore, aerobactin, by C. diphtheriae has been 
reported (Russell, et al. 1984). Interestingly, the C. diphtheriae siderophore, CiuE, tested 
negative in Arnow and Csaky tests for phenolate and hydroxamate siderophore (Russell, et al. 
1984), and it was subsequently postulated that the properties of the corynebacterial 
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siderophore were not identical to aerobactin. Interestingly, partially-purified C. diphtheriae 
siderophore manifested a positive reaction to the phenolate spray test (which detects all 
phenolate compounds) in a study conducted by Russell et al. (1984), however, the Arnow test 
is considered to be more stringent (Russell, et al. 1984), and the non-phenolate classification 
of the C. diphtheriae siderophore would appear to stand at this time.  Since the structure of the 
C. diphtheriae siderophore has yet to be elucidated, conclusive evidence as to what type of 
siderophore it is does not exist. Furthermore, it is not known whether the bacterium produces 
more than one siderophore, although a defined CiuE-deficient mutant of C. diphtheriae did not 
appear to produce any other siderophore that would facilitate growth of the mutant under 
reduced-iron growth conditions (Kunkle & Schmitt, 2005).  
 
The use of xenosiderophores by corynebacteria has been well documented (Russell, et al. 
1984) (Wennerhold & Bott, 2006; Billington, et al. 2002). For example, Wennerhold and Bott 
(2006) inspected the C. glutamicum ATCC 13032 genome and were unable to identify obvious 
siderophore biosynthesis genes; the authors subsequently suggested that this C. glutamicum 
strain copes with iron starvation by using a variety of siderophores produced by other 
microbes (Wennerhold & Bott, 2006). Interestingly however, it has been suggested that 
another C. glutamicum strain (ATCC 14067) does in fact produce a cyclic catecholate-type 
siderophore (Budzikiewicz et al. 1997 in Wennerhold and Bott (2006)) (Wennerhold & Bott, 
2006).  On the one-hand it is possible that strain-specific differences exist among different C. 
glutamicum strains, with respect to the ability to produce siderophore, however, there has been 
significant debate over the accuracy of the data pertaining to the ability of C. glutamicum 
ATCC 14067 to produce a cyclic catecholate siderophore (Dertz, et al. 2006).   
 
Like C. diphtheriae, the structure of the C. pseudotuberculosis siderophore described here has 
yet to be elucidated.  Therefore, it is not currently possible to conclusively determine whether 
the type of siderophore produced is the same in both organisms.  However, an interesting 
experiment to study the functionality of the C. pseudotuberculosis siderophore was conducted, 
whereby the C. pseudotuberculosis siderophore was used to complement a C. diphtheriae 
CiuE-deficient mutant (Figure 6.4). During a working visit to the laboratory of Prof. Randall 
Holmes at the University of Colorado at Denver and Health Sciences Centre, and in 
collaboration with Dr Sheryl Zajdowicz of Prof. Holmes‘ lab, a bioassay was conducted. The 
results of the bioassay revealed that the C. pseudotuberculosis siderophore (produced only 
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under low-iron growth conditions and secreted into the culture supernatant) was effectively 
utilised by the C. diphtheriae mutant, allowing acquisition of iron and subsequent growth, in a 
manner identical to that observed upon supplementing the mutant strain with culture 
supernatant containing wild-type C. diphtheriae supernatant. These results indicate that C. 
diphtheriae is able to utilise C. pseudotuberculosis siderophore; however, it should be noted 
that the results shown here do not prove that the siderophore types are the same, and there is 
also a possibility that the C. pseudotuberculosis siderophore was transported into the C. 
diphtheriae cell via another transporter.  In this respect, the alternative putative ABC-
transporter, Irp6 has been suggested to be involved in the uptake of xenosiderophores in C. 
diphtheriae (Kunkle & Schmitt, 2005).  Therefore, unless equivalent experiments were 
conducted using siderophore-deficient mutant strains, also deficient in either the Ciu or the 
Irp6 ABC-transporter, it is not possible to prove that the C. pseudotuberculosis and C. 
diphtheriae siderophores are functionally similar;  however, it would seem highly likely that 
they are, given the 52 % identity and 68 % similarity between the two proteins.  
 
CCDM growth medium supplemented with a range of concentrations of FeCl3 was assessed to 
determine whether the C. pseudotuberculosis siderophore was produced in response to 
declining environmental iron concentrations.  Results showed conclusively that the lower the 
concentration of iron in the growth medium was, the greater was the level of siderophore 
production.  However, a further interesting observation was also made at this point.  
Previously during this investigation, high-iron growth conditions had been determined, and 
utilised in preliminary experiments, and the amount of iron (in the form of FeCl3) used to 
supplement CCDM for high-iron growth was based upon the observation that an FeCl3 
concentration beyond  1 μM did not improve the growth of C. pseudotuberculosis in CCDM 
any further. However, despite the fact that this concentration was sufficient to allow optimal 
growth, during the analyses which were conducted to investigate whether siderophore was 
produced in response to environmental iron concentration, it was observed that 10 μM (final 
concentration) of FeCl3 was required for maximum repression of siderophore production.  
Obviously, this concentration was significantly higher than that of the medium previously 
designated optimal for high-iron growth. It was considered entirely possible that if siderophore 
production was repressed more-fully by this higher concentration of iron, then the same may 
also be true of the repression of other genes which were regulated in a similar manner; as a 
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result, an FeCl3 concentration of 10 μM was used for all subsequent experiments as well as 
experiments in Chapter 5 which were carried out concurrently with the work presented here. 
 
Following the discovery of a C. pseudotuberculosis siderophore it was desirable to identify the 
responsible genes. Efficient generation of C. pseudotuberculosis transposon random-insertion 
libraries has been achieved in our laboratory (unpublished data) and by others (Dorella, et al. 
2006).  Initially, it was intended that such a library would be screened in order to identify 
mutants deficient in siderophore production, through which it would be possible to identify the 
genes responsible.  However, towards the end of this investigation it was fortuitous that a 
partial C. pseudotuberculosis genome sequence became available as part of a separate study in 
the same laboratory.  Therefore, rather than constructing a transposon-insertion library and 
subjecting it to time-consuming screening, it was considered a quicker approach to scan the 
preliminary annotation of the genome sequence with a view to identifying anything relating to 
a siderophore-encoding sequence.  As discussed above, a locus which at this time is simply 
designated ORFs 02945-02949, which shared significant (between 54-84%) amino acid 
homology to the C. diphtheriae ciu locus (NCTC 13129 locus tag DIP 0582-DIP 0586) was 
identified.  However, were more time available within the current study, it would have been 
interesting to complement the bioinformatic approach with the molecular approach of 
screening a transposon-insertion library for siderophore-deficient mutants.  In that way it 
would have been possible to corroborate the involvement of certain genes in the 
production/transport of siderophore, and relate these findings back to the bioinformatic 
predictions.  In addition, it would have been possible to identify potential regulatory 
components involved in siderophore production.  
 
It is common for genes involved in siderophore biosynthesis and transport to be regulated in 
an iron-dependent manner (Hantke, 2001). To determine whether the genes in the C. 
diphtheriae ciu locus were regulated in response to iron concentration, Kunkle and Schmitt 
(2005) analysed the transcription of these genes under varying environmental iron conditions. 
The researchers identified two putative promoter regions, one upstream of the ciuA gene and 
the other upstream of the ciuE gene (Kunkle & Schmitt, 2005), both of which were regulated 
in an iron-dependent manner. Similarly in C. pseudotuberculosis, a DtxR binding locus was 
identified upstream of the C. diphtheriae ciuA and ciuE equivalent genes, ORF02945 and 
ORF02949.  As part of the comparative approach of this investigation, and, in order to further 
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characterise the putative siderophore locus (ORFs 02945-02949) in C. pseudotuberculosis, a 
promoter fusion assay was employed to study the promoter activity upstream of the ORF 
02949 in C. pseudotuberculosis; however, due to lack of time it was not possible to study the 
promoter upstream of ORF02945. The 309 bp chromosomal fragment, taken from 
immediately upstream of the putative siderophore-encoding gene (ORF02949) was cloned into 
pSPZ (Oram, et al. 2006), and expression of the lacZ reporter gene from the resulting 
construct (designated pCAW009) was assessed in the natural host, C. pseudotuberculosis. 
Following growth under high- and low-iron conditions, and using the fagA gene promoter as a 
positive control (Chapter 5), β-galactosidase activity was measured. In agreement with what 
had been seen previously for ciuE in C. diphtheriae, the predicted promoter region upstream 
of C. pseudotuberculosis ORF02949 was shown to be functional, as determined by its ability 
to drive expression of the promoterless lacZ gene.  In addition, mirroring the observations of 
the CAS assays, ORF02949 was shown to be expressed in an iron-dependent manner, with 
greater expression occurring in low-iron growth medium (Figure 6.5).  
 
The identification of a functional DtxR protein in C. pseudotuberculosis (Chapter 5), allowed 
the investigation of any involvement of DtxR in the regulation of iron-dependent expression of 
the putative siderophore-encoding gene. The observation that ORF02949 contained a potential 
DtxR-binding motif immediately upstream lent weight to the potential involvement of DtxR in 
the regulation of this gene.  In order to confirm the involvement of DtxR in the regulation of 
expression of ORF02949, the pCAW009 promoter fusion vector was introduced into the 
DtxR-deficient C. pseudotuberculosis mutant (Cp-ΔdtxR) constructed during the work 
presented in Chapter 5. Interestingly, the results demonstrated that ORF02949 was indeed 
regulated by DtxR in an iron-dependent manner. As expected, the lack of a functional DtxR 
protein resulted in a non-significant difference between the expression of ORF02949 under 
high- and low-iron growth conditions (as demonstrated by a paired t-test). This result was as 
expected since ORF02949 was shown to be expressed in an iron-dependent manner in wild-
type C. pseudotuberculosis and it was highly likely this iron-dependent regulation was a result 
of the DtxR protein. As was noted with the expression of fagA (previously shown to be 
regulated by DtxR in Chapter 5) there was a significant difference between the expression of 
ORF02949 in wild-type and Cp-ΔdtxR strains (p= 0.009). Significantly, this difference was 
more apparent at the higher level of iron suggesting an interaction effect between strain and 
iron.  
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Previously, Billington et al. (2002) identified a genetic locus in a goat-derived C. 
pseudotuberculosis isolate that contained open reading frames which shared significant 
homology to genes encoding iron transport systems.  The researchers identified an operon 
designated fagABC, which encoded proteins that collectively resemble cytoplasmic membrane 
transport systems for iron-siderophore uptake (Billington, et al. 2002).  The researchers 
reported that, in particular, the genes shared a high degree of similarity to proteins involved in 
uptake of the catecholate siderophore enterochelin (enterobactin) (Billington, et al. 2002), 
although no C. pseudotuberculosis siderophore was detected in that study.  Subsequently, the 
researchers constructed a fagB-deficient knock out strain, and examined the ability of the 
mutant to acquire iron from FeCl3, FeSO4, hemin, haemoglobin and transferrin.  Interestingly, 
the mutation within the fag operon had no affect on the ability of C. pseudotuberculosis to 
obtain iron from any of the sources tested. The researchers subsequently hypothesised that the 
effect of the mutation in the Fag uptake system was masked by another uptake system with 
similar specificity; they also suggested that the products of the fag genes are responsible for 
the uptake of a xenosiderophore, which they hypothesised was supported by the fact that there 
was no siderophore biosynthetic gene(s) clustered with the fag genes (Billington, et al. 2002). 
It is interesting to postulate that the C. pseudotuberculosis putative siderophore biosynthesis 
gene (ORF02949) and upstream putative siderophore transporter-encoding genes (ORFs 
02945, 02946, 02947, 02948), which collectively share more homology with the ciuE locus of 
C. diphtheriae than with any other gene so far reported in any other bacterium, are in fact the 
true C. pseudotuberculosis siderophore biosynthesis and transport genes.  Furthermore, it 
could be possible that the fagABC operon is the C. pseudotuberculosis equivalent of the C. 
diphtheriae irp6ABC operon, involved in the uptake of xenosiderophores; however, although 
an attractive hypothesis, further work is required to confirm this, and it is significant to note 
that a BLAST search of the C. diphtheriae irp6ABC genes against the (ca. 98 % complete) C. 
pseudotuberculosis genome did not identify any significant homologues.  Therefore, while it is 
entirely possible that the fag and irp6 loci encode genes with a similar function, they have 
either been acquired independently, or have diverged significantly over time.  
 
Unfortunately, because of a lack of time remaining at the end of this project, it was not 
possible to conclusively prove that C. pseudotuberculosis ORF 02949 encodes the siderophore 
biosynthesis gene, although the available evidence would tend to support this hypothesis.  
Preliminary attempts to construct a defined mutant deficient in the expression of the 
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ORF02949 failed. It subsequently appeared likely that this was due to experimental error and 
that the initial mutagenesis construct was incorrect; however, a second attempt was not 
possible due to time constraints. At some point it will be imperative to revisit this work to 
allow confirmation of the involvement of this gene in siderophore production by C. 
pseudotuberculosis.  Subsequently, it would be possible to conduct a variety of assays, 
including assessment of the mutant‘s ability to utilise transferrin and bacterial 
xenosiderophores as sources of iron.  Further interesting work could involve the construction 
of mutant strains in which the ORF02945 and fagA genes had been serially-deleted; it would 
then be possible to determine whether such a mutant was still able to uptake both C. 
pseudotuberculosis siderophore and xenosiderophores. This would provide evidence as to 
which transport system is being controlled by which locus, since if a deletion in ORF02945 
was found to prevent the uptake of C. pseudotuberculosis siderophore but a deletion in fagA 
did not then it could be postulated that ORF02945 is involved in transport of C. 
pseudotuberculosis siderophore while fagA is not.   
 
At this time, no attempt has been made to give the C. pseudotuberculosis siderophore 
biosynthetic and transport genes any more meaningful designation, this being primarily due to 
the fact that further analysis of this region is required to conclusively confirm the role that 
these genes play in siderophore production and uptake.  However, the apparent absence of any 
other siderophore-encoding gene from the C. pseudotuberculosis genome sequence so-far 
available would tend to implicate ORF02949 as the only candidate for the siderophore 
biosynthesis gene.  Through their proximity to ORF02949 and their homology with the 
ciuABCD ABC transporter genes of C. diphtheriae, ORF02945, ORF02946, ORF02947 and 
ORF02948 are likely candidates for the C. pseudotuberculosis siderophore-uptake machinery.  
Although further work is required to conclusively prove (or disprove) this hypothesis, the 
previous observation by Billington et al. (2002) that the Fag-deficient C. pseudotuberculosis 
mutant was still able to acquire iron from transferrin would suggest that, if siderophore is 
required for such a process in C. pseudotuberculosis, then the only other possible siderophore 
transporter identified thus-far is that encoded by ORFs 2945-2948.  
 
In conclusion, the work described in this chapter has lead to the discovery of a novel C. 
pseudotuberculosis siderophore, which is produced in response to declining environmental 
iron conditions.  The translated products of the ORFs encoded within the genetic locus which 
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has been putatively associated with biosynthesis and transport of the siderophore have been 
shown to share between 54-84 % homology (dependent on the ORF) to the proteins encoded 
by the ciu locus of C. diphtheriae, which is responsible for the production of siderophore in 
that organism.  However, it should be noted that a significant degree of divergence of 
sequence has occurred between the two loci, and more importantly that the two loci exist in 
completely different regions of the C. pseudotuberculosis and C. diphtheriae chromosomes.  
There is evidence that the locus in C. pseudotuberculosis has been acquired by horizontal gene 
transfer and although the siderophore-encoding locus in either C. pseudotuberculosis or C. 
diphtheriae may have resulted from infection with the equivalent (e.g.) bacteriophage, it 
would appear that these acquisitions occurred independently of each other.  Irrespective of the 
origin of the siderophore-encoding locus, it is clear that further work into this aspect of C. 
pseudotuberculosis virulence would be worthwhile with respect to beginning to elucidate the 
organism‘s ability to survive and persist within its chosen host.   
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In recent years, CLA has become endemic in the UK and, in addition to issues of animal 
welfare, is becoming of increasing concern as a cause of financial loss to the sheep-producing 
industry. Vaccination options against CLA are limited, especially in the UK, and it is therefore 
imperative that novel strategies for combating this disease are developed.  At the simplest 
level, such strategies could be focused upon the development of improved diagnostic reagents, 
to allow diseased animals to be identified more efficiently.  However, the increasing incidence 
of CLA within the national flock is such that it is becoming increasingly expensive (and 
therefore unlikely) that the disease will be combated by a ―test and cull‖ strategy alone.  
Rather, the majority of sheep-producing communities, both in the UK and elsewhere, all look 
to the development of an effective vaccine as a solution to the problem.  Traditionally, the vast 
majority of sub-unit vaccines against bacterial diseases are based upon derivatives of bacterial 
virulence proteins (a relevant example being the Diphtheria vaccine, which contains toxoided 
C. diphtheriae toxin). This highlights the link between vaccine development and the 
fundamental science upon which it is based. In order to identify an effective vaccine 
candidate, it is first necessary to understand the involvement of that candidate in the natural 
infection process.  As such, it is often through studies into microbial pathogenicity that 
suitable vaccine candidates are identified.  Taking all of this into account, the basic lack of 
understanding in relation to C. pseudotuberculosis has clearly been a sticking point, not only 
in the development of new CLA vaccines but also of diagnostic reagents and other methods to 
limit disease spread.   
 
Taking the above into account, the impact of the work described in this thesis is significant, 
first and foremost with respect to building upon the weak foundations that formed the level of 
understanding of C. pseudotuberculosis and its interaction with the ovine/caprine host that 
existed when the work described here was begun.  As a result of this work, genetic 
manipulation, which was previously a difficult and relatively imprecise methodology, is now a 
routine procedure.  In this respect, the work described here has paved the way for several other 
studies already underway in this laboratory.  Through this work, it is anticipated that our 
understanding not only of C. pseudotuberculosis itself, but of the comparative similarities 
between it and the other members of the ―diphtheria‖ group of organisms will increase, 
allowing us to gain further insight into the evolution of these organisms from their common 
host, and begin to unravel the factors which contribute to host-specificity.  This type of 
approach will be particularly interesting with respect to C. pseudotuberculosis, since of all the 
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diphtheria group it appears to be the only species which has undergone further evolutionary 
changes that have resulted in the emergence of distinct C. pseudotuberculosis biotypes, which 
are specific for either ovine/caprine or equine hosts.  Undoubtedly the C. pseudotuberculosis 
genome project, ongoing in this laboratory, will expand our understanding of this divergence; 
however, without tools with which to study novel determinants, the availability of genome 
sequence(s) is of limited benefit. 
 
Significantly, the allele-replacement system altered and optimised during the course of this 
study was one previously reported for use in C. glutamicum.  Based upon the applicability of 
the system within both C. glutamicum and C. pseudotuberculosis, it is extremely likely that 
the same system is equally as applicable to use in other corynebacterial species, including C. 
diphtheriae.  Currently, in this latter species, the most frequently used system of mutagenesis 
is by the plasmid pK19mobsacB (Schafer, Kalinowski, & Puhler, 1994). This system works by 
RP4-mediated conjugation (rather than transformation of electrocompetent cells) and a 
modified sacB gene to aid the isolation of organisms which have undergone secondary 
recombination. However, pK19mobsacB is a non-replicative vector and, as discussed in detail 
in chapter 4, non-replicative vectors are less efficient than replicative vectors such as pCARV.  
Furthermore, corynebacterial plasmids are frequently able to replicate in mycobacterial hosts 
(e.g. pEP2, based upon the pNG2 plasmid (Messerotti, et al. 1990)), and it is therefore entirely 
possible that the pCARV mutagenesis vector is equally applicable to the genetic manipulation 
of this related actinomycete genus. 
 
While the mutagenesis vector utilised in this study derived from a plasmid previously used in 
C. glutamicum, it is important to note that it was changed significantly during the course of the 
work described here.  In the first instance, the deletion of ORFs 1 and 2 served to reduce the 
overall size of the plasmid, thus increasing the ease by which the plasmid could be introduced 
into host cells by electroporation, but also decreasing the metabolic burden to the host cell.  In 
addition, the replacement of the kanamycin resistance marker with an erythromycin resistance 
marker facilitated the application of a novel approach to the selection of secondary cross-over 
mutants through the ability to inhibit the growth of the ―desired‖ cells through the action of the 
bacteriostatic antibiotic erythromycin prior to killing unwanted cells through the action of 
ampicillin.  The author is not aware of such an approach having been reported previously, and 
it has the significant advantage of enriching secondary cross-over cultures for the desired cells, 
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greatly facilitating downstream screening for the identification of the desired mutant.  This is 
particularly important with respect to allele-replacement by homologous recombination 
between extremely short sequences.  In the current study, the smallest fragment size assessed 
for the ability to drive homologous recombination in the chromosomal region surrounding the 
cp40 gene was 250 bp.  It was thought in advance of this work being conducted that using a 
fragment of this size would render it extremely difficult to isolate cells having undergone 
subsequent homologous recombination events.  However, in reality, although the frequency of 
recombination using this length of fragment was clearly lower than with larger fragments, the 
rate of recombination was still determined to be up to 13 % (although ranging from 0-13 %).  
Therefore, in combination with the novel antibiotic enrichment procedure, there is clearly the 
capacity to undertake targeted homologous recombination experiments using even shorter 
sequence lengths.  This is particularly significant in cases where very little DNA sequence 
information exists for the target region.  While to some extent the existence of a genome 
sequence negates the importance of being able to conduct targeted gene replacement with very 
short sequences, it must be noted that genome sequences do not exist for all 
strains/species/genera which could potentially be mutagenised using this plasmid system. The 
other important point to make is that the mutagenesis plasmid pCARV could be manipulated 
further to allow its use in human-pathogenic organisms where it is unethical to use 
erythromycin antibiotic resistance markers due to the routine clinical use of the antibiotic to 
treat human infections; an important case in point is C. diphtheriae. In such cases the novel 
enrichment procedure could still be used if the erythromycin antibiotic resistance marker was 
replaced with another bacteriostatic antibiotic; however, it would seem that the improvement 
in recombination resulting from the build up of single-stranded intermediates associated with 
the replication of pCARV, might be sufficient in many cases to allow efficient mutagenesis 
without the need to employ the enrichment process.  
 
During this project the newly developed allele mutagenesis procedure was applied to C. 
pseudotuberculosis in order to create a mutant strain, deficient in the production of serine 
protease (Cp40). The key reason for using this gene to trial the novel mutagenesis protocol 
was due to the accessibility of the published gene sequence prior to the availability of the 
partial C. pseudotuberculosis genome sequence; however, of added interest was the fact that 
Cp40 had also previously been shown to exhibit immunogenic properties (Wilson, et al., 
1995). Interestingly, an M. tuberculosis serine protease was implicated in the intracellular 
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survival of the pathogen within macrophages (Vandal, et al. 2008). M. tuberculosis survives 
within macrophages by preventing fusion of phagosomes with lysosomes; however, it also 
persists within acidic phagolysosomes. Using ratiometric fluorescence measurements, Vandal 
et al. (2008) demonstrated that M. tuberculosis is acid resistant and is able to control its 
intrabacterial pH in acid in vitro as well as in both activated and non-activated macrophages 
(Vandal, et al. 2008). The researchers also demonstrated that a mutant strain disrupted in ORF 
Rv3671c (encoding a predicted serine protease) was unable to control its intrabacterial pH and 
survive within activated macrophages; furthermore, the Rv3671c mutant derivative was 
severely attenuated in mice (Vandal, et al. 2008). With this in mind, it is tempting to speculate 
a similar role may exist for the Cp40 serine protease.  Subsequently, it would be of great 
interest to characterise the properties of the Δcp40 strain further.  In particular, exposing the 
mutant strain to varying concentrations of acid, and comparing its growth to that of  the wild-
type strain grown under the same conditions could be achieved easily; thereby making it 
possible to observe what effect the deletion of the cp40 gene has with regards to the acid 
tolerance of C. pseudotuberculosis.  These initial experiments could be followed up by 
comparing the intracellular survival of the mutant against that of wild-type C. 
pseudotuberculosis, which could be achieved using flow cytometry or gentamycin killing 
assays in the first instance. Further experiments, as the tools become available, could include 
microarray analysis of gene expression in macrophages; these experiments would allow the 
comparative gene expression between mutant and wild-type. This work highlights the use of 
an ‗informed selection‘ exercise whereby genes that are involved in virulence in closely 
related organisms (such as the well studied pathogens C. diphtheriae and M. tuberculosis) can 
be assessed for a similar role in C. pseudotuberculosis.  
 
It is significant that, through the course of the work described here, greater similarities have 
been shown to exist between C. pseudotuberculosis and C. diphtheriae than might have been 
thought.  Until a full comparative analysis of the ongoing C. pseudotuberculosis genome has 
been conducted, it is not possible to speculate as to the extent of these similarities; however, at 
least with respect to the conservation of and expression of genes within the dtxR chromosomal 
locus, and the action of C. pseudotuberculosis DtxR as a regulator of target gene expression 
under low-iron growth conditions, the similarities between the two species are striking.  Since 
DtxR in C. diphtheriae is associated with the regulation of genes associated with iron storage 
and homeostasis, it seems highly likely that the same will also be true of C. 
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pseudotuberculosis.  However, it seems that at least some virulence genes which have evolved 
to be expressed under the control of DtxR, are likely to vary between the two species, since 
these factors are likely to have been subjected to the greatest environmental pressure to 
change, being intimately associated with the bacterium and its association with its chosen host. 
Significantly however, on infection with a tox positive bacteriophage, both C. 
pseudotuberculosis and C. ulcerans are capable of producing the potent diphtheria toxin in an 
iron-dependent manner, and, as such in the UK, isolation of any toxigenic Corynebacterium, 
including C. pseudotuberculosis and C. ulcerans, requires notification of local and national 
communicable disease control agencies (Efstratiou & George, 1999). The presence of these 
toxigenic strains of corynebacteria, other than C. diphtheriae, highlight the importance of 
employing a comparative approach to determine DtxR-regulated genes of C. 
pseudotuberculosis, since there may be other important DtxR-regulated genes which are 
involved in virulence of C. pseudotuberculosis and/or C. ulcerans that have, as yet, not been 
identified.  
 
During the early stages of this work, a chemically defined medium was developed. At the time 
the medium was developed, several factors were kept in mind. Firstly, it was necessary to 
create a medium which was relatively simple to make; furthermore, the medium was required 
to be easily manipulated in order to study different parameters of growth; for example, the 
effect of different metal ions, the concentration of amino acids and the effect of different 
carbon sources. The resulting medium, so-called CCDM, was designed in such a way that 
these parameters, and indeed other such parameters, could be easily studied. The CCDM was 
proven to be useful in determining the effect of environmental iron concentrations on growth 
of C. pseudotuberculosis and preliminary experiments demonstrated that the CCDM was 
capable of supporting C. diphtheriae growth, however these experiments highlighted the 
requirement for optimisation of the CCDM when growth of organisms other than C. 
pseudotuberculosis was required since the medium has been developed specifically with C. 
pseudotuberculosis in mind.  
 
During the initial stages of this investigation the ability of C. pseudotuberculosis to utilise iron 
from various sources was determined (Chapter 3). Interestingly, C. pseudotuberculosis was 
able to utilise iron from host iron binding proteins transferrin and lactoferrin. Previously, 
Schmitt et al. (1997) had suggested that in order for C. diphtheriae to utilise iron from 
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transferrin, it was necessary for there to be a functional siderophore uptake system (Schmitt, 
1997b). Taking into account the many similarities observed between the two species with 
regards to iron mechanisms it appeared likely that the same be true for C. pseudotuberculosis.  
Prior to this study however, there had been no previously documented evidence of a C. 
pseudotuberculosis siderophore. Continuing with the comparative theme, and making use of 
the partial C. pseudotuberculosis genome that became available during the later stages of this 
project, BLAST analysis identified a locus which shared significant homology  to the Ciu 
locus of C. diphtheriae, which encodes siderophore biosynthesis and transport genes. Using 
this information, a more thorough examination of the iron-dependent expression of ORF02949 
(a putative siderophore biosynthesis gene) was carried out. In addition, functional assays were 
employed to prove the existence of a siderophore in C. pseudotuberculosis. Functional assays 
identified a C. pseudotuberculosis siderophore, however, until such a time that an isogenic 
mutant of ORF02949 is created it is not possible to confirm or refute whether the ORF02949 
gene is responsible for the expression of C. pseudotuberculosis siderophore. Further work 
could include testing the mutant strain for its ability to produce siderophore and obtain iron 
from transferrin. Also since there is no information regarding the C. pseudotuberculosis 
siderophore it would be interesting to elucidate the structure of the siderophore and to compare 
it to that of C. diphtheriae siderophore as and when this information becomes available.  In 
order to identify genes encoding the siderophore transport machinery, it would be interesting 
to screen a transposon library using the CAS assay.  
 
The work from this project has added significantly to the available information regarding the 
mechanisms by which iron-dependent genes of C. pseudotuberculosis are regulated. 
Furthermore, the identification of the DtxR-dependent regulation of fagA, together with 
previous research by Billington et al. (2002), has demonstrated that DtxR plays a role in the 
regulation of virulence genes in C. pseudotuberculosis. Further work is required to determine 
whether any other DtxR regulated genes are involved in virulence. Since the genome has 
become available, using bioinformatics, it is now possible to identify DtxR binding loci. 
Importantly, genes that are DtxR-regulated could be involved in pathogenesis. Using the 
newly developed allele replacement mutagenesis system, it would be interesting to construct 
mutations in these genes and perform in vitro and in vivo assays in order to determine their 
involvement in pathogenesis of C. pseudotuberculosis. In addition, it would be interesting to 
revisit the application of proteomic approaches in an attempt to identify exported proteins 
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from C. pseudotuberculosis grown under high- and low-iron conditions; particularly, with the 
intention of complementing previous work which identified DtxR-regulated genes. By 
comparing the exported proteins profiles under high- and low-iron resulting from the Cp-
ΔdtxR strain, wild-type and complemented Cp-ΔdtxR it would be possible to identify those 
proteins that are regulated by iron, via DtxR in C. pseudotuberculosis. To complement this 
work it may also be valuable to perform a further Western blot with CLA positive sera in an 
attempt to identify the antigenic proteins regulated by DtxR/iron.  Once these proteins are 
identified, it would be possible to create recombinant proteins, and subsequently assess the 
vaccine potential of the recombinant proteins in more detail using, for example, in vivo and in 
vitro virulence studies. Such experiments could be carried out in a mouse model of infection 
or preferably using the well-established sheep infection model that has been created at 
Moredun Research Institute.   
 
In conclusion, this project has added significantly to the understanding of C. 
pseudotuberculosis and possible mechanisms by which it causes disease.  Furthermore, the 
conducted work has provided important tools for the growth/manipulation of the organism 
which previously did not exist.  Using these newly available tools, it has been possible to 
demonstrate the existence of a functional DtxR protein, which has not only been shown to be a 
functional homologue of the C. diphtheriae DtxR, but has also been shown to be involved in 
the regulation of several C. pseudotuberculosis genes, at least one of which (fag) has currently 
been shown to be associated with virulence. In addition, the first evidence of a C. 
pseudotuberculosis siderophore has been presented. A putative siderophore biosynthesis gene 
has been identified and shown to be regulated by iron, via DtxR. The ‗user friendly‘ 
chemically defined medium described here has allowed the investigation of iron-dependent 
gene and protein expression. This tool will allow subsequent studies into the DtxR-regulation 
of, and more generally, iron or metal ion regulated genes. In addition, the newly developed 
effective allele replacement mutagenesis system for C. pseudotuberculosis, along with the 
genome sequence, will promote the construction of C. pseudotuberculosis isogenic mutants 
that will ultimately provide evidence for the mechanisms of pathogenesis of C. 
pseudotuberculosis. Armed with the understanding that these tools will facilitate, the 
development of novel control strategies against this organism could eventually see effective 
control of, and perhaps even eradication of, CLA from the UK. 
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Appendix One: Common Buffers and reagents  
 
Reagent  Recipe 
Buffer P1 
 
50 mM  Tris-HCl, 10 mM EDTA (pH 8.0)  
FA gel buffer (10 x) 200 mM 3-[N-morpholino] 
propanesulfonic (MOPS), 50 mM sodium 
acetate and 10 mM EDTA, adjusted to pH 
7 with NaOH 
FA gel running buffer (1 x) 100 ml 10 x FA gel buffer, 20ml of 37 % 
(12.3 M) formaldehyde 880 ml of RNase 
free water 
Luria- Bertani (LB)  Agar 1 % w/v Bacto-tryptone; 0.5 % w/v Bacto 
yeast extract; 1 % w/v NaCl; 1.5 % agar 
Luria- Bertani (LB)  Broth  1 % w/v Bacto-tryptone; 0.5 % w/v Bacto 
yeast extract; 1 % w/v NaCl 
Phosphate buffer pH range 7-9 0.1 M K2HPO4 adjusted to required pH 
with 0.1 M KH2PO4 
Phosphate-buffered saline 
 
0.1 M phosphate buffer pH 7.5 with 0.9% 
w/v NaCl in ddH2O 
RNA loading buffer (5 x) 16 μl saturated aqueous bromophenol blue 
solution, 80 μl 500 mM EDTA, pH 8, 720 
μl 37 % (12.3 M) formaldehyde, 2 ml 100 
% glycerol, 3084 µl formamide, 4 ml 10 x 
FA gel buffer, RNase free water up to 10 
ml 
SDS-PAGE Resolving gel mixture (10 
%) 
 10% w/v N,N‘– methylenebisacrylamide 
375 mM Tris-HCl (pH 8.8), 0.1% SDS, 
0.025% ammonium persulphate (APS), 
0.005% N, N, N‘, - 
tetramethylethyldiamine (TEMED) 
SDS-PAGE Running buffer (10 x)  25 mM Tris, 192mM glycine and 0.1 % 
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SDS in 1 L ddH2O 
SDS-PAGE sample loading buffer (5 x) 0.125 M Tris-HCl pH 6.8; 20% v/v 
glycerol; 0.01% w/v SDS; 0.02% v/v 
bromophenol blue; 0.4 ml β-
mercaptoethanol 
SDS-PAGE Stacking gel buffer  0.5 M Tris-HCl (pH 6.8) 
SDS-PAGE Stacking gel mixture (5 %)   1.15 ml ddH2O, 0.33 ml N,N‘– 
methylenebisacrylamide [30 % (w/v)], 0.5 
ml stacking gel buffer 0.02 ml 10 % SDS, 
0.02 ml 10 % APS 0.002 TEMED 
SOB medium 2% w/v  tryptone, 0.5% w/v yeast extract, 
10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 
10 mM MgSO4 
SOC medium  Identical to SOB except with addition of 20 
mM glucose 
SSC buffer (20 x) 
 
3 M NaCl and 0.3 M sodium citrate (pH 7) 
TAE buffer  
 
 
40 mM Tris-acetate, pH 8.0; 1 mM EDTA 
in ddH2O 
Transformation buffer  
 
14 ml rubidium chloride (2.6 g into 111 ml 
of ddH2O), 1.14 ml 1 M manganese 
chloride, 1.5 ml 1 M Calcium chloride, 1.0 
ml 1 M potassium acetate, 7.5 ml of 50 % 
sucrose.  Filter sterilised 
Tris-buffered saline (10x) pH 7 
 
 
0.5 M Tris-HCl pH 8.8; 1.5 M NaCl 
adjusted to pH 7.0 with HCl in ddH2O 
Tris-glycine buffer (transfer buffer) 25 mM Tris, 192 mM glycine, 20 % 
methanol 
Z buffer 0.06 M Na2HPO4, 0.04 M NaH2PO4, 0.01 
M KCl and 0.001M MgSO4 and 2.7 μl/ml  
Β-mercaptoethanol 
10 × blocking buffer  
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1 × blocking solution 1: 10 dilution of 10 × blocking solution 
with maleic acid buffer 
DIG washing buffer  0.1 M maleic acid, 0.15 M NaCl, 0.3 % 
(v/v) Tween 20 
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Appendix Two: Siderophore assay solutions 
 
Reagent  Recipe 
1 M HCl 4 ml conc. HCl (12 M) diluted in 44 ml 
ddH2O (48 ml total) 
10 mM FeCl3 in 100 mM HCl Dissolve 0.135 g FeCl3.6H2O + 5 ml 1 M 
HCl in 50 ml ddH2O 
2 mM CAS Dissolve 0.061 g CAS dye in 50 ml ddH2O; 
cover conical in foil to protect from light 
10 mM HDTMA Dissolve 0.182 g hexadecyl –trimethyl-
ammonium bromide in 50 ml ddH2O with 
stirring 
Pipes Buffer Dissolve 4.307 g pipes in 75 ml ddH2O, 
add ~ 8 ml 12 M HCL to pH 5.6 
CAS Assay buffer Stir in 6 ml 10 mM HDTMA, 0.15 ml 10 
mM FeCl3 in 100 mM HCl, and 7.5 ml 
CAS into the 75 ml pipers buffer (pH 5.6) 
solution. Add ddH2O to 100 ml. Store at 
RT in plastic bottle covered in foil. 
Solution should not be colloidal, and will 
gradually become dark blue as dye binds to 
iron 
 
 
      M        1           
2  
